data_1afo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1afo _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.546 -0.539 . . . . 1.6399999999999999 109.546 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.3 -47.63 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.896 -1.127 . . . . 1.6599999999999999 108.213 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.71 -47.2 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.64 -0.874 . . . . 2.0699999999999998 108.64 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.94 -47.14 81.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.601 -0.687 . . . . 2.8900000000000001 109.468 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.52 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.02 -47.43 87.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.991 -1.644 . . . . 0.35999999999999999 108.991 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.551 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 60.9 t -57.48 -47.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -1.234 . . . . 1.1000000000000001 108.708 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.433 ' O ' HG12 ' A' ' 85' ' ' ILE . 7.0 mtt -57.54 -46.99 83.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 2.23 109.393 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.6 82.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.414 -0.804 . . . . 1.1000000000000001 109.722 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.42 87.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.744 -1.742 . . . . 0.29999999999999999 108.744 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -47.16 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -1.096 . . . . 1.0900000000000001 109.317 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 81' ' ' MET . 21.6 mm -57.06 -47.15 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 1.9099999999999999 110.038 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.37 88.08 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.297 -1.521 . . . . 0.38 109.297 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.518 HG23 ' CG2' ' B' ' 87' ' ' THR . 91.6 m -57.45 -47.19 82.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -1.145 . . . . 1.1000000000000001 109.065 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 1.21 109.43 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.508 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -47.05 81.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 1.3700000000000001 108.722 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 15.2 tp -57.21 -47.17 81.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 2.54 108.928 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 81.7 mt -57.28 -46.91 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 1.3100000000000001 109.578 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.481 ' O ' HG21 ' A' ' 95' ' ' ILE . 51.0 m -56.93 -47.5 80.46 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.157 -1.017 . . . . 1.3999999999999999 108.873 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -47.72 81.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 3.3799999999999999 109.18 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.35 89.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.593 -1.403 . . . . 1.29 109.593 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 92' ' ' SER . 2.1 tp -57.18 -46.81 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -1.069 . . . . 2.6000000000000001 109.212 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 16.7 mtm180 -56.68 -46.6 81.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.897 . . . . 3.6600000000000001 109.09 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 120.776 -1.203 . . . . 4.1600000000000001 109.201 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.551 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.328 -1.509 . . . . 0.34000000000000002 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 87.7 t -57.1 -47.76 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.295 . . . . 1.1399999999999999 108.681 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 61.3 mtm -57.67 -47.31 82.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 2.4199999999999999 108.654 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' B' ' 85' ' ' ILE . . . -57.2 -46.16 83.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.72 -0.613 . . . . 1.1000000000000001 109.835 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.67 -47.3 86.03 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.302 -1.519 . . . . 0.28999999999999998 109.302 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.18 -47.58 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.3 . . . . 1.1399999999999999 108.993 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' B' ' 82' ' ' ALA . 48.0 mt -57.4 -47.1 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 1.6599999999999999 109.866 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.91 -47.08 89.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.33000000000000002 109.745 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 87' ' ' THR . 25.2 m -57.03 -47.15 81.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.161 -1.199 . . . . 1.0900000000000001 109.115 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.11 -47.02 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 109.169 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.08 -46.8 82.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 1.72 108.963 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 27.1 tp . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 2.6200000000000001 109.538 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.194 -0.669 . . . . 1.6399999999999999 109.194 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.75 -47.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.981 -1.074 . . . . 1.6599999999999999 108.668 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.8 mt -57.5 -47.3 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.243 -0.911 . . . . 2.0699999999999998 108.556 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -57.37 -47.0 82.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.702 -0.624 . . . . 2.8900000000000001 109.462 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.48 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.89 -47.22 88.32 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.685 -1.366 . . . . 0.35999999999999999 109.685 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 62.0 t -57.29 -47.81 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.935 -1.332 . . . . 1.1000000000000001 108.8 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 mtm -57.72 -47.31 82.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 2.23 108.729 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.15 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.662 -0.649 . . . . 1.1000000000000001 109.738 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.6 -47.31 85.41 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.258 -1.537 . . . . 0.29999999999999999 109.258 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.23 -47.55 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.284 . . . . 1.0900000000000001 109.033 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.29 -46.95 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.9099999999999999 109.478 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.7 90.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.329 -1.509 . . . . 0.38 109.329 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.459 HG23 HG23 ' B' ' 87' ' ' THR . 98.0 m -56.77 -47.04 81.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.253 -1.145 . . . . 1.1000000000000001 109.013 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.2 -47.3 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 1.21 108.826 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.24 -46.83 82.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.478 -0.934 . . . . 1.3700000000000001 108.478 179.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.541 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 39.1 tp -57.01 -46.81 82.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 2.54 109.14 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 95' ' ' ILE . 87.7 mt -56.78 -46.99 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.185 -0.947 . . . . 1.3100000000000001 109.326 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -47.6 80.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.021 -1.072 . . . . 1.3999999999999999 108.2 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -57.5 -47.43 81.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.318 -0.863 . . . . 3.3799999999999999 108.953 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.17 89.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.366 -1.494 . . . . 1.29 109.366 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 91' ' ' ILE . 1.4 mt -57.09 -47.32 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -1.127 . . . . 2.6000000000000001 108.63 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -57.31 -47.01 82.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 3.6600000000000001 108.833 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 4.1600000000000001 109.806 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.441 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.065 -1.614 . . . . 0.34000000000000002 109.065 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 89.4 t -57.26 -47.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 1.1399999999999999 108.799 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 14.5 mtp -57.67 -47.35 82.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.291 -0.881 . . . . 2.4199999999999999 108.957 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.46 83.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.533 -0.729 . . . . 1.1000000000000001 109.962 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.37 87.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.319 -1.512 . . . . 0.28999999999999998 109.319 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.29 -47.54 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -1.217 . . . . 1.1399999999999999 109.431 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -57.35 -47.22 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.6599999999999999 109.79 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' B' ' 89' ' ' LEU . . . -57.04 -47.0 90.91 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.653 -1.379 . . . . 0.33000000000000002 109.653 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.459 HG23 HG23 ' A' ' 87' ' ' THR . 93.7 m -56.93 -47.18 81.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -1.172 . . . . 1.0900000000000001 109.521 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.02 -47.24 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 109.207 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.3 OUTLIER -57.28 -46.61 82.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 1.72 109.134 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.538 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 2.8 tm? . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.299 -0.875 . . . . 2.6200000000000001 109.451 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.981 -0.378 . . . . 1.6399999999999999 109.981 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.2 mt -57.27 -48.48 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.744 -1.223 . . . . 1.6599999999999999 108.955 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 4.3 tt -58.41 -47.48 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.135 -0.978 . . . . 2.0699999999999998 108.97 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 2.7 m-85 -57.28 -47.5 81.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.745 . . . . 2.8900000000000001 110.404 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.527 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.26 -47.6 86.56 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.353 -1.499 . . . . 0.35999999999999999 109.353 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.51 HG21 ' CA ' ' B' ' 79' ' ' GLY . 47.5 t -57.59 -47.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -1.168 . . . . 1.1000000000000001 109.139 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -46.86 82.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 2.23 109.065 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.04 81.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.423 -0.798 . . . . 1.1000000000000001 109.08 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.436 ' O ' HG21 ' B' ' 84' ' ' VAL . . . -56.62 -46.97 87.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.249 -1.54 . . . . 0.29999999999999999 109.249 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 80' ' ' VAL . 8.4 t -57.09 -47.39 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.063 -1.257 . . . . 1.0900000000000001 109.062 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -57.2 -46.86 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 1.9099999999999999 109.454 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.71 89.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.5 -1.44 . . . . 0.38 109.5 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' CG2' ' B' ' 87' ' ' THR . 60.4 m -56.69 -47.0 80.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.257 . . . . 1.1000000000000001 108.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 84' ' ' VAL . 49.5 mt -57.01 -46.76 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.115 -0.991 . . . . 1.21 108.705 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.95 -46.51 82.06 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.682 -0.859 . . . . 1.3700000000000001 108.682 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.507 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.7 mt -56.72 -46.6 81.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 2.54 109.053 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 82.0 mt -56.85 -47.04 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 1.3100000000000001 109.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.502 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -56.88 -47.68 79.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.983 -1.087 . . . . 1.3999999999999999 108.483 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -57.57 -47.5 81.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 3.3799999999999999 109.004 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.58 -47.17 90.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.345 -1.102 . . . . 1.29 110.345 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER -57.13 -47.1 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.025 -1.279 . . . . 2.6000000000000001 109.267 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.485 ' N ' ' CG1' ' A' ' 95' ' ' ILE . 9.5 mtp180 -57.14 -47.22 81.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 3.6600000000000001 109.395 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.529 0 O-C-N 120.776 -1.203 . . . . 4.1600000000000001 109.814 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.51 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 108.813 -1.715 . . . . 0.34000000000000002 108.813 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.527 ' CG2' ' CA ' ' A' ' 79' ' ' GLY . 52.0 t -57.68 -47.46 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.267 -1.137 . . . . 1.1399999999999999 108.951 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 8.3 mtp -57.55 -46.93 83.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 2.4199999999999999 109.164 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.27 81.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.796 . . . . 1.1000000000000001 109.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.17 87.93 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.838 -1.705 . . . . 0.28999999999999998 108.838 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 83' ' ' GLY . 87.0 t -57.14 -47.35 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -1.233 . . . . 1.1399999999999999 109.05 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -57.22 -47.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 1.6599999999999999 109.639 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.06 90.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.574 -1.41 . . . . 0.33000000000000002 109.574 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.516 ' CG2' HG23 ' A' ' 87' ' ' THR . 56.3 m -57.07 -47.26 81.42 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.159 -1.201 . . . . 1.0900000000000001 109.431 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 58.7 mt -57.4 -47.53 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 1.1399999999999999 109.098 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.44 -47.04 82.83 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.587 -0.894 . . . . 1.72 108.587 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' B' ' 90' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.524 -0.735 . . . . 2.6200000000000001 109.435 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.526 . . . . 1.6399999999999999 109.581 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.8 mt -56.97 -47.44 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.058 -1.026 . . . . 1.6599999999999999 108.644 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.69 -47.45 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.169 -0.957 . . . . 2.0699999999999998 108.685 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -57.42 -47.31 82.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 2.8900000000000001 109.682 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.469 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.23 -47.13 90.13 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.241 -1.544 . . . . 0.35999999999999999 109.241 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 92.6 t -57.36 -47.81 83.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -1.137 . . . . 1.1000000000000001 109.962 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -57.8 -47.82 81.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 2.23 108.859 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.37 84.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.626 -0.671 . . . . 1.1000000000000001 109.887 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -47.27 87.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.845 -1.302 . . . . 0.29999999999999999 109.845 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.474 HG12 ' OG1' ' B' ' 87' ' ' THR . 97.3 t -57.16 -47.98 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.323 . . . . 1.0900000000000001 109.199 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mt -57.67 -47.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.012 . . . . 1.9099999999999999 109.629 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.25 89.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.099 -1.2 . . . . 0.38 110.099 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.4 m -57.11 -47.28 81.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -1.141 . . . . 1.1000000000000001 109.839 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 88' ' ' ILE . 14.9 mt -57.43 -47.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 1.21 109.808 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.63 -47.86 81.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 1.3700000000000001 109.209 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tt -57.71 -47.5 82.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -0.955 . . . . 2.54 109.298 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.481 ' O ' HD11 ' A' ' 95' ' ' ILE . 76.2 mt -57.33 -47.04 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.551 -0.718 . . . . 1.3100000000000001 109.948 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -47.7 79.82 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.974 -1.079 . . . . 1.3999999999999999 109.176 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.81 -47.97 81.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.008 -1.058 . . . . 3.3799999999999999 109.537 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.67 87.47 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.854 -1.298 . . . . 1.29 109.854 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.481 HD11 ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -57.37 -47.21 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -1.085 . . . . 2.6000000000000001 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -56.99 -47.16 81.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.873 . . . . 3.6600000000000001 109.472 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 4.1600000000000001 110.075 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.414 ' C ' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.009 -1.636 . . . . 0.34000000000000002 109.009 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 94.1 t -57.34 -47.71 84.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.282 -1.128 . . . . 1.1399999999999999 109.714 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 2.9 mtt -57.74 -47.76 81.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 2.4199999999999999 109.001 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.58 83.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.497 -0.752 . . . . 1.1000000000000001 109.656 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -46.97 90.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.599 -1.4 . . . . 0.28999999999999998 109.599 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -56.89 -47.6 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -1.188 . . . . 1.1399999999999999 109.764 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 85' ' ' ILE . 43.6 mm -57.41 -47.91 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.835 -1.165 . . . . 1.6599999999999999 109.418 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.14 90.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.364 -1.494 . . . . 0.33000000000000002 109.364 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.474 ' OG1' HG12 ' A' ' 84' ' ' VAL . 98.5 m -57.1 -47.06 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.999 . . . . 1.0900000000000001 109.695 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.415 HD12 HG22 ' B' ' 88' ' ' ILE . 37.7 mt -57.01 -47.66 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.132 -0.98 . . . . 1.1399999999999999 109.763 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.025 -1.047 . . . . 1.72 108.752 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.507 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 66.1 mt . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 2.6200000000000001 109.429 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.708 -0.479 . . . . 1.6399999999999999 109.708 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.0 mt -56.92 -48.01 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.85 -1.157 . . . . 1.6599999999999999 108.72 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.3 mm -58.02 -47.61 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 2.0699999999999998 108.693 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.44 -47.25 82.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.753 -0.592 . . . . 2.8900000000000001 110.278 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.527 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.87 -47.66 84.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.35999999999999999 109.659 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.491 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 92.3 t -57.67 -47.49 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.904 -1.351 . . . . 1.1000000000000001 108.628 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.84 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 2.23 109.037 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.08 81.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.559 -0.713 . . . . 1.1000000000000001 109.453 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' C ' HG21 ' B' ' 84' ' ' VAL . . . -56.54 -47.22 85.67 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.077 -1.609 . . . . 0.29999999999999999 109.077 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 HG21 ' C ' ' B' ' 83' ' ' GLY . 41.7 t -56.93 -47.32 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.973 -1.31 . . . . 1.0900000000000001 108.907 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 mt -57.21 -46.69 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 1.9099999999999999 109.813 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.7 -46.9 88.66 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.52 -1.432 . . . . 0.38 109.52 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.7 m -57.08 -47.13 81.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.985 -1.303 . . . . 1.1000000000000001 108.528 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.3 -46.85 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.21 109.226 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -56.81 -46.52 81.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 1.3700000000000001 109.371 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 3.7 mm? -56.66 -47.05 80.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 2.54 108.926 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.486 ' O ' HD11 ' A' ' 95' ' ' ILE . 27.1 mt -56.96 -46.91 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 1.3100000000000001 109.302 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -47.28 80.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 1.3999999999999999 108.466 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -47.57 81.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 3.3799999999999999 108.976 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.55 -47.24 89.68 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.263 -1.535 . . . . 1.29 109.263 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 91' ' ' ILE . 1.6 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -1.1 . . . . 2.6000000000000001 109.258 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -57.02 -47.29 81.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 3.6600000000000001 109.394 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.016 -1.052 . . . . 4.1600000000000001 109.676 179.817 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.491 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.129 -1.588 . . . . 0.34000000000000002 109.129 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.527 ' CG2' ' CA ' ' A' ' 79' ' ' GLY . 94.4 t -57.44 -47.42 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -1.193 . . . . 1.1399999999999999 108.585 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' MET . . . . . 0.465 ' O ' HD13 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -57.45 -46.75 83.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.535 -0.913 . . . . 2.4199999999999999 108.535 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.82 82.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.208 -0.664 . . . . 1.1000000000000001 109.208 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.425 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -56.54 -47.09 86.59 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.662 -1.775 . . . . 0.28999999999999998 108.662 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.438 HG21 ' C ' ' A' ' 83' ' ' GLY . 87.0 t -57.0 -47.37 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -1.233 . . . . 1.1399999999999999 108.592 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.482 ' O ' HD22 ' B' ' 89' ' ' LEU . 3.9 mt -57.17 -46.74 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.409 -0.807 . . . . 1.6599999999999999 109.736 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.39 -46.72 86.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.069 -1.612 . . . . 0.33000000000000002 109.069 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 25.0 m -56.68 -46.75 80.97 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -1.139 . . . . 1.0900000000000001 109.051 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.483 HD11 HG23 ' B' ' 88' ' ' ILE . 31.6 mt -57.14 -47.3 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 1.1399999999999999 109.951 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.31 -46.64 82.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.91 -1.119 . . . . 1.72 108.307 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 27.6 tp . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 2.6200000000000001 109.013 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.412 -0.588 . . . . 1.6399999999999999 109.412 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.2 mt -57.04 -47.39 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.167 -1.013 . . . . 1.6599999999999999 108.519 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.58 -47.54 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.482 -0.933 . . . . 2.0699999999999998 108.482 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 2.8900000000000001 109.583 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.44 ' HA3' ' CG2' ' B' ' 80' ' ' VAL . . . -57.19 -47.31 88.67 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.641 -1.384 . . . . 0.35999999999999999 109.641 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 57.4 t -57.42 -47.65 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.124 -1.221 . . . . 1.1000000000000001 108.89 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -47.37 82.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.413 -0.805 . . . . 2.23 109.112 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.64 83.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.718 . . . . 1.1000000000000001 110.121 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.3 -47.37 88.35 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.251 -1.539 . . . . 0.29999999999999999 109.251 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.26 -47.32 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 1.0900000000000001 109.609 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.3 -47.39 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 1.9099999999999999 110.004 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.35 -47.31 88.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.232 -1.547 . . . . 0.38 109.232 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.523 HG23 ' CG2' ' B' ' 87' ' ' THR . 25.0 m -57.3 -47.01 82.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -1.039 . . . . 1.1000000000000001 109.44 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.96 -47.25 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 1.21 109.596 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -57.11 -46.73 82.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.005 . . . . 1.3700000000000001 108.745 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 9.5 tt -57.29 -47.02 82.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 2.54 109.277 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.464 ' O ' HD11 ' A' ' 95' ' ' ILE . 66.4 mt -57.02 -47.12 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 1.3100000000000001 109.805 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -57.01 -47.66 80.33 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.909 -1.119 . . . . 1.3999999999999999 108.3 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.59 -47.56 81.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.854 . . . . 3.3799999999999999 109.298 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.35 88.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 1.29 109.5 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 91' ' ' ILE . 1.3 mt -57.04 -47.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -1.071 . . . . 2.6000000000000001 109.096 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.01 -47.2 81.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 3.6600000000000001 109.459 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? . . . . . 0 C--N 1.3 -1.572 0 O-C-N 120.764 -1.21 . . . . 4.1600000000000001 109.745 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.528 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.921 -1.272 . . . . 0.34000000000000002 109.921 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 40.4 t -57.5 -47.98 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.338 . . . . 1.1399999999999999 108.898 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' MET . . . . . 0.424 ' O ' HG12 ' B' ' 85' ' ' ILE . 1.4 mtt -57.77 -47.3 82.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.829 . . . . 2.4199999999999999 109.139 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.44 82.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.703 -0.623 . . . . 1.1000000000000001 110.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.5 86.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.072 -1.611 . . . . 0.28999999999999998 109.072 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.45 -47.38 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -1.19 . . . . 1.1399999999999999 109.375 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.481 HG21 HD11 ' B' ' 85' ' ' ILE . 45.5 mm -57.3 -47.23 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 1.6599999999999999 109.989 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.98 -47.06 90.22 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.396 -1.482 . . . . 0.33000000000000002 109.396 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.523 ' CG2' HG23 ' A' ' 87' ' ' THR . 50.9 m -57.03 -47.0 81.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.168 -1.196 . . . . 1.0900000000000001 109.174 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.92 -47.17 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 1.1399999999999999 109.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -46.98 82.35 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.247 -0.908 . . . . 1.72 108.651 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.454 HD11 ' N ' ' B' ' 90' ' ' LEU . 6.9 mp . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 2.6200000000000001 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 ' C ' HD21 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.204 -0.295 . . . . 1.6399999999999999 110.204 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.0 mt -57.45 -48.1 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 1.6599999999999999 109.69 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.529 HG13 ' N ' ' A' ' 78' ' ' PHE . 23.1 pt -57.95 -47.14 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.84 -1.162 . . . . 2.0699999999999998 108.423 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.529 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -57.17 -46.92 82.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.652 . . . . 2.8900000000000001 109.571 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.532 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.86 -47.4 86.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.651 -1.38 . . . . 0.35999999999999999 109.651 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 95.2 t -57.31 -47.63 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.951 -1.323 . . . . 1.1000000000000001 108.738 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 mmt -57.72 -47.08 83.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 2.23 108.793 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.28 82.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.666 -0.646 . . . . 1.1000000000000001 109.82 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.45 86.42 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.182 -1.567 . . . . 0.29999999999999999 109.182 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -57.27 -47.75 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.997 -1.296 . . . . 1.0900000000000001 108.969 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.9 mt -57.5 -46.97 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 1.9099999999999999 109.859 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.04 89.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.758 -1.337 . . . . 0.38 109.758 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.525 ' CG2' HG23 ' B' ' 87' ' ' THR . 95.7 m -56.86 -47.21 80.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.021 -1.282 . . . . 1.1000000000000001 108.753 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 88' ' ' ILE . 47.9 mt -57.24 -47.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 1.21 108.565 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.508 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.1 -46.73 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.487 -0.931 . . . . 1.3700000000000001 108.487 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.78 -46.84 81.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.478 -0.764 . . . . 2.54 109.124 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.87 -46.84 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 1.3100000000000001 109.031 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.7 m -56.95 -47.58 80.35 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.007 -1.058 . . . . 1.3999999999999999 108.371 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.57 -47.72 81.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 3.3799999999999999 109.05 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.08 90.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.362 -1.495 . . . . 1.29 109.362 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mm -57.06 -47.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.413 -1.051 . . . . 2.6000000000000001 109.01 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 92' ' ' SER . 6.8 mtp180 -57.14 -47.19 81.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 3.6600000000000001 109.438 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 4.1600000000000001 109.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.494 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.123 -1.591 . . . . 0.34000000000000002 109.123 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.532 ' CG2' ' CA ' ' A' ' 79' ' ' GLY . 97.7 t -57.37 -47.37 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -1.128 . . . . 1.1399999999999999 108.79 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -46.95 83.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 2.4199999999999999 109.41 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.94 -46.4 82.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.444 -0.785 . . . . 1.1000000000000001 109.65 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.0 90.41 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.783 -1.727 . . . . 0.28999999999999998 108.783 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.05 -47.21 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.11 . . . . 1.1399999999999999 109.42 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.99 -47.32 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.051 -1.031 . . . . 1.6599999999999999 109.779 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.19 89.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.378 -1.489 . . . . 0.33000000000000002 109.378 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.525 HG23 ' CG2' ' A' ' 87' ' ' THR . 31.5 m -57.1 -46.93 82.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.091 . . . . 1.0900000000000001 109.361 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.497 HG22 HD11 ' B' ' 88' ' ' ILE . 38.3 mt -56.92 -46.86 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 1.1399999999999999 109.148 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -56.97 -46.98 81.8 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.029 -1.1 . . . . 1.72 108.029 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.478 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 10.9 tp . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.351 -0.843 . . . . 2.6200000000000001 109.118 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.64 -0.504 . . . . 1.6399999999999999 109.64 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -56.93 -47.85 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 1.6599999999999999 108.975 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 77' ' ' ILE . 16.5 mm -57.79 -47.46 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 2.0699999999999998 108.708 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.55 -47.39 82.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 2.8900000000000001 110.119 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.25 -47.58 86.66 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.467 -1.453 . . . . 0.35999999999999999 109.467 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 87.7 t -57.65 -47.63 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.249 -1.148 . . . . 1.1000000000000001 109.095 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -47.29 82.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 2.23 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.47 82.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 1.1000000000000001 109.766 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.35 88.08 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.529 -1.428 . . . . 0.29999999999999999 109.529 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.35 -47.58 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -1.228 . . . . 1.0900000000000001 109.49 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.0 mm -57.37 -47.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.934 . . . . 1.9099999999999999 109.829 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.99 90.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.884 -1.287 . . . . 0.38 109.884 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' HG13 ' A' ' 91' ' ' ILE . 82.1 m -56.99 -47.16 81.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 1.1000000000000001 109.503 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' A' ' 91' ' ' ILE . 56.2 mt -57.33 -47.28 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 1.21 109.321 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.29 -46.95 82.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 1.3700000000000001 109.208 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 38.5 tp -56.97 -47.01 81.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 2.54 109.466 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 60.7 mt -56.92 -47.02 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 1.3100000000000001 109.493 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -56.96 -47.56 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.033 -1.067 . . . . 1.3999999999999999 108.804 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -47.51 81.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.948 -1.095 . . . . 3.3799999999999999 109.325 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.51 87.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.406 -1.078 . . . . 1.29 110.406 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 92' ' ' SER . 0.8 OUTLIER -57.28 -46.99 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.028 -1.278 . . . . 2.6000000000000001 109.013 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' N ' ' CG1' ' A' ' 95' ' ' ILE . 14.7 mtm180 -57.01 -46.86 82.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 3.6600000000000001 109.206 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? . . . . . 0 C--N 1.299 -1.622 0 O-C-N 120.998 -1.064 . . . . 4.1600000000000001 109.716 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.439 ' C ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.669 -1.373 . . . . 0.34000000000000002 109.669 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 97.5 t -57.62 -47.85 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.089 -1.242 . . . . 1.1399999999999999 109.076 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 29.0 mtt -57.81 -47.43 82.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 2.4199999999999999 109.103 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.34 83.1 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.719 -0.613 . . . . 1.1000000000000001 109.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.55 85.78 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.393 -1.483 . . . . 0.28999999999999998 109.393 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.38 -47.86 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.971 -1.311 . . . . 1.1399999999999999 109.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.46 -47.2 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 1.6599999999999999 109.718 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -57.07 -46.95 90.98 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.869 -1.292 . . . . 0.33000000000000002 109.869 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.435 HG23 HG23 ' A' ' 87' ' ' THR . 41.6 m -56.97 -47.43 80.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -1.214 . . . . 1.0900000000000001 109.351 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.31 -47.47 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 1.1399999999999999 108.938 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.4 -46.98 82.9 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 1.72 109.12 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.54 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 91.2 mt . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 2.6200000000000001 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.564 HD22 ' CD2' ' A' ' 78' ' ' PHE . 3.2 tt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.801 -0.444 . . . . 1.6399999999999999 109.801 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.88 -1.138 . . . . 1.6599999999999999 109.111 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.2 -47.82 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 2.0699999999999998 109.122 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.564 ' CD2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -57.62 -47.05 83.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.678 -0.639 . . . . 2.8900000000000001 109.35 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' HG21 ' B' ' 80' ' ' VAL . . . -56.82 -47.17 88.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.362 -1.495 . . . . 0.35999999999999999 109.362 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 61.2 t -57.16 -47.84 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.041 -1.27 . . . . 1.1000000000000001 108.774 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.9 mtm -57.73 -47.21 83.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 2.23 108.93 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.42 82.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 1.1000000000000001 109.825 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.92 -47.26 88.18 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.204 -1.558 . . . . 0.29999999999999999 109.204 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.3 -47.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.243 . . . . 1.0900000000000001 109.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.54 -47.16 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 1.9099999999999999 109.858 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.07 89.42 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.714 -1.354 . . . . 0.38 109.714 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -56.99 -47.12 81.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.167 -1.196 . . . . 1.1000000000000001 109.157 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.11 -47.15 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 1.21 109.133 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.15 -46.9 82.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.214 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.542 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.6 mt -57.02 -47.11 81.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 2.54 109.455 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 95' ' ' ILE . 18.7 mt -57.2 -46.99 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 1.3100000000000001 109.305 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.519 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 67.5 m -57.05 -47.41 81.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.027 -1.069 . . . . 1.3999999999999999 108.231 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.24 -46.77 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.539 -0.725 . . . . 3.3799999999999999 109.12 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.6 -46.25 88.91 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.496 -1.842 . . . . 1.29 108.496 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 91' ' ' ILE . 1.9 mt -56.32 -46.5 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -1.081 . . . . 2.6000000000000001 108.833 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 92' ' ' SER . 10.6 mmt180 -56.66 -47.0 80.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.856 -1.152 . . . . 3.6600000000000001 108.649 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 4.1600000000000001 109.737 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.461 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.698 -1.361 . . . . 0.34000000000000002 109.698 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 95.8 t -57.56 -47.79 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.057 -1.261 . . . . 1.1399999999999999 108.911 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mtm -57.74 -47.25 82.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.413 -0.804 . . . . 2.4199999999999999 109.337 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.54 82.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.495 -0.753 . . . . 1.1000000000000001 109.891 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.45 87.3 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.063 -1.615 . . . . 0.28999999999999998 109.063 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.26 -47.41 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.1399999999999999 109.437 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.4 -47.16 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 1.6599999999999999 110.021 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.35 88.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.816 -1.314 . . . . 0.33000000000000002 109.816 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 33.8 m -57.31 -47.36 81.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.13 -1.218 . . . . 1.0900000000000001 109.226 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.28 -47.2 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 1.1399999999999999 109.643 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.19 -47.12 82.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 1.72 109.178 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 70.3 mt . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.965 . . . . 2.6200000000000001 109.512 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.681 -0.488 . . . . 1.6399999999999999 109.681 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.43 -48.13 83.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.833 -1.167 . . . . 1.6599999999999999 109.039 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 9.3 tt -58.06 -47.29 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.202 -0.936 . . . . 2.0699999999999998 108.717 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.5 m-85 -57.39 -47.01 82.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.495 -0.753 . . . . 2.8900000000000001 109.726 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.444 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.9 -47.29 87.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.504 -1.438 . . . . 0.35999999999999999 109.504 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 92.2 t -57.41 -47.58 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.296 . . . . 1.1000000000000001 108.703 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.459 ' O ' HG12 ' A' ' 85' ' ' ILE . 2.3 mmm -57.75 -47.07 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.85 . . . . 2.23 108.991 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.24 82.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 1.1000000000000001 109.759 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.76 -47.3 86.66 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.04 -1.624 . . . . 0.29999999999999999 109.04 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' B' ' 87' ' ' THR . 86.4 t -57.3 -47.63 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.1 -1.236 . . . . 1.0900000000000001 109.356 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 81' ' ' MET . 26.5 mm -57.43 -47.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 1.9099999999999999 109.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.14 -46.95 91.05 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.789 -1.324 . . . . 0.38 109.789 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.2 m -56.95 -47.42 80.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -1.199 . . . . 1.1000000000000001 109.5 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 88' ' ' ILE . 46.3 mt -57.39 -47.56 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 1.21 109.273 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.65 -47.12 83.14 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.662 -0.866 . . . . 1.3700000000000001 108.662 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.507 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 11.8 mt -57.26 -46.81 82.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 2.54 109.601 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' O ' HD11 ' A' ' 95' ' ' ILE . 42.4 mt -57.02 -47.13 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 1.3100000000000001 109.75 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -57.11 -47.74 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.674 -1.21 . . . . 1.3999999999999999 108.089 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -46.87 82.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.697 . . . . 3.3799999999999999 109.25 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.54 -46.22 88.58 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.943 -1.663 . . . . 1.29 108.943 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.454 HD11 ' HA ' ' A' ' 92' ' ' SER . 1.3 mp -56.26 -46.78 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -1.119 . . . . 2.6000000000000001 108.847 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.515 ' HD3' ' N ' ' A' ' 96' ' ' ARG . 9.4 mmt180 -56.88 -47.16 81.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.888 -1.133 . . . . 3.6600000000000001 108.726 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 4.1600000000000001 109.935 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.463 ' C ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.763 -1.335 . . . . 0.34000000000000002 109.763 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 53.4 t -57.08 -47.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.987 -1.302 . . . . 1.1399999999999999 108.697 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 36.3 mmm -57.74 -47.06 83.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 2.4199999999999999 108.749 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.9 -46.25 82.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.64 -0.662 . . . . 1.1000000000000001 109.777 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.433 ' CA ' HG11 ' A' ' 80' ' ' VAL . . . -56.57 -47.21 85.94 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.148 -1.581 . . . . 0.28999999999999998 109.148 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.13 -47.51 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.021 -1.282 . . . . 1.1399999999999999 109.171 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.26 -46.95 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 1.6599999999999999 109.814 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -46.76 90.28 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.6 -1.4 . . . . 0.33000000000000002 109.6 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 84' ' ' VAL . 63.0 m -56.71 -47.06 80.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.162 -1.199 . . . . 1.0900000000000001 109.309 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.476 HG22 HD11 ' B' ' 88' ' ' ILE . 68.2 mt -56.96 -47.24 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 1.1399999999999999 109.022 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.509 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.17 -46.84 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 1.72 108.998 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.88 . . . . 2.6200000000000001 109.312 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.7 0.286 . . . . 1.6399999999999999 110.259 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.3 mt -57.58 -48.24 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.676 -1.265 . . . . 1.6599999999999999 109.457 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 78' ' ' PHE . 19.8 tt -58.28 -47.58 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 2.0699999999999998 108.975 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.525 ' N ' HG22 ' A' ' 77' ' ' ILE . 8.9 m-30 -57.5 -47.11 82.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 2.8900000000000001 109.812 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.47 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -57.1 -47.28 88.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.7 -1.36 . . . . 0.35999999999999999 109.7 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.501 ' CG2' ' C ' ' B' ' 79' ' ' GLY . 56.4 t -57.37 -47.59 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.046 -1.267 . . . . 1.1000000000000001 109.148 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -57.61 -47.1 83.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 2.23 109.323 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.42 82.54 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.514 -0.741 . . . . 1.1000000000000001 109.892 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.34 87.27 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.371 -1.492 . . . . 0.29999999999999999 109.371 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.1 -47.37 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.121 -1.223 . . . . 1.0900000000000001 109.74 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.32 -46.91 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 1.9099999999999999 110.008 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.05 90.46 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.849 -1.3 . . . . 0.38 109.849 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.514 ' CG2' ' CG2' ' B' ' 87' ' ' THR . 17.0 m -57.24 -47.3 81.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -1.214 . . . . 1.1000000000000001 109.348 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.22 -47.08 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 1.21 109.208 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.0 -46.8 82.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 1.3700000000000001 109.108 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.53 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 32.3 mt -57.01 -47.06 81.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 2.54 109.672 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.485 ' CG2' HD13 ' A' ' 95' ' ' ILE . 95.9 mt -57.16 -47.19 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 1.3100000000000001 109.141 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.09 -47.43 81.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.212 -1.033 . . . . 1.3999999999999999 108.212 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -57.47 -47.55 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 3.3799999999999999 109.253 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.33 -47.25 89.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.266 -1.533 . . . . 1.29 109.266 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.485 HD13 ' CG2' ' A' ' 91' ' ' ILE . 1.3 mp -57.08 -47.03 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.104 . . . . 2.6000000000000001 108.677 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -57.05 -47.04 81.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 3.6600000000000001 109.276 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 4.1600000000000001 109.839 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.501 ' C ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.505 . . . . 0.34000000000000002 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 60.4 t -57.32 -47.64 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 108.663 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.1 mmm -57.74 -47.04 83.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.424 -0.798 . . . . 2.4199999999999999 108.968 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.56 82.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.534 -0.729 . . . . 1.1000000000000001 109.86 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.68 85.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.763 -1.735 . . . . 0.28999999999999998 108.763 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.39 -47.61 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 1.1399999999999999 108.931 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.37 -47.0 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.82 . . . . 1.6599999999999999 110.031 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' B' ' 89' ' ' LEU . . . -56.93 -47.21 88.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.626 -1.39 . . . . 0.33000000000000002 109.626 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.514 ' CG2' ' CG2' ' A' ' 87' ' ' THR . 78.5 m -57.28 -47.26 81.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.276 . . . . 1.0900000000000001 108.588 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.23 -46.96 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.443 -0.786 . . . . 1.1399999999999999 109.216 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.3 OUTLIER -56.93 -46.47 82.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 1.72 109.25 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.543 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 2.6200000000000001 108.893 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.04 -0.355 . . . . 1.6399999999999999 110.04 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.35 -48.35 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.719 -1.238 . . . . 1.6599999999999999 110.116 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -47.65 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.838 -1.164 . . . . 2.0699999999999998 108.487 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.26 -47.08 82.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.804 -0.56 . . . . 2.8900000000000001 109.965 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -56.91 -47.41 86.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.595 -1.402 . . . . 0.35999999999999999 109.595 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.516 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 61.4 t -57.41 -47.66 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.254 . . . . 1.1000000000000001 108.626 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.3 mmt -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.716 -0.846 . . . . 2.23 108.716 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.32 82.52 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.634 -0.666 . . . . 1.1000000000000001 109.839 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.52 85.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.838 -1.705 . . . . 0.29999999999999999 108.838 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG11 ' OG1' ' B' ' 87' ' ' THR . 61.6 t -57.39 -47.49 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.255 . . . . 1.0900000000000001 108.908 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.9 mt -57.2 -47.07 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.414 -0.804 . . . . 1.9099999999999999 109.798 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.65 -46.92 88.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.546 -1.422 . . . . 0.38 109.546 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 m -56.97 -47.26 81.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.078 -1.248 . . . . 1.1000000000000001 108.837 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.4 mt -57.23 -47.16 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.85 . . . . 1.21 109.184 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.2 -46.95 82.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.806 . . . . 1.3700000000000001 109.017 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 18.2 mt -56.92 -46.89 81.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 2.54 109.074 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.462 ' O ' HD11 ' A' ' 95' ' ' ILE . 33.6 mt -56.85 -46.78 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 1.3100000000000001 109.127 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.3 80.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.087 -1.008 . . . . 1.3999999999999999 108.536 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -47.53 81.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 3.3799999999999999 108.897 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.54 -47.15 90.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.172 -1.571 . . . . 1.29 109.172 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 91' ' ' ILE . 1.5 mt -57.02 -46.91 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -1.013 . . . . 2.6000000000000001 109.142 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.477 ' HB2' ' NH2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -56.67 -46.62 81.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 3.6600000000000001 109.079 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 120.94 -1.1 . . . . 4.1600000000000001 109.205 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.516 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.776 -1.33 . . . . 0.34000000000000002 109.776 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 65.8 t -57.37 -47.57 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.002 -1.293 . . . . 1.1399999999999999 109.065 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' MET . . . . . 0.464 ' O ' HG13 ' B' ' 85' ' ' ILE . 4.7 mtm -57.62 -47.21 82.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.309 -0.869 . . . . 2.4199999999999999 108.945 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.39 82.76 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.546 -0.722 . . . . 1.1000000000000001 109.913 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.56 86.15 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.476 -1.45 . . . . 0.28999999999999998 109.476 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.38 -47.56 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.31 . . . . 1.1399999999999999 109.004 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.464 HG13 ' O ' ' B' ' 81' ' ' MET . 63.8 mt -57.33 -46.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 1.6599999999999999 109.759 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.01 90.36 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.836 -1.306 . . . . 0.33000000000000002 109.836 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.418 ' OG1' HG11 ' A' ' 84' ' ' VAL . 40.5 m -57.04 -47.44 80.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.973 -1.31 . . . . 1.0900000000000001 108.918 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 35.1 mt -57.4 -46.98 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 1.1399999999999999 108.803 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -56.95 -46.59 82.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.029 -0.73 . . . . 1.72 109.029 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.541 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.238 -0.914 . . . . 2.6200000000000001 109.145 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.16 -0.682 . . . . 1.6399999999999999 109.16 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.446 HD12 HG22 ' A' ' 76' ' ' ILE . 26.8 mt -56.66 -47.68 81.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.059 -1.025 . . . . 1.6599999999999999 108.899 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.8 mt -57.72 -47.88 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.091 -1.006 . . . . 2.0699999999999998 109.338 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.92 -48.43 79.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 2.8900000000000001 109.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.54 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.91 -47.34 89.56 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.104 -1.598 . . . . 0.35999999999999999 109.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.547 HG11 ' CA ' ' B' ' 83' ' ' GLY . 44.9 t -57.17 -47.26 84.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.708 -0.878 . . . . 1.1000000000000001 109.934 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 mmm -57.16 -47.32 81.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 2.23 109.153 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.41 82.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.374 -0.829 . . . . 1.1000000000000001 109.41 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.487 ' HA3' HG11 ' B' ' 80' ' ' VAL . . . -57.0 -47.1 90.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.936 -1.266 . . . . 0.29999999999999999 109.936 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.15 -47.49 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.251 . . . . 1.0900000000000001 109.619 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -57.29 -47.22 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 1.9099999999999999 109.565 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.13 -46.9 91.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.97 -1.252 . . . . 0.38 109.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.521 HG23 ' CG2' ' B' ' 87' ' ' THR . 74.7 m -56.88 -47.17 81.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -1.182 . . . . 1.1000000000000001 109.209 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.14 -46.94 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 1.21 108.901 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.14 -46.74 82.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 1.3700000000000001 109.066 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 9.5 tt -56.85 -46.88 81.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 2.54 109.494 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.03 -46.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.993 . . . . 1.3100000000000001 108.905 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -47.39 81.2 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.093 -1.005 . . . . 1.3999999999999999 108.399 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -57.3 -47.54 81.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 3.3799999999999999 109.196 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.31 -46.98 91.2 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.036 -1.626 . . . . 1.29 109.036 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mt -57.05 -46.82 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 2.6000000000000001 108.86 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -56.93 -47.07 81.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 3.6600000000000001 109.291 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 4.1600000000000001 109.891 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.542 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.009 -1.636 . . . . 0.34000000000000002 109.009 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.54 HG21 ' CA ' ' A' ' 79' ' ' GLY . 46.2 t -57.43 -47.14 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.644 -0.915 . . . . 1.1399999999999999 109.733 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.5 mmt -56.95 -46.97 81.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 2.4199999999999999 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.36 81.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 1.1000000000000001 109.361 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.547 ' CA ' HG11 ' A' ' 80' ' ' VAL . . . -56.99 -47.16 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.618 -1.393 . . . . 0.28999999999999998 109.618 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.408 ' O ' HG13 ' B' ' 88' ' ' ILE . 5.3 t -57.02 -47.52 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.283 . . . . 1.1399999999999999 109.241 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.27 -47.07 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.6599999999999999 109.669 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.08 89.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.425 -1.47 . . . . 0.33000000000000002 109.425 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 87' ' ' THR . 91.6 m -57.14 -47.07 82.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -1.156 . . . . 1.0900000000000001 108.975 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.476 HG22 HD11 ' B' ' 88' ' ' ILE . 37.1 mt -57.11 -47.03 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 1.1399999999999999 109.14 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -56.81 -46.95 81.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.307 -0.871 . . . . 1.72 109.0 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.517 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 6.7 mt . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 2.6200000000000001 109.06 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.464 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.908 -0.405 . . . . 1.6399999999999999 109.908 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.6 mt -57.11 -47.7 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.909 -1.119 . . . . 1.6599999999999999 108.754 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 1.1 mp -57.66 -47.11 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.327 -0.99 . . . . 2.0699999999999998 108.327 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.24 -47.28 81.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 2.8900000000000001 109.83 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.06 -47.38 87.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.178 -1.569 . . . . 0.35999999999999999 109.178 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 48.4 t -57.59 -47.5 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -1.162 . . . . 1.1000000000000001 109.238 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 85.0 mtp -57.63 -47.35 82.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 2.23 109.303 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.53 82.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 1.1000000000000001 109.876 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.99 -47.42 87.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.529 -1.429 . . . . 0.29999999999999999 109.529 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.28 -47.48 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 1.0900000000000001 109.495 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 HG21 HD11 ' A' ' 85' ' ' ILE . 33.4 mm -57.28 -47.41 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 1.9099999999999999 110.081 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.24 -47.19 89.66 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.38 109.642 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.465 HG23 ' CG2' ' B' ' 87' ' ' THR . 98.1 m -57.16 -47.14 81.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -1.194 . . . . 1.1000000000000001 109.537 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 88' ' ' ILE . 64.4 mt -56.97 -47.23 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 1.21 109.536 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -57.18 -46.55 82.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 109.044 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 8.7 mt -57.13 -47.0 82.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 2.54 109.461 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.86 -47.16 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.3100000000000001 109.453 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.495 ' O ' HG23 ' A' ' 95' ' ' ILE . 1.4 m -57.16 -47.69 80.55 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.922 -1.111 . . . . 1.3999999999999999 108.487 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -47.48 82.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.071 -1.018 . . . . 3.3799999999999999 109.611 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.36 88.77 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.16 -1.176 . . . . 1.29 110.16 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 96' ' ' ARG . 1.5 tp -57.07 -46.95 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -1.227 . . . . 2.6000000000000001 108.983 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 19.2 mtp180 -56.87 -46.82 81.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 3.6600000000000001 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 O-C-N 120.867 -1.146 . . . . 4.1600000000000001 109.365 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.432 ' C ' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.525 -1.43 . . . . 0.34000000000000002 109.525 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 69.7 t -57.1 -47.67 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.24 . . . . 1.1399999999999999 109.189 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' MET . . . . . 0.458 ' O ' HG13 ' B' ' 85' ' ' ILE . 63.6 mtm -57.57 -47.22 82.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 2.4199999999999999 108.95 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.26 82.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.616 -0.678 . . . . 1.1000000000000001 109.672 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.22 86.31 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.28999999999999998 109.34 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.02 -47.47 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 109.191 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 81' ' ' MET . 30.7 mt -57.27 -47.12 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 1.6599999999999999 109.633 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.95 90.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.663 -1.375 . . . . 0.33000000000000002 109.663 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.465 ' CG2' HG23 ' A' ' 87' ' ' THR . 41.4 m -56.93 -47.03 81.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -1.197 . . . . 1.0900000000000001 109.37 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 91.7 mt -57.06 -47.08 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.088 -1.008 . . . . 1.1399999999999999 108.724 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.503 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.04 -46.77 82.15 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.363 -0.977 . . . . 1.72 108.363 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.503 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 94.6 mt . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 2.6200000000000001 109.154 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.277 -0.638 . . . . 1.6399999999999999 109.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mt -57.14 -47.91 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 118.868 -1.133 . . . . 1.6599999999999999 108.579 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -58.12 -47.92 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.474 -0.89 . . . . 2.0699999999999998 109.336 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -57.86 -47.84 81.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.329 -0.857 . . . . 2.8900000000000001 110.029 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.566 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.5 -47.41 88.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.35999999999999999 109.908 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.541 HG21 ' CA ' ' B' ' 79' ' ' GLY . 48.7 t -57.25 -47.3 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -1.128 . . . . 1.1000000000000001 109.037 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.1 mmm -57.41 -47.32 82.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 2.23 108.72 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -57.29 -46.68 82.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -0.797 . . . . 1.1000000000000001 109.749 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' HG12 ' B' ' 80' ' ' VAL . . . -57.22 -47.35 88.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.376 -1.49 . . . . 0.29999999999999999 109.376 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.35 -47.26 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -1.172 . . . . 1.0900000000000001 109.644 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.2 OUTLIER -57.09 -47.17 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 1.9099999999999999 109.599 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.03 -47.16 89.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.28 -1.528 . . . . 0.38 109.28 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.0 m -57.17 -46.96 82.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -1.105 . . . . 1.1000000000000001 109.158 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.05 -47.0 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 1.21 109.11 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.97 -47.02 81.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 1.3700000000000001 108.985 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tp -57.17 -47.24 81.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.187 -0.946 . . . . 2.54 109.285 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.441 HG21 HD13 ' A' ' 95' ' ' ILE . 91.6 mt -57.24 -47.29 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 1.3100000000000001 109.374 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.8 m -57.26 -47.57 81.07 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.073 -1.017 . . . . 1.3999999999999999 108.603 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.51 -47.68 81.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 3.3799999999999999 109.387 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.42 -47.5 87.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.623 . . . . 1.29 109.041 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 91' ' ' ILE . 1.4 mt -57.4 -47.36 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -1.073 . . . . 2.6000000000000001 108.841 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -57.21 -47.06 82.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.865 . . . . 3.6600000000000001 109.55 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 . . . . . 0 C--N 1.299 -1.589 0 O-C-N 120.995 -1.065 . . . . 4.1600000000000001 109.743 -179.794 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.541 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.487 2.041 0 N-CA-C 109.301 -1.519 . . . . 0.34000000000000002 109.301 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.566 HG21 ' CA ' ' A' ' 79' ' ' GLY . 26.0 t -57.2 -47.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.498 -1.001 . . . . 1.1399999999999999 109.704 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 3.4 mtm -57.3 -47.3 81.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 2.4199999999999999 109.576 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.91 82.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 1.1000000000000001 109.72 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.47 -47.31 89.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.646 -1.382 . . . . 0.28999999999999998 109.646 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.24 -47.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.157 . . . . 1.1399999999999999 109.668 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 87.4 mt -57.32 -47.22 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.176 -0.952 . . . . 1.6599999999999999 110.027 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.33 88.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.648 -1.381 . . . . 0.33000000000000002 109.648 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 73.5 m -57.47 -47.29 82.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -1.215 . . . . 1.0900000000000001 109.326 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.8 mt -57.41 -47.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 1.1399999999999999 109.649 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.1 -46.84 82.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.412 -0.805 . . . . 1.72 109.216 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.51 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 2.6200000000000001 109.212 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.392 -0.596 . . . . 1.6399999999999999 109.392 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.3 mt -56.89 -47.57 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.947 -1.095 . . . . 1.6599999999999999 108.696 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -57.78 -47.77 85.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.46 -0.896 . . . . 2.0699999999999998 109.448 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -57.7 -48.08 80.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 2.8900000000000001 109.495 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.66 -47.61 87.24 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.07 -1.612 . . . . 0.35999999999999999 109.07 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.524 HG21 ' CA ' ' B' ' 79' ' ' GLY . 43.3 t -57.43 -47.19 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.567 -0.96 . . . . 1.1000000000000001 109.148 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmm -57.13 -46.9 82.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.37 -0.831 . . . . 2.23 109.074 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.23 81.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.1000000000000001 109.314 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.514 ' CA ' HG11 ' B' ' 80' ' ' VAL . . . -56.76 -46.98 89.06 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.314 -1.514 . . . . 0.29999999999999999 109.314 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.4 t -56.88 -47.22 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.031 -1.276 . . . . 1.0900000000000001 109.202 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.1 -46.93 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.159 -0.963 . . . . 1.9099999999999999 109.354 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.84 91.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.38 109.703 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.8 m -56.78 -47.46 80.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -1.199 . . . . 1.1000000000000001 109.068 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.23 -47.11 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 1.21 108.781 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.19 -46.71 82.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.5 -0.75 . . . . 1.3700000000000001 108.987 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.481 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 16.8 tp -56.66 -47.02 80.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 2.54 109.463 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 95' ' ' ILE . 57.2 mt -57.03 -47.11 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.043 -1.035 . . . . 1.3100000000000001 108.408 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.571 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -57.14 -47.23 81.64 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.348 -0.982 . . . . 1.3999999999999999 108.348 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.92 80.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.956 -1.09 . . . . 3.3799999999999999 109.344 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.09 -48.2 84.43 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.941 -1.123 . . . . 1.29 110.557 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 92' ' ' SER . 2.8 tp -57.71 -47.02 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.064 -1.256 . . . . 2.6000000000000001 109.145 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 92' ' ' SER . 8.1 mtm180 -56.95 -47.05 81.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.858 . . . . 3.6600000000000001 109.429 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.07 -1.019 . . . . 4.1600000000000001 109.481 -179.827 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.524 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.154 -1.578 . . . . 0.34000000000000002 109.154 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.542 HG21 ' CA ' ' A' ' 79' ' ' GLY . 40.9 t -57.37 -47.22 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -1.013 . . . . 1.1399999999999999 109.578 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.8 mmm -56.97 -47.04 81.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 2.4199999999999999 108.946 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.554 -0.716 . . . . 1.1000000000000001 109.298 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.452 ' HA3' HG11 ' A' ' 80' ' ' VAL . . . -56.81 -47.12 88.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.743 -1.343 . . . . 0.28999999999999998 109.743 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.1 -47.46 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.387 . . . . 1.1399999999999999 109.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -57.11 -46.95 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 1.6599999999999999 109.347 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -56.85 -46.87 89.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.811 -1.316 . . . . 0.33000000000000002 109.811 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 31.7 m -56.65 -47.32 80.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.262 . . . . 1.0900000000000001 109.193 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 mt -57.21 -47.14 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.039 -1.038 . . . . 1.1399999999999999 108.944 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.05 -46.83 82.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.511 -0.743 . . . . 1.72 109.306 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 87.6 mt . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.95 . . . . 2.6200000000000001 109.459 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.593 -0.521 . . . . 1.6399999999999999 109.593 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.91 -47.51 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 118.854 -1.139 . . . . 1.6599999999999999 108.262 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.455 HD11 HG23 ' A' ' 77' ' ' ILE . 25.7 mt -57.57 -47.33 85.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.524 -0.917 . . . . 2.0699999999999998 108.524 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.3 -46.98 82.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 2.8900000000000001 109.528 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.47 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.05 -47.42 87.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.885 -1.686 . . . . 0.35999999999999999 108.885 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 88.7 t -57.48 -47.61 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -1.189 . . . . 1.1000000000000001 108.541 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -47.15 83.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.555 -0.716 . . . . 2.23 109.532 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.486 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -57.16 -46.76 82.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 1.1000000000000001 109.98 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.4 88.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.491 -1.843 . . . . 0.29999999999999999 108.491 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 80' ' ' VAL . 58.1 t -57.48 -47.5 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.459 -1.024 . . . . 1.0900000000000001 110.252 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -57.33 -47.53 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 1.9099999999999999 110.153 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.38 -47.6 86.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.599 . . . . 0.38 109.101 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.479 ' CG2' HG23 ' B' ' 87' ' ' THR . 10.6 m -57.58 -46.91 83.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.46 -1.024 . . . . 1.1000000000000001 109.175 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 84' ' ' VAL . 19.3 mt -56.86 -47.07 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.497 -0.752 . . . . 1.21 109.621 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -57.15 -46.78 82.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.3700000000000001 109.015 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 28.3 mt -57.47 -47.31 82.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.007 -1.058 . . . . 2.54 109.27 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.522 ' CG2' HD13 ' A' ' 95' ' ' ILE . 70.1 mt -57.32 -47.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.803 . . . . 1.3100000000000001 109.686 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -47.63 80.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.092 -1.005 . . . . 1.3999999999999999 108.817 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.61 -47.66 81.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 109.391 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.63 -47.57 87.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.435 . . . . 1.29 109.511 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.522 HD13 ' CG2' ' A' ' 91' ' ' ILE . 1.3 mp -57.32 -47.23 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -1.108 . . . . 2.6000000000000001 108.956 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -57.13 -47.19 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 3.6600000000000001 109.565 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 4.1600000000000001 109.912 -179.768 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.526 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.579 -1.408 . . . . 0.34000000000000002 109.579 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 44.5 t -57.19 -47.72 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.895 -1.356 . . . . 1.1399999999999999 108.938 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -47.31 83.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.197 -0.939 . . . . 2.4199999999999999 108.928 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.7 83.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 1.1000000000000001 110.151 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.34 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.359 -1.496 . . . . 0.28999999999999998 109.359 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.24 -47.3 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 1.1399999999999999 109.559 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -57.27 -47.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 1.6599999999999999 110.364 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.21 -47.42 87.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.333 -1.507 . . . . 0.33000000000000002 109.333 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.479 HG23 ' CG2' ' A' ' 87' ' ' THR . 50.7 m -57.34 -46.97 82.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.246 -1.149 . . . . 1.0900000000000001 108.904 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 mt -56.92 -46.77 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.573 -0.704 . . . . 1.1399999999999999 109.792 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.2 OUTLIER -56.72 -46.79 81.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 1.72 109.006 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 2.6200000000000001 108.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.619 ' CD2' ' N ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 110.024 -0.361 . . . . 1.6399999999999999 110.024 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.619 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 44.2 mt -57.66 -48.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.413 -1.429 . . . . 1.6599999999999999 109.265 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.546 HG21 ' N ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -58.27 -46.74 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.147 -1.057 . . . . 2.0699999999999998 108.147 177.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.546 ' N ' HG21 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -56.94 -46.87 81.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.683 -0.636 . . . . 2.8900000000000001 109.898 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -56.89 -47.38 86.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.257 -1.537 . . . . 0.35999999999999999 109.257 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.537 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 39.3 t -57.36 -47.56 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.281 . . . . 1.1000000000000001 108.557 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.64 -46.88 83.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 2.23 109.323 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.42 81.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.58 -0.7 . . . . 1.1000000000000001 109.75 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.29 87.79 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.801 -1.72 . . . . 0.29999999999999999 108.801 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.32 -47.34 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.143 -1.21 . . . . 1.0900000000000001 109.179 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.32 -47.01 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 1.9099999999999999 109.883 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.04 90.04 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.738 -1.345 . . . . 0.38 109.738 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 91' ' ' ILE . 37.2 m -57.09 -47.15 81.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -1.18 . . . . 1.1000000000000001 109.121 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.849 . . . . 1.21 109.538 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.03 -47.02 81.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.38 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.528 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 6.2 mt -56.94 -47.05 81.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 2.54 109.337 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 63.6 mt -57.03 -47.09 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 1.3100000000000001 109.356 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.39 80.84 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.026 -1.046 . . . . 1.3999999999999999 108.576 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -57.41 -47.25 82.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.24 -0.913 . . . . 3.3799999999999999 109.387 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.22 -47.34 88.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.014 -1.634 . . . . 1.29 109.014 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.12 -47.01 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -1.126 . . . . 2.6000000000000001 108.786 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -56.9 -47.07 81.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.828 . . . . 3.6600000000000001 109.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 4.1600000000000001 109.698 179.915 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.537 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.605 -1.398 . . . . 0.34000000000000002 109.605 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 86.0 t -57.74 -47.67 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.286 . . . . 1.1399999999999999 108.928 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 43.5 mtm -57.72 -47.13 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 2.4199999999999999 109.664 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.41 82.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 1.1000000000000001 110.035 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.487 ' CA ' HG11 ' A' ' 80' ' ' VAL . . . -57.01 -47.51 86.76 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.228 -1.549 . . . . 0.28999999999999998 109.228 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.412 ' O ' HG13 ' B' ' 88' ' ' ILE . 48.5 t -57.46 -47.53 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -1.185 . . . . 1.1399999999999999 109.451 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.404 HG22 HD11 ' B' ' 85' ' ' ILE . 30.6 mt -57.33 -47.16 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 1.6599999999999999 110.177 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.31 87.38 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.296 . . . . 0.33000000000000002 109.859 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.429 HG23 ' CG2' ' A' ' 87' ' ' THR . 19.3 m -57.23 -47.27 81.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -1.225 . . . . 1.0900000000000001 109.256 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.412 HG13 ' O ' ' B' ' 84' ' ' VAL . 49.4 mt -57.44 -47.23 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.809 . . . . 1.1399999999999999 109.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.21 -46.99 82.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 1.72 109.534 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 40.4 tp . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.182 -0.949 . . . . 2.6200000000000001 109.509 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.826 -0.805 . . . . 1.6399999999999999 108.826 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.6 mt -56.79 -47.69 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 118.899 -1.121 . . . . 1.6599999999999999 108.155 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mm -57.85 -47.62 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 2.0699999999999998 108.857 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -57.57 -47.89 80.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.341 -0.85 . . . . 2.8900000000000001 109.968 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.562 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.5 -47.45 88.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.389 -1.484 . . . . 0.35999999999999999 109.389 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.543 HG21 ' CA ' ' B' ' 79' ' ' GLY . 41.8 t -57.34 -47.36 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.366 -1.079 . . . . 1.1000000000000001 109.121 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 85' ' ' ILE . 16.9 mtp -57.44 -47.21 82.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 2.23 108.966 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.41 83.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.546 -0.721 . . . . 1.1000000000000001 109.311 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.512 ' N ' HG12 ' B' ' 80' ' ' VAL . . . -57.1 -47.14 89.86 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.325 -1.51 . . . . 0.29999999999999999 109.325 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.17 -47.64 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -1.217 . . . . 1.0900000000000001 109.16 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 81' ' ' MET . 1.9 mt -57.42 -47.15 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 1.9099999999999999 109.373 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -57.12 -47.27 88.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.756 -1.338 . . . . 0.38 109.756 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.6 m -57.21 -47.51 81.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -1.21 . . . . 1.1000000000000001 109.042 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.48 -47.37 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.21 109.329 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.29 -47.0 82.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.456 -0.777 . . . . 1.3700000000000001 109.363 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 86' ' ' GLY . 4.7 mp -57.07 -47.06 81.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 2.54 109.204 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 95' ' ' ILE . 78.8 mt -57.16 -47.13 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 1.3100000000000001 109.629 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -57.1 -47.59 80.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.164 -1.014 . . . . 1.3999999999999999 108.823 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -57.86 -48.1 80.79 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.772 -1.205 . . . . 3.3799999999999999 109.493 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.05 -48.26 83.92 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.064 -1.065 . . . . 1.29 110.668 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -57.63 -46.89 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -1.224 . . . . 2.6000000000000001 109.373 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 mtm180 -57.18 -47.31 81.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 3.6600000000000001 109.592 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 4.1600000000000001 110.212 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.543 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 109.307 -1.517 . . . . 0.34000000000000002 109.307 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.562 HG21 ' CA ' ' A' ' 79' ' ' GLY . 33.2 t -56.93 -47.27 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -1.051 . . . . 1.1399999999999999 109.571 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 56.6 mmm -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.03 -1.044 . . . . 2.4199999999999999 108.722 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.17 82.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.435 -0.79 . . . . 1.1000000000000001 109.076 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.77 -46.76 89.37 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.28999999999999998 109.454 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.45 ' O ' HG13 ' B' ' 88' ' ' ILE . 54.7 t -56.92 -47.25 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.256 . . . . 1.1399999999999999 109.336 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.2 -46.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 1.6599999999999999 109.419 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' B' ' 89' ' ' LEU . . . -57.11 -46.85 91.12 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 0.33000000000000002 109.465 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 14.2 m -56.76 -47.17 80.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -1.155 . . . . 1.0900000000000001 109.004 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 84' ' ' VAL . 51.0 mt -57.08 -46.98 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 1.1399999999999999 109.019 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.2 OUTLIER -56.99 -46.45 82.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.403 -0.811 . . . . 1.72 109.156 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.535 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 23.3 tp . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 2.6200000000000001 108.961 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' O ' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.423 -0.584 . . . . 1.6399999999999999 109.423 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.6 mt -57.42 -48.29 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.798 -1.161 . . . . 1.6599999999999999 109.309 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 3.9 tt -58.17 -47.43 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.914 -1.116 . . . . 2.0699999999999998 108.787 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.543 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.6 m-30 -57.23 -46.79 82.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.524 -0.735 . . . . 2.8900000000000001 109.557 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -56.81 -47.04 89.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.629 -1.389 . . . . 0.35999999999999999 109.629 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 26.3 t -56.91 -47.59 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.979 -1.306 . . . . 1.1000000000000001 108.566 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.424 ' O ' HG13 ' A' ' 85' ' ' ILE . 59.0 mtp -57.51 -46.92 83.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.433 -0.951 . . . . 2.23 108.433 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.88 81.69 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.748 -0.595 . . . . 1.1000000000000001 109.616 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' HG21 ' B' ' 84' ' ' VAL . . . -56.36 -46.99 85.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.08 -1.608 . . . . 0.29999999999999999 109.08 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.98 -47.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.347 . . . . 1.0900000000000001 108.8 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 81' ' ' MET . 64.3 mt -57.16 -46.83 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 1.9099999999999999 109.528 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.67 89.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.38 109.536 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.442 HG23 HG22 ' B' ' 87' ' ' THR . 22.5 m -56.69 -46.95 80.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.225 . . . . 1.1000000000000001 109.001 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.1 -46.9 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.21 109.073 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -46.66 82.07 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.399 -0.813 . . . . 1.3700000000000001 109.012 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.5 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.3 mp -56.69 -47.0 80.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -0.856 . . . . 2.54 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.93 -47.12 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.093 -1.004 . . . . 1.3100000000000001 109.261 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 95' ' ' ILE . 1.7 p -57.16 -47.58 80.84 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.027 -1.069 . . . . 1.3999999999999999 108.441 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -47.45 82.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.17 -0.956 . . . . 3.3799999999999999 109.341 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.31 89.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.905 -1.278 . . . . 1.29 109.905 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -57.25 -47.06 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.235 . . . . 2.6000000000000001 108.939 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 9.1 mtm180 -57.06 -47.04 81.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 3.6600000000000001 109.209 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.248 -0.908 . . . . 4.1600000000000001 109.964 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 108.754 -1.739 . . . . 0.34000000000000002 108.754 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 40.1 t -57.35 -47.5 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.191 -1.182 . . . . 1.1399999999999999 108.698 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.6 -47.0 83.34 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.83 . . . . 2.4199999999999999 109.193 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' B' ' 85' ' ' ILE . . . -56.98 -46.68 82.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 1.1000000000000001 109.815 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.49 87.1 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.605 -1.798 . . . . 0.28999999999999998 108.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 83' ' ' GLY . 43.2 t -57.53 -47.3 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -1.1 . . . . 1.1399999999999999 109.203 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' B' ' 82' ' ' ALA . 38.9 mt -57.25 -47.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 1.6599999999999999 109.904 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.29 88.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.229 -1.548 . . . . 0.33000000000000002 109.229 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.442 HG22 HG23 ' A' ' 87' ' ' THR . 73.8 m -57.34 -47.09 82.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -1.092 . . . . 1.0900000000000001 109.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ILE . . . . . 0.412 HD12 HG22 ' B' ' 88' ' ' ILE . 57.4 mt -57.13 -47.1 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.1399999999999999 109.694 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.536 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.0 -47.33 81.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 1.72 109.168 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . 0.536 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.6200000000000001 108.871 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 62' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.457 -0.572 . . . . 19.079999999999998 109.457 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 30.9 tp60 -104.98 14.14 29.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 16.93 109.55 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.11 -165.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 17.030000000000001 109.533 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.0 31.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 14.640000000000001 109.415 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 67' ' ' HIS . 32.3 m80 -157.06 -179.61 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 14.630000000000001 109.306 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 170.12 -53.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 11.25 109.903 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 69' ' ' SER . 4.6 m-85 -67.47 147.14 53.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 12.35 109.949 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.1 p 51.29 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 7.4199999999999999 109.99 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -122.12 94.32 48.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 6.4900000000000002 109.216 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.519 ' HB2' ' CG2' ' A' ' 74' ' ' THR . 2.5 Cg_endo -60.43 104.91 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.091 1.861 . . . . 3.25 110.479 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -53.07 -39.19 63.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 3.0099999999999998 109.211 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 74' ' ' THR . 5.4 tp -64.02 -45.2 97.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.206 -0.934 . . . . 2.0499999999999998 109.813 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.519 ' CG2' ' HB2' ' A' ' 71' ' ' PRO . 45.4 p -57.0 -46.92 81.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 1.8400000000000001 109.563 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.523 HD12 ' CD1' ' B' ' 76' ' ' ILE . 0.4 OUTLIER -67.12 -47.37 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.033 . . . . 1.6399999999999999 109.546 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.501 HD11 ' CD1' ' B' ' 75' ' ' LEU . 85.8 mt -57.3 -47.63 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.896 -1.127 . . . . 1.6599999999999999 108.213 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.71 -47.2 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.64 -0.874 . . . . 2.0699999999999998 108.64 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.94 -47.14 81.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.601 -0.687 . . . . 2.8900000000000001 109.468 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.52 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.02 -47.43 87.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.991 -1.644 . . . . 0.35999999999999999 108.991 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.551 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 60.9 t -57.48 -47.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -1.234 . . . . 1.1000000000000001 108.708 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.433 ' O ' HG12 ' A' ' 85' ' ' ILE . 7.0 mtt -57.54 -46.99 83.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 2.23 109.393 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.6 82.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.414 -0.804 . . . . 1.1000000000000001 109.722 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.42 87.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.744 -1.742 . . . . 0.29999999999999999 108.744 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -47.16 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -1.096 . . . . 1.0900000000000001 109.317 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 81' ' ' MET . 21.6 mm -57.06 -47.15 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 1.9099999999999999 110.038 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.37 88.08 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.297 -1.521 . . . . 0.38 109.297 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.518 HG23 ' CG2' ' B' ' 87' ' ' THR . 91.6 m -57.45 -47.19 82.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -1.145 . . . . 1.1000000000000001 109.065 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 1.21 109.43 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.508 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -47.05 81.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 1.3700000000000001 108.722 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 15.2 tp -57.21 -47.17 81.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 2.54 108.928 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 HD12 ' CD1' ' B' ' 91' ' ' ILE . 81.7 mt -57.28 -46.91 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 1.3100000000000001 109.578 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.481 ' O ' HG21 ' A' ' 95' ' ' ILE . 51.0 m -56.93 -47.5 80.46 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.157 -1.017 . . . . 1.3999999999999999 108.873 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -47.72 81.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 3.3799999999999999 109.18 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.35 89.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.593 -1.403 . . . . 1.29 109.593 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 92' ' ' SER . 2.1 tp -57.18 -46.81 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -1.069 . . . . 2.6000000000000001 109.212 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HG13 ' A' ' 99' ' ' ILE . 16.7 mtm180 -56.68 -46.6 81.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.897 . . . . 3.6600000000000001 109.09 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -46.78 82.39 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.776 -1.203 . . . . 4.1600000000000001 109.201 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -46.96 81.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 3.1499999999999999 109.564 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 96' ' ' ARG . 2.1 pt -82.55 -112.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 2.3900000000000001 109.109 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER 47.63 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.777 -1.202 . . . . 4.2000000000000002 109.575 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.011 -0.995 . . . . 6.79 109.525 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' B' ' 62' ' ' VAL . 12.0 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.486 -0.561 . . . . 20.579999999999998 109.486 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -64.87 146.0 55.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 18.100000000000001 109.364 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 tp -137.73 6.95 2.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 17.890000000000001 109.623 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' B' ' 66' ' ' HIS . . . -80.24 -13.31 59.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 15.779999999999999 109.548 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.497 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 1.9 t60 77.93 114.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.354 -0.842 . . . . 14.390000000000001 109.645 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' B' ' 66' ' ' HIS . 0.2 OUTLIER 168.2 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 13.77 109.436 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -141.98 -88.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 13.279999999999999 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.469 ' HB2' ' HA ' ' B' ' 75' ' ' LEU . 64.9 m -88.08 105.96 17.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 8.2300000000000004 109.467 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 0.8 OUTLIER -68.15 -55.04 13.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 7.29 109.98 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 5.0 Cg_exo -60.08 156.61 38.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.96 1.773 . . . . 3.6600000000000001 110.537 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' B' ' 73' ' ' ILE . 1.6 mt-10 -66.3 -73.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 2.8900000000000001 109.809 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.5 OUTLIER -39.57 -41.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 2.5800000000000001 110.184 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.524 ' O ' HG23 ' B' ' 77' ' ' ILE . 2.0 p -61.38 -46.63 89.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.99 109.433 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.501 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -74.11 -47.34 36.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 2.1899999999999999 109.97 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' A' ' 75' ' ' LEU . 64.0 mt -57.56 -48.45 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.702 -1.248 . . . . 1.51 109.492 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.552 HG21 ' N ' ' B' ' 78' ' ' PHE . 0.8 OUTLIER -58.25 -47.21 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 2.48 108.66 178.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.552 ' N ' HG21 ' B' ' 77' ' ' ILE . 2.0 m-85 -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.655 -0.653 . . . . 3.52 109.51 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.551 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -56.66 -47.02 88.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.328 -1.509 . . . . 0.34000000000000002 109.328 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 87.7 t -57.1 -47.76 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.295 . . . . 1.1399999999999999 108.681 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 61.3 mtm -57.67 -47.31 82.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 2.4199999999999999 108.654 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' B' ' 85' ' ' ILE . . . -57.2 -46.16 83.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.72 -0.613 . . . . 1.1000000000000001 109.835 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.67 -47.3 86.03 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.302 -1.519 . . . . 0.28999999999999998 109.302 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.18 -47.58 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.3 . . . . 1.1399999999999999 108.993 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' B' ' 82' ' ' ALA . 48.0 mt -57.4 -47.1 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 1.6599999999999999 109.866 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.91 -47.08 89.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.33000000000000002 109.745 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 87' ' ' THR . 25.2 m -57.03 -47.15 81.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.161 -1.199 . . . . 1.0900000000000001 109.115 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.11 -47.02 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 109.169 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.08 -46.8 82.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 1.72 108.963 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 27.1 tp -56.9 -47.14 81.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 2.6200000000000001 109.538 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.527 ' CD1' HD12 ' A' ' 91' ' ' ILE . 86.6 mt -57.09 -47.35 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.13 -0.981 . . . . 1.3899999999999999 109.454 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -47.52 80.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.084 -1.047 . . . . 1.76 108.347 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.44 81.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.405 -0.81 . . . . 2.7799999999999998 109.307 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.46 87.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.251 -1.539 . . . . 1.24 109.251 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' B' ' 91' ' ' ILE . 1.3 mp -57.21 -47.09 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -1.104 . . . . 2.29 108.86 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -57.17 -46.74 82.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.85 . . . . 3.1099999999999999 109.639 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.51 -47.19 79.84 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.762 -1.199 . . . . 3.71 107.762 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' B' ' 99' ' ' ILE . 3.9 mt -57.26 -46.43 83.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.829 -1.174 . . . . 2.5600000000000001 107.829 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.561 ' CB ' ' O ' ' B' ' 98' ' ' LEU . 3.6 mt 94.28 102.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.761 0.791 . . . . 2.7200000000000002 109.362 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' B' ' 101' ' ' LYS . 2.1 tttt -84.94 124.86 32.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.641 -0.662 . . . . 5.5700000000000003 109.646 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 18.0 mmtp . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.938 -1.03 . . . . 7.8300000000000001 109.374 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 63' ' ' GLN . 4.7 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.544 -0.539 . . . . 19.079999999999998 109.544 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' N ' HG11 ' A' ' 62' ' ' VAL . 63.1 tp60 179.89 143.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 16.93 109.541 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -53.46 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 17.030000000000001 109.443 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' HIS . . . 64.15 60.5 0.98 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.308 -0.87 . . . . 14.640000000000001 109.301 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -42.99 -61.46 1.29 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 14.630000000000001 109.536 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -152.35 74.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 11.25 109.583 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.74 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 12.35 109.301 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' HIS . 85.4 p -104.06 -152.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.183 -0.948 . . . . 7.4199999999999999 109.753 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.56 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.68 -55.38 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.388 -0.82 . . . . 6.4900000000000002 109.339 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 3.8 Cg_exo -58.12 83.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.895 1.73 . . . . 3.25 109.839 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' GLU . 4.4 mt-10 -67.51 -72.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.841 . . . . 3.0099999999999998 109.918 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.53 HD11 ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -52.22 -37.98 23.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.098 -1.002 . . . . 2.0499999999999998 109.421 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.53 ' N ' HD11 ' A' ' 73' ' ' ILE . 16.5 m -61.16 -46.96 88.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 1.8400000000000001 108.972 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.588 ' CD1' ' CD1' ' B' ' 76' ' ' ILE . 0.3 OUTLIER -67.71 -46.62 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.821 . . . . 1.6399999999999999 109.194 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.535 HD12 ' CD1' ' B' ' 75' ' ' LEU . 51.1 mt -56.75 -47.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.981 -1.074 . . . . 1.6599999999999999 108.668 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.525 ' CD1' HD12 ' A' ' 73' ' ' ILE . 37.8 mt -57.5 -47.3 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.243 -0.911 . . . . 2.0699999999999998 108.556 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -57.37 -47.0 82.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.702 -0.624 . . . . 2.8900000000000001 109.462 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.48 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.89 -47.22 88.32 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.685 -1.366 . . . . 0.35999999999999999 109.685 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 62.0 t -57.29 -47.81 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.935 -1.332 . . . . 1.1000000000000001 108.8 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 mtm -57.72 -47.31 82.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 2.23 108.729 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.15 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.662 -0.649 . . . . 1.1000000000000001 109.738 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.6 -47.31 85.41 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.258 -1.537 . . . . 0.29999999999999999 109.258 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.23 -47.55 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.284 . . . . 1.0900000000000001 109.033 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.29 -46.95 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.9099999999999999 109.478 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.7 90.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.329 -1.509 . . . . 0.38 109.329 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.459 HG23 HG23 ' B' ' 87' ' ' THR . 98.0 m -56.77 -47.04 81.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.253 -1.145 . . . . 1.1000000000000001 109.013 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.2 -47.3 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 1.21 108.826 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.24 -46.83 82.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.478 -0.934 . . . . 1.3700000000000001 108.478 179.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.541 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 39.1 tp -57.01 -46.81 82.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 2.54 109.14 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 95' ' ' ILE . 87.7 mt -56.78 -46.99 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.185 -0.947 . . . . 1.3100000000000001 109.326 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -47.6 80.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.021 -1.072 . . . . 1.3999999999999999 108.2 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -57.5 -47.43 81.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.318 -0.863 . . . . 3.3799999999999999 108.953 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.17 89.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.366 -1.494 . . . . 1.29 109.366 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 91' ' ' ILE . 1.4 mt -57.09 -47.32 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -1.127 . . . . 2.6000000000000001 108.63 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.485 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -57.31 -47.01 82.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 3.6600000000000001 108.833 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.27 -47.07 82.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 4.1600000000000001 109.806 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.9 mt -56.96 -46.84 81.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.029 -1.045 . . . . 3.1499999999999999 109.161 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 100' ' ' LYS . 18.6 pt -74.99 -45.88 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 2.3900000000000001 110.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.499 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -128.71 166.56 18.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 4.2000000000000002 109.902 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 6.9 mmtm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.024 -0.989 . . . . 6.79 109.465 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.241 0.543 . . . . 20.579999999999998 109.556 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' B' ' 64' ' ' LEU . 0.4 OUTLIER -131.42 38.39 3.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 18.100000000000001 109.57 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.461 ' O ' ' NE2' ' B' ' 63' ' ' GLN . 0.5 OUTLIER 67.71 159.23 0.15 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.402 -0.811 . . . . 17.890000000000001 109.572 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.87 68.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 15.779999999999999 109.429 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.6 m80 55.86 62.09 2.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 14.390000000000001 109.396 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -15.18 62.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.83 . . . . 13.77 109.579 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -71.65 167.75 19.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 13.279999999999999 109.666 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' B' ' 70' ' ' GLU . 0.3 OUTLIER -150.57 -152.33 0.43 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 8.2300000000000004 109.308 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' B' ' 72' ' ' GLU . 0.0 OUTLIER 73.34 98.23 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 7.29 109.53 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.28 58.48 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.369 2.046 . . . . 3.6600000000000001 110.345 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' B' ' 70' ' ' GLU . 16.3 mt-10 -65.15 -74.95 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 2.8900000000000001 109.415 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.528 ' O ' ' CG2' ' B' ' 77' ' ' ILE . 0.5 OUTLIER -44.01 -38.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.228 -0.92 . . . . 2.5800000000000001 109.538 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.53 ' O ' HG12 ' B' ' 77' ' ' ILE . 89.7 m -59.09 -46.97 86.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 1.99 109.674 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.535 ' CD1' HD12 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -75.24 -47.08 29.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.883 -1.135 . . . . 2.1899999999999999 109.538 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 11.7 mt -57.43 -48.14 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.855 -1.153 . . . . 1.51 109.602 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.53 HG12 ' O ' ' B' ' 74' ' ' THR . 15.9 pt -58.0 -47.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.043 -1.036 . . . . 2.48 108.522 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.518 ' N ' HG13 ' B' ' 77' ' ' ILE . 0.8 OUTLIER -57.14 -47.28 81.54 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.801 -0.76 . . . . 3.52 109.085 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.441 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -57.08 -47.3 88.56 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.065 -1.614 . . . . 0.34000000000000002 109.065 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 89.4 t -57.26 -47.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 1.1399999999999999 108.799 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' B' ' 77' ' ' ILE . 14.5 mtp -57.67 -47.35 82.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.291 -0.881 . . . . 2.4199999999999999 108.957 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.46 83.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.533 -0.729 . . . . 1.1000000000000001 109.962 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.37 87.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.319 -1.512 . . . . 0.28999999999999998 109.319 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.29 -47.54 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -1.217 . . . . 1.1399999999999999 109.431 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -57.35 -47.22 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.6599999999999999 109.79 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' B' ' 89' ' ' LEU . . . -57.04 -47.0 90.91 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.653 -1.379 . . . . 0.33000000000000002 109.653 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.459 HG23 HG23 ' A' ' 87' ' ' THR . 93.7 m -56.93 -47.18 81.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -1.172 . . . . 1.0900000000000001 109.521 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.02 -47.24 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 109.207 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.538 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.3 OUTLIER -57.28 -46.61 82.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 1.72 109.134 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.538 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 2.8 tm? -57.2 -46.92 82.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.299 -0.875 . . . . 2.6200000000000001 109.451 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' B' ' 95' ' ' ILE . 99.2 mt -57.0 -47.14 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 1.3899999999999999 109.623 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.497 ' O ' HG12 ' B' ' 95' ' ' ILE . 28.5 m -57.14 -47.6 80.77 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.891 -1.131 . . . . 1.76 108.634 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -57.69 -47.57 81.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.008 -1.057 . . . . 2.7799999999999998 109.571 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.53 -47.61 87.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.284 -1.126 . . . . 1.24 110.284 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.497 HG12 ' O ' ' B' ' 92' ' ' SER . 0.8 OUTLIER -57.33 -47.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.048 -1.266 . . . . 2.29 109.352 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.524 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 22.2 mtm180 -57.07 -47.08 81.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 3.1099999999999999 109.539 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -46.86 83.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.977 . . . . 3.71 109.812 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -47.07 81.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 2.5600000000000001 109.374 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.524 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 32.2 pt -70.87 -15.68 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 2.7200000000000002 108.937 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -115.08 -162.83 0.84 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.432 -0.793 . . . . 5.5700000000000003 109.374 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' B' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.911 -1.042 . . . . 7.8300000000000001 109.618 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.379 -0.6 . . . . 19.079999999999998 109.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 3.0 pp0? -178.77 153.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 16.93 109.409 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -53.98 173.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 17.030000000000001 109.342 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.49 104.28 0.61 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.234 -0.916 . . . . 14.640000000000001 109.42 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -70.32 -148.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 14.630000000000001 109.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -65.94 -175.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 11.25 109.666 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.33 -8.18 11.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 12.35 109.525 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 p -46.62 157.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.885 . . . . 7.4199999999999999 109.755 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -137.61 154.8 75.28 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 6.4900000000000002 109.63 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 3.7 Cg_exo -60.67 170.15 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.274 1.983 . . . . 3.25 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.0 mt-10 -63.21 -74.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 3.0099999999999998 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -41.03 -35.97 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.41 -0.806 . . . . 2.0499999999999998 110.007 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -64.77 -46.82 80.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 1.8400000000000001 109.38 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.536 HD12 ' CD1' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -77.45 -47.15 20.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 1.6399999999999999 109.981 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.556 HG12 ' CD2' ' B' ' 75' ' ' LEU . 42.2 mt -57.27 -48.48 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.744 -1.223 . . . . 1.6599999999999999 108.955 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 4.3 tt -58.41 -47.48 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.135 -0.978 . . . . 2.0699999999999998 108.97 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 2.7 m-85 -57.28 -47.5 81.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.745 . . . . 2.8900000000000001 110.404 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.26 -47.6 86.56 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.353 -1.499 . . . . 0.35999999999999999 109.353 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.51 HG21 ' CA ' ' B' ' 79' ' ' GLY . 47.5 t -57.59 -47.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -1.168 . . . . 1.1000000000000001 109.139 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -46.86 82.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 2.23 109.065 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.04 81.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.423 -0.798 . . . . 1.1000000000000001 109.08 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.436 ' O ' HG21 ' B' ' 84' ' ' VAL . . . -56.62 -46.97 87.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.249 -1.54 . . . . 0.29999999999999999 109.249 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 80' ' ' VAL . 8.4 t -57.09 -47.39 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.063 -1.257 . . . . 1.0900000000000001 109.062 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -57.2 -46.86 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 1.9099999999999999 109.454 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.71 89.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.5 -1.44 . . . . 0.38 109.5 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' CG2' ' B' ' 87' ' ' THR . 60.4 m -56.69 -47.0 80.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.257 . . . . 1.1000000000000001 108.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 84' ' ' VAL . 49.5 mt -57.01 -46.76 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.115 -0.991 . . . . 1.21 108.705 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.95 -46.51 82.06 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.682 -0.859 . . . . 1.3700000000000001 108.682 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.7 mt -56.72 -46.6 81.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 2.54 109.053 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 82.0 mt -56.85 -47.04 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 1.3100000000000001 109.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.502 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -56.88 -47.68 79.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.983 -1.087 . . . . 1.3999999999999999 108.483 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -57.57 -47.5 81.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 3.3799999999999999 109.004 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.58 -47.17 90.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.345 -1.102 . . . . 1.29 110.345 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER -57.13 -47.1 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.025 -1.279 . . . . 2.6000000000000001 109.267 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 99' ' ' ILE . 9.5 mtp180 -57.14 -47.22 81.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 3.6600000000000001 109.395 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -47.18 83.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.776 -1.203 . . . . 4.1600000000000001 109.814 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.23 -47.03 82.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.382 -0.824 . . . . 3.1499999999999999 110.09 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 96' ' ' ARG . 1.0 OUTLIER -81.39 6.25 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 2.3900000000000001 109.713 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -129.12 80.92 2.0 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 4.2000000000000002 109.408 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 6.79 109.39 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.305 0.574 . . . . 20.579999999999998 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' B' ' 63' ' ' GLN . 20.1 tp60 -128.72 26.07 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 18.100000000000001 109.44 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.86 1.81 14.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.843 . . . . 17.890000000000001 109.921 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.75 145.86 36.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 15.779999999999999 109.397 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 -177.2 3.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 14.390000000000001 109.455 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.528 ' O ' ' CB ' ' B' ' 68' ' ' PHE . 11.9 p80 -163.84 -169.49 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 13.77 109.491 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' B' ' 67' ' ' HIS . 0.2 OUTLIER 75.94 -56.15 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 13.279999999999999 109.361 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.418 ' O ' ' C ' ' B' ' 70' ' ' GLU . 2.7 m -121.28 128.43 52.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 8.2300000000000004 109.49 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 69' ' ' SER . 33.5 mt-10 -43.77 110.13 0.92 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 7.29 109.419 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.512 ' HB2' ' CG2' ' B' ' 74' ' ' THR . 4.0 Cg_exo -59.72 106.43 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.912 1.741 . . . . 3.6600000000000001 110.287 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.462 ' O ' HG13 ' B' ' 76' ' ' ILE . 4.2 mt-10 -51.98 -48.22 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 2.8900000000000001 109.237 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' B' ' 74' ' ' THR . 1.5 tp -55.86 -47.4 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.307 -0.87 . . . . 2.5800000000000001 110.085 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' B' ' 78' ' ' PHE . 53.4 p -55.05 -46.87 75.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.932 -1.105 . . . . 1.99 109.349 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.632 ' CD2' ' N ' ' B' ' 76' ' ' ILE . 0.0 OUTLIER -65.98 -47.0 76.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 2.1899999999999999 109.373 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.632 ' N ' ' CD2' ' B' ' 75' ' ' LEU . 51.8 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.651 -1.281 . . . . 1.51 108.219 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mm -57.7 -47.18 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.503 -0.925 . . . . 2.48 108.503 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' B' ' 74' ' ' THR . 18.5 m-85 -57.12 -47.36 81.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.655 -0.653 . . . . 3.52 110.304 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.51 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . -57.04 -47.65 85.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.813 -1.715 . . . . 0.34000000000000002 108.813 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.527 ' CG2' ' CA ' ' A' ' 79' ' ' GLY . 52.0 t -57.68 -47.46 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.267 -1.137 . . . . 1.1399999999999999 108.951 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 8.3 mtp -57.55 -46.93 83.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 2.4199999999999999 109.164 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.27 81.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.796 . . . . 1.1000000000000001 109.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.17 87.93 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.838 -1.705 . . . . 0.28999999999999998 108.838 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 83' ' ' GLY . 87.0 t -57.14 -47.35 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -1.233 . . . . 1.1399999999999999 109.05 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -57.22 -47.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 1.6599999999999999 109.639 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.06 90.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.574 -1.41 . . . . 0.33000000000000002 109.574 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.516 ' CG2' HG23 ' A' ' 87' ' ' THR . 56.3 m -57.07 -47.26 81.42 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.159 -1.201 . . . . 1.0900000000000001 109.431 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 58.7 mt -57.4 -47.53 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 1.1399999999999999 109.098 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.44 -47.04 82.83 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.587 -0.894 . . . . 1.72 108.587 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' B' ' 90' ' ' LEU . 3.4 tm? -57.02 -46.99 81.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.524 -0.735 . . . . 2.6200000000000001 109.435 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.465 ' O ' HD13 ' B' ' 95' ' ' ILE . 70.0 mt -56.97 -47.2 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 1.3899999999999999 109.418 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' B' ' 96' ' ' ARG . 0.3 OUTLIER -57.37 -47.54 81.38 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.929 -1.108 . . . . 1.76 108.398 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.82 81.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.352 -0.842 . . . . 2.7799999999999998 109.343 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.65 -47.22 90.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.427 -1.469 . . . . 1.24 109.427 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 91' ' ' ILE . 1.4 mt -57.1 -47.11 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.46 -1.023 . . . . 2.29 109.214 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' B' ' 99' ' ' ILE . 4.5 mtm180 -57.08 -47.23 81.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.112 -0.993 . . . . 3.1099999999999999 109.499 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 100' ' ' LYS . 8.5 ttt180 -57.48 -47.02 83.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 3.71 109.781 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -46.99 81.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.853 . . . . 2.5600000000000001 109.308 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.504 HG13 ' N ' ' B' ' 100' ' ' LYS . 38.4 pt -75.27 -35.01 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.514 -0.742 . . . . 2.7200000000000002 109.442 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' B' ' 101' ' ' LYS . 3.1 mmtp -91.78 115.41 28.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -0.819 . . . . 5.5700000000000003 109.56 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' B' ' 100' ' ' LYS . 4.0 mtmp? . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.049 -0.977 . . . . 7.8300000000000001 109.416 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.465 -0.568 . . . . 19.079999999999998 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.431 ' OE1' ' HB1' ' A' ' 65' ' ' ALA . 2.6 pp0? -143.08 159.99 41.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 16.93 109.559 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.4 mt -130.31 93.15 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 17.030000000000001 109.525 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB1' ' OE1' ' A' ' 63' ' ' GLN . . . -144.24 24.52 1.6 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.026 . . . . 14.640000000000001 109.581 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 t60 51.41 77.86 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 14.630000000000001 109.277 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -158.88 -55.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 11.25 109.353 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 68.38 -62.92 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 12.35 109.42 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 1.5 m 76.17 48.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 7.4199999999999999 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 69' ' ' SER . 15.0 mt-10 55.46 101.54 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 6.4900000000000002 109.49 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 74' ' ' THR . 5.1 Cg_exo -58.21 154.96 37.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.955 1.77 . . . . 3.25 110.209 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -59.29 -70.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 3.0099999999999998 109.99 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -39.24 -45.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.454 -0.779 . . . . 2.0499999999999998 110.587 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -59.23 -46.96 87.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.072 -1.018 . . . . 1.8400000000000001 109.489 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -69.14 -47.06 66.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 1.6399999999999999 109.581 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.522 HD11 ' CD1' ' B' ' 75' ' ' LEU . 63.8 mt -56.97 -47.44 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.058 -1.026 . . . . 1.6599999999999999 108.644 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.69 -47.45 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.169 -0.957 . . . . 2.0699999999999998 108.685 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 74' ' ' THR . 18.8 m-30 -57.42 -47.31 82.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 2.8900000000000001 109.682 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.469 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.23 -47.13 90.13 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.241 -1.544 . . . . 0.35999999999999999 109.241 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 92.6 t -57.36 -47.81 83.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -1.137 . . . . 1.1000000000000001 109.962 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -57.8 -47.82 81.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 2.23 108.859 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.37 84.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.626 -0.671 . . . . 1.1000000000000001 109.887 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -47.27 87.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.845 -1.302 . . . . 0.29999999999999999 109.845 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.474 HG12 ' OG1' ' B' ' 87' ' ' THR . 97.3 t -57.16 -47.98 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.323 . . . . 1.0900000000000001 109.199 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mt -57.67 -47.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.012 . . . . 1.9099999999999999 109.629 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.25 89.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.099 -1.2 . . . . 0.38 110.099 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.4 m -57.11 -47.28 81.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -1.141 . . . . 1.1000000000000001 109.839 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 88' ' ' ILE . 14.9 mt -57.43 -47.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 1.21 109.808 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.63 -47.86 81.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 1.3700000000000001 109.209 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tt -57.71 -47.5 82.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -0.955 . . . . 2.54 109.298 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' CD1' ' CD1' ' B' ' 91' ' ' ILE . 76.2 mt -57.33 -47.04 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.551 -0.718 . . . . 1.3100000000000001 109.948 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -47.7 79.82 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.974 -1.079 . . . . 1.3999999999999999 109.176 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.81 -47.97 81.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.008 -1.058 . . . . 3.3799999999999999 109.537 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.67 87.47 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.854 -1.298 . . . . 1.29 109.854 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.481 HD11 ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -57.37 -47.21 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -1.085 . . . . 2.6000000000000001 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' O ' ' CG1' ' A' ' 99' ' ' ILE . 22.1 mtm180 -56.99 -47.16 81.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.873 . . . . 3.6600000000000001 109.472 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.94 82.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 4.1600000000000001 110.075 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -56.97 -46.9 81.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -0.982 . . . . 3.1499999999999999 108.821 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 100' ' ' LYS . 37.7 pt -74.87 -36.0 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 2.3900000000000001 109.432 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -62.99 134.8 56.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.82 . . . . 4.2000000000000002 109.752 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.07 -0.967 . . . . 6.79 109.467 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' B' ' 63' ' ' GLN . 73.1 t . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.492 -0.559 . . . . 20.579999999999998 109.492 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.54 ' CG ' ' N ' ' B' ' 64' ' ' LEU . 10.9 tt0 61.01 167.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 18.100000000000001 109.08 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' B' ' 63' ' ' GLN . 0.2 OUTLIER 175.8 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 17.890000000000001 109.692 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' B' ' 66' ' ' HIS . . . -106.24 37.76 2.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 15.779999999999999 109.37 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.421 ' CG ' ' O ' ' B' ' 65' ' ' ALA . 78.8 m80 -154.74 63.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 14.390000000000001 109.447 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' B' ' 67' ' ' HIS . 54.0 p-80 -101.28 69.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 13.77 109.529 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.52 ' O ' ' CB ' ' B' ' 69' ' ' SER . 44.9 m-85 -67.17 90.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 13.279999999999999 109.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' B' ' 68' ' ' PHE . 0.1 OUTLIER 75.9 109.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 8.2300000000000004 109.546 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.49 145.59 99.04 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 7.29 109.381 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.69 -23.53 74.6 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.249 1.966 . . . . 3.6600000000000001 110.281 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.436 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 18.1 mt-10 -48.54 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 2.8900000000000001 109.698 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.497 ' O ' HG21 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -45.9 -30.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.206 -0.934 . . . . 2.5800000000000001 109.926 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.57 ' O ' ' CD2' ' B' ' 78' ' ' PHE . 0.5 OUTLIER -64.68 -46.77 80.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 1.99 109.695 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -74.62 -46.85 35.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.997 -1.065 . . . . 2.1899999999999999 109.624 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.526 HD11 ' CD1' ' A' ' 75' ' ' LEU . 66.9 mt -56.96 -48.0 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 1.51 109.518 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.547 HG21 ' O ' ' B' ' 74' ' ' THR . 1.5 tt -57.9 -47.53 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.792 -1.192 . . . . 2.48 108.45 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' B' ' 74' ' ' THR . 23.1 m-30 -57.33 -47.26 82.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 3.52 109.721 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.414 ' C ' HG21 ' A' ' 80' ' ' VAL . . . -57.22 -47.29 88.88 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.009 -1.636 . . . . 0.34000000000000002 109.009 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 94.1 t -57.34 -47.71 84.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.282 -1.128 . . . . 1.1399999999999999 109.714 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 2.9 mtt -57.74 -47.76 81.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 2.4199999999999999 109.001 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.58 83.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.497 -0.752 . . . . 1.1000000000000001 109.656 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -46.97 90.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.599 -1.4 . . . . 0.28999999999999998 109.599 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -56.89 -47.6 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -1.188 . . . . 1.1399999999999999 109.764 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 85' ' ' ILE . 43.6 mm -57.41 -47.91 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.835 -1.165 . . . . 1.6599999999999999 109.418 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.14 90.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.364 -1.494 . . . . 0.33000000000000002 109.364 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.474 ' OG1' HG12 ' A' ' 84' ' ' VAL . 98.5 m -57.1 -47.06 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.999 . . . . 1.0900000000000001 109.695 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.415 HD12 HG22 ' B' ' 88' ' ' ILE . 37.7 mt -57.01 -47.66 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.132 -0.98 . . . . 1.1399999999999999 109.763 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.025 -1.047 . . . . 1.72 108.752 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.507 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 66.1 mt -57.59 -47.22 82.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 2.6200000000000001 109.429 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 91' ' ' ILE . 73.4 mt -57.15 -47.14 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.444 -0.785 . . . . 1.3899999999999999 110.038 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.496 ' O ' HG21 ' B' ' 95' ' ' ILE . 52.4 m -57.03 -48.01 79.54 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.831 -1.168 . . . . 1.76 108.656 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.9 -47.79 81.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.837 -1.165 . . . . 2.7799999999999998 109.12 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.27 89.63 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.572 -1.011 . . . . 1.24 110.572 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.496 HG21 ' O ' ' B' ' 92' ' ' SER . 1.6 tt -57.08 -47.22 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -1.212 . . . . 2.29 109.408 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.487 ' N ' ' CG2' ' B' ' 95' ' ' ILE . 7.2 mtm180 -57.26 -47.28 81.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 3.1099999999999999 108.898 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.79 83.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 3.71 109.811 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -46.98 80.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 2.5600000000000001 109.106 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.522 HG13 ' N ' ' B' ' 100' ' ' LYS . 10.4 pt -79.71 -131.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.593 -0.891 . . . . 2.7200000000000002 108.593 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.522 ' N ' HG13 ' B' ' 99' ' ' ILE . 6.8 tttm 59.47 136.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.137 -0.977 . . . . 5.5700000000000003 109.958 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' B' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.998 -1.001 . . . . 7.8300000000000001 109.532 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.342 0.592 . . . . 19.079999999999998 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -148.18 164.09 34.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 16.93 109.45 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.3 3.53 15.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 17.030000000000001 109.583 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.77 77.77 4.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 14.640000000000001 109.531 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.68 145.84 1.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 14.630000000000001 109.576 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.54 123.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 11.25 109.503 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.72 153.3 40.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 12.35 109.403 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -126.77 179.61 5.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 7.4199999999999999 109.614 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.571 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 161.78 -50.03 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.642 -0.661 . . . . 6.4900000000000002 109.71 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.9 Cg_endo -61.22 75.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.553 1.502 . . . . 3.25 110.024 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -52.85 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 3.0099999999999998 110.02 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 74' ' ' THR . 0.8 OUTLIER -42.8 -47.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -0.929 . . . . 2.0499999999999998 109.836 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.541 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.34 -46.86 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 1.8400000000000001 108.897 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 HD12 ' CD1' ' B' ' 76' ' ' ILE . 0.4 OUTLIER -67.43 -46.87 71.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 1.6399999999999999 109.708 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.544 HD12 ' CD1' ' B' ' 75' ' ' LEU . 35.0 mt -56.92 -48.01 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.85 -1.157 . . . . 1.6599999999999999 108.72 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.3 mm -58.02 -47.61 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 2.0699999999999998 108.693 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.44 -47.25 82.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.753 -0.592 . . . . 2.8900000000000001 110.278 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.87 -47.66 84.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.35999999999999999 109.659 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.491 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 92.3 t -57.67 -47.49 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.904 -1.351 . . . . 1.1000000000000001 108.628 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.84 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 2.23 109.037 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.08 81.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.559 -0.713 . . . . 1.1000000000000001 109.453 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' C ' HG21 ' B' ' 84' ' ' VAL . . . -56.54 -47.22 85.67 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.077 -1.609 . . . . 0.29999999999999999 109.077 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 HG21 ' C ' ' B' ' 83' ' ' GLY . 41.7 t -56.93 -47.32 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.973 -1.31 . . . . 1.0900000000000001 108.907 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 mt -57.21 -46.69 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 1.9099999999999999 109.813 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.7 -46.9 88.66 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.52 -1.432 . . . . 0.38 109.52 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.7 m -57.08 -47.13 81.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.985 -1.303 . . . . 1.1000000000000001 108.528 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.3 -46.85 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 1.21 109.226 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -56.81 -46.52 81.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 1.3700000000000001 109.371 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 3.7 mm? -56.66 -47.05 80.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 2.54 108.926 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.486 ' O ' HD11 ' A' ' 95' ' ' ILE . 27.1 mt -56.96 -46.91 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 1.3100000000000001 109.302 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -47.28 80.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 1.3999999999999999 108.466 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -47.57 81.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 3.3799999999999999 108.976 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.55 -47.24 89.68 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.263 -1.535 . . . . 1.29 109.263 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 91' ' ' ILE . 1.6 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -1.1 . . . . 2.6000000000000001 109.258 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.517 ' O ' HG13 ' A' ' 99' ' ' ILE . 6.2 ttp180 -57.02 -47.29 81.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 3.6600000000000001 109.394 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 100' ' ' LYS . 13.9 ttm180 -57.51 -47.0 83.13 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.016 -1.052 . . . . 4.1600000000000001 109.676 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.06 -46.98 82.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 3.1499999999999999 110.19 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.543 HG13 ' N ' ' A' ' 100' ' ' LYS . 1.7 pt -76.47 -27.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.101 -0.999 . . . . 2.3900000000000001 110.376 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.543 ' N ' HG13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -142.56 146.92 35.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.997 -1.064 . . . . 4.2000000000000002 109.748 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 100' ' ' LYS . 1.7 mptp? . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.996 -1.002 . . . . 6.79 109.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.502 -0.555 . . . . 20.579999999999998 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' B' ' 66' ' ' HIS . 0.0 OUTLIER -156.47 157.55 35.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 18.100000000000001 109.518 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.64 7.41 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 17.890000000000001 109.537 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.62 6.64 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.185 -0.947 . . . . 15.779999999999999 109.653 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.426 ' HB2' ' CG ' ' B' ' 63' ' ' GLN . 0.1 OUTLIER -115.57 168.04 10.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 14.390000000000001 109.472 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -91.59 7.78 39.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 13.77 109.652 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -80.55 -0.61 38.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 13.279999999999999 109.552 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.81 36.49 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 8.2300000000000004 109.559 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.492 ' CG ' ' HD2' ' B' ' 71' ' ' PRO . 0.2 OUTLIER -64.75 166.67 11.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 7.29 109.55 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' B' ' 70' ' ' GLU . 5.6 Cg_exo -59.6 158.9 25.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.289 1.993 . . . . 3.6600000000000001 110.503 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.46 ' O ' HD21 ' B' ' 75' ' ' LEU . 3.3 mp0 -57.89 -72.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 2.8900000000000001 109.835 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.7 OUTLIER -41.35 -42.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 2.5800000000000001 110.013 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.486 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 6.4 m -57.95 -46.92 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.006 . . . . 1.99 109.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.613 ' CD2' ' N ' ' B' ' 76' ' ' ILE . 0.0 OUTLIER -67.37 -46.76 72.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.955 . . . . 2.1899999999999999 109.367 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.613 ' N ' ' CD2' ' B' ' 75' ' ' LEU . 82.8 mt -56.99 -47.5 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.666 -1.271 . . . . 1.51 108.326 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.51 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.346 -0.983 . . . . 2.48 108.346 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.22 -47.1 82.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.658 -0.651 . . . . 3.52 109.885 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.491 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -56.85 -47.41 86.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.129 -1.588 . . . . 0.34000000000000002 109.129 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.527 ' CG2' ' CA ' ' A' ' 79' ' ' GLY . 94.4 t -57.44 -47.42 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -1.193 . . . . 1.1399999999999999 108.585 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' MET . . . . . 0.465 ' O ' HD13 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -57.45 -46.75 83.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.535 -0.913 . . . . 2.4199999999999999 108.535 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.82 82.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.208 -0.664 . . . . 1.1000000000000001 109.208 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.425 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -56.54 -47.09 86.59 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.662 -1.775 . . . . 0.28999999999999998 108.662 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.438 HG21 ' C ' ' A' ' 83' ' ' GLY . 87.0 t -57.0 -47.37 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -1.233 . . . . 1.1399999999999999 108.592 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.482 ' O ' HD22 ' B' ' 89' ' ' LEU . 3.9 mt -57.17 -46.74 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.409 -0.807 . . . . 1.6599999999999999 109.736 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.39 -46.72 86.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.069 -1.612 . . . . 0.33000000000000002 109.069 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 25.0 m -56.68 -46.75 80.97 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -1.139 . . . . 1.0900000000000001 109.051 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.483 HD11 HG23 ' B' ' 88' ' ' ILE . 31.6 mt -57.14 -47.3 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 1.1399999999999999 109.951 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.31 -46.64 82.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.91 -1.119 . . . . 1.72 108.307 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.99 -47.11 81.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 2.6200000000000001 109.013 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' B' ' 95' ' ' ILE . 73.2 mt -57.13 -47.13 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.883 . . . . 1.3899999999999999 109.192 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' B' ' 89' ' ' LEU . 84.2 p -57.05 -47.58 80.61 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.073 -1.017 . . . . 1.76 108.433 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -47.56 81.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 2.7799999999999998 109.237 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.49 -47.4 88.45 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.307 -1.517 . . . . 1.24 109.307 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.525 ' CD1' HG23 ' B' ' 91' ' ' ILE . 1.3 mt -57.33 -47.16 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -1.09 . . . . 2.29 109.151 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.554 ' O ' HG13 ' B' ' 99' ' ' ILE . 9.9 mtm180 -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 3.1099999999999999 109.678 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 29.2 ttt180 -57.82 -47.49 82.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.791 -1.193 . . . . 3.71 109.883 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -47.09 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 2.5600000000000001 110.486 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.554 HG13 ' O ' ' B' ' 96' ' ' ARG . 1.0 OUTLIER -80.24 -13.74 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.918 . . . . 2.7200000000000002 110.23 -179.091 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 97' ' ' ARG . 0.1 OUTLIER -157.82 146.11 19.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.068 -1.02 . . . . 5.5700000000000003 109.745 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 1.6 tttp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.031 -0.985 . . . . 7.8300000000000001 109.527 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 1 N--CA 1.568 5.445 0 N-CA-C 107.978 -1.119 . . . . 19.079999999999998 107.978 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -157.72 100.91 1.79 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 16.93 109.412 -177.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp 54.47 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 17.030000000000001 109.402 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' GLN . . . -159.55 127.86 5.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 14.640000000000001 109.299 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -56.16 -77.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.026 -1.046 . . . . 14.630000000000001 109.307 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -162.02 -69.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 11.25 109.393 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -86.06 117.2 24.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 12.35 109.278 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 97.7 p -172.98 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.986 -1.071 . . . . 7.4199999999999999 109.603 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -145.21 136.56 12.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 6.4900000000000002 109.392 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.02 -34.7 57.86 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.051 1.834 . . . . 3.25 110.115 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -45.49 -58.43 3.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 3.0099999999999998 109.75 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG21 ' N ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -56.29 -33.66 38.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.106 -0.996 . . . . 2.0499999999999998 109.936 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.413 ' N ' HG21 ' A' ' 73' ' ' ILE . 2.2 m -64.15 -47.14 81.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.022 . . . . 1.8400000000000001 109.748 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.453 HD12 HD11 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -75.38 -46.96 29.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.987 . . . . 1.6399999999999999 109.412 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' B' ' 75' ' ' LEU . 48.2 mt -57.04 -47.39 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.167 -1.013 . . . . 1.6599999999999999 108.519 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.58 -47.54 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.482 -0.933 . . . . 2.0699999999999998 108.482 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 2.8900000000000001 109.583 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.44 ' HA3' ' CG2' ' B' ' 80' ' ' VAL . . . -57.19 -47.31 88.67 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.641 -1.384 . . . . 0.35999999999999999 109.641 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 57.4 t -57.42 -47.65 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.124 -1.221 . . . . 1.1000000000000001 108.89 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -47.37 82.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.413 -0.805 . . . . 2.23 109.112 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.64 83.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.718 . . . . 1.1000000000000001 110.121 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.3 -47.37 88.35 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.251 -1.539 . . . . 0.29999999999999999 109.251 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.26 -47.32 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 1.0900000000000001 109.609 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.3 -47.39 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 1.9099999999999999 110.004 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.35 -47.31 88.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.232 -1.547 . . . . 0.38 109.232 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.523 HG23 ' CG2' ' B' ' 87' ' ' THR . 25.0 m -57.3 -47.01 82.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -1.039 . . . . 1.1000000000000001 109.44 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.96 -47.25 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 1.21 109.596 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -57.11 -46.73 82.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.005 . . . . 1.3700000000000001 108.745 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 9.5 tt -57.29 -47.02 82.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 2.54 109.277 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' CD1' HD12 ' B' ' 91' ' ' ILE . 66.4 mt -57.02 -47.12 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 1.3100000000000001 109.805 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -57.01 -47.66 80.33 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.909 -1.119 . . . . 1.3999999999999999 108.3 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.59 -47.56 81.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.854 . . . . 3.3799999999999999 109.298 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.35 88.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 1.29 109.5 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 91' ' ' ILE . 1.3 mt -57.04 -47.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -1.071 . . . . 2.6000000000000001 109.096 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 99' ' ' ILE . 3.4 ttp180 -57.01 -47.2 81.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 3.6600000000000001 109.459 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.491 ' CD ' ' O ' ' A' ' 101' ' ' LYS . 6.3 tmm_? -57.83 -47.28 83.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.764 -1.21 . . . . 4.1600000000000001 109.745 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.19 -47.14 82.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -0.867 . . . . 3.1499999999999999 110.156 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -80.38 -19.32 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 2.3900000000000001 109.83 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -142.53 121.09 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 4.2000000000000002 109.515 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 5.5 tttt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 6.79 109.421 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.439 -0.578 . . . . 20.579999999999998 109.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' B' ' 63' ' ' GLN . 8.3 tp60 -116.34 23.37 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 18.100000000000001 109.316 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' B' ' 63' ' ' GLN . 8.9 mt -42.23 145.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.341 -0.849 . . . . 17.890000000000001 109.436 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.84 122.35 45.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.118 -0.989 . . . . 15.779999999999999 109.64 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.35 159.1 4.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 14.390000000000001 109.419 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -61.13 -62.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 13.77 109.54 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -81.39 -165.36 0.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 13.279999999999999 109.587 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.2 15.12 1.68 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 8.2300000000000004 109.682 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.71 153.72 52.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 7.29 109.361 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.477 ' HG2' ' OG1' ' B' ' 74' ' ' THR . 4.2 Cg_exo -56.83 150.97 51.23 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 3.6600000000000001 110.468 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 72' ' ' GLU . 67.2 mt-10 -52.63 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 2.8900000000000001 109.958 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.503 HG21 ' N ' ' B' ' 74' ' ' THR . 5.8 tp -44.05 -43.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.152 -0.968 . . . . 2.5800000000000001 109.837 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.503 ' N ' HG21 ' B' ' 73' ' ' ILE . 6.3 m -55.12 -47.0 75.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 1.99 108.988 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.525 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -66.54 -46.77 75.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 2.1899999999999999 109.416 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.517 ' CG1' HG12 ' A' ' 76' ' ' ILE . 60.5 mt -56.75 -47.58 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.046 -1.034 . . . . 1.51 108.68 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.6 -47.4 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -0.901 . . . . 2.48 108.645 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -57.42 -47.17 82.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.586 -0.696 . . . . 3.52 109.635 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.528 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -57.01 -47.54 86.58 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.62 -1.276 . . . . 0.34000000000000002 109.921 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 40.4 t -57.5 -47.98 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.338 . . . . 1.1399999999999999 108.898 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' MET . . . . . 0.424 ' O ' HG12 ' B' ' 85' ' ' ILE . 1.4 mtt -57.77 -47.3 82.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.829 . . . . 2.4199999999999999 109.139 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.44 82.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.703 -0.623 . . . . 1.1000000000000001 110.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.5 86.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.072 -1.611 . . . . 0.28999999999999998 109.072 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.45 -47.38 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -1.19 . . . . 1.1399999999999999 109.375 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.481 HG21 HD11 ' B' ' 85' ' ' ILE . 45.5 mm -57.3 -47.23 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 1.6599999999999999 109.989 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.98 -47.06 90.22 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.396 -1.482 . . . . 0.33000000000000002 109.396 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.523 ' CG2' HG23 ' A' ' 87' ' ' THR . 50.9 m -57.03 -47.0 81.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.168 -1.196 . . . . 1.0900000000000001 109.174 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.92 -47.17 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 1.1399999999999999 109.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -46.98 82.35 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.247 -0.908 . . . . 1.72 108.651 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.454 HD11 ' N ' ' B' ' 90' ' ' LEU . 6.9 mp -56.97 -47.14 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 2.6200000000000001 109.51 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.487 HD12 ' CD1' ' A' ' 91' ' ' ILE . 99.7 mt -57.13 -47.14 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.988 . . . . 1.3899999999999999 109.206 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 67.2 m -57.22 -47.67 80.72 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.098 -1.041 . . . . 1.76 108.5 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -47.57 82.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.626 -0.829 . . . . 2.7799999999999998 109.357 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.48 87.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.949 -1.661 . . . . 1.24 108.949 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mm -57.3 -47.0 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -1.072 . . . . 2.29 108.251 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.58 ' O ' HG13 ' B' ' 99' ' ' ILE . 0.5 OUTLIER -57.04 -46.96 82.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.769 . . . . 3.1099999999999999 109.242 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 3.8 ttt180 -57.53 -47.12 82.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.764 -1.21 . . . . 3.71 109.549 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.07 -47.1 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 2.5600000000000001 109.989 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.58 HG13 ' O ' ' B' ' 96' ' ' ARG . 2.3 pp -79.48 -28.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 2.7200000000000002 109.928 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 97' ' ' ARG . 0.3 OUTLIER -134.67 129.93 35.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 5.5700000000000003 109.661 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.993 -1.003 . . . . 7.8300000000000001 109.505 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 63' ' ' GLN . 9.8 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.485 -0.561 . . . . 19.079999999999998 109.485 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 48.0 tp60 -109.63 22.21 16.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 16.93 109.362 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -97.72 -0.79 44.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 17.030000000000001 109.627 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' HIS . . . -58.87 -19.85 45.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 14.640000000000001 109.63 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CB ' ' O ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER 70.62 -66.05 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 14.630000000000001 109.458 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.12 -172.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 11.25 109.497 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.92 -176.07 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 12.35 109.43 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.6 m 54.67 74.58 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 7.4199999999999999 109.676 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -141.12 149.16 54.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.943 . . . . 6.4900000000000002 109.425 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.475 ' O ' ' OG1' ' A' ' 74' ' ' THR . 2.8 Cg_endo -60.96 121.38 9.59 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.139 1.892 . . . . 3.25 110.002 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -58.31 -58.19 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 3.0099999999999998 109.625 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 74' ' ' THR . 1.1 tp -47.56 -46.63 10.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.217 -0.927 . . . . 2.0499999999999998 110.255 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.516 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 64.5 p -58.33 -46.55 85.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 1.8400000000000001 110.032 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.515 ' CD1' HD11 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -71.78 -47.38 53.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 1.6399999999999999 110.204 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.477 HG12 ' CG1' ' B' ' 76' ' ' ILE . 73.0 mt -57.45 -48.1 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 1.6599999999999999 109.69 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.529 HG13 ' N ' ' A' ' 78' ' ' PHE . 23.1 pt -57.95 -47.14 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.84 -1.162 . . . . 2.0699999999999998 108.423 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.529 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -57.17 -46.92 82.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.652 . . . . 2.8900000000000001 109.571 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.532 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.86 -47.4 86.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.651 -1.38 . . . . 0.35999999999999999 109.651 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 95.2 t -57.31 -47.63 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.951 -1.323 . . . . 1.1000000000000001 108.738 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 mmt -57.72 -47.08 83.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 2.23 108.793 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.28 82.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.666 -0.646 . . . . 1.1000000000000001 109.82 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.45 86.42 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.182 -1.567 . . . . 0.29999999999999999 109.182 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -57.27 -47.75 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.997 -1.296 . . . . 1.0900000000000001 108.969 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.9 mt -57.5 -46.97 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 1.9099999999999999 109.859 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.04 89.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.758 -1.337 . . . . 0.38 109.758 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.525 ' CG2' HG23 ' B' ' 87' ' ' THR . 95.7 m -56.86 -47.21 80.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.021 -1.282 . . . . 1.1000000000000001 108.753 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 88' ' ' ILE . 47.9 mt -57.24 -47.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 1.21 108.565 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.508 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.1 -46.73 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.487 -0.931 . . . . 1.3700000000000001 108.487 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.78 -46.84 81.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.478 -0.764 . . . . 2.54 109.124 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.87 -46.84 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 1.3100000000000001 109.031 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.7 m -56.95 -47.58 80.35 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.007 -1.058 . . . . 1.3999999999999999 108.371 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.57 -47.72 81.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 3.3799999999999999 109.05 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.08 90.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.362 -1.495 . . . . 1.29 109.362 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.428 ' O ' HG12 ' A' ' 99' ' ' ILE . 1.5 mm -57.06 -47.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.413 -1.051 . . . . 2.6000000000000001 109.01 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.514 ' O ' ' CG1' ' A' ' 99' ' ' ILE . 6.8 mtp180 -57.14 -47.19 81.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 3.6600000000000001 109.438 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -57.31 -47.11 82.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 4.1600000000000001 109.825 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mt -56.84 -46.93 81.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 3.1499999999999999 109.333 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 36.4 pt -72.98 -15.35 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 2.3900000000000001 109.532 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -123.02 -163.78 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.961 . . . . 4.2000000000000002 109.521 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.03 -0.986 . . . . 6.79 109.454 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.305 0.574 . . . . 20.579999999999998 109.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.443 ' HG3' ' N ' ' B' ' 64' ' ' LEU . 71.0 tp60 -120.86 159.53 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 18.100000000000001 109.304 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.443 ' N ' ' HG3' ' B' ' 63' ' ' GLN . 0.3 OUTLIER -160.98 34.33 0.15 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 17.890000000000001 109.905 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -112.91 -25.42 9.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.973 -1.079 . . . . 15.779999999999999 109.703 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 65' ' ' ALA . 93.7 m-70 60.92 131.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 14.390000000000001 109.558 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -131.77 113.48 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 13.77 109.46 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -137.01 152.16 49.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 13.279999999999999 109.56 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' B' ' 70' ' ' GLU . 0.5 OUTLIER -124.13 123.7 40.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 8.2300000000000004 109.358 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.567 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 3.6 mm-40 163.18 -52.97 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 7.29 109.95 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 4.6 Cg_exo -61.0 169.55 5.82 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.222 1.948 . . . . 3.6600000000000001 111.601 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' B' ' 73' ' ' ILE . 10.2 pt-20 -52.39 -44.97 65.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.352 -0.843 . . . . 2.8900000000000001 109.619 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' B' ' 74' ' ' THR . 2.5 tp -47.56 -46.34 10.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.053 -1.03 . . . . 2.5800000000000001 109.798 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.537 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 0.6 OUTLIER -60.81 -46.98 88.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.107 -0.995 . . . . 1.99 108.93 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.495 ' N ' ' CG2' ' B' ' 74' ' ' THR . 0.4 OUTLIER -64.13 -47.25 80.68 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.304 -0.958 . . . . 2.1899999999999999 109.294 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 75' ' ' LEU . 71.1 mt -57.14 -47.68 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.994 -1.066 . . . . 1.51 108.362 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.33 -47.18 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.483 -0.932 . . . . 2.48 108.483 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -57.25 -47.23 81.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.474 -0.766 . . . . 3.52 109.455 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.494 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -56.9 -47.28 87.89 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.123 -1.591 . . . . 0.34000000000000002 109.123 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.532 ' CG2' ' CA ' ' A' ' 79' ' ' GLY . 97.7 t -57.37 -47.37 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -1.128 . . . . 1.1399999999999999 108.79 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -46.95 83.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 2.4199999999999999 109.41 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.94 -46.4 82.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.444 -0.785 . . . . 1.1000000000000001 109.65 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.0 90.41 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.783 -1.727 . . . . 0.28999999999999998 108.783 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.05 -47.21 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.11 . . . . 1.1399999999999999 109.42 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.99 -47.32 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.051 -1.031 . . . . 1.6599999999999999 109.779 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.19 89.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.378 -1.489 . . . . 0.33000000000000002 109.378 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.525 HG23 ' CG2' ' A' ' 87' ' ' THR . 31.5 m -57.1 -46.93 82.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.091 . . . . 1.0900000000000001 109.361 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.497 HG22 HD11 ' B' ' 88' ' ' ILE . 38.3 mt -56.92 -46.86 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 1.1399999999999999 109.148 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -56.97 -46.98 81.8 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.029 -1.1 . . . . 1.72 108.029 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.478 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 10.9 tp -57.19 -46.97 82.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.351 -0.843 . . . . 2.6200000000000001 109.118 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.528 HG23 ' CD1' ' B' ' 95' ' ' ILE . 75.0 mt -57.09 -47.2 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.339 -0.851 . . . . 1.3899999999999999 109.493 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 75.1 m -57.03 -47.36 81.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.117 -1.068 . . . . 1.76 108.117 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -57.42 -47.62 81.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 2.7799999999999998 109.147 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.61 -47.47 88.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.337 -1.505 . . . . 1.24 109.337 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.528 ' CD1' HG23 ' B' ' 91' ' ' ILE . 1.3 mp -57.28 -46.95 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -1.046 . . . . 2.29 109.108 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.516 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 6.8 mtm180 -57.08 -47.27 81.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 3.1099999999999999 109.369 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.448 ' HA ' ' HG2' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.34 -47.02 82.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 3.71 109.93 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.85 -46.85 81.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 2.5600000000000001 109.092 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 42.0 pt -72.93 -35.12 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.7200000000000002 109.601 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.483 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -82.51 9.73 8.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.928 . . . . 5.5700000000000003 109.862 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.944 -1.027 . . . . 7.8300000000000001 109.823 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 63' ' ' GLN . 3.9 m . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.492 -0.558 . . . . 19.079999999999998 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 62' ' ' VAL . 53.2 tp60 57.37 159.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 16.93 109.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.5 -177.05 5.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.163 -0.961 . . . . 17.030000000000001 109.59 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.98 54.16 0.79 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 14.640000000000001 109.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -101.04 -5.15 26.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 14.630000000000001 109.421 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.436 ' CG ' ' O ' ' A' ' 67' ' ' HIS . 42.8 t-80 -68.29 68.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 11.25 109.544 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -87.34 175.29 8.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 12.35 109.332 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.4 m -51.05 -57.8 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 7.4199999999999999 109.666 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 72' ' ' GLU . 2.7 mm-40 -148.06 101.63 3.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 6.4900000000000002 109.545 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 4.5 Cg_exo -59.06 76.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.108 1.872 . . . . 3.25 110.053 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 70' ' ' GLU . 14.3 pt-20 -57.43 -48.6 78.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 3.0099999999999998 109.705 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 74' ' ' THR . 1.5 tp -56.11 -46.4 80.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.096 -1.003 . . . . 2.0499999999999998 109.996 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.532 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -57.1 -47.02 82.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 1.8400000000000001 109.194 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.516 ' CD1' HD12 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -66.83 -47.03 73.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.6399999999999999 109.64 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' CG2' ' CD2' ' B' ' 75' ' ' LEU . 82.3 mt -56.93 -47.85 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 1.6599999999999999 108.975 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 77' ' ' ILE . 16.5 mm -57.79 -47.46 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 2.0699999999999998 108.708 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.55 -47.39 82.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 2.8900000000000001 110.119 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.25 -47.58 86.66 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.467 -1.453 . . . . 0.35999999999999999 109.467 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 87.7 t -57.65 -47.63 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.249 -1.148 . . . . 1.1000000000000001 109.095 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -47.29 82.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 2.23 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.47 82.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 1.1000000000000001 109.766 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.35 88.08 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.529 -1.428 . . . . 0.29999999999999999 109.529 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.35 -47.58 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -1.228 . . . . 1.0900000000000001 109.49 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.0 mm -57.37 -47.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.934 . . . . 1.9099999999999999 109.829 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.99 90.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.884 -1.287 . . . . 0.38 109.884 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' HG13 ' A' ' 91' ' ' ILE . 82.1 m -56.99 -47.16 81.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 1.1000000000000001 109.503 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' A' ' 91' ' ' ILE . 56.2 mt -57.33 -47.28 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 1.21 109.321 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.29 -46.95 82.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 1.3700000000000001 109.208 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 38.5 tp -56.97 -47.01 81.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 2.54 109.466 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.506 ' CD1' HD12 ' B' ' 91' ' ' ILE . 60.7 mt -56.92 -47.02 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 1.3100000000000001 109.493 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -56.96 -47.56 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.033 -1.067 . . . . 1.3999999999999999 108.804 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -47.51 81.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.948 -1.095 . . . . 3.3799999999999999 109.325 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.51 87.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.406 -1.078 . . . . 1.29 110.406 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 92' ' ' SER . 0.8 OUTLIER -57.28 -46.99 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.028 -1.278 . . . . 2.6000000000000001 109.013 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 99' ' ' ILE . 14.7 mtm180 -57.01 -46.86 82.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 3.6600000000000001 109.206 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -57.14 -46.64 82.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.998 -1.064 . . . . 4.1600000000000001 109.716 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mt -56.68 -47.01 80.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 3.1499999999999999 109.604 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER -74.75 -18.77 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 2.3900000000000001 109.169 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.479 ' N ' HG13 ' A' ' 99' ' ' ILE . 9.6 tptp -96.56 123.0 40.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 4.2000000000000002 109.761 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.001 -1.0 . . . . 6.79 109.303 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.477 -0.564 . . . . 20.579999999999998 109.477 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 161.12 31.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 18.100000000000001 109.527 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 71.51 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 17.890000000000001 109.464 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.25 78.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 15.779999999999999 109.542 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -144.8 -169.6 3.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 14.390000000000001 109.31 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -174.65 172.4 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 13.77 109.632 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' B' ' 69' ' ' SER . 26.6 m-85 -116.35 -74.54 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 13.279999999999999 109.447 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 68' ' ' PHE . 0.5 OUTLIER 64.58 125.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 8.2300000000000004 109.492 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' B' ' 71' ' ' PRO . 2.5 mt-10 -169.41 167.7 5.27 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 7.29 109.437 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 70' ' ' GLU . 4.7 Cg_exo -59.35 96.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.128 1.886 . . . . 3.6600000000000001 110.154 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.468 ' O ' HG13 ' B' ' 76' ' ' ILE . 13.5 pt-20 -49.92 -34.62 21.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 2.8900000000000001 109.526 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.499 HD11 ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -71.02 -37.97 69.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.192 -0.943 . . . . 2.5800000000000001 109.324 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.499 ' N ' HD11 ' B' ' 73' ' ' ILE . 23.7 m -63.54 -46.96 83.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.147 -0.97 . . . . 1.99 109.117 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.53 ' CD2' ' CG2' ' A' ' 76' ' ' ILE . 3.5 tt -73.28 -47.35 43.65 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 2.1899999999999999 109.55 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.517 ' CG1' ' CG1' ' A' ' 76' ' ' ILE . 82.2 mt -57.36 -48.14 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.955 -1.09 . . . . 1.51 109.179 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.484 HD11 ' O ' ' B' ' 73' ' ' ILE . 1.1 mp -58.28 -47.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 2.48 108.756 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.508 ' CD2' HD22 ' B' ' 75' ' ' LEU . 0.0 OUTLIER -57.7 -47.16 83.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.614 -0.679 . . . . 3.52 109.621 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.439 ' C ' ' CG2' ' A' ' 80' ' ' VAL . . . -57.31 -47.65 86.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.669 -1.373 . . . . 0.34000000000000002 109.669 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 97.5 t -57.62 -47.85 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.089 -1.242 . . . . 1.1399999999999999 109.076 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 29.0 mtt -57.81 -47.43 82.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 2.4199999999999999 109.103 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.34 83.1 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.719 -0.613 . . . . 1.1000000000000001 109.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.55 85.78 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.393 -1.483 . . . . 0.28999999999999998 109.393 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.38 -47.86 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.971 -1.311 . . . . 1.1399999999999999 109.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.46 -47.2 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 1.6599999999999999 109.718 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -57.07 -46.95 90.98 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.869 -1.292 . . . . 0.33000000000000002 109.869 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.435 HG23 HG23 ' A' ' 87' ' ' THR . 41.6 m -56.97 -47.43 80.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -1.214 . . . . 1.0900000000000001 109.351 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.31 -47.47 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 1.1399999999999999 108.938 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.4 -46.98 82.9 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 1.72 109.12 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.54 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 91.2 mt -56.99 -47.17 81.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 2.6200000000000001 109.808 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.506 HD12 ' CD1' ' A' ' 91' ' ' ILE . 62.4 mt -57.19 -47.43 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.09 -1.006 . . . . 1.3899999999999999 109.622 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.73 81.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.693 -1.203 . . . . 1.76 108.533 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -47.51 82.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.7799999999999998 109.879 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.49 -47.61 86.96 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 1.24 109.645 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.488 HD11 ' O ' ' B' ' 91' ' ' ILE . 1.1 mp -57.35 -47.4 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -1.183 . . . . 2.29 108.712 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.528 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 21.1 mtm180 -57.24 -47.39 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 3.1099999999999999 109.571 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -57.4 -47.04 82.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 3.71 109.95 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -47.11 81.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 2.5600000000000001 109.36 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 39.5 pt -71.45 -32.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.369 -0.832 . . . . 2.7200000000000002 109.556 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' B' ' 101' ' ' LYS . 0.1 OUTLIER -104.68 103.95 13.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -0.879 . . . . 5.5700000000000003 109.528 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.981 -1.009 . . . . 7.8300000000000001 109.494 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 7.4 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.489 -0.56 . . . . 19.079999999999998 109.489 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 16.7 tt0 60.44 159.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.943 . . . . 16.93 109.074 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -88.84 -63.32 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 17.030000000000001 109.379 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 64' ' ' LEU . . . 73.77 144.06 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.301 -0.874 . . . . 14.640000000000001 109.277 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -147.66 -67.65 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 14.630000000000001 109.713 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 69' ' ' SER . 18.1 t-80 -166.88 34.68 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 11.25 109.742 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 65.9 -67.71 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 12.35 109.527 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' HIS . 0.4 OUTLIER -60.35 143.57 52.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 7.4199999999999999 109.525 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' CG ' ' C ' ' A' ' 69' ' ' SER . 0.2 OUTLIER 166.97 93.05 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 6.4900000000000002 109.62 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.53 ' HG2' ' CB ' ' A' ' 74' ' ' THR . 5.7 Cg_exo -58.16 158.49 21.8 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.194 1.929 . . . . 3.25 110.372 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 48.9 tt0 -64.65 -86.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 3.0099999999999998 109.866 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.487 ' CG1' HD13 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -39.51 -39.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 2.0499999999999998 110.071 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.53 ' CB ' ' HG2' ' A' ' 71' ' ' PRO . 99.9 m -59.98 -46.95 87.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.24 -0.913 . . . . 1.8400000000000001 109.268 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.564 HD22 ' CD2' ' A' ' 78' ' ' PHE . 3.2 tt -67.91 -47.28 69.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 1.6399999999999999 109.801 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.48 HG12 HG13 ' B' ' 76' ' ' ILE . 57.7 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.88 -1.138 . . . . 1.6599999999999999 109.111 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.487 HD13 ' CG1' ' A' ' 73' ' ' ILE . 21.0 mt -58.2 -47.82 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 2.0699999999999998 109.122 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.564 ' CD2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -57.62 -47.05 83.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.678 -0.639 . . . . 2.8900000000000001 109.35 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' HG21 ' B' ' 80' ' ' VAL . . . -56.82 -47.17 88.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.362 -1.495 . . . . 0.35999999999999999 109.362 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 61.2 t -57.16 -47.84 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.041 -1.27 . . . . 1.1000000000000001 108.774 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.9 mtm -57.73 -47.21 83.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 2.23 108.93 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.42 82.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 1.1000000000000001 109.825 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.92 -47.26 88.18 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.204 -1.558 . . . . 0.29999999999999999 109.204 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.3 -47.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.243 . . . . 1.0900000000000001 109.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.54 -47.16 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 1.9099999999999999 109.858 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.07 89.42 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.714 -1.354 . . . . 0.38 109.714 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -56.99 -47.12 81.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.167 -1.196 . . . . 1.1000000000000001 109.157 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.11 -47.15 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 1.21 109.133 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.15 -46.9 82.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.214 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.542 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.6 mt -57.02 -47.11 81.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 2.54 109.455 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 95' ' ' ILE . 18.7 mt -57.2 -46.99 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 1.3100000000000001 109.305 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.519 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 67.5 m -57.05 -47.41 81.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.027 -1.069 . . . . 1.3999999999999999 108.231 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.24 -46.77 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.539 -0.725 . . . . 3.3799999999999999 109.12 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.6 -46.25 88.91 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.496 -1.842 . . . . 1.29 108.496 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 91' ' ' ILE . 1.9 mt -56.32 -46.5 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -1.081 . . . . 2.6000000000000001 108.833 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 92' ' ' SER . 10.6 mmt180 -56.66 -47.0 80.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.856 -1.152 . . . . 3.6600000000000001 108.649 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -57.13 -46.75 82.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 4.1600000000000001 109.737 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -46.96 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 3.1499999999999999 109.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 38.7 pt -72.46 -30.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 2.3900000000000001 109.304 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.493 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.3 OUTLIER -82.83 150.84 26.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 4.2000000000000002 109.547 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.995 -1.002 . . . . 6.79 109.338 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.273 0.559 . . . . 20.579999999999998 109.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.84 122.52 24.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 18.100000000000001 109.482 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.22 6.0 6.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 17.890000000000001 109.573 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -97.25 -10.16 26.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 15.779999999999999 109.575 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' B' ' 65' ' ' ALA . 5.4 m80 51.85 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 14.390000000000001 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -57.73 -72.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 13.77 109.532 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.49 151.26 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 13.279999999999999 109.657 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 73.6 m -105.2 157.72 17.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 8.2300000000000004 109.382 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -127.66 143.22 46.74 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 7.29 109.643 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.447 ' O ' ' HB ' ' B' ' 74' ' ' THR . 1.7 Cg_endo -63.67 -23.35 69.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.193 1.928 . . . . 3.6600000000000001 110.124 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 71' ' ' PRO . 0.3 OUTLIER -42.47 -59.99 1.67 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.439 -0.788 . . . . 2.8900000000000001 109.445 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' B' ' 74' ' ' THR . 3.9 pt -56.47 -45.33 81.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.129 -0.982 . . . . 2.5800000000000001 108.547 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.548 ' N ' ' CG1' ' B' ' 73' ' ' ILE . 36.4 m -42.81 -47.0 5.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 1.99 108.979 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' B' ' 78' ' ' PHE . 0.5 OUTLIER -72.75 -47.58 45.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 2.1899999999999999 108.84 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.53 ' CD1' HD12 ' A' ' 75' ' ' LEU . 84.9 mt -57.79 -48.44 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.145 -1.022 . . . . 1.51 110.222 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.478 HD13 HG13 ' B' ' 73' ' ' ILE . 9.4 mt -58.6 -47.98 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.92 -1.113 . . . . 2.48 109.064 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.518 ' CE2' HD22 ' B' ' 75' ' ' LEU . 0.0 OUTLIER -57.68 -46.99 83.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.575 -0.528 . . . . 3.52 109.575 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.461 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -57.21 -47.59 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.698 -1.361 . . . . 0.34000000000000002 109.698 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 95.8 t -57.56 -47.79 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.057 -1.261 . . . . 1.1399999999999999 108.911 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mtm -57.74 -47.25 82.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.413 -0.804 . . . . 2.4199999999999999 109.337 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.54 82.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.495 -0.753 . . . . 1.1000000000000001 109.891 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.45 87.3 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.063 -1.615 . . . . 0.28999999999999998 109.063 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.26 -47.41 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 1.1399999999999999 109.437 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.4 -47.16 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 1.6599999999999999 110.021 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.35 88.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.816 -1.314 . . . . 0.33000000000000002 109.816 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 33.8 m -57.31 -47.36 81.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.13 -1.218 . . . . 1.0900000000000001 109.226 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.28 -47.2 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 1.1399999999999999 109.643 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.19 -47.12 82.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 1.72 109.178 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 70.3 mt -57.21 -47.17 81.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.965 . . . . 2.6200000000000001 109.512 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.517 HG23 ' CD1' ' B' ' 95' ' ' ILE . 84.4 mt -57.14 -47.26 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.88 . . . . 1.3899999999999999 109.512 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 5.4 p -57.18 -47.56 80.93 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.056 -1.027 . . . . 1.76 108.672 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -57.77 -47.54 82.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.7799999999999998 109.449 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.34 89.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.538 -1.425 . . . . 1.24 109.538 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.517 ' CD1' HG23 ' B' ' 91' ' ' ILE . 1.1 mp -57.19 -47.25 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -1.099 . . . . 2.29 109.36 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.444 ' HA ' HD12 ' B' ' 99' ' ' ILE . 1.8 ttp180 -57.16 -47.25 81.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 3.1099999999999999 109.482 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.49 -47.34 82.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 3.71 110.17 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -46.94 82.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 2.5600000000000001 109.598 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.534 HG13 ' N ' ' B' ' 100' ' ' LYS . 36.2 pt -74.01 -34.28 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.505 -0.747 . . . . 2.7200000000000002 110.203 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.534 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -142.68 136.92 29.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.078 -1.014 . . . . 5.5700000000000003 110.054 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.918 -1.039 . . . . 7.8300000000000001 109.329 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 62' ' ' VAL . 70.7 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.413 -0.588 . . . . 19.079999999999998 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -115.1 21.47 14.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 16.93 109.411 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 3.8 mm? 53.03 -87.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 17.030000000000001 109.617 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 63' ' ' GLN . . . 164.68 -22.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 14.640000000000001 109.911 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.49 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 2.8 m-70 -103.02 -155.28 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 14.630000000000001 109.661 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER 71.83 157.01 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 11.25 109.549 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -122.08 -43.57 2.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 12.35 109.627 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.78 -170.76 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 7.4199999999999999 109.567 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.7 147.93 37.33 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 6.4900000000000002 109.411 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 74' ' ' THR . 2.6 Cg_endo -61.72 -11.86 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.199 1.932 . . . . 3.25 110.156 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' CG ' ' HG2' ' B' ' 72' ' ' GLU . 1.3 mt-10 -45.25 -37.27 4.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 3.0099999999999998 109.299 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 2.9 tp -69.43 -34.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.171 -0.956 . . . . 2.0499999999999998 109.339 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -63.79 -47.0 82.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.304 -0.872 . . . . 1.8400000000000001 109.336 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' B' ' 76' ' ' ILE . 0.5 OUTLIER -78.57 -47.26 17.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 1.6399999999999999 109.681 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.531 ' CD1' HD12 ' B' ' 75' ' ' LEU . 81.3 mt -57.43 -48.13 83.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.833 -1.167 . . . . 1.6599999999999999 109.039 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 9.3 tt -58.06 -47.29 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.202 -0.936 . . . . 2.0699999999999998 108.717 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.5 m-85 -57.39 -47.01 82.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.495 -0.753 . . . . 2.8900000000000001 109.726 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.444 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -56.9 -47.29 87.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.504 -1.438 . . . . 0.35999999999999999 109.504 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 92.2 t -57.41 -47.58 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.296 . . . . 1.1000000000000001 108.703 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.459 ' O ' HG12 ' A' ' 85' ' ' ILE . 2.3 mmm -57.75 -47.07 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.85 . . . . 2.23 108.991 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.24 82.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 1.1000000000000001 109.759 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.76 -47.3 86.66 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.04 -1.624 . . . . 0.29999999999999999 109.04 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' B' ' 87' ' ' THR . 86.4 t -57.3 -47.63 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.1 -1.236 . . . . 1.0900000000000001 109.356 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 81' ' ' MET . 26.5 mm -57.43 -47.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 1.9099999999999999 109.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.14 -46.95 91.05 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.789 -1.324 . . . . 0.38 109.789 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.2 m -56.95 -47.42 80.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -1.199 . . . . 1.1000000000000001 109.5 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 88' ' ' ILE . 46.3 mt -57.39 -47.56 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 1.21 109.273 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.65 -47.12 83.14 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.662 -0.866 . . . . 1.3700000000000001 108.662 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 11.8 mt -57.26 -46.81 82.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 2.54 109.601 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' O ' HD11 ' A' ' 95' ' ' ILE . 42.4 mt -57.02 -47.13 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 1.3100000000000001 109.75 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -57.11 -47.74 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.674 -1.21 . . . . 1.3999999999999999 108.089 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -46.87 82.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.697 . . . . 3.3799999999999999 109.25 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.54 -46.22 88.58 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.943 -1.663 . . . . 1.29 108.943 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' O ' HG12 ' A' ' 99' ' ' ILE . 1.3 mp -56.26 -46.78 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -1.119 . . . . 2.6000000000000001 108.847 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.515 ' HD3' ' N ' ' A' ' 96' ' ' ARG . 9.4 mmt180 -56.88 -47.16 81.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.888 -1.133 . . . . 3.6600000000000001 108.726 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -46.96 82.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 4.1600000000000001 109.935 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -46.95 81.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 3.1499999999999999 108.752 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 46.7 pt -75.51 -14.32 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.383 -0.823 . . . . 2.3900000000000001 109.062 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 5.3 tttm -92.15 82.49 5.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 4.2000000000000002 109.663 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.971 -1.014 . . . . 6.79 109.338 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.438 ' O ' HG12 ' B' ' 62' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.466 -0.568 . . . . 20.579999999999998 109.466 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 143.21 5.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 18.100000000000001 109.391 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.22 37.01 1.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 17.890000000000001 109.663 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' B' ' 66' ' ' HIS . . . -111.61 34.16 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.118 -0.989 . . . . 15.779999999999999 109.694 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 0.3 OUTLIER 73.63 -150.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.944 . . . . 14.390000000000001 109.541 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -145.27 -149.79 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 13.77 109.373 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -120.28 172.61 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.978 . . . . 13.279999999999999 109.507 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.476 ' O ' ' CG ' ' B' ' 70' ' ' GLU . 38.8 m -59.58 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 8.2300000000000004 109.618 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' B' ' 69' ' ' SER . 86.7 mt-10 -157.92 99.45 1.82 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 7.29 109.391 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.64 59.21 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.168 1.912 . . . . 3.6600000000000001 110.453 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 72' ' ' GLU . 16.2 mt-10 -69.12 -69.26 0.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 2.8900000000000001 109.75 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.502 ' C ' ' CD1' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -52.47 -34.08 18.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.254 -0.904 . . . . 2.5800000000000001 109.208 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.484 ' N ' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -63.09 -47.0 84.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 1.99 109.425 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.576 HD22 ' CD2' ' B' ' 78' ' ' PHE . 3.7 tt -72.05 -47.23 53.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 2.1899999999999999 109.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.522 ' CD1' HD12 ' A' ' 75' ' ' LEU . 82.6 mt -57.19 -47.65 83.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.147 -0.971 . . . . 1.51 109.25 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.97 -47.73 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.207 -0.933 . . . . 2.48 108.854 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.576 ' CD2' HD22 ' B' ' 75' ' ' LEU . 0.0 OUTLIER -57.72 -46.93 83.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 3.52 109.261 179.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.463 ' C ' ' CG2' ' A' ' 80' ' ' VAL . . . -56.73 -47.14 87.75 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.763 -1.335 . . . . 0.34000000000000002 109.763 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 53.4 t -57.08 -47.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.987 -1.302 . . . . 1.1399999999999999 108.697 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 36.3 mmm -57.74 -47.06 83.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 2.4199999999999999 108.749 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.9 -46.25 82.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.64 -0.662 . . . . 1.1000000000000001 109.777 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.433 ' CA ' HG11 ' A' ' 80' ' ' VAL . . . -56.57 -47.21 85.94 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.148 -1.581 . . . . 0.28999999999999998 109.148 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.13 -47.51 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.021 -1.282 . . . . 1.1399999999999999 109.171 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.26 -46.95 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 1.6599999999999999 109.814 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -46.76 90.28 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.6 -1.4 . . . . 0.33000000000000002 109.6 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 84' ' ' VAL . 63.0 m -56.71 -47.06 80.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.162 -1.199 . . . . 1.0900000000000001 109.309 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.476 HG22 HD11 ' B' ' 88' ' ' ILE . 68.2 mt -56.96 -47.24 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 1.1399999999999999 109.022 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.509 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.17 -46.84 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 1.72 108.998 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.9 -46.84 81.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.88 . . . . 2.6200000000000001 109.312 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.539 ' O ' ' CD1' ' B' ' 95' ' ' ILE . 79.8 mt -56.73 -46.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.185 -0.947 . . . . 1.3899999999999999 108.99 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -56.62 -47.38 79.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.984 -1.073 . . . . 1.76 108.661 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' B' ' 96' ' ' ARG . 0.7 OUTLIER -57.4 -47.4 81.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 2.7799999999999998 109.19 179.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.7 -47.38 88.93 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.487 -1.445 . . . . 1.24 109.487 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.539 ' CD1' ' O ' ' B' ' 91' ' ' ILE . 1.4 mp -57.47 -47.84 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -1.08 . . . . 2.29 110.562 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' B' ' 93' ' ' TYR . 7.0 ptp180 -57.5 -46.79 83.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.851 -1.156 . . . . 3.1099999999999999 109.291 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' B' ' 100' ' ' LYS . 22.7 ttp180 -57.1 -46.82 82.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 3.71 109.818 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -47.04 80.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.07 -1.019 . . . . 2.5600000000000001 109.134 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 42.3 pt -72.26 -26.74 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 2.7200000000000002 109.133 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' B' ' 101' ' ' LYS . 5.8 tmtm? -109.14 102.21 11.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 5.5700000000000003 109.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.964 -1.017 . . . . 7.8300000000000001 109.371 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 32.7 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.356 -0.609 . . . . 19.079999999999998 109.356 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 11.6 pt20 39.31 96.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.498 0.666 . . . . 16.93 110.55 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -9.05 36.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 17.030000000000001 109.205 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 66' ' ' HIS . . . -82.77 90.12 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 14.640000000000001 109.673 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 6.4 m170 71.04 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 14.630000000000001 109.488 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.74 -154.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 11.25 109.406 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.77 156.18 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 12.35 109.523 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 t -110.58 94.14 4.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 7.4199999999999999 109.595 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.6 OUTLIER -46.21 -53.2 23.88 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 6.4900000000000002 110.093 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 5.9 Cg_exo -58.91 73.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.751 . . . . 3.25 110.445 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' CG ' HD13 ' A' ' 76' ' ' ILE . 66.0 tt0 -64.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 3.0099999999999998 109.6 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -42.46 -31.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.341 -0.849 . . . . 2.0499999999999998 109.767 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.513 ' O ' HG21 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -65.11 -46.81 79.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 1.8400000000000001 109.888 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' CD1' HD11 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -76.09 -47.37 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.6399999999999999 110.259 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.536 HD13 ' CG ' ' A' ' 72' ' ' GLU . 72.3 mt -57.58 -48.24 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.676 -1.265 . . . . 1.6599999999999999 109.457 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 78' ' ' PHE . 19.8 tt -58.28 -47.58 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 2.0699999999999998 108.975 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.525 ' N ' HG22 ' A' ' 77' ' ' ILE . 8.9 m-30 -57.5 -47.11 82.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 2.8900000000000001 109.812 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.47 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -57.1 -47.28 88.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.7 -1.36 . . . . 0.35999999999999999 109.7 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.501 ' CG2' ' C ' ' B' ' 79' ' ' GLY . 56.4 t -57.37 -47.59 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.046 -1.267 . . . . 1.1000000000000001 109.148 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -57.61 -47.1 83.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 2.23 109.323 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.42 82.54 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.514 -0.741 . . . . 1.1000000000000001 109.892 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.34 87.27 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.371 -1.492 . . . . 0.29999999999999999 109.371 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.1 -47.37 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.121 -1.223 . . . . 1.0900000000000001 109.74 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.32 -46.91 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 1.9099999999999999 110.008 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.05 90.46 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.849 -1.3 . . . . 0.38 109.849 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.514 ' CG2' ' CG2' ' B' ' 87' ' ' THR . 17.0 m -57.24 -47.3 81.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -1.214 . . . . 1.1000000000000001 109.348 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.22 -47.08 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 1.21 109.208 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.0 -46.8 82.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 1.3700000000000001 109.108 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.53 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 32.3 mt -57.01 -47.06 81.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 2.54 109.672 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.485 ' CG2' HD13 ' A' ' 95' ' ' ILE . 95.9 mt -57.16 -47.19 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 1.3100000000000001 109.141 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.09 -47.43 81.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.212 -1.033 . . . . 1.3999999999999999 108.212 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -57.47 -47.55 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 3.3799999999999999 109.253 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.33 -47.25 89.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.266 -1.533 . . . . 1.29 109.266 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.485 HD13 ' CG2' ' A' ' 91' ' ' ILE . 1.3 mp -57.08 -47.03 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.104 . . . . 2.6000000000000001 108.677 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' O ' ' CG1' ' A' ' 99' ' ' ILE . 10.4 mtm180 -57.05 -47.04 81.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 3.6600000000000001 109.276 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.17 -46.83 82.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 4.1600000000000001 109.839 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -46.95 81.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 3.1499999999999999 109.074 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 30.8 pt -73.15 -39.0 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 2.3900000000000001 109.763 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' N ' HG13 ' A' ' 99' ' ' ILE . 1.2 mttm -97.9 -166.98 1.45 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 4.2000000000000002 109.765 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.031 -0.985 . . . . 6.79 109.459 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.427 -0.583 . . . . 20.579999999999998 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.426 ' C ' HD22 ' B' ' 64' ' ' LEU . 23.7 tt0 -158.32 143.12 16.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 18.100000000000001 109.268 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.426 HD22 ' C ' ' B' ' 63' ' ' GLN . 0.0 OUTLIER -144.78 55.48 1.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 17.890000000000001 109.595 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.7 66.74 1.4 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.088 -1.007 . . . . 15.779999999999999 109.425 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -92.06 116.93 29.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 14.390000000000001 109.525 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -123.37 101.38 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.858 . . . . 13.77 109.094 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.83 84.93 6.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 13.279999999999999 109.723 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.67 5.06 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.938 . . . . 8.2300000000000004 109.446 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.6 ' N ' ' CD ' ' B' ' 71' ' ' PRO . 1.0 OUTLIER -76.95 -45.18 2.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 7.29 110.562 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' B' ' 70' ' ' GLU . 1.8 Cg_endo -65.17 55.57 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.658 1.572 . . . . 3.6600000000000001 110.695 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -72.37 -71.97 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 2.8900000000000001 109.219 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.8 OUTLIER -50.54 -36.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 2.5800000000000001 109.456 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.404 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 58.9 p -62.27 -47.13 85.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 1.99 109.587 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.524 ' CD1' HD12 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -70.24 -47.08 62.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 2.1899999999999999 109.612 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 75' ' ' LEU . 81.8 mt -57.03 -47.59 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.837 -1.164 . . . . 1.51 108.594 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.75 -47.29 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.302 -0.873 . . . . 2.48 108.736 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.26 -47.3 81.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 3.52 109.535 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.501 ' C ' ' CG2' ' A' ' 80' ' ' VAL . . . -56.89 -47.49 86.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.505 . . . . 0.34000000000000002 109.336 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 60.4 t -57.32 -47.64 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 108.663 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.1 mmm -57.74 -47.04 83.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.424 -0.798 . . . . 2.4199999999999999 108.968 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.56 82.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.534 -0.729 . . . . 1.1000000000000001 109.86 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.68 85.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.763 -1.735 . . . . 0.28999999999999998 108.763 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.39 -47.61 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 1.1399999999999999 108.931 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.37 -47.0 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.82 . . . . 1.6599999999999999 110.031 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' B' ' 89' ' ' LEU . . . -56.93 -47.21 88.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.626 -1.39 . . . . 0.33000000000000002 109.626 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.514 ' CG2' ' CG2' ' A' ' 87' ' ' THR . 78.5 m -57.28 -47.26 81.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.276 . . . . 1.0900000000000001 108.588 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.23 -46.96 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.443 -0.786 . . . . 1.1399999999999999 109.216 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.3 OUTLIER -56.93 -46.47 82.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 1.72 109.25 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.543 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.08 -47.25 81.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 2.6200000000000001 108.893 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.469 HG21 HD13 ' B' ' 95' ' ' ILE . 65.5 mt -57.12 -47.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.185 -0.947 . . . . 1.3899999999999999 109.115 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.06 -47.36 81.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.122 -0.987 . . . . 1.76 108.427 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -47.47 81.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 2.7799999999999998 109.494 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.52 87.61 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.119 -1.592 . . . . 1.24 109.119 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.485 ' O ' HG12 ' B' ' 99' ' ' ILE . 1.1 mt -57.21 -47.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -1.06 . . . . 2.29 108.943 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.536 ' O ' HG13 ' B' ' 99' ' ' ILE . 2.8 tpp180 -57.07 -46.89 82.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 3.1099999999999999 109.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -46.66 82.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.859 -1.15 . . . . 3.71 109.453 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mt -56.78 -46.85 81.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 2.5600000000000001 109.548 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.536 HG13 ' O ' ' B' ' 96' ' ' ARG . 3.9 pt -82.27 -119.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.112 -0.992 . . . . 2.7200000000000002 109.199 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' B' ' 101' ' ' LYS . 0.1 OUTLIER 43.38 81.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.841 -1.162 . . . . 5.5700000000000003 109.683 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.047 -0.978 . . . . 7.8300000000000001 109.445 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 63' ' ' GLN . 8.1 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.337 0.589 . . . . 19.079999999999998 109.443 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.555 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 5.5 tp60 -94.32 -160.8 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 16.93 109.086 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.555 ' CB ' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 80.44 7.16 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 17.030000000000001 109.398 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 66' ' ' HIS . . . -90.59 30.46 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 14.640000000000001 109.515 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.59 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 39.8 m80 66.82 8.42 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 14.630000000000001 109.783 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 18.4 p80 40.56 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.498 -0.751 . . . . 11.25 110.105 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' HIS . 0.3 OUTLIER -42.77 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 12.35 109.433 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 1.9 m -105.85 -94.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.987 . . . . 7.4199999999999999 109.764 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.83 -57.56 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 6.4900000000000002 109.882 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.9 Cg_exo -54.82 -75.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.026 1.817 . . . . 3.25 110.336 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 75' ' ' LEU . 4.4 mt-10 34.25 -131.5 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.804 -0.56 . . . . 3.0099999999999998 110.89 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -36.75 -47.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 2.0499999999999998 109.881 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 3.1 p -55.2 -46.19 75.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 1.8400000000000001 108.801 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -71.76 -46.93 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.006 . . . . 1.6399999999999999 110.04 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' B' ' 75' ' ' LEU . 59.7 mt -57.35 -48.35 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.719 -1.238 . . . . 1.6599999999999999 110.116 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 HG21 ' O ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -58.23 -47.65 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.838 -1.164 . . . . 2.0699999999999998 108.487 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.26 -47.08 82.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.804 -0.56 . . . . 2.8900000000000001 109.965 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -56.91 -47.41 86.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.595 -1.402 . . . . 0.35999999999999999 109.595 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.516 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 61.4 t -57.41 -47.66 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.254 . . . . 1.1000000000000001 108.626 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.3 mmt -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.716 -0.846 . . . . 2.23 108.716 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.32 82.52 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.634 -0.666 . . . . 1.1000000000000001 109.839 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.52 85.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.838 -1.705 . . . . 0.29999999999999999 108.838 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG11 ' OG1' ' B' ' 87' ' ' THR . 61.6 t -57.39 -47.49 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.255 . . . . 1.0900000000000001 108.908 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.9 mt -57.2 -47.07 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.414 -0.804 . . . . 1.9099999999999999 109.798 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.65 -46.92 88.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.546 -1.422 . . . . 0.38 109.546 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 m -56.97 -47.26 81.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.078 -1.248 . . . . 1.1000000000000001 108.837 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.4 mt -57.23 -47.16 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.85 . . . . 1.21 109.184 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.2 -46.95 82.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.806 . . . . 1.3700000000000001 109.017 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 18.2 mt -56.92 -46.89 81.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 2.54 109.074 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' O ' HD11 ' A' ' 95' ' ' ILE . 33.6 mt -56.85 -46.78 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 1.3100000000000001 109.127 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.3 80.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.087 -1.008 . . . . 1.3999999999999999 108.536 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -47.53 81.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 3.3799999999999999 108.897 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.54 -47.15 90.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.172 -1.571 . . . . 1.29 109.172 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.505 ' O ' HG12 ' A' ' 99' ' ' ILE . 1.5 mt -57.02 -46.91 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -1.013 . . . . 2.6000000000000001 109.142 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -56.67 -46.62 81.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 3.6600000000000001 109.079 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.66 81.96 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.94 -1.1 . . . . 4.1600000000000001 109.205 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.66 -47.03 80.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 3.1499999999999999 109.325 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 96' ' ' ARG . 6.3 pt -82.03 -118.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 2.3900000000000001 108.703 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER 61.19 141.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.617 -1.302 . . . . 4.2000000000000002 109.704 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mttt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.977 -1.011 . . . . 6.79 109.498 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.459 HG13 ' HG3' ' B' ' 63' ' ' GLN . 45.8 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.442 -0.577 . . . . 20.579999999999998 109.442 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.459 ' HG3' HG13 ' B' ' 62' ' ' VAL . 2.5 pp0? -172.12 163.52 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 18.100000000000001 109.4 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.68 57.41 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 17.890000000000001 109.581 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.22 32.63 1.69 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.082 -1.011 . . . . 15.779999999999999 109.527 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.58 166.71 11.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 14.390000000000001 109.266 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 m170 55.29 72.22 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 13.77 109.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -59.02 -169.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 13.279999999999999 109.685 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.2 p -168.56 -163.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 8.2300000000000004 109.519 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.518 ' CB ' ' HD2' ' B' ' 71' ' ' PRO . 0.7 OUTLIER -125.27 172.92 5.46 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 7.29 109.259 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' B' ' 70' ' ' GLU . 4.4 Cg_exo -57.73 134.1 60.64 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.17 1.913 . . . . 3.6600000000000001 110.402 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.15 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.436 -0.79 . . . . 2.8900000000000001 110.586 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.528 HD11 ' N ' ' B' ' 74' ' ' THR . 0.0 OUTLIER -43.08 -38.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.101 -0.999 . . . . 2.5800000000000001 110.33 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.53 ' O ' HG21 ' B' ' 77' ' ' ILE . 19.6 m -63.46 -46.78 84.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 1.99 109.713 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -76.32 -47.15 24.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.982 -1.074 . . . . 2.1899999999999999 109.662 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.469 HG12 ' CG1' ' A' ' 76' ' ' ILE . 58.3 mt -57.26 -48.24 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.926 -1.109 . . . . 1.51 109.329 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.53 HG21 ' O ' ' B' ' 74' ' ' THR . 0.6 OUTLIER -57.98 -47.24 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.979 -1.076 . . . . 2.48 108.618 178.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.529 ' N ' HG22 ' B' ' 77' ' ' ILE . 1.5 m-85 -57.24 -47.14 82.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.525 -0.734 . . . . 3.52 109.861 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.516 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -57.13 -47.38 88.03 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.776 -1.33 . . . . 0.34000000000000002 109.776 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 65.8 t -57.37 -47.57 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.002 -1.293 . . . . 1.1399999999999999 109.065 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' MET . . . . . 0.464 ' O ' HG13 ' B' ' 85' ' ' ILE . 4.7 mtm -57.62 -47.21 82.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.309 -0.869 . . . . 2.4199999999999999 108.945 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.39 82.76 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.546 -0.722 . . . . 1.1000000000000001 109.913 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.56 86.15 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.476 -1.45 . . . . 0.28999999999999998 109.476 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.38 -47.56 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.31 . . . . 1.1399999999999999 109.004 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.464 HG13 ' O ' ' B' ' 81' ' ' MET . 63.8 mt -57.33 -46.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 1.6599999999999999 109.759 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.01 90.36 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.836 -1.306 . . . . 0.33000000000000002 109.836 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.418 ' OG1' HG11 ' A' ' 84' ' ' VAL . 40.5 m -57.04 -47.44 80.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.973 -1.31 . . . . 1.0900000000000001 108.918 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 35.1 mt -57.4 -46.98 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 1.1399999999999999 108.803 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -56.95 -46.59 82.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.029 -0.73 . . . . 1.72 109.029 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.541 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER -56.67 -46.97 80.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.238 -0.914 . . . . 2.6200000000000001 109.145 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.478 ' O ' HD11 ' B' ' 95' ' ' ILE . 82.3 mt -57.03 -47.02 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.124 -0.985 . . . . 1.3899999999999999 109.074 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 14.8 m -57.01 -47.3 81.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.033 -1.042 . . . . 1.76 108.471 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -47.38 81.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 2.7799999999999998 108.863 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.2 89.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.175 -1.57 . . . . 1.24 109.175 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.478 HD11 ' O ' ' B' ' 91' ' ' ILE . 1.3 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -1.088 . . . . 2.29 108.908 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.488 ' O ' HG13 ' B' ' 99' ' ' ILE . 3.9 mtm180 -57.01 -47.08 81.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 3.1099999999999999 108.937 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -46.65 82.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.211 -0.931 . . . . 3.71 109.601 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.57 -46.85 80.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 2.5600000000000001 109.305 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.527 HG13 ' N ' ' B' ' 100' ' ' LYS . 21.6 pt -77.06 -125.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.203 -0.936 . . . . 2.7200000000000002 108.638 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.527 ' N ' HG13 ' B' ' 99' ' ' ILE . 8.3 tptt 43.53 64.79 1.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.88 -1.138 . . . . 5.5700000000000003 109.491 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 28.8 mttm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.001 -1.0 . . . . 7.8300000000000001 109.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.406 -0.59 . . . . 19.079999999999998 109.406 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -113.35 121.3 43.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 16.93 109.536 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mt -114.31 179.99 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 17.030000000000001 109.405 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 66.32 15.26 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 14.640000000000001 109.45 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 171.0 7.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 14.630000000000001 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.44 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 11.25 109.5 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -79.29 156.46 28.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 12.35 109.36 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 t -107.27 104.27 13.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 7.4199999999999999 109.297 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -43.97 -54.22 11.57 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 6.4900000000000002 109.707 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.0 Cg_endo -63.55 57.73 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.086 1.857 . . . . 3.25 110.285 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 70' ' ' GLU . 7.8 mt-10 -66.15 -49.18 68.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 3.0099999999999998 109.734 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.526 HD11 ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.68 -39.03 80.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.257 -0.902 . . . . 2.0499999999999998 109.594 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.535 ' OG1' ' CB ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -61.69 -46.99 87.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.969 -1.082 . . . . 1.8400000000000001 109.006 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' B' ' 76' ' ' ILE . 1.4 mt -66.96 -46.65 74.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 1.6399999999999999 109.16 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.584 ' CG1' ' CD2' ' B' ' 75' ' ' LEU . 26.8 mt -56.66 -47.68 81.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.059 -1.025 . . . . 1.6599999999999999 108.899 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 73' ' ' ILE . 35.8 mt -57.72 -47.88 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.091 -1.006 . . . . 2.0699999999999998 109.338 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.92 -48.43 79.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 2.8900000000000001 109.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.54 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.91 -47.34 89.56 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.104 -1.598 . . . . 0.35999999999999999 109.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.547 HG11 ' CA ' ' B' ' 83' ' ' GLY . 44.9 t -57.17 -47.26 84.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.708 -0.878 . . . . 1.1000000000000001 109.934 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 mmm -57.16 -47.32 81.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 2.23 109.153 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.41 82.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.374 -0.829 . . . . 1.1000000000000001 109.41 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.487 ' HA3' HG11 ' B' ' 80' ' ' VAL . . . -57.0 -47.1 90.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.936 -1.266 . . . . 0.29999999999999999 109.936 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.15 -47.49 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.251 . . . . 1.0900000000000001 109.619 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -57.29 -47.22 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 1.9099999999999999 109.565 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.13 -46.9 91.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.97 -1.252 . . . . 0.38 109.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.521 HG23 ' CG2' ' B' ' 87' ' ' THR . 74.7 m -56.88 -47.17 81.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -1.182 . . . . 1.1000000000000001 109.209 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.14 -46.94 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 1.21 108.901 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.14 -46.74 82.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 1.3700000000000001 109.066 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 9.5 tt -56.85 -46.88 81.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 2.54 109.494 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -57.03 -46.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.993 . . . . 1.3100000000000001 108.905 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -47.39 81.2 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.093 -1.005 . . . . 1.3999999999999999 108.399 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -57.3 -47.54 81.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 3.3799999999999999 109.196 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.31 -46.98 91.2 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.036 -1.626 . . . . 1.29 109.036 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' HG12 ' A' ' 99' ' ' ILE . 2.2 mt -57.05 -46.82 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 2.6000000000000001 108.86 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.533 ' O ' ' CG1' ' A' ' 99' ' ' ILE . 34.1 ttp180 -56.93 -47.07 81.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 3.6600000000000001 109.291 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -57.32 -46.88 82.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 4.1600000000000001 109.891 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -56.84 -46.95 81.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 3.1499999999999999 108.777 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 34.5 pt -72.59 -19.71 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.91 . . . . 2.3900000000000001 109.167 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -110.07 84.68 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 4.2000000000000002 109.565 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.977 -1.011 . . . . 6.79 109.385 -179.898 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.687 -0.486 . . . . 20.579999999999998 109.687 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.83 121.04 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 18.100000000000001 109.513 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.71 109.35 0.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 17.890000000000001 109.39 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.59 22.44 9.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.002 -1.061 . . . . 15.779999999999999 109.543 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 46.19 68.05 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 14.390000000000001 109.541 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.69 -165.5 2.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 13.77 109.415 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.43 ' CE1' ' OE1' ' B' ' 70' ' ' GLU . 1.1 p90 -61.73 -171.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 13.279999999999999 109.349 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 22.5 m -127.98 104.36 7.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 8.2300000000000004 109.604 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.518 ' CG ' ' HD2' ' B' ' 71' ' ' PRO . 0.1 OUTLIER -64.48 174.12 1.31 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 7.29 109.444 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' B' ' 70' ' ' GLU . 2.4 Cg_endo -62.92 -53.07 1.78 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.982 1.788 . . . . 3.6600000000000001 110.303 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -48.61 -56.21 9.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 2.8900000000000001 109.967 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.549 HG21 ' N ' ' B' ' 74' ' ' THR . 0.3 OUTLIER -56.9 -33.4 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.949 -1.095 . . . . 2.5800000000000001 109.54 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.549 ' N ' HG21 ' B' ' 73' ' ' ILE . 21.0 m -62.08 -47.02 86.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.238 -0.914 . . . . 1.99 109.135 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.584 ' CD2' ' CG1' ' A' ' 76' ' ' ILE . 2.8 tt -67.27 -47.23 71.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 2.1899999999999999 109.343 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.527 ' CD1' HD23 ' A' ' 75' ' ' LEU . 45.5 mt -57.12 -47.42 83.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.975 -1.078 . . . . 1.51 108.634 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.514 ' N ' HD11 ' B' ' 77' ' ' ILE . 1.5 mp -57.46 -47.56 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 2.48 109.416 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.52 -48.13 80.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.975 -1.078 . . . . 3.52 109.529 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.542 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . -57.73 -47.38 89.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.009 -1.636 . . . . 0.34000000000000002 109.009 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.54 HG21 ' CA ' ' A' ' 79' ' ' GLY . 46.2 t -57.43 -47.14 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.644 -0.915 . . . . 1.1399999999999999 109.733 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.5 mmt -56.95 -46.97 81.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 2.4199999999999999 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.36 81.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 1.1000000000000001 109.361 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.547 ' CA ' HG11 ' A' ' 80' ' ' VAL . . . -56.99 -47.16 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.618 -1.393 . . . . 0.28999999999999998 109.618 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.408 ' O ' HG13 ' B' ' 88' ' ' ILE . 5.3 t -57.02 -47.52 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.283 . . . . 1.1399999999999999 109.241 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.27 -47.07 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.6599999999999999 109.669 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.08 89.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.425 -1.47 . . . . 0.33000000000000002 109.425 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 87' ' ' THR . 91.6 m -57.14 -47.07 82.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -1.156 . . . . 1.0900000000000001 108.975 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.476 HG22 HD11 ' B' ' 88' ' ' ILE . 37.1 mt -57.11 -47.03 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 1.1399999999999999 109.14 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -56.81 -46.95 81.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.307 -0.871 . . . . 1.72 109.0 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.517 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 6.7 mt -56.8 -47.12 80.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 2.6200000000000001 109.06 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 87' ' ' THR . 53.8 mt -57.12 -47.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 1.3899999999999999 109.405 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 89' ' ' LEU . 91.4 p -57.29 -47.77 80.64 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.037 . . . . 1.76 108.651 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -47.66 81.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 2.7799999999999998 109.231 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.61 -47.27 89.58 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.301 -1.52 . . . . 1.24 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.448 ' O ' HG12 ' B' ' 99' ' ' ILE . 1.9 mm -57.16 -47.31 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.324 -1.104 . . . . 2.29 108.66 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.535 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 5.3 mtm180 -57.36 -47.26 82.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 3.1099999999999999 109.206 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 100' ' ' LYS . 1.2 tmt_? -57.52 -47.12 82.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 3.71 109.883 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 50.0 mt -57.02 -47.0 81.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.989 . . . . 2.5600000000000001 109.295 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 32.9 pt -71.2 -35.87 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 2.7200000000000002 109.653 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 97' ' ' ARG . 4.4 tptp -117.79 120.54 38.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 5.5700000000000003 109.814 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.994 -1.003 . . . . 7.8300000000000001 109.533 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.475 -0.565 . . . . 19.079999999999998 109.475 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -165.59 119.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 16.93 109.491 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -18.05 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 17.030000000000001 109.516 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.83 -15.08 10.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 14.640000000000001 109.596 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -110.36 104.8 13.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.904 . . . . 14.630000000000001 109.616 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 67' ' ' HIS . 47.4 p-80 -166.87 121.17 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 11.25 109.459 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.1 15.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.913 . . . . 12.35 109.564 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -128.66 29.23 5.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 7.4199999999999999 109.425 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.542 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -78.47 -53.37 1.29 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 6.4900000000000002 110.375 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 4.8 Cg_exo -61.38 -11.19 18.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.103 1.869 . . . . 3.25 110.981 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 73' ' ' ILE . 15.9 pt-20 -60.68 -47.39 86.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 3.0099999999999998 109.322 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.533 ' N ' ' CG ' ' A' ' 72' ' ' GLU . 5.7 tp -63.25 -44.7 99.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.141 -0.974 . . . . 2.0499999999999998 109.353 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -53.64 -46.89 70.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 1.8400000000000001 109.816 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.521 ' CD1' HD11 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -69.09 -47.16 65.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.02 -1.05 . . . . 1.6399999999999999 109.908 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.559 HD12 ' CD1' ' B' ' 75' ' ' LEU . 61.6 mt -57.11 -47.7 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.909 -1.119 . . . . 1.6599999999999999 108.754 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 73' ' ' ILE . 1.1 mp -57.66 -47.11 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.327 -0.99 . . . . 2.0699999999999998 108.327 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.24 -47.28 81.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 2.8900000000000001 109.83 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.06 -47.38 87.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.178 -1.569 . . . . 0.35999999999999999 109.178 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 48.4 t -57.59 -47.5 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -1.162 . . . . 1.1000000000000001 109.238 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 85.0 mtp -57.63 -47.35 82.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 2.23 109.303 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.53 82.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 1.1000000000000001 109.876 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.99 -47.42 87.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.529 -1.429 . . . . 0.29999999999999999 109.529 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.28 -47.48 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 1.0900000000000001 109.495 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 HG21 HD11 ' A' ' 85' ' ' ILE . 33.4 mm -57.28 -47.41 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 1.9099999999999999 110.081 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.24 -47.19 89.66 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.38 109.642 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.465 HG23 ' CG2' ' B' ' 87' ' ' THR . 98.1 m -57.16 -47.14 81.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -1.194 . . . . 1.1000000000000001 109.537 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 88' ' ' ILE . 64.4 mt -56.97 -47.23 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 1.21 109.536 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -57.18 -46.55 82.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 109.044 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 8.7 mt -57.13 -47.0 82.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 2.54 109.461 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.482 ' CD1' ' CD1' ' B' ' 91' ' ' ILE . 89.2 mt -56.86 -47.16 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 1.3100000000000001 109.453 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.495 ' O ' HG23 ' A' ' 95' ' ' ILE . 1.4 m -57.16 -47.69 80.55 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.922 -1.111 . . . . 1.3999999999999999 108.487 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -47.48 82.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.071 -1.018 . . . . 3.3799999999999999 109.611 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.36 88.77 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.16 -1.176 . . . . 1.29 110.16 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 96' ' ' ARG . 1.5 tp -57.07 -46.95 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -1.227 . . . . 2.6000000000000001 108.983 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.538 ' O ' HG13 ' A' ' 99' ' ' ILE . 19.2 mtp180 -56.87 -46.82 81.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 3.6600000000000001 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -46.96 82.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.867 -1.146 . . . . 4.1600000000000001 109.365 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -46.97 81.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 3.1499999999999999 109.139 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -82.77 -103.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.376 -0.828 . . . . 2.3900000000000001 109.286 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 1.3 tptt 48.27 31.17 2.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.901 -1.125 . . . . 4.2000000000000002 109.786 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 tptp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.944 -1.027 . . . . 6.79 109.471 179.854 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.3 0.571 . . . . 20.579999999999998 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.83 149.4 23.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 18.100000000000001 109.637 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 168.04 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 17.890000000000001 109.461 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.69 130.75 38.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.196 -0.94 . . . . 15.779999999999999 109.339 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -115.49 137.17 52.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 14.390000000000001 109.541 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -127.6 11.52 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 13.77 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.427 ' O ' ' CB ' ' B' ' 69' ' ' SER . 2.6 m-85 -106.56 35.9 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 13.279999999999999 109.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' B' ' 68' ' ' PHE . 2.6 p 170.38 86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 8.2300000000000004 109.511 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -156.86 154.32 26.26 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 7.29 109.345 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.457 ' O ' ' HB ' ' B' ' 74' ' ' THR . 2.1 Cg_endo -62.07 -21.72 72.94 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.166 1.911 . . . . 3.6600000000000001 109.999 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -48.43 -65.63 0.53 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.88 . . . . 2.8900000000000001 109.473 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.494 ' O ' HG12 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -46.67 -40.89 4.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.277 -0.89 . . . . 2.5800000000000001 109.616 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.524 ' O ' HG12 ' B' ' 77' ' ' ILE . 58.8 m -56.28 -46.94 79.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 1.99 109.698 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.559 ' CD1' HD12 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -69.83 -46.82 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 2.1899999999999999 109.52 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.528 ' CG1' HG12 ' A' ' 76' ' ' ILE . 66.3 mt -57.07 -47.8 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.896 -1.127 . . . . 1.51 109.532 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.538 HG13 ' N ' ' B' ' 78' ' ' PHE . 33.7 pt -57.91 -47.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.876 -1.14 . . . . 2.48 108.721 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.538 ' N ' HG13 ' B' ' 77' ' ' ILE . 8.7 m-85 -57.35 -47.05 82.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 3.52 109.505 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.432 ' C ' HG21 ' A' ' 80' ' ' VAL . . . -56.95 -47.14 89.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.525 -1.43 . . . . 0.34000000000000002 109.525 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 69.7 t -57.1 -47.67 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.24 . . . . 1.1399999999999999 109.189 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' MET . . . . . 0.458 ' O ' HG13 ' B' ' 85' ' ' ILE . 63.6 mtm -57.57 -47.22 82.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 2.4199999999999999 108.95 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.26 82.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.616 -0.678 . . . . 1.1000000000000001 109.672 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.22 86.31 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.28999999999999998 109.34 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.02 -47.47 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 109.191 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 81' ' ' MET . 30.7 mt -57.27 -47.12 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 1.6599999999999999 109.633 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.95 90.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.663 -1.375 . . . . 0.33000000000000002 109.663 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.465 ' CG2' HG23 ' A' ' 87' ' ' THR . 41.4 m -56.93 -47.03 81.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -1.197 . . . . 1.0900000000000001 109.37 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 91.7 mt -57.06 -47.08 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.088 -1.008 . . . . 1.1399999999999999 108.724 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.503 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.04 -46.77 82.15 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.363 -0.977 . . . . 1.72 108.363 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.503 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 94.6 mt -56.68 -46.56 81.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 2.6200000000000001 109.154 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.482 ' CD1' ' CD1' ' A' ' 91' ' ' ILE . 88.6 mt -56.56 -46.9 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 1.3899999999999999 109.191 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.56 ' O ' ' CG2' ' B' ' 95' ' ' ILE . 5.8 m -56.84 -47.43 80.35 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.893 -1.129 . . . . 1.76 108.185 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -47.63 81.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.854 -1.154 . . . . 2.7799999999999998 109.034 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.84 85.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.785 -0.926 . . . . 1.24 110.785 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.56 ' CG2' ' O ' ' B' ' 92' ' ' SER . 1.2 tt -57.27 -46.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.935 -1.332 . . . . 2.29 109.302 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.467 ' HA ' ' CG1' ' B' ' 99' ' ' ILE . 3.9 mtm180 -56.9 -47.05 81.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.172 -0.955 . . . . 3.1099999999999999 109.388 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -46.88 82.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 3.71 109.679 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.71 -46.85 81.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.934 . . . . 2.5600000000000001 108.971 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.525 HG13 ' N ' ' B' ' 100' ' ' LYS . 35.7 pt -76.61 -130.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.401 -0.812 . . . . 2.7200000000000002 108.847 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.525 ' N ' HG13 ' B' ' 99' ' ' ILE . 3.5 ttpt 56.3 161.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.939 -1.101 . . . . 5.5700000000000003 109.748 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' B' ' 100' ' ' LYS . 3.3 mttm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.022 -0.99 . . . . 7.8300000000000001 109.52 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 42.7 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.366 -0.605 . . . . 19.079999999999998 109.366 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 7.8 tp-100 71.13 172.81 0.31 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 16.93 109.361 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 81.34 -4.82 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.756 . . . . 17.030000000000001 109.574 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' HIS . . . -93.8 -26.63 16.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 14.640000000000001 109.257 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 65' ' ' ALA . 1.7 m-70 54.74 170.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 14.630000000000001 109.737 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.2 23.23 0.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -0.859 . . . . 11.25 109.236 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 51.1 -176.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 12.35 109.404 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m 58.39 86.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 7.4199999999999999 109.262 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -144.77 92.3 5.9 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 6.4900000000000002 109.581 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 5.0 Cg_exo -59.09 92.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.139 1.893 . . . . 3.25 109.966 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HG3' ' CD1' ' B' ' 75' ' ' LEU . 74.2 tt0 -68.44 -81.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 3.0099999999999998 109.878 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -45.43 -31.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.124 -0.985 . . . . 2.0499999999999998 110.109 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -68.04 -47.13 69.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.092 -1.005 . . . . 1.8400000000000001 109.847 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.539 ' CD2' HD12 ' B' ' 76' ' ' ILE . 6.9 mt -74.28 -47.25 36.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 1.6399999999999999 109.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' B' ' 75' ' ' LEU . 26.7 mt -57.14 -47.91 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 118.868 -1.133 . . . . 1.6599999999999999 108.579 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 73' ' ' ILE . 16.5 mm -58.12 -47.92 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.474 -0.89 . . . . 2.0699999999999998 109.336 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -57.86 -47.84 81.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.329 -0.857 . . . . 2.8900000000000001 110.029 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.566 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.5 -47.41 88.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.35999999999999999 109.908 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.541 HG21 ' CA ' ' B' ' 79' ' ' GLY . 48.7 t -57.25 -47.3 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -1.128 . . . . 1.1000000000000001 109.037 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.1 mmm -57.41 -47.32 82.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 2.23 108.72 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -57.29 -46.68 82.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -0.797 . . . . 1.1000000000000001 109.749 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' HG12 ' B' ' 80' ' ' VAL . . . -57.22 -47.35 88.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.376 -1.49 . . . . 0.29999999999999999 109.376 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.35 -47.26 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -1.172 . . . . 1.0900000000000001 109.644 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.2 OUTLIER -57.09 -47.17 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 1.9099999999999999 109.599 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.03 -47.16 89.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.28 -1.528 . . . . 0.38 109.28 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.0 m -57.17 -46.96 82.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -1.105 . . . . 1.1000000000000001 109.158 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.05 -47.0 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 1.21 109.11 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.97 -47.02 81.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 1.3700000000000001 108.985 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tp -57.17 -47.24 81.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.187 -0.946 . . . . 2.54 109.285 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.441 HG21 HD13 ' A' ' 95' ' ' ILE . 91.6 mt -57.24 -47.29 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 1.3100000000000001 109.374 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.8 m -57.26 -47.57 81.07 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.073 -1.017 . . . . 1.3999999999999999 108.603 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.51 -47.68 81.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 3.3799999999999999 109.387 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.42 -47.5 87.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.623 . . . . 1.29 109.041 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.452 ' O ' HG12 ' A' ' 99' ' ' ILE . 1.4 mt -57.4 -47.36 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -1.073 . . . . 2.6000000000000001 108.841 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 99' ' ' ILE . 6.1 mtm180 -57.21 -47.06 82.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.865 . . . . 3.6600000000000001 109.55 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.455 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 4.6 ttt180 -57.54 -47.3 82.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.995 -1.065 . . . . 4.1600000000000001 109.743 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -57.3 -46.72 82.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 3.1499999999999999 109.494 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -78.22 -81.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 2.3900000000000001 110.264 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 2.0 mtmt -94.44 125.09 38.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 4.2000000000000002 110.009 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.043 -0.98 . . . . 6.79 109.459 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.481 -0.562 . . . . 20.579999999999998 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.474 ' OE1' ' CB ' ' B' ' 65' ' ' ALA . 1.7 pp0? -124.19 153.57 41.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 18.100000000000001 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 94.39 9.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 17.890000000000001 109.553 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.474 ' CB ' ' OE1' ' B' ' 63' ' ' GLN . . . -123.37 17.7 9.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.178 -0.952 . . . . 15.779999999999999 109.432 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 0.0 OUTLIER 170.21 142.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 14.390000000000001 109.397 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 81.29 1.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 13.77 109.515 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 48.6 -171.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 13.279999999999999 109.505 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.29 2.4 5.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 8.2300000000000004 109.548 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.48 ' O ' HG23 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -115.48 115.23 42.25 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 7.29 109.265 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.84 -27.89 85.53 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.911 1.741 . . . . 3.6600000000000001 110.456 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.77 -53.61 48.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 2.8900000000000001 109.785 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.48 HG23 ' O ' ' B' ' 70' ' ' GLU . 9.5 tp -66.73 -31.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.04 -1.038 . . . . 2.5800000000000001 109.177 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.437 ' N ' HG21 ' B' ' 73' ' ' ILE . 51.4 m -62.08 -47.01 86.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.304 -0.873 . . . . 1.99 109.31 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.533 ' CD1' ' HG3' ' A' ' 72' ' ' GLU . 6.0 mt -68.72 -46.99 67.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -0.944 . . . . 2.1899999999999999 109.265 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.539 HD12 ' CD2' ' A' ' 75' ' ' LEU . 72.3 mt -56.98 -47.78 82.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.94 -1.104 . . . . 1.51 108.731 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' B' ' 77' ' ' ILE . 14.1 mm -57.9 -47.79 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 2.48 109.567 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.7 -47.76 81.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 3.52 109.663 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.541 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . -57.46 -47.22 89.74 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.301 -1.519 . . . . 0.34000000000000002 109.301 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.566 HG21 ' CA ' ' A' ' 79' ' ' GLY . 26.0 t -57.2 -47.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.498 -1.001 . . . . 1.1399999999999999 109.704 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 3.4 mtm -57.3 -47.3 81.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 2.4199999999999999 109.576 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.91 82.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 1.1000000000000001 109.72 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.47 -47.31 89.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.646 -1.382 . . . . 0.28999999999999998 109.646 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.24 -47.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.157 . . . . 1.1399999999999999 109.668 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 87.4 mt -57.32 -47.22 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.176 -0.952 . . . . 1.6599999999999999 110.027 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.33 88.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.648 -1.381 . . . . 0.33000000000000002 109.648 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 73.5 m -57.47 -47.29 82.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -1.215 . . . . 1.0900000000000001 109.326 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.8 mt -57.41 -47.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 1.1399999999999999 109.649 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.1 -46.84 82.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.412 -0.805 . . . . 1.72 109.216 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.51 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -47.21 81.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 2.6200000000000001 109.212 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 70.7 mt -57.36 -47.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 1.3899999999999999 109.678 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.2 m -57.24 -47.62 80.89 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.947 -1.096 . . . . 1.76 108.919 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.6 -47.5 81.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 2.7799999999999998 109.244 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.36 -47.17 89.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.184 -1.566 . . . . 1.24 109.184 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.409 ' O ' HG12 ' B' ' 99' ' ' ILE . 1.9 mt -57.0 -47.08 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -1.085 . . . . 2.29 108.854 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.506 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 8.5 mtm180 -57.0 -47.4 80.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.078 -1.014 . . . . 3.1099999999999999 109.516 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -57.38 -47.04 82.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 3.71 109.974 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -46.91 81.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 2.5600000000000001 109.3 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 44.5 pt -72.54 -18.73 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 2.7200000000000002 109.435 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.96 59.6 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 5.5700000000000003 109.581 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.007 -0.997 . . . . 7.8300000000000001 109.544 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.522 -0.547 . . . . 19.079999999999998 109.522 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -126.7 145.76 50.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 16.93 109.506 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -76.6 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.215 -0.928 . . . . 17.030000000000001 109.262 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.49 132.06 46.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 14.640000000000001 109.333 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.46 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 50.2 t-80 -61.71 -18.07 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 14.630000000000001 109.432 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -123.99 -79.25 0.61 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 11.25 109.535 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 67' ' ' HIS . 0.2 OUTLIER 75.45 -175.62 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 12.35 109.468 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.55 -167.0 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 7.4199999999999999 109.396 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 73' ' ' ILE . 0.4 OUTLIER 58.17 101.06 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 6.4900000000000002 109.489 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.29 -37.6 81.3 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.019 1.813 . . . . 3.25 110.348 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' HG3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -47.39 -69.34 0.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -0.935 . . . . 3.0099999999999998 109.812 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 70' ' ' GLU . 5.0 tp -50.85 -38.33 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.132 -0.98 . . . . 2.0499999999999998 109.58 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 16.6 m -58.08 -46.94 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 1.8400000000000001 109.08 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.55 HD11 ' CG1' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -67.34 -46.83 72.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 1.6399999999999999 109.392 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.565 ' CG1' ' CD2' ' B' ' 75' ' ' LEU . 25.3 mt -56.89 -47.57 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.947 -1.095 . . . . 1.6599999999999999 108.696 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -57.78 -47.77 85.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.46 -0.896 . . . . 2.0699999999999998 109.448 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -57.7 -48.08 80.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 2.8900000000000001 109.495 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.66 -47.61 87.24 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.07 -1.612 . . . . 0.35999999999999999 109.07 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.524 HG21 ' CA ' ' B' ' 79' ' ' GLY . 43.3 t -57.43 -47.19 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.567 -0.96 . . . . 1.1000000000000001 109.148 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmm -57.13 -46.9 82.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.37 -0.831 . . . . 2.23 109.074 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.23 81.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.1000000000000001 109.314 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.514 ' CA ' HG11 ' B' ' 80' ' ' VAL . . . -56.76 -46.98 89.06 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.314 -1.514 . . . . 0.29999999999999999 109.314 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.4 t -56.88 -47.22 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.031 -1.276 . . . . 1.0900000000000001 109.202 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.1 -46.93 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.159 -0.963 . . . . 1.9099999999999999 109.354 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.84 91.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.38 109.703 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.8 m -56.78 -47.46 80.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -1.199 . . . . 1.1000000000000001 109.068 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.23 -47.11 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 1.21 108.781 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.19 -46.71 82.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.5 -0.75 . . . . 1.3700000000000001 108.987 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.481 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 16.8 tp -56.66 -47.02 80.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 2.54 109.463 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 95' ' ' ILE . 57.2 mt -57.03 -47.11 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.043 -1.035 . . . . 1.3100000000000001 108.408 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.571 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -57.14 -47.23 81.64 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.348 -0.982 . . . . 1.3999999999999999 108.348 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.92 80.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.956 -1.09 . . . . 3.3799999999999999 109.344 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.09 -48.2 84.43 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.941 -1.123 . . . . 1.29 110.557 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 92' ' ' SER . 2.8 tp -57.71 -47.02 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.064 -1.256 . . . . 2.6000000000000001 109.145 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.507 ' O ' HG13 ' A' ' 99' ' ' ILE . 8.1 mtm180 -56.95 -47.05 81.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.858 . . . . 3.6600000000000001 109.429 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -57.05 -46.85 82.13 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.07 -1.019 . . . . 4.1600000000000001 109.481 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -56.75 -46.9 81.11 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.418 -0.956 . . . . 3.1499999999999999 108.418 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 96' ' ' ARG . 5.3 pt -85.63 39.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 2.3900000000000001 109.634 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -155.72 102.17 2.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.995 . . . . 4.2000000000000002 109.628 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 6.79 109.484 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.393 -0.595 . . . . 20.579999999999998 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' B' ' 63' ' ' GLN . 0.7 OUTLIER -150.74 91.08 1.69 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 18.100000000000001 109.499 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' B' ' 63' ' ' GLN . 0.1 OUTLIER 44.13 58.28 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 17.890000000000001 109.341 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 107.44 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 15.779999999999999 109.553 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 1.9 p80 -168.01 122.6 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 14.390000000000001 109.368 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 12.3 t-160 66.82 129.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.916 . . . . 13.77 109.206 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -120.62 76.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 13.279999999999999 109.689 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 70' ' ' GLU . 1.5 m -150.45 99.76 2.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 8.2300000000000004 109.297 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.552 ' CB ' ' HD3' ' B' ' 71' ' ' PRO . 1.6 mt-10 172.48 -57.17 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 7.29 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' B' ' 70' ' ' GLU . 3.5 Cg_exo -59.81 156.34 38.62 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.926 1.751 . . . . 3.6600000000000001 110.424 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' B' ' 73' ' ' ILE . 65.5 mm-40 -53.01 -65.99 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 2.8900000000000001 109.488 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.5 OUTLIER -42.46 -46.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.328 -0.857 . . . . 2.5800000000000001 110.274 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -56.69 -47.06 80.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.032 -1.043 . . . . 1.99 109.898 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.565 ' CD2' ' CG1' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -70.89 -47.12 60.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 2.1899999999999999 109.861 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.55 ' CG1' HD11 ' A' ' 75' ' ' LEU . 59.4 mt -57.03 -47.32 83.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.887 -1.133 . . . . 1.51 108.633 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 mp -57.61 -47.15 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.78 . . . . 2.48 109.195 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -57.08 -47.62 80.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.089 -1.007 . . . . 3.52 109.767 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.524 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . -57.39 -47.39 88.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.154 -1.578 . . . . 0.34000000000000002 109.154 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.542 HG21 ' CA ' ' A' ' 79' ' ' GLY . 40.9 t -57.37 -47.22 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -1.013 . . . . 1.1399999999999999 109.578 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.8 mmm -56.97 -47.04 81.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 2.4199999999999999 108.946 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.554 -0.716 . . . . 1.1000000000000001 109.298 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.452 ' HA3' HG11 ' A' ' 80' ' ' VAL . . . -56.81 -47.12 88.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.743 -1.343 . . . . 0.28999999999999998 109.743 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.1 -47.46 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.387 . . . . 1.1399999999999999 109.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -57.11 -46.95 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 1.6599999999999999 109.347 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -56.85 -46.87 89.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.811 -1.316 . . . . 0.33000000000000002 109.811 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 31.7 m -56.65 -47.32 80.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.262 . . . . 1.0900000000000001 109.193 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 mt -57.21 -47.14 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.039 -1.038 . . . . 1.1399999999999999 108.944 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.05 -46.83 82.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.511 -0.743 . . . . 1.72 109.306 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 87.6 mt -57.08 -47.04 81.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.95 . . . . 2.6200000000000001 109.459 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.522 HG23 ' CD1' ' B' ' 95' ' ' ILE . 72.0 mt -57.08 -47.32 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 1.3899999999999999 109.602 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 53.4 p -57.22 -47.62 80.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.942 -1.099 . . . . 1.76 108.563 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -47.32 82.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -0.788 . . . . 2.7799999999999998 109.396 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.33 88.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.685 -1.366 . . . . 1.24 109.685 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.522 ' CD1' HG23 ' B' ' 91' ' ' ILE . 1.3 mp -57.14 -47.4 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.109 -1.23 . . . . 2.29 109.048 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 1.5 mtt-85 -57.37 -47.06 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 3.1099999999999999 109.315 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 100' ' ' LYS . 1.3 ttt-85 -57.23 -46.93 82.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 3.71 109.981 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.77 -46.95 81.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.144 -0.972 . . . . 2.5600000000000001 109.216 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 44.5 pt -72.56 -28.8 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 2.7200000000000002 109.189 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.1 OUTLIER -115.52 109.08 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.424 -0.797 . . . . 5.5700000000000003 109.665 -179.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 7.8300000000000001 109.622 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 7.8 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.403 -0.592 . . . . 19.079999999999998 109.403 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -174.6 167.4 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 16.93 109.633 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.04 68.08 9.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 17.030000000000001 109.514 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.493 ' O ' ' ND1' ' A' ' 66' ' ' HIS . . . -110.76 -15.57 13.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.079 -1.013 . . . . 14.640000000000001 109.543 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 65' ' ' ALA . 14.9 m80 -163.05 54.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 14.630000000000001 109.411 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -133.51 158.41 43.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 11.25 109.535 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -162.89 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 12.35 109.521 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.77 138.6 36.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 7.4199999999999999 109.53 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 46.83 70.46 2.06 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 6.4900000000000002 109.45 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 3.9 Cg_exo -60.33 90.83 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.237 1.958 . . . . 3.25 110.169 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -92.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 3.0099999999999998 109.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -44.16 -32.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.127 -0.983 . . . . 2.0499999999999998 109.508 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -63.35 -46.98 84.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 1.8400000000000001 109.398 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.511 ' CD1' HD12 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -70.57 -46.99 62.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 1.6399999999999999 109.593 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.473 HD11 ' CD1' ' B' ' 75' ' ' LEU . 64.9 mt -56.91 -47.51 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 118.854 -1.139 . . . . 1.6599999999999999 108.262 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.455 HD11 HG23 ' A' ' 77' ' ' ILE . 25.7 mt -57.57 -47.33 85.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.524 -0.917 . . . . 2.0699999999999998 108.524 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.3 -46.98 82.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 2.8900000000000001 109.528 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.47 ' CA ' ' CG2' ' B' ' 80' ' ' VAL . . . -57.05 -47.42 87.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.885 -1.686 . . . . 0.35999999999999999 108.885 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 88.7 t -57.48 -47.61 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -1.189 . . . . 1.1000000000000001 108.541 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -47.15 83.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.555 -0.716 . . . . 2.23 109.532 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.486 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -57.16 -46.76 82.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 1.1000000000000001 109.98 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.4 88.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.491 -1.843 . . . . 0.29999999999999999 108.491 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 80' ' ' VAL . 58.1 t -57.48 -47.5 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.459 -1.024 . . . . 1.0900000000000001 110.252 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -57.33 -47.53 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 1.9099999999999999 110.153 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.38 -47.6 86.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.599 . . . . 0.38 109.101 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.479 ' CG2' HG23 ' B' ' 87' ' ' THR . 10.6 m -57.58 -46.91 83.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.46 -1.024 . . . . 1.1000000000000001 109.175 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 84' ' ' VAL . 19.3 mt -56.86 -47.07 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.497 -0.752 . . . . 1.21 109.621 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -57.15 -46.78 82.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.3700000000000001 109.015 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 28.3 mt -57.47 -47.31 82.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.007 -1.058 . . . . 2.54 109.27 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.522 ' CG2' HD13 ' A' ' 95' ' ' ILE . 70.1 mt -57.32 -47.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.803 . . . . 1.3100000000000001 109.686 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -47.63 80.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.092 -1.005 . . . . 1.3999999999999999 108.817 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.61 -47.66 81.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 109.391 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.63 -47.57 87.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.435 . . . . 1.29 109.511 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.522 HD13 ' CG2' ' A' ' 91' ' ' ILE . 1.3 mp -57.32 -47.23 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -1.108 . . . . 2.6000000000000001 108.956 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' O ' ' CG1' ' A' ' 99' ' ' ILE . 4.1 tpp180 -57.13 -47.19 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 3.6600000000000001 109.565 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -57.27 -47.02 82.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 4.1600000000000001 109.912 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -57.1 -46.91 82.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 3.1499999999999999 108.792 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 39.6 pt -72.56 -28.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 2.3900000000000001 109.499 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -90.02 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 4.2000000000000002 109.245 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.043 -0.98 . . . . 6.79 109.56 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.461 -0.57 . . . . 20.579999999999998 109.461 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.51 124.62 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 18.100000000000001 109.503 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.73 39.84 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 17.890000000000001 109.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.88 29.7 5.6 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 15.779999999999999 109.637 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.562 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 29.2 p-80 -120.83 119.04 31.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.004 . . . . 14.390000000000001 109.71 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.08 -57.5 0.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 13.77 109.454 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 42.07 3.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.925 . . . . 13.279999999999999 109.527 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.42 ' O ' ' C ' ' B' ' 70' ' ' GLU . 0.3 OUTLIER 47.08 43.71 14.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 8.2300000000000004 109.621 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.548 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 2.1 mm-40 -44.04 -54.82 10.52 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 7.29 109.58 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 4.0 Cg_exo -61.71 64.71 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.039 1.826 . . . . 3.6600000000000001 110.175 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' B' ' 70' ' ' GLU . 3.4 tp10 -67.62 -73.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.905 . . . . 2.8900000000000001 109.922 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.7 OUTLIER -43.55 -46.8 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.176 -0.952 . . . . 2.5800000000000001 109.577 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.55 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 44.1 p -54.68 -46.85 74.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 1.99 109.177 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.473 ' CD1' HD11 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -67.97 -46.77 70.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 2.1899999999999999 109.457 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.511 HD12 ' CD1' ' A' ' 75' ' ' LEU . 59.0 mt -56.87 -47.92 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.946 -1.096 . . . . 1.51 109.579 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.513 HG23 ' O ' ' B' ' 74' ' ' THR . 0.4 OUTLIER -57.77 -47.33 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.91 -1.119 . . . . 2.48 108.474 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 74' ' ' THR . 17.8 m-30 -57.37 -46.94 82.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.555 -0.716 . . . . 3.52 109.425 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.526 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -56.9 -47.16 88.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.579 -1.408 . . . . 0.34000000000000002 109.579 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 44.5 t -57.19 -47.72 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.895 -1.356 . . . . 1.1399999999999999 108.938 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -47.31 83.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.197 -0.939 . . . . 2.4199999999999999 108.928 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.7 83.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 1.1000000000000001 110.151 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.34 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.359 -1.496 . . . . 0.28999999999999998 109.359 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.24 -47.3 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 1.1399999999999999 109.559 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -57.27 -47.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 1.6599999999999999 110.364 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.21 -47.42 87.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.333 -1.507 . . . . 0.33000000000000002 109.333 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.479 HG23 ' CG2' ' A' ' 87' ' ' THR . 50.7 m -57.34 -46.97 82.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.246 -1.149 . . . . 1.0900000000000001 108.904 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 mt -56.92 -46.77 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.573 -0.704 . . . . 1.1399999999999999 109.792 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.55 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.2 OUTLIER -56.72 -46.79 81.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 1.72 109.006 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER -57.1 -47.14 81.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 2.6200000000000001 108.763 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.517 HD13 ' CD1' ' A' ' 91' ' ' ILE . 84.9 mt -57.23 -46.84 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 1.3899999999999999 109.583 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 96' ' ' ARG . 0.4 OUTLIER -56.73 -47.56 79.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.152 -0.968 . . . . 1.76 109.372 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -47.62 81.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.069 . . . . 2.7799999999999998 109.009 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.41 -47.0 91.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.736 -1.746 . . . . 1.24 108.736 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mm -56.84 -46.88 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.972 . . . . 2.29 109.138 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.551 ' O ' HG13 ' B' ' 99' ' ' ILE . 0.9 OUTLIER -56.84 -47.33 80.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.025 -1.047 . . . . 3.1099999999999999 109.45 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 1.4 ttp180 -57.85 -47.21 83.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.767 -1.208 . . . . 3.71 109.587 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -47.07 82.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 2.5600000000000001 110.215 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.551 HG13 ' O ' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -80.87 -13.93 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 2.7200000000000002 109.808 -179.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' B' ' 101' ' ' LYS . 0.6 OUTLIER -147.49 130.67 16.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 5.5700000000000003 109.505 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.026 -0.988 . . . . 7.8300000000000001 109.403 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.273 0.558 . . . . 19.079999999999998 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.6 126.75 24.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 16.93 109.415 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.51 -55.4 2.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 17.030000000000001 109.443 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.08 86.6 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 14.640000000000001 109.488 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 4.3 t-160 -114.44 -71.81 0.73 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 14.630000000000001 109.536 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 1.9 m-70 169.11 131.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 11.25 109.603 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.81 38.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 12.35 109.18 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 4.9 m -145.58 -151.78 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 7.4199999999999999 109.18 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 173.49 -58.0 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.07 -1.019 . . . . 6.4900000000000002 110.038 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 5.1 Cg_exo -58.82 152.22 58.77 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.901 1.734 . . . . 3.25 110.227 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 73' ' ' ILE . 34.7 mt-10 -65.65 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 3.0099999999999998 110.008 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -38.91 -38.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.456 -0.778 . . . . 2.0499999999999998 110.069 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 77' ' ' ILE . 27.3 m -60.9 -46.46 90.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.847 . . . . 1.8400000000000001 109.476 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.619 ' CD2' ' N ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -75.32 -47.04 29.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.981 -1.074 . . . . 1.6399999999999999 110.024 -179.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.619 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 44.2 mt -57.66 -48.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.413 -1.429 . . . . 1.6599999999999999 109.265 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.546 HG21 ' N ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -58.27 -46.74 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.147 -1.057 . . . . 2.0699999999999998 108.147 177.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.546 ' N ' HG21 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -56.94 -46.87 81.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.683 -0.636 . . . . 2.8900000000000001 109.898 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -56.89 -47.38 86.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.257 -1.537 . . . . 0.35999999999999999 109.257 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.537 ' CG2' ' CA ' ' B' ' 79' ' ' GLY . 39.3 t -57.36 -47.56 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.281 . . . . 1.1000000000000001 108.557 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.64 -46.88 83.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 2.23 109.323 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.42 81.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.58 -0.7 . . . . 1.1000000000000001 109.75 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.29 87.79 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.801 -1.72 . . . . 0.29999999999999999 108.801 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.32 -47.34 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.143 -1.21 . . . . 1.0900000000000001 109.179 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.7 mt -57.32 -47.01 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 1.9099999999999999 109.883 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.04 90.04 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.738 -1.345 . . . . 0.38 109.738 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 91' ' ' ILE . 37.2 m -57.09 -47.15 81.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -1.18 . . . . 1.1000000000000001 109.121 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.849 . . . . 1.21 109.538 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.03 -47.02 81.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.38 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.528 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 6.2 mt -56.94 -47.05 81.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 2.54 109.337 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 63.6 mt -57.03 -47.09 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 1.3100000000000001 109.356 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.39 80.84 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.026 -1.046 . . . . 1.3999999999999999 108.576 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -57.41 -47.25 82.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.24 -0.913 . . . . 3.3799999999999999 109.387 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.22 -47.34 88.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.014 -1.634 . . . . 1.29 109.014 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.12 -47.01 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -1.126 . . . . 2.6000000000000001 108.786 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 100' ' ' LYS . 3.3 ttp180 -56.9 -47.07 81.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.828 . . . . 3.6600000000000001 109.333 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 100' ' ' LYS . 1.4 ttm-85 -57.14 -46.59 82.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 4.1600000000000001 109.698 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.545 ' HG ' ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -56.63 -46.76 80.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 3.1499999999999999 108.753 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 25.9 pt -76.84 -26.32 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 2.3900000000000001 109.268 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 96' ' ' ARG . 0.7 OUTLIER -94.27 118.18 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 4.2000000000000002 109.591 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' OXT' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.902 -1.047 . . . . 6.79 109.356 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.278 0.561 . . . . 20.579999999999998 109.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' B' ' 65' ' ' ALA . 2.8 pm0 -110.7 157.22 19.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 18.100000000000001 109.59 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.72 75.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 17.890000000000001 109.573 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' B' ' 63' ' ' GLN . . . -100.98 -19.12 15.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.11 -0.994 . . . . 15.779999999999999 109.317 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.7 177.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 14.390000000000001 109.297 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -154.14 167.08 31.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 13.77 109.576 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.67 59.49 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -0.958 . . . . 13.279999999999999 109.578 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.454 ' O ' ' O ' ' B' ' 70' ' ' GLU . 0.9 OUTLIER -77.02 165.04 25.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 8.2300000000000004 109.316 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' B' ' 72' ' ' GLU . 13.7 mt-10 49.41 95.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 7.29 109.334 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.404 ' HB2' ' HB ' ' B' ' 74' ' ' THR . 3.0 Cg_exo -60.53 67.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.243 1.962 . . . . 3.6600000000000001 110.413 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -64.67 -72.39 0.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 2.8900000000000001 109.477 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.465 ' O ' HG13 ' B' ' 77' ' ' ILE . 0.7 OUTLIER -43.12 -32.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.25 -0.906 . . . . 2.5800000000000001 109.589 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' B' ' 78' ' ' PHE . 39.1 m -67.2 -47.08 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 1.99 109.067 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.475 HD12 ' CD1' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -72.95 -46.85 50.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 2.1899999999999999 109.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.527 HD12 ' CD1' ' A' ' 75' ' ' LEU . 21.2 mt -56.9 -48.11 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.046 -1.061 . . . . 1.51 108.326 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.465 HG13 ' O ' ' B' ' 73' ' ' ILE . 20.4 mt -58.02 -47.44 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.341 -0.849 . . . . 2.48 108.863 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' B' ' 74' ' ' THR . 3.2 m-85 -57.43 -47.52 81.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.681 -0.637 . . . . 3.52 110.251 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.537 ' CA ' ' CG2' ' A' ' 80' ' ' VAL . . . -57.35 -47.74 85.69 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.605 -1.398 . . . . 0.34000000000000002 109.605 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 86.0 t -57.74 -47.67 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.286 . . . . 1.1399999999999999 108.928 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 43.5 mtm -57.72 -47.13 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 2.4199999999999999 109.664 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.41 82.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 1.1000000000000001 110.035 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.487 ' CA ' HG11 ' A' ' 80' ' ' VAL . . . -57.01 -47.51 86.76 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.228 -1.549 . . . . 0.28999999999999998 109.228 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.412 ' O ' HG13 ' B' ' 88' ' ' ILE . 48.5 t -57.46 -47.53 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -1.185 . . . . 1.1399999999999999 109.451 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.404 HG22 HD11 ' B' ' 85' ' ' ILE . 30.6 mt -57.33 -47.16 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 1.6599999999999999 110.177 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.31 87.38 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.296 . . . . 0.33000000000000002 109.859 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.429 HG23 ' CG2' ' A' ' 87' ' ' THR . 19.3 m -57.23 -47.27 81.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -1.225 . . . . 1.0900000000000001 109.256 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.412 HG13 ' O ' ' B' ' 84' ' ' VAL . 49.4 mt -57.44 -47.23 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.809 . . . . 1.1399999999999999 109.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.21 -46.99 82.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 1.72 109.534 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 40.4 tp -57.0 -47.35 81.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.182 -0.949 . . . . 2.6200000000000001 109.509 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 46.4 mt -57.21 -47.17 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 1.3899999999999999 109.693 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.2 -47.8 80.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.07 . . . . 1.76 108.975 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.64 -47.54 81.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 2.7799999999999998 109.585 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.32 88.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.724 -1.35 . . . . 1.24 109.724 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mt -57.06 -47.16 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.269 -1.136 . . . . 2.29 109.201 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.499 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 10.2 ttp180 -57.04 -47.3 81.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 3.1099999999999999 109.505 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.447 ' HG3' ' OXT' ' B' ' 101' ' ' LYS . 1.1 ttp180 -57.35 -47.28 82.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 3.71 110.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.78 -47.09 80.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 2.5600000000000001 109.616 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 17.9 pt -71.57 -21.59 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 2.7200000000000002 109.446 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.451 ' N ' HG13 ' B' ' 99' ' ' ILE . 2.2 mttt -142.13 103.88 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 5.5700000000000003 109.608 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.447 ' OXT' ' HG3' ' B' ' 97' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.986 -1.007 . . . . 7.8300000000000001 109.47 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 19.079999999999998 109.402 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -78.86 159.82 27.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 16.93 109.472 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -119.47 147.56 44.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.935 . . . . 17.030000000000001 109.376 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 64' ' ' LEU . . . 162.33 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 14.640000000000001 109.463 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -117.84 136.83 53.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 14.630000000000001 109.483 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.576 ' N ' ' CD2' ' A' ' 67' ' ' HIS . 1.3 m-70 -126.61 35.73 4.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 11.25 109.31 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 69' ' ' SER . 41.7 m-85 -100.91 96.02 7.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 12.35 109.59 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 5.5 m 70.09 -165.44 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 7.4199999999999999 109.628 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 72' ' ' GLU . 2.7 pt-20 -89.68 151.79 46.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 6.4900000000000002 109.316 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.95 56.72 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.25 1.967 . . . . 3.25 110.692 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 70' ' ' GLU . 11.4 tt0 -73.04 -72.72 0.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.987 . . . . 3.0099999999999998 108.866 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tp -55.95 -26.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.173 -0.954 . . . . 2.0499999999999998 108.697 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.6 m -66.26 -47.01 75.1 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.728 -0.841 . . . . 1.8400000000000001 108.728 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD2' HD12 ' B' ' 76' ' ' ILE . 5.0 mt -65.71 -47.01 76.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 1.6399999999999999 108.826 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' B' ' 75' ' ' LEU . 35.6 mt -56.79 -47.69 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 118.899 -1.121 . . . . 1.6599999999999999 108.155 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mm -57.85 -47.62 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 2.0699999999999998 108.857 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -57.57 -47.89 80.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.341 -0.85 . . . . 2.8900000000000001 109.968 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.562 ' CA ' HG21 ' B' ' 80' ' ' VAL . . . -57.5 -47.45 88.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.389 -1.484 . . . . 0.35999999999999999 109.389 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.543 HG21 ' CA ' ' B' ' 79' ' ' GLY . 41.8 t -57.34 -47.36 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.366 -1.079 . . . . 1.1000000000000001 109.121 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 85' ' ' ILE . 16.9 mtp -57.44 -47.21 82.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 2.23 108.966 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.41 83.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.546 -0.721 . . . . 1.1000000000000001 109.311 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.512 ' N ' HG12 ' B' ' 80' ' ' VAL . . . -57.1 -47.14 89.86 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.325 -1.51 . . . . 0.29999999999999999 109.325 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.17 -47.64 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -1.217 . . . . 1.0900000000000001 109.16 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 81' ' ' MET . 1.9 mt -57.42 -47.15 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 1.9099999999999999 109.373 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -57.12 -47.27 88.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.756 -1.338 . . . . 0.38 109.756 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.6 m -57.21 -47.51 81.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -1.21 . . . . 1.1000000000000001 109.042 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.48 -47.37 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.21 109.329 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -57.29 -47.0 82.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.456 -0.777 . . . . 1.3700000000000001 109.363 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 86' ' ' GLY . 4.7 mp -57.07 -47.06 81.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 2.54 109.204 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 95' ' ' ILE . 78.8 mt -57.16 -47.13 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 1.3100000000000001 109.629 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -57.1 -47.59 80.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.164 -1.014 . . . . 1.3999999999999999 108.823 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -57.86 -48.1 80.79 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.772 -1.205 . . . . 3.3799999999999999 109.493 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.05 -48.26 83.92 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.064 -1.065 . . . . 1.29 110.668 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -57.63 -46.89 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -1.224 . . . . 2.6000000000000001 109.373 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 1.7 mtm180 -57.18 -47.31 81.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 3.6600000000000001 109.592 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -47.17 82.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 4.1600000000000001 110.212 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -57.17 -47.01 82.26 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.157 -0.964 . . . . 3.1499999999999999 108.815 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 96' ' ' ARG . 33.8 pt -72.25 -36.46 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 2.3900000000000001 109.364 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -97.16 63.49 1.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 4.2000000000000002 109.408 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.011 -0.995 . . . . 6.79 109.499 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.461 -0.57 . . . . 20.579999999999998 109.461 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . 0.464 ' OE1' ' N ' ' B' ' 64' ' ' LEU . 4.5 tp-100 -171.75 143.26 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 18.100000000000001 109.479 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' B' ' 63' ' ' GLN . 0.2 OUTLIER -113.2 -20.31 11.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 17.890000000000001 109.505 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.11 21.29 16.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 15.779999999999999 109.38 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 m170 56.28 175.09 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 14.390000000000001 109.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.552 ' C ' ' CG ' ' B' ' 68' ' ' PHE . 1.9 p80 -144.15 -49.3 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 13.77 109.47 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.552 ' CG ' ' C ' ' B' ' 67' ' ' HIS . 4.1 p90 39.41 52.22 2.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.745 . . . . 13.279999999999999 109.802 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 86.1 p -118.49 -157.14 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 8.2300000000000004 109.691 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.511 ' CB ' ' HD2' ' B' ' 71' ' ' PRO . 1.8 mt-10 -81.43 174.4 6.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 7.29 109.448 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' B' ' 70' ' ' GLU . 1.9 Cg_endo -63.56 -5.14 8.01 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.421 2.081 . . . . 3.6600000000000001 110.928 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 24.6 mm-40 -36.86 -56.35 0.86 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.488 -0.758 . . . . 2.8900000000000001 109.967 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.53 ' CG2' ' N ' ' B' ' 74' ' ' THR . 6.1 tp -54.71 -45.89 73.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.144 -0.973 . . . . 2.5800000000000001 109.21 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.53 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 3.7 m -50.77 -46.8 59.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 1.99 109.318 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 76' ' ' ILE . 8.3 mt -68.71 -46.63 68.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 2.1899999999999999 109.515 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.53 HD12 ' CD2' ' A' ' 75' ' ' LEU . 79.2 mt -56.81 -48.25 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.002 -1.079 . . . . 1.51 109.264 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . 0.502 HG13 ' N ' ' B' ' 78' ' ' PHE . 28.3 pt -58.21 -47.61 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.069 . . . . 2.48 109.492 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.502 ' N ' HG13 ' B' ' 77' ' ' ILE . 2.2 m-85 -57.76 -47.3 82.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.27 -0.893 . . . . 3.52 109.496 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.543 ' CA ' HG21 ' A' ' 80' ' ' VAL . . . -57.23 -46.88 91.22 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.307 -1.517 . . . . 0.34000000000000002 109.307 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.562 HG21 ' CA ' ' A' ' 79' ' ' GLY . 33.2 t -56.93 -47.27 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -1.051 . . . . 1.1399999999999999 109.571 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 56.6 mmm -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.03 -1.044 . . . . 2.4199999999999999 108.722 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.17 82.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.435 -0.79 . . . . 1.1000000000000001 109.076 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.77 -46.76 89.37 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.28999999999999998 109.454 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.45 ' O ' HG13 ' B' ' 88' ' ' ILE . 54.7 t -56.92 -47.25 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.256 . . . . 1.1399999999999999 109.336 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.2 -46.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 1.6599999999999999 109.419 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' B' ' 89' ' ' LEU . . . -57.11 -46.85 91.12 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 0.33000000000000002 109.465 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 14.2 m -56.76 -47.17 80.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -1.155 . . . . 1.0900000000000001 109.004 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 84' ' ' VAL . 51.0 mt -57.08 -46.98 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 1.1399999999999999 109.019 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.2 OUTLIER -56.99 -46.45 82.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.403 -0.811 . . . . 1.72 109.156 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.535 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 23.3 tp -56.76 -46.9 81.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 2.6200000000000001 108.961 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.02 -47.01 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 1.3899999999999999 108.713 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.498 ' O ' HG21 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -57.01 -47.4 80.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.241 -1.022 . . . . 1.76 108.241 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -47.44 82.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 2.7799999999999998 109.214 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.43 -47.37 88.61 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.527 -1.429 . . . . 1.24 109.527 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.498 HG21 ' O ' ' B' ' 92' ' ' SER . 0.1 OUTLIER -57.04 -46.83 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -1.159 . . . . 2.29 109.11 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 7.0 mtm180 -56.91 -47.08 81.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 3.1099999999999999 109.044 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.17 -46.92 82.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 3.71 109.755 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.81 -47.05 81.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 2.5600000000000001 109.266 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.522 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 40.3 pt -71.45 -20.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 2.7200000000000002 109.177 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 79.68 1.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 5.5700000000000003 109.279 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 tttm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.915 -1.041 . . . . 7.8300000000000001 109.514 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 11.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.491 -0.559 . . . . 19.079999999999998 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 71.52 98.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 16.93 109.35 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD21 ' C ' ' A' ' 63' ' ' GLN . 1.8 mm? -118.77 -75.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 17.030000000000001 109.158 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.13 135.07 54.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.364 -0.835 . . . . 14.640000000000001 109.201 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -65.72 118.16 9.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 14.630000000000001 109.508 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' CD2' ' N ' ' A' ' 68' ' ' PHE . 40.6 p-80 -166.94 -150.76 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 11.25 109.564 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' N ' ' CD2' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -58.14 161.07 4.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 12.35 109.589 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 t -105.29 84.92 2.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 7.4199999999999999 109.476 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -62.41 -56.65 28.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 6.4900000000000002 109.71 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 4.6 Cg_exo -60.01 76.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.867 1.711 . . . . 3.25 110.016 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 70' ' ' GLU . 13.1 mp0 -61.55 -88.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 3.0099999999999998 109.815 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -49.4 -32.57 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.019 -1.051 . . . . 2.0499999999999998 108.822 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.524 ' OG1' ' CA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -53.23 -47.07 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.955 -1.091 . . . . 1.8400000000000001 108.574 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD12 ' CD1' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -78.84 -47.16 17.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 1.6399999999999999 109.423 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.522 ' CD1' HD12 ' B' ' 75' ' ' LEU . 54.6 mt -57.42 -48.29 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.798 -1.161 . . . . 1.6599999999999999 109.309 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 3.9 tt -58.17 -47.43 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.914 -1.116 . . . . 2.0699999999999998 108.787 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.543 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.6 m-30 -57.23 -46.79 82.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.524 -0.735 . . . . 2.8900000000000001 109.557 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' B' ' 80' ' ' VAL . . . -56.81 -47.04 89.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.629 -1.389 . . . . 0.35999999999999999 109.629 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' B' ' 80' ' ' VAL . 26.3 t -56.91 -47.59 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.979 -1.306 . . . . 1.1000000000000001 108.566 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.424 ' O ' HG13 ' A' ' 85' ' ' ILE . 59.0 mtp -57.51 -46.92 83.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.433 -0.951 . . . . 2.23 108.433 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.88 81.69 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.748 -0.595 . . . . 1.1000000000000001 109.616 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' HG21 ' B' ' 84' ' ' VAL . . . -56.36 -46.99 85.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.08 -1.608 . . . . 0.29999999999999999 109.08 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.98 -47.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.347 . . . . 1.0900000000000001 108.8 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 81' ' ' MET . 64.3 mt -57.16 -46.83 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 1.9099999999999999 109.528 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.67 89.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.38 109.536 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.442 HG23 HG22 ' B' ' 87' ' ' THR . 22.5 m -56.69 -46.95 80.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.225 . . . . 1.1000000000000001 109.001 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.6 mt -57.1 -46.9 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.21 109.073 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.5 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -46.66 82.07 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.399 -0.813 . . . . 1.3700000000000001 109.012 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.5 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.3 mp -56.69 -47.0 80.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -0.856 . . . . 2.54 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.3 mt -56.93 -47.12 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.093 -1.004 . . . . 1.3100000000000001 109.261 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 95' ' ' ILE . 1.7 p -57.16 -47.58 80.84 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.027 -1.069 . . . . 1.3999999999999999 108.441 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -47.45 82.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.17 -0.956 . . . . 3.3799999999999999 109.341 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.31 89.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.905 -1.278 . . . . 1.29 109.905 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.477 HG21 ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -57.25 -47.06 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.235 . . . . 2.6000000000000001 108.939 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 99' ' ' ILE . 9.1 mtm180 -57.06 -47.04 81.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 3.6600000000000001 109.209 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.07 -46.87 82.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.248 -0.908 . . . . 4.1600000000000001 109.964 -179.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.561 ' HG ' ' N ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -56.74 -46.74 81.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.912 -1.118 . . . . 3.1499999999999999 108.722 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.561 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 19.3 pt -77.0 -14.38 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.3900000000000001 109.522 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 97' ' ' ARG . 2.2 ttpp -105.26 137.08 43.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 4.2000000000000002 109.847 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 6.79 109.343 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.29 0.567 . . . . 20.579999999999998 109.473 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.17 166.24 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 18.100000000000001 109.367 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mp -113.34 11.85 18.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 17.890000000000001 109.7 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -80.33 -6.56 58.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 15.779999999999999 109.805 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' ALA . 87.8 m-70 -44.32 167.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 14.390000000000001 109.485 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -80.5 -76.23 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 13.77 109.55 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.05 -158.4 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -0.956 . . . . 13.279999999999999 109.467 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.7 p -115.52 34.86 4.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 8.2300000000000004 109.388 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.463 ' O ' ' CG2' ' B' ' 74' ' ' THR . 14.5 mt-10 -130.53 100.6 17.91 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.853 . . . . 7.29 109.394 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.475 ' O ' ' OG1' ' B' ' 74' ' ' THR . 4.8 Cg_exo -59.14 -27.17 84.27 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.001 1.801 . . . . 3.6600000000000001 110.106 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.449 ' OE2' ' OE1' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -62.44 -60.92 2.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 2.8900000000000001 109.518 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.448 HG23 ' O ' ' B' ' 70' ' ' GLU . 2.6 tp -61.04 -26.8 40.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.048 -1.033 . . . . 2.5800000000000001 109.677 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.577 ' O ' ' CD2' ' B' ' 78' ' ' PHE . 31.7 p -68.12 -46.93 69.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 1.99 109.501 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -70.23 -47.0 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 2.1899999999999999 109.389 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.481 ' CD1' HD12 ' A' ' 75' ' ' LEU . 59.3 mt -56.98 -47.61 83.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 1.51 108.243 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.64 -47.19 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.588 -0.893 . . . . 2.48 108.588 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 74' ' ' THR . 16.3 m-85 -57.21 -47.11 82.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.571 -0.706 . . . . 3.52 109.543 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 80' ' ' VAL . . . -56.96 -47.33 87.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.754 -1.739 . . . . 0.34000000000000002 108.754 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 40.1 t -57.35 -47.5 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.191 -1.182 . . . . 1.1399999999999999 108.698 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.6 -47.0 83.34 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.83 . . . . 2.4199999999999999 109.193 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' B' ' 85' ' ' ILE . . . -56.98 -46.68 82.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 1.1000000000000001 109.815 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.49 87.1 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.605 -1.798 . . . . 0.28999999999999998 108.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 83' ' ' GLY . 43.2 t -57.53 -47.3 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -1.1 . . . . 1.1399999999999999 109.203 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' B' ' 82' ' ' ALA . 38.9 mt -57.25 -47.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 1.6599999999999999 109.904 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.29 88.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.229 -1.548 . . . . 0.33000000000000002 109.229 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.451 ' O ' HG13 ' B' ' 91' ' ' ILE . 73.8 m -57.34 -47.09 82.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -1.092 . . . . 1.0900000000000001 109.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.412 HD12 HG22 ' B' ' 88' ' ' ILE . 57.4 mt -57.13 -47.1 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 1.1399999999999999 109.694 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.536 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.0 -47.33 81.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 1.72 109.168 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . 0.536 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 1.1 mm? -57.41 -47.6 81.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.6200000000000001 108.871 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.451 HG13 ' O ' ' B' ' 87' ' ' THR . 67.9 mt -57.56 -47.17 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.395 -0.815 . . . . 1.3899999999999999 109.286 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' SER . . . . . 0.48 ' O ' HG21 ' B' ' 95' ' ' ILE . 2.2 m -57.08 -47.51 80.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.361 -0.936 . . . . 1.76 108.587 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.51 -47.87 80.79 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.361 -0.935 . . . . 2.7799999999999998 109.158 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.69 87.3 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.618 -1.393 . . . . 1.24 109.618 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' B' ' 96' ' ' ARG . 0.1 OUTLIER -57.47 -47.15 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -1.091 . . . . 2.29 109.24 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.518 ' O ' HG13 ' B' ' 99' ' ' ILE . 21.9 ttp180 -57.03 -47.21 81.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 3.1099999999999999 109.26 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.23 -46.69 82.73 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.066 -1.021 . . . . 3.71 109.645 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -46.86 81.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 2.5600000000000001 109.616 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . 0.532 HG13 ' N ' ' B' ' 100' ' ' LYS . 2.7 pt -78.84 -24.5 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 2.7200000000000002 110.243 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.532 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -133.82 135.7 43.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.071 -1.018 . . . . 5.5700000000000003 109.873 -179.438 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.979 -1.01 . . . . 7.8300000000000001 109.477 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.598 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.546 -0.539 . . . . 1.02 109.546 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.3 -47.63 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.896 -1.127 . . . . 1.1 108.213 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.71 -47.2 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.64 -0.874 . . . . 1.58 108.64 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.94 -47.14 81.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.601 -0.687 . . . . 2.09 109.468 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.886 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.02 -47.43 87.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.991 -1.644 . . . . 0.32 108.991 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 60.9 t -57.48 -47.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -1.234 . . . . 0.28 108.708 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.447 ' O ' HG12 ' A' ' 85' ' ' ILE . 7.0 mtt -57.54 -46.99 83.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 1.7 109.393 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.6 82.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.414 -0.804 . . . . 0.37 109.722 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.42 87.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.744 -1.742 . . . . 0.28 108.744 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -47.16 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -1.096 . . . . 0.28 109.317 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 81' ' ' MET . 21.6 mm -57.06 -47.15 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 1.2 110.038 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.37 88.08 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.297 -1.521 . . . . 0.33 109.297 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.437 ' OG1' HG13 ' B' ' 84' ' ' VAL . 91.6 m -57.45 -47.19 82.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -1.145 . . . . 0.34 109.065 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' A' ' 91' ' ' ILE . 34.5 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.49 109.43 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -47.05 81.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.68 108.722 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 15.2 tp -57.21 -47.17 81.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 1.92 108.928 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 88' ' ' ILE . 81.7 mt -57.28 -46.91 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.87 109.578 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 95' ' ' ILE . 51.0 m -56.93 -47.5 80.46 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.157 -1.017 . . . . 1.29 108.873 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -47.72 81.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 2.64 109.18 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.35 89.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.593 -1.403 . . . . 1.29 109.593 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 92' ' ' SER . 2.1 tp -57.18 -46.81 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -1.069 . . . . 2.19 109.212 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 16.7 mtm180 -56.68 -46.6 81.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.897 . . . . 3.14 109.09 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 120.776 -1.203 . . . . 3.58 109.201 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.328 -1.509 . . . . 0.3 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.886 HG22 ' C ' ' A' ' 79' ' ' GLY . 87.7 t -57.1 -47.76 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.295 . . . . 0.33 108.681 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 61.3 mtm -57.67 -47.31 82.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 1.83 108.654 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.2 -46.16 83.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.72 -0.613 . . . . 0.31 109.835 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.67 -47.3 86.03 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.302 -1.519 . . . . 0.26 109.302 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.437 HG13 ' OG1' ' A' ' 87' ' ' THR . 58.0 t -57.18 -47.58 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.3 . . . . 0.31 108.993 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 82' ' ' ALA . 48.0 mt -57.4 -47.1 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 1.06 109.866 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.91 -47.08 89.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.3 109.745 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 25.2 m -57.03 -47.15 81.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.161 -1.199 . . . . 0.32 109.115 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.11 -47.02 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.41 109.169 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.08 -46.8 82.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 1.14 108.963 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 27.1 tp . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 2.02 109.538 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.194 -0.669 . . . . 1.02 109.194 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.75 -47.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.981 -1.074 . . . . 1.1 108.668 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.8 mt -57.5 -47.3 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.243 -0.911 . . . . 1.58 108.556 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -57.37 -47.0 82.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.702 -0.624 . . . . 2.09 109.462 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.844 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.22 88.32 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.685 -1.366 . . . . 0.32 109.685 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.881 HG22 ' C ' ' B' ' 79' ' ' GLY . 62.0 t -57.29 -47.81 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.935 -1.332 . . . . 0.28 108.8 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 mtm -57.72 -47.31 82.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 1.7 108.729 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.15 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.662 -0.649 . . . . 0.37 109.738 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.6 -47.31 85.41 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.258 -1.537 . . . . 0.28 109.258 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 93.3 t -57.23 -47.55 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.284 . . . . 0.28 109.033 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.29 -46.95 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.2 109.478 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.7 90.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.329 -1.509 . . . . 0.33 109.329 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.445 ' OG1' HG13 ' B' ' 84' ' ' VAL . 98.0 m -56.77 -47.04 81.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.253 -1.145 . . . . 0.34 109.013 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 91' ' ' ILE . 96.4 mt -57.2 -47.3 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.49 108.826 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.696 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.24 -46.83 82.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.478 -0.934 . . . . 0.68 108.478 179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 39.1 tp -57.01 -46.81 82.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 1.92 109.14 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 95' ' ' ILE . 87.7 mt -56.78 -46.99 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.185 -0.947 . . . . 0.87 109.326 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -47.6 80.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.021 -1.072 . . . . 1.29 108.2 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -57.5 -47.43 81.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.318 -0.863 . . . . 2.64 108.953 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.17 89.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.366 -1.494 . . . . 1.29 109.366 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.09 -47.32 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -1.127 . . . . 2.19 108.63 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -57.31 -47.01 82.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 3.14 108.833 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 3.58 109.806 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.881 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.065 -1.614 . . . . 0.3 109.065 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.844 HG22 ' C ' ' A' ' 79' ' ' GLY . 89.4 t -57.26 -47.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 0.33 108.799 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 14.5 mtp -57.67 -47.35 82.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.291 -0.881 . . . . 1.83 108.957 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.46 83.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.533 -0.729 . . . . 0.31 109.962 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.37 87.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.319 -1.512 . . . . 0.26 109.319 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.445 HG13 ' OG1' ' A' ' 87' ' ' THR . 55.7 t -57.29 -47.54 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -1.217 . . . . 0.31 109.431 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -57.35 -47.22 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.06 109.79 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.04 -47.0 90.91 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.653 -1.379 . . . . 0.3 109.653 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 93.7 m -56.93 -47.18 81.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -1.172 . . . . 0.32 109.521 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.02 -47.24 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.123 -0.986 . . . . 0.41 109.207 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.731 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -57.28 -46.61 82.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 1.14 109.134 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.8 ' O ' HD13 ' B' ' 90' ' ' LEU . 2.8 tm? . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.299 -0.875 . . . . 2.02 109.451 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.981 -0.378 . . . . 1.02 109.981 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 80' ' ' VAL . 42.2 mt -57.27 -48.48 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.744 -1.223 . . . . 1.1 108.955 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 4.3 tt -58.41 -47.48 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.135 -0.978 . . . . 1.58 108.97 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 2.7 m-85 -57.28 -47.5 81.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.745 . . . . 2.09 110.404 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.881 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.26 -47.6 86.56 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.353 -1.499 . . . . 0.32 109.353 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.71 HG22 ' C ' ' B' ' 79' ' ' GLY . 47.5 t -57.59 -47.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -1.168 . . . . 0.28 109.139 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -46.86 82.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 1.7 109.065 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.67 -46.04 81.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.423 -0.798 . . . . 0.37 109.08 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.488 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.62 -46.97 87.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.249 -1.54 . . . . 0.28 109.249 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.762 HG13 ' OG1' ' B' ' 87' ' ' THR . 8.4 t -57.09 -47.39 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.063 -1.257 . . . . 0.28 109.062 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.7 mt -57.2 -46.86 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 1.2 109.454 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.71 89.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.5 -1.44 . . . . 0.33 109.5 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.661 ' OG1' HG13 ' B' ' 84' ' ' VAL . 60.4 m -56.69 -47.0 80.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.257 . . . . 0.34 108.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 91' ' ' ILE . 49.5 mt -57.01 -46.76 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.115 -0.991 . . . . 0.49 108.705 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.51 82.06 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.682 -0.859 . . . . 0.68 108.682 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.7 mt -56.72 -46.6 81.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 1.92 109.053 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 95' ' ' ILE . 82.0 mt -56.85 -47.04 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 0.87 109.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -56.88 -47.68 79.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.983 -1.087 . . . . 1.29 108.483 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -57.57 -47.5 81.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 2.64 109.004 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.58 -47.17 90.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.345 -1.102 . . . . 1.29 110.345 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.91 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER -57.13 -47.1 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.025 -1.279 . . . . 2.19 109.267 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.485 ' N ' ' CG1' ' A' ' 95' ' ' ILE . 9.5 mtp180 -57.14 -47.22 81.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 3.14 109.395 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.529 0 O-C-N 120.776 -1.203 . . . . 3.58 109.814 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.71 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 108.813 -1.715 . . . . 0.3 108.813 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 79' ' ' GLY . 52.0 t -57.68 -47.46 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.267 -1.137 . . . . 0.33 108.951 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 8.3 mtp -57.55 -46.93 83.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 1.83 109.164 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.27 81.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.796 . . . . 0.31 109.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.17 87.93 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.838 -1.705 . . . . 0.26 108.838 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.14 -47.35 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -1.233 . . . . 0.31 109.05 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -57.22 -47.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 1.06 109.639 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.06 90.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.574 -1.41 . . . . 0.3 109.574 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.762 ' OG1' HG13 ' A' ' 84' ' ' VAL . 56.3 m -57.07 -47.26 81.42 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.159 -1.201 . . . . 0.32 109.431 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 58.7 mt -57.4 -47.53 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.41 109.098 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.619 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.44 -47.04 82.83 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.747 HD13 ' C ' ' B' ' 90' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.524 -0.735 . . . . 2.02 109.435 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.526 . . . . 1.02 109.581 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.8 mt -56.97 -47.44 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.058 -1.026 . . . . 1.1 108.644 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.69 -47.45 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.169 -0.957 . . . . 1.58 108.685 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -57.42 -47.31 82.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 2.09 109.682 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.897 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.23 -47.13 90.13 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.241 -1.544 . . . . 0.32 109.241 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.843 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.6 t -57.36 -47.81 83.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -1.137 . . . . 0.28 109.962 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -57.8 -47.82 81.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 1.7 108.859 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.37 84.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.626 -0.671 . . . . 0.37 109.887 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' HG13 ' B' ' 80' ' ' VAL . . . -56.85 -47.27 87.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.845 -1.302 . . . . 0.28 109.845 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' OG1' ' B' ' 87' ' ' THR . 97.3 t -57.16 -47.98 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.323 . . . . 0.28 109.199 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mt -57.67 -47.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.012 . . . . 1.2 109.629 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.25 89.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.099 -1.2 . . . . 0.33 110.099 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.447 ' OG1' HG13 ' B' ' 84' ' ' VAL . 47.4 m -57.11 -47.28 81.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -1.141 . . . . 0.34 109.839 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.9 mt -57.43 -47.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.49 109.808 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.86 81.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.68 109.209 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.526 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tt -57.71 -47.5 82.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -0.955 . . . . 1.92 109.298 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 95' ' ' ILE . 76.2 mt -57.33 -47.04 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.551 -0.718 . . . . 0.87 109.948 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -47.7 79.82 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.974 -1.079 . . . . 1.29 109.176 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.81 -47.97 81.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.008 -1.058 . . . . 2.64 109.537 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.67 87.47 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.854 -1.298 . . . . 1.29 109.854 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -57.37 -47.21 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -1.085 . . . . 2.19 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -56.99 -47.16 81.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.873 . . . . 3.14 109.472 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 3.58 110.075 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.843 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.897 HG22 ' C ' ' A' ' 79' ' ' GLY . 94.1 t -57.34 -47.71 84.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.282 -1.128 . . . . 0.33 109.714 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 2.9 mtt -57.74 -47.76 81.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 1.83 109.001 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.58 83.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.497 -0.752 . . . . 0.31 109.656 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -56.95 -46.97 90.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.599 -1.4 . . . . 0.26 109.599 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 87' ' ' THR . 98.5 t -56.89 -47.6 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -1.188 . . . . 0.31 109.764 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 85' ' ' ILE . 43.6 mm -57.41 -47.91 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.835 -1.165 . . . . 1.06 109.418 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.14 90.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.364 -1.494 . . . . 0.3 109.364 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.438 ' OG1' HG22 ' A' ' 84' ' ' VAL . 98.5 m -57.1 -47.06 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.999 . . . . 0.32 109.695 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 37.7 mt -57.01 -47.66 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.132 -0.98 . . . . 0.41 109.763 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.025 -1.047 . . . . 1.14 108.752 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 66.1 mt . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 2.02 109.429 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.708 -0.479 . . . . 1.02 109.708 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.0 mt -56.92 -48.01 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.85 -1.157 . . . . 1.1 108.72 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 77' ' ' ILE . 34.3 mm -58.02 -47.61 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 1.58 108.693 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.44 -47.25 82.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.753 -0.592 . . . . 2.09 110.278 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.818 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.87 -47.66 84.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.32 109.659 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.824 HG22 ' O ' ' B' ' 79' ' ' GLY . 92.3 t -57.67 -47.49 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.904 -1.351 . . . . 0.28 108.628 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.84 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 1.7 109.037 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.08 81.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.559 -0.713 . . . . 0.37 109.453 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.22 85.67 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.077 -1.609 . . . . 0.28 109.077 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.41 HG22 ' OG1' ' B' ' 87' ' ' THR . 41.7 t -56.93 -47.32 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.973 -1.31 . . . . 0.28 108.907 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 mt -57.21 -46.69 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 1.2 109.813 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.566 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -56.7 -46.9 88.66 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.52 -1.432 . . . . 0.33 109.52 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.793 ' OG1' HG13 ' B' ' 84' ' ' VAL . 17.7 m -57.08 -47.13 81.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.985 -1.303 . . . . 0.34 108.528 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.3 -46.85 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.49 109.226 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -56.81 -46.52 81.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.68 109.371 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.569 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 3.7 mm? -56.66 -47.05 80.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 1.92 108.926 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 95' ' ' ILE . 27.1 mt -56.96 -46.91 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.87 109.302 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -47.28 80.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 1.29 108.466 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -47.57 81.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 2.64 108.976 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.55 -47.24 89.68 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.263 -1.535 . . . . 1.29 109.263 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 91' ' ' ILE . 1.6 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -1.1 . . . . 2.19 109.258 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -57.02 -47.29 81.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 3.14 109.394 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.016 -1.052 . . . . 3.58 109.676 179.817 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.824 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.129 -1.588 . . . . 0.3 109.129 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 79' ' ' GLY . 94.4 t -57.44 -47.42 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -1.193 . . . . 0.33 108.585 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' MET . . . . . 0.558 ' O ' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -57.45 -46.75 83.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.535 -0.913 . . . . 1.83 108.535 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.82 82.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.208 -0.664 . . . . 0.31 109.208 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.09 86.59 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.662 -1.775 . . . . 0.26 108.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.793 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.0 -47.37 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -1.233 . . . . 0.31 108.592 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.558 HD12 ' O ' ' B' ' 81' ' ' MET . 3.9 mt -57.17 -46.74 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.409 -0.807 . . . . 1.06 109.736 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.39 -46.72 86.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.069 -1.612 . . . . 0.3 109.069 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.41 ' OG1' HG22 ' A' ' 84' ' ' VAL . 25.0 m -56.68 -46.75 80.97 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -1.139 . . . . 0.32 109.051 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.14 -47.3 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.41 109.951 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.31 -46.64 82.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.91 -1.119 . . . . 1.14 108.307 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' B' ' 90' ' ' LEU . 27.6 tp . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 2.02 109.013 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.412 -0.588 . . . . 1.02 109.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 80' ' ' VAL . 48.2 mt -57.04 -47.39 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.167 -1.013 . . . . 1.1 108.519 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.58 -47.54 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.482 -0.933 . . . . 1.58 108.482 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 2.09 109.583 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.812 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.19 -47.31 88.67 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.641 -1.384 . . . . 0.32 109.641 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 57.4 t -57.42 -47.65 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.124 -1.221 . . . . 0.28 108.89 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -47.37 82.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.413 -0.805 . . . . 1.7 109.112 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.64 83.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.718 . . . . 0.37 110.121 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.3 -47.37 88.35 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.251 -1.539 . . . . 0.28 109.251 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.26 -47.32 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.28 109.609 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.3 -47.39 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 1.2 110.004 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.35 -47.31 88.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.232 -1.547 . . . . 0.33 109.232 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG13 ' A' ' 91' ' ' ILE . 25.0 m -57.3 -47.01 82.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -1.039 . . . . 0.34 109.44 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.96 -47.25 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.49 109.596 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.11 -46.73 82.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.005 . . . . 0.68 108.745 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -57.29 -47.02 82.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 1.92 109.277 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.694 ' O ' HD12 ' A' ' 95' ' ' ILE . 66.4 mt -57.02 -47.12 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.87 109.805 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -57.01 -47.66 80.33 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.909 -1.119 . . . . 1.29 108.3 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.59 -47.56 81.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.854 . . . . 2.64 109.298 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.35 88.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 1.29 109.5 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mt -57.04 -47.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -1.071 . . . . 2.19 109.096 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.01 -47.2 81.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 3.14 109.459 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? . . . . . 0 C--N 1.3 -1.572 0 O-C-N 120.764 -1.21 . . . . 3.58 109.745 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.921 -1.272 . . . . 0.3 109.921 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.812 HG22 ' C ' ' A' ' 79' ' ' GLY . 40.4 t -57.5 -47.98 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.338 . . . . 0.33 108.898 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' MET . . . . . 0.436 ' O ' HG12 ' B' ' 85' ' ' ILE . 1.4 mtt -57.77 -47.3 82.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.829 . . . . 1.83 109.139 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.44 82.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.703 -0.623 . . . . 0.31 110.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.5 86.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.072 -1.611 . . . . 0.26 109.072 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.45 -47.38 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -1.19 . . . . 0.31 109.375 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.436 HG12 ' O ' ' B' ' 81' ' ' MET . 45.5 mm -57.3 -47.23 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 1.06 109.989 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.98 -47.06 90.22 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.396 -1.482 . . . . 0.3 109.396 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 87' ' ' THR . 50.9 m -57.03 -47.0 81.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.168 -1.196 . . . . 0.32 109.174 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.92 -47.17 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.41 109.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.767 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -46.98 82.35 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.247 -0.908 . . . . 1.14 108.651 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' B' ' 89' ' ' LEU . 6.9 mp . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 2.02 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.204 -0.295 . . . . 1.02 110.204 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.0 mt -57.45 -48.1 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 1.1 109.69 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.547 HG13 ' N ' ' A' ' 78' ' ' PHE . 23.1 pt -57.95 -47.14 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.84 -1.162 . . . . 1.58 108.423 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -57.17 -46.92 82.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.652 . . . . 2.09 109.571 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.909 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.86 -47.4 86.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.651 -1.38 . . . . 0.32 109.651 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.871 HG22 ' C ' ' B' ' 79' ' ' GLY . 95.2 t -57.31 -47.63 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.951 -1.323 . . . . 0.28 108.738 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 mmt -57.72 -47.08 83.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 1.7 108.793 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.02 -46.28 82.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.666 -0.646 . . . . 0.37 109.82 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.45 86.42 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.182 -1.567 . . . . 0.28 109.182 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -57.27 -47.75 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.997 -1.296 . . . . 0.28 108.969 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.9 mt -57.5 -46.97 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 1.2 109.859 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.04 89.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.758 -1.337 . . . . 0.33 109.758 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.558 HG21 ' CG2' ' B' ' 87' ' ' THR . 95.7 m -56.86 -47.21 80.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.021 -1.282 . . . . 0.34 108.753 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -57.24 -47.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.49 108.565 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.73 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.487 -0.931 . . . . 0.68 108.487 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.78 -46.84 81.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.478 -0.764 . . . . 1.92 109.124 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.87 -46.84 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.87 109.031 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.462 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.7 m -56.95 -47.58 80.35 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.007 -1.058 . . . . 1.29 108.371 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.57 -47.72 81.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 2.64 109.05 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.08 90.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.362 -1.495 . . . . 1.29 109.362 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 95' ' ' ILE . 1.5 mm -57.06 -47.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.413 -1.051 . . . . 2.19 109.01 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 92' ' ' SER . 6.8 mtp180 -57.14 -47.19 81.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 3.14 109.438 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 3.58 109.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.871 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.123 -1.591 . . . . 0.3 109.123 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.909 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.7 t -57.37 -47.37 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -1.128 . . . . 0.33 108.79 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -46.95 83.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 1.83 109.41 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.94 -46.4 82.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.444 -0.785 . . . . 0.31 109.65 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.0 90.41 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.783 -1.727 . . . . 0.26 108.783 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.05 -47.21 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.11 . . . . 0.31 109.42 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.99 -47.32 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.051 -1.031 . . . . 1.06 109.779 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.19 89.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.378 -1.489 . . . . 0.3 109.378 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.558 ' CG2' HG21 ' A' ' 87' ' ' THR . 31.5 m -57.1 -46.93 82.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.091 . . . . 0.32 109.361 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.3 mt -56.92 -46.86 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.41 109.148 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.621 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -46.98 81.8 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.029 -1.1 . . . . 1.14 108.029 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.479 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 10.9 tp . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.351 -0.843 . . . . 2.02 109.118 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.681 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.64 -0.504 . . . . 1.02 109.64 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -56.93 -47.85 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 1.1 108.975 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -57.79 -47.46 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 1.58 108.708 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.55 -47.39 82.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 2.09 110.119 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.873 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.25 -47.58 86.66 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.467 -1.453 . . . . 0.32 109.467 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.879 HG22 ' C ' ' B' ' 79' ' ' GLY . 87.7 t -57.65 -47.63 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.249 -1.148 . . . . 0.28 109.095 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -47.29 82.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 1.7 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.47 82.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.37 109.766 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.35 88.08 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.529 -1.428 . . . . 0.28 109.529 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.35 -47.58 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -1.228 . . . . 0.28 109.49 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 85' ' ' ILE . 43.0 mm -57.37 -47.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.934 . . . . 1.2 109.829 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.99 90.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.884 -1.287 . . . . 0.33 109.884 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 91' ' ' ILE . 82.1 m -56.99 -47.16 81.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.34 109.503 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 91' ' ' ILE . 56.2 mt -57.33 -47.28 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.49 109.321 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -46.95 82.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.68 109.208 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 38.5 tp -56.97 -47.01 81.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 1.92 109.466 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.896 ' O ' HG23 ' A' ' 95' ' ' ILE . 60.7 mt -56.92 -47.02 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.87 109.493 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -56.96 -47.56 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.033 -1.067 . . . . 1.29 108.804 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -47.51 81.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.948 -1.095 . . . . 2.64 109.325 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.51 87.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.406 -1.078 . . . . 1.29 110.406 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -57.28 -46.99 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.028 -1.278 . . . . 2.19 109.013 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' N ' ' CG1' ' A' ' 95' ' ' ILE . 14.7 mtm180 -57.01 -46.86 82.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 3.14 109.206 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? . . . . . 0 C--N 1.299 -1.622 0 O-C-N 120.998 -1.064 . . . . 3.58 109.716 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.879 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.669 -1.373 . . . . 0.3 109.669 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.873 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.5 t -57.62 -47.85 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.089 -1.242 . . . . 0.33 109.076 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 29.0 mtt -57.81 -47.43 82.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 1.83 109.103 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.34 83.1 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.719 -0.613 . . . . 0.31 109.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.55 85.78 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.393 -1.483 . . . . 0.26 109.393 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.38 -47.86 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.971 -1.311 . . . . 0.31 109.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.46 -47.2 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 1.06 109.718 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -57.07 -46.95 90.98 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.869 -1.292 . . . . 0.3 109.869 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 87' ' ' THR . 41.6 m -56.97 -47.43 80.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -1.214 . . . . 0.32 109.351 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.31 -47.47 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.41 108.938 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.4 -46.98 82.9 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 1.14 109.12 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.547 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 91.2 mt . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 2.02 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 75' ' ' LEU . 3.2 tt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.801 -0.444 . . . . 1.02 109.801 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.88 -1.138 . . . . 1.1 109.111 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.2 -47.82 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.58 109.122 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -57.62 -47.05 83.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.678 -0.639 . . . . 2.09 109.35 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.806 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.82 -47.17 88.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.884 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.2 t -57.16 -47.84 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.041 -1.27 . . . . 0.28 108.774 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.9 mtm -57.73 -47.21 83.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 1.7 108.93 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.14 -46.42 82.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.37 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.92 -47.26 88.18 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.204 -1.558 . . . . 0.28 109.204 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.3 -47.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.243 . . . . 0.28 109.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.0 mt -57.54 -47.16 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 1.2 109.858 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.07 89.42 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.714 -1.354 . . . . 0.33 109.714 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -56.99 -47.12 81.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.167 -1.196 . . . . 0.34 109.157 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.11 -47.15 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.49 109.133 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.689 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.15 -46.9 82.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.68 109.214 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.6 mt -57.02 -47.11 81.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 1.92 109.455 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 mt -57.2 -46.99 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.87 109.305 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 67.5 m -57.05 -47.41 81.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.231 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.24 -46.77 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.539 -0.725 . . . . 2.64 109.12 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.6 -46.25 88.91 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.496 -1.842 . . . . 1.29 108.496 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mt -56.32 -46.5 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -1.081 . . . . 2.19 108.833 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 92' ' ' SER . 10.6 mmt180 -56.66 -47.0 80.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.856 -1.152 . . . . 3.14 108.649 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 3.58 109.737 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.884 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.698 -1.361 . . . . 0.3 109.698 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.806 HG22 ' C ' ' A' ' 79' ' ' GLY . 95.8 t -57.56 -47.79 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.057 -1.261 . . . . 0.33 108.911 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mtm -57.74 -47.25 82.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.413 -0.804 . . . . 1.83 109.337 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.54 82.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.495 -0.753 . . . . 0.31 109.891 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.45 87.3 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.063 -1.615 . . . . 0.26 109.063 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.26 -47.41 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 0.31 109.437 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.4 -47.16 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 1.06 110.021 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.35 88.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.816 -1.314 . . . . 0.3 109.816 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 33.8 m -57.31 -47.36 81.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.13 -1.218 . . . . 0.32 109.226 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.28 -47.2 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.41 109.643 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.577 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -47.12 82.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 1.14 109.178 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 70.3 mt . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.965 . . . . 2.02 109.512 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.681 -0.488 . . . . 1.02 109.681 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.43 -48.13 83.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.833 -1.167 . . . . 1.1 109.039 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 9.3 tt -58.06 -47.29 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.202 -0.936 . . . . 1.58 108.717 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.5 m-85 -57.39 -47.01 82.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.495 -0.753 . . . . 2.09 109.726 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.799 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.9 -47.29 87.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.504 -1.438 . . . . 0.32 109.504 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.2 t -57.41 -47.58 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.296 . . . . 0.28 108.703 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 85' ' ' ILE . 2.3 mmm -57.75 -47.07 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.85 . . . . 1.7 108.991 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.24 82.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.37 109.759 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.76 -47.3 86.66 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.04 -1.624 . . . . 0.28 109.04 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.457 HG13 ' OG1' ' B' ' 87' ' ' THR . 86.4 t -57.3 -47.63 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.1 -1.236 . . . . 0.28 109.356 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 81' ' ' MET . 26.5 mm -57.43 -47.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 1.2 109.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.14 -46.95 91.05 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.789 -1.324 . . . . 0.33 109.789 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.458 ' HA ' HD12 ' A' ' 90' ' ' LEU . 71.2 m -56.95 -47.42 80.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -1.199 . . . . 0.34 109.5 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.39 -47.56 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.49 109.273 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.65 -47.12 83.14 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.662 -0.866 . . . . 0.68 108.662 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 11.8 mt -57.26 -46.81 82.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 1.92 109.601 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.88 ' O ' HD12 ' A' ' 95' ' ' ILE . 42.4 mt -57.02 -47.13 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.87 109.75 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -57.11 -47.74 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.674 -1.21 . . . . 1.29 108.089 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -46.87 82.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.697 . . . . 2.64 109.25 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.54 -46.22 88.58 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.943 -1.663 . . . . 1.29 108.943 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.88 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -56.26 -46.78 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -1.119 . . . . 2.19 108.847 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 92' ' ' SER . 9.4 mmt180 -56.88 -47.16 81.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.888 -1.133 . . . . 3.14 108.726 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 3.58 109.935 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.907 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.763 -1.335 . . . . 0.3 109.763 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 79' ' ' GLY . 53.4 t -57.08 -47.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.987 -1.302 . . . . 0.33 108.697 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 36.3 mmm -57.74 -47.06 83.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 1.83 108.749 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.9 -46.25 82.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.64 -0.662 . . . . 0.31 109.777 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.57 -47.21 85.94 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.148 -1.581 . . . . 0.26 109.148 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.13 -47.51 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.021 -1.282 . . . . 0.31 109.171 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.26 -46.95 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 1.06 109.814 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -46.76 90.28 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.6 -1.4 . . . . 0.3 109.6 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 84' ' ' VAL . 63.0 m -56.71 -47.06 80.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.162 -1.199 . . . . 0.32 109.309 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.96 -47.24 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.41 109.022 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.17 -46.84 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 1.14 108.998 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.542 ' O ' HD13 ' B' ' 90' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.88 . . . . 2.02 109.312 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.7 0.286 . . . . 1.02 110.259 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 80' ' ' VAL . 72.3 mt -57.58 -48.24 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.676 -1.265 . . . . 1.1 109.457 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 78' ' ' PHE . 19.8 tt -58.28 -47.58 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 1.58 108.975 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 77' ' ' ILE . 8.9 m-30 -57.5 -47.11 82.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 2.09 109.812 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -57.1 -47.28 88.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.7 -1.36 . . . . 0.32 109.7 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.95 HG22 ' C ' ' B' ' 79' ' ' GLY . 56.4 t -57.37 -47.59 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.046 -1.267 . . . . 0.28 109.148 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -57.61 -47.1 83.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.7 109.323 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.42 82.54 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.514 -0.741 . . . . 0.37 109.892 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.34 87.27 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.371 -1.492 . . . . 0.28 109.371 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.8 t -57.1 -47.37 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.121 -1.223 . . . . 0.28 109.74 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.32 -46.91 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 1.2 110.008 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.05 90.46 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.849 -1.3 . . . . 0.33 109.849 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.66 ' CG2' HG21 ' B' ' 87' ' ' THR . 17.0 m -57.24 -47.3 81.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -1.214 . . . . 0.34 109.348 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.22 -47.08 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.49 109.208 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -46.8 82.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.68 109.108 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 32.3 mt -57.01 -47.06 81.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 1.92 109.672 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.926 ' O ' HD12 ' A' ' 95' ' ' ILE . 95.9 mt -57.16 -47.19 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.87 109.141 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.09 -47.43 81.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.212 -1.033 . . . . 1.29 108.212 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -57.47 -47.55 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 2.64 109.253 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.33 -47.25 89.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.266 -1.533 . . . . 1.29 109.266 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.08 -47.03 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.104 . . . . 2.19 108.677 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -57.05 -47.04 81.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 3.14 109.276 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 3.58 109.839 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.95 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.505 . . . . 0.3 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 79' ' ' GLY . 60.4 t -57.32 -47.64 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -1.234 . . . . 0.33 108.663 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.1 mmm -57.74 -47.04 83.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.424 -0.798 . . . . 1.83 108.968 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.08 -46.56 82.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.534 -0.729 . . . . 0.31 109.86 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.68 85.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.763 -1.735 . . . . 0.26 108.763 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.39 -47.61 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.31 108.931 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' B' ' 88' ' ' ILE . 80.1 mt -57.37 -47.0 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.82 . . . . 1.06 110.031 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.655 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -56.93 -47.21 88.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.626 -1.39 . . . . 0.3 109.626 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 87' ' ' THR . 78.5 m -57.28 -47.26 81.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.276 . . . . 0.32 108.588 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 85' ' ' ILE . 85.9 mt -57.23 -46.96 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.443 -0.786 . . . . 0.41 109.216 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -56.93 -46.47 82.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 1.14 109.25 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 2.02 108.893 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.04 -0.355 . . . . 1.02 110.04 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.35 -48.35 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.719 -1.238 . . . . 1.1 110.116 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -58.23 -47.65 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.838 -1.164 . . . . 1.58 108.487 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' N ' HG23 ' A' ' 77' ' ' ILE . 4.4 m-30 -57.26 -47.08 82.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.804 -0.56 . . . . 2.09 109.965 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.781 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.91 -47.41 86.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.595 -1.402 . . . . 0.32 109.595 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.4 t -57.41 -47.66 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.254 . . . . 0.28 108.626 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.3 mmt -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.716 -0.846 . . . . 1.7 108.716 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.05 -46.32 82.52 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.634 -0.666 . . . . 0.37 109.839 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.52 85.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.838 -1.705 . . . . 0.28 108.838 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 61.6 t -57.39 -47.49 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.255 . . . . 0.28 108.908 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 82' ' ' ALA . 20.9 mt -57.2 -47.07 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.414 -0.804 . . . . 1.2 109.798 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.65 -46.92 88.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.546 -1.422 . . . . 0.33 109.546 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 m -56.97 -47.26 81.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.078 -1.248 . . . . 0.34 108.837 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.4 mt -57.23 -47.16 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.85 . . . . 0.49 109.184 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.2 -46.95 82.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.806 . . . . 0.68 109.017 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.48 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 18.2 mt -56.92 -46.89 81.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 1.92 109.074 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 95' ' ' ILE . 33.6 mt -56.85 -46.78 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.87 109.127 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.3 80.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.087 -1.008 . . . . 1.29 108.536 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -47.53 81.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 2.64 108.897 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.54 -47.15 90.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.172 -1.571 . . . . 1.29 109.172 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 91' ' ' ILE . 1.5 mt -57.02 -46.91 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -1.013 . . . . 2.19 109.142 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' NH2' ' HB2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -56.67 -46.62 81.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 3.14 109.079 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 120.94 -1.1 . . . . 3.58 109.205 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.776 -1.33 . . . . 0.3 109.776 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.781 HG22 ' C ' ' A' ' 79' ' ' GLY . 65.8 t -57.37 -47.57 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.002 -1.293 . . . . 0.33 109.065 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' MET . . . . . 0.458 ' O ' HG13 ' B' ' 85' ' ' ILE . 4.7 mtm -57.62 -47.21 82.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.309 -0.869 . . . . 1.83 108.945 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.15 -46.39 82.76 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.546 -0.722 . . . . 0.31 109.913 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.56 86.15 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.476 -1.45 . . . . 0.26 109.476 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.38 -47.56 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.31 . . . . 0.31 109.004 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 82' ' ' ALA . 63.8 mt -57.33 -46.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 1.06 109.759 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.01 90.36 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.836 -1.306 . . . . 0.3 109.836 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 40.5 m -57.04 -47.44 80.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.973 -1.31 . . . . 0.32 108.918 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 35.1 mt -57.4 -46.98 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.41 108.803 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.675 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.59 82.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.029 -0.73 . . . . 1.14 109.029 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.613 ' O ' HD23 ' B' ' 90' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.238 -0.914 . . . . 2.02 109.145 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.546 ' HA ' HD23 ' A' ' 75' ' ' LEU . 1.4 mt . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.16 -0.682 . . . . 1.02 109.16 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.906 ' O ' HG23 ' A' ' 80' ' ' VAL . 26.8 mt -56.66 -47.68 81.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.059 -1.025 . . . . 1.1 108.899 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.8 mt -57.72 -47.88 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.091 -1.006 . . . . 1.58 109.338 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.92 -48.43 79.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 2.09 109.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.914 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.91 -47.34 89.56 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.104 -1.598 . . . . 0.32 109.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' O ' ' B' ' 79' ' ' GLY . 44.9 t -57.17 -47.26 84.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.708 -0.878 . . . . 0.28 109.934 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 mmm -57.16 -47.32 81.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 1.7 109.153 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.41 82.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.374 -0.829 . . . . 0.37 109.41 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.0 -47.1 90.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.936 -1.266 . . . . 0.28 109.936 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.15 -47.49 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.251 . . . . 0.28 109.619 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -57.29 -47.22 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 1.2 109.565 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.13 -46.9 91.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.97 -1.252 . . . . 0.33 109.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.631 ' OG1' HG13 ' B' ' 84' ' ' VAL . 74.7 m -56.88 -47.17 81.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -1.182 . . . . 0.34 109.209 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.14 -46.94 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.49 108.901 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.14 -46.74 82.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.68 109.066 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -56.85 -46.88 81.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 1.92 109.494 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.457 HG22 HD12 ' A' ' 95' ' ' ILE . 98.1 mt -57.03 -46.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.993 . . . . 0.87 108.905 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -47.39 81.2 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.093 -1.005 . . . . 1.29 108.399 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -57.3 -47.54 81.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 2.64 109.196 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.31 -46.98 91.2 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.036 -1.626 . . . . 1.29 109.036 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 91' ' ' ILE . 2.2 mt -57.05 -46.82 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 2.19 108.86 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -56.93 -47.07 81.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 3.14 109.291 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 3.58 109.891 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.907 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.914 HG22 ' O ' ' A' ' 79' ' ' GLY . 46.2 t -57.43 -47.14 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.644 -0.915 . . . . 0.33 109.733 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.5 mmt -56.95 -46.97 81.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 1.83 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.36 81.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.31 109.361 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.99 -47.16 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.618 -1.393 . . . . 0.26 109.618 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 80' ' ' VAL . 5.3 t -57.02 -47.52 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.283 . . . . 0.31 109.241 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.27 -47.07 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.06 109.669 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.08 89.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.425 -1.47 . . . . 0.3 109.425 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -57.14 -47.07 82.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -1.156 . . . . 0.32 108.975 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.41 HG13 ' O ' ' B' ' 84' ' ' VAL . 37.1 mt -57.11 -47.03 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.41 109.14 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.701 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.81 -46.95 81.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.307 -0.871 . . . . 1.14 109.0 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.522 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 6.7 mt . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 2.02 109.06 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.908 -0.405 . . . . 1.02 109.908 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 80' ' ' VAL . 61.6 mt -57.11 -47.7 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.909 -1.119 . . . . 1.1 108.754 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 1.1 mp -57.66 -47.11 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.327 -0.99 . . . . 1.58 108.327 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.24 -47.28 81.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 2.09 109.83 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.859 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.06 -47.38 87.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.178 -1.569 . . . . 0.32 109.178 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 48.4 t -57.59 -47.5 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -1.162 . . . . 0.28 109.238 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 85.0 mtp -57.63 -47.35 82.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 1.7 109.303 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.53 82.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.37 109.876 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.99 -47.42 87.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.529 -1.429 . . . . 0.28 109.529 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.28 -47.48 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 0.28 109.495 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 85' ' ' ILE . 33.4 mm -57.28 -47.41 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 1.2 110.081 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -57.24 -47.19 89.66 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.33 109.642 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 90' ' ' LEU . 98.1 m -57.16 -47.14 81.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -1.194 . . . . 0.34 109.537 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.4 mt -56.97 -47.23 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.49 109.536 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.18 -46.55 82.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.159 -0.963 . . . . 0.68 109.044 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 87' ' ' THR . 8.7 mt -57.13 -47.0 82.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 1.92 109.461 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.86 -47.16 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.87 109.453 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.4 m -57.16 -47.69 80.55 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.922 -1.111 . . . . 1.29 108.487 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -47.48 82.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.071 -1.018 . . . . 2.64 109.611 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.36 88.77 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.16 -1.176 . . . . 1.29 110.16 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 92' ' ' SER . 1.5 tp -57.07 -46.95 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -1.227 . . . . 2.19 108.983 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 19.2 mtp180 -56.87 -46.82 81.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 3.14 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 O-C-N 120.867 -1.146 . . . . 3.58 109.365 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.525 -1.43 . . . . 0.3 109.525 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' C ' ' A' ' 79' ' ' GLY . 69.7 t -57.1 -47.67 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.24 . . . . 0.33 109.189 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' MET . . . . . 0.461 ' O ' HG13 ' B' ' 85' ' ' ILE . 63.6 mtm -57.57 -47.22 82.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 1.83 108.95 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.26 82.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.616 -0.678 . . . . 0.31 109.672 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.22 86.31 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.26 109.34 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.02 -47.47 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -1.234 . . . . 0.31 109.191 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 81' ' ' MET . 30.7 mt -57.27 -47.12 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 1.06 109.633 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.95 90.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.663 -1.375 . . . . 0.3 109.663 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.504 HG21 ' CG2' ' A' ' 87' ' ' THR . 41.4 m -56.93 -47.03 81.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -1.197 . . . . 0.32 109.37 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 91.7 mt -57.06 -47.08 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.088 -1.008 . . . . 0.41 108.724 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.04 -46.77 82.15 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.363 -0.977 . . . . 1.14 108.363 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 94.6 mt . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 2.02 109.154 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HA ' HD23 ' A' ' 75' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 80' ' ' VAL . 26.7 mt -57.14 -47.91 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 118.868 -1.133 . . . . 1.1 108.579 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -58.12 -47.92 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.474 -0.89 . . . . 1.58 109.336 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -57.86 -47.84 81.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.329 -0.857 . . . . 2.09 110.029 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.866 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.41 88.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.32 109.908 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 ' O ' ' B' ' 79' ' ' GLY . 48.7 t -57.25 -47.3 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -1.128 . . . . 0.28 109.037 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.1 mmm -57.41 -47.32 82.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.7 108.72 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.29 -46.68 82.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -0.797 . . . . 0.37 109.749 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.747 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.22 -47.35 88.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.376 -1.49 . . . . 0.28 109.376 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.35 -47.26 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -1.172 . . . . 0.28 109.644 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.2 OUTLIER -57.09 -47.17 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 1.2 109.599 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.03 -47.16 89.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.28 -1.528 . . . . 0.33 109.28 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.0 m -57.17 -46.96 82.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -1.105 . . . . 0.34 109.158 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.05 -47.0 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.49 109.11 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -47.02 81.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.68 108.985 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.548 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tp -57.17 -47.24 81.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.187 -0.946 . . . . 1.92 109.285 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 95' ' ' ILE . 91.6 mt -57.24 -47.29 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.87 109.374 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.8 m -57.26 -47.57 81.07 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.073 -1.017 . . . . 1.29 108.603 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.51 -47.68 81.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 2.64 109.387 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.42 -47.5 87.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.623 . . . . 1.29 109.041 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.4 -47.36 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -1.073 . . . . 2.19 108.841 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -57.21 -47.06 82.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.865 . . . . 3.14 109.55 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 . . . . . 0 C--N 1.299 -1.589 0 O-C-N 120.995 -1.065 . . . . 3.58 109.743 -179.794 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.487 2.041 0 N-CA-C 109.301 -1.519 . . . . 0.3 109.301 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 79' ' ' GLY . 26.0 t -57.2 -47.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.498 -1.001 . . . . 0.33 109.704 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 3.4 mtm -57.3 -47.3 81.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 1.83 109.576 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.91 82.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.31 109.72 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.47 -47.31 89.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.646 -1.382 . . . . 0.26 109.646 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.24 -47.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.157 . . . . 0.31 109.668 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 87.4 mt -57.32 -47.22 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.176 -0.952 . . . . 1.06 110.027 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.33 88.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.648 -1.381 . . . . 0.3 109.648 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 73.5 m -57.47 -47.29 82.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -1.215 . . . . 0.32 109.326 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.8 mt -57.41 -47.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.41 109.649 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.84 82.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.412 -0.805 . . . . 1.14 109.216 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 2.02 109.212 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.392 -0.596 . . . . 1.02 109.392 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 80' ' ' VAL . 25.3 mt -56.89 -47.57 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.947 -1.095 . . . . 1.1 108.696 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -57.78 -47.77 85.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.46 -0.896 . . . . 1.58 109.448 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -57.7 -48.08 80.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 2.09 109.495 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.859 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.66 -47.61 87.24 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.07 -1.612 . . . . 0.32 109.07 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.889 HG22 ' O ' ' B' ' 79' ' ' GLY . 43.3 t -57.43 -47.19 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.567 -0.96 . . . . 0.28 109.148 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmm -57.13 -46.9 82.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.37 -0.831 . . . . 1.7 109.074 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.81 -46.23 81.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 0.37 109.314 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.493 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.76 -46.98 89.06 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.314 -1.514 . . . . 0.28 109.314 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.566 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.4 t -56.88 -47.22 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.031 -1.276 . . . . 0.28 109.202 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 82' ' ' ALA . 75.3 mt -57.1 -46.93 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.159 -0.963 . . . . 1.2 109.354 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.84 91.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.33 109.703 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.705 ' OG1' HG13 ' B' ' 84' ' ' VAL . 92.8 m -56.78 -47.46 80.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -1.199 . . . . 0.34 109.068 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.23 -47.11 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.49 108.781 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -46.71 82.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.5 -0.75 . . . . 0.68 108.987 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.483 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 16.8 tp -56.66 -47.02 80.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 1.92 109.463 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 95' ' ' ILE . 57.2 mt -57.03 -47.11 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.043 -1.035 . . . . 0.87 108.408 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.571 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -57.14 -47.23 81.64 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.348 -0.982 . . . . 1.29 108.348 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.92 80.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.956 -1.09 . . . . 2.64 109.344 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.09 -48.2 84.43 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.941 -1.123 . . . . 1.29 110.557 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 92' ' ' SER . 2.8 tp -57.71 -47.02 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.064 -1.256 . . . . 2.19 109.145 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 92' ' ' SER . 8.1 mtm180 -56.95 -47.05 81.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.858 . . . . 3.14 109.429 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.07 -1.019 . . . . 3.58 109.481 -179.827 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.889 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.154 -1.578 . . . . 0.3 109.154 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 79' ' ' GLY . 40.9 t -57.37 -47.22 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -1.013 . . . . 0.33 109.578 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.8 mmm -56.97 -47.04 81.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 1.83 108.946 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.554 -0.716 . . . . 0.31 109.298 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.581 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.81 -47.12 88.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.743 -1.343 . . . . 0.26 109.743 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.705 HG13 ' OG1' ' A' ' 87' ' ' THR . 30.1 t -57.1 -47.46 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.387 . . . . 0.31 109.078 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -57.11 -46.95 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 1.06 109.347 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -56.85 -46.87 89.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.811 -1.316 . . . . 0.3 109.811 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.566 ' OG1' HG13 ' A' ' 84' ' ' VAL . 31.7 m -56.65 -47.32 80.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.262 . . . . 0.32 109.193 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' B' ' 88' ' ' ILE . 14.0 mt -57.21 -47.14 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.039 -1.038 . . . . 0.41 108.944 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.669 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.05 -46.83 82.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.511 -0.743 . . . . 1.14 109.306 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.531 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 87.6 mt . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.95 . . . . 2.02 109.459 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.593 -0.521 . . . . 1.02 109.593 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.91 -47.51 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 118.854 -1.139 . . . . 1.1 108.262 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.7 mt -57.57 -47.33 85.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.524 -0.917 . . . . 1.58 108.524 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.3 -46.98 82.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 2.09 109.528 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.891 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.05 -47.42 87.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.885 -1.686 . . . . 0.32 108.885 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.908 HG22 ' C ' ' B' ' 79' ' ' GLY . 88.7 t -57.48 -47.61 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -1.189 . . . . 0.28 108.541 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -47.15 83.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.555 -0.716 . . . . 1.7 109.532 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.16 -46.76 82.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 0.37 109.98 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.4 88.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.491 -1.843 . . . . 0.28 108.491 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' ILE . 58.1 t -57.48 -47.5 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.459 -1.024 . . . . 0.28 110.252 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -57.33 -47.53 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 1.2 110.153 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.38 -47.6 86.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.599 . . . . 0.33 109.101 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.6 m -57.58 -46.91 83.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.46 -1.024 . . . . 0.34 109.175 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 84' ' ' VAL . 19.3 mt -56.86 -47.07 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.497 -0.752 . . . . 0.49 109.621 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.15 -46.78 82.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 0.68 109.015 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 28.3 mt -57.47 -47.31 82.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.007 -1.058 . . . . 1.92 109.27 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.897 ' O ' HD12 ' A' ' 95' ' ' ILE . 70.1 mt -57.32 -47.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.803 . . . . 0.87 109.686 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -47.63 80.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.092 -1.005 . . . . 1.29 108.817 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.61 -47.66 81.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.127 -0.983 . . . . 2.64 109.391 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.63 -47.57 87.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.435 . . . . 1.29 109.511 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.32 -47.23 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -1.108 . . . . 2.19 108.956 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -57.13 -47.19 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 3.14 109.565 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 3.58 109.912 -179.768 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.908 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.579 -1.408 . . . . 0.3 109.579 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.891 HG22 ' C ' ' A' ' 79' ' ' GLY . 44.5 t -57.19 -47.72 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.895 -1.356 . . . . 0.33 108.938 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -47.31 83.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.197 -0.939 . . . . 1.83 108.928 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.7 83.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.31 110.151 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.34 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.359 -1.496 . . . . 0.26 109.359 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.24 -47.3 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.31 109.559 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -57.27 -47.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 1.06 110.364 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.21 -47.42 87.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.333 -1.507 . . . . 0.3 109.333 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 87' ' ' THR . 50.7 m -57.34 -46.97 82.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.246 -1.149 . . . . 0.32 108.904 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 mt -56.92 -46.77 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.573 -0.704 . . . . 0.41 109.792 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.72 -46.79 81.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 1.14 109.006 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 2.02 108.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.063 HD23 ' N ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 110.024 -0.361 . . . . 1.02 110.024 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 1.063 ' N ' HD23 ' A' ' 75' ' ' LEU . 44.2 mt -57.66 -48.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.413 -1.429 . . . . 1.1 109.265 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -58.27 -46.74 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.147 -1.057 . . . . 1.58 108.147 177.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' N ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -56.94 -46.87 81.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.683 -0.636 . . . . 2.09 109.898 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.712 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.38 86.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.257 -1.537 . . . . 0.32 109.257 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.975 HG22 ' C ' ' B' ' 79' ' ' GLY . 39.3 t -57.36 -47.56 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.281 . . . . 0.28 108.557 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.64 -46.88 83.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.7 109.323 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.91 -46.42 81.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.58 -0.7 . . . . 0.37 109.75 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.29 87.79 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.801 -1.72 . . . . 0.28 108.801 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' B' ' 87' ' ' THR . 60.6 t -57.32 -47.34 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.143 -1.21 . . . . 0.28 109.179 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.7 mt -57.32 -47.01 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 1.2 109.883 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.04 90.04 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.738 -1.345 . . . . 0.33 109.738 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.637 ' HA ' HD12 ' A' ' 90' ' ' LEU . 37.2 m -57.09 -47.15 81.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -1.18 . . . . 0.34 109.121 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.849 . . . . 0.49 109.538 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.03 -47.02 81.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.68 109.38 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.637 HD12 ' HA ' ' A' ' 87' ' ' THR . 6.2 mt -56.94 -47.05 81.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 1.92 109.337 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 95' ' ' ILE . 63.6 mt -57.03 -47.09 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.87 109.356 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.39 80.84 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.026 -1.046 . . . . 1.29 108.576 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -57.41 -47.25 82.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.24 -0.913 . . . . 2.64 109.387 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.22 -47.34 88.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.014 -1.634 . . . . 1.29 109.014 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.12 -47.01 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -1.126 . . . . 2.19 108.786 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -56.9 -47.07 81.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.828 . . . . 3.14 109.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 3.58 109.698 179.915 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.975 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.605 -1.398 . . . . 0.3 109.605 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 79' ' ' GLY . 86.0 t -57.74 -47.67 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.286 . . . . 0.33 108.928 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 43.5 mtm -57.72 -47.13 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 1.83 109.664 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.41 82.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.31 110.035 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.51 86.76 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.228 -1.549 . . . . 0.26 109.228 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.415 ' O ' HG13 ' B' ' 88' ' ' ILE . 48.5 t -57.46 -47.53 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -1.185 . . . . 0.31 109.451 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 85' ' ' ILE . 30.6 mt -57.33 -47.16 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 1.06 110.177 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.31 87.38 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.296 . . . . 0.3 109.859 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 84' ' ' VAL . 19.3 m -57.23 -47.27 81.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -1.225 . . . . 0.32 109.256 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 84' ' ' VAL . 49.4 mt -57.44 -47.23 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.809 . . . . 0.41 109.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.589 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.21 -46.99 82.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 1.14 109.534 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 40.4 tp . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.182 -0.949 . . . . 2.02 109.509 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 75' ' ' LEU . 5.0 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.826 -0.805 . . . . 1.02 108.826 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.664 ' O ' HG23 ' A' ' 80' ' ' VAL . 35.6 mt -56.79 -47.69 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 118.899 -1.121 . . . . 1.1 108.155 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 77' ' ' ILE . 2.5 mm -57.85 -47.62 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.58 108.857 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -57.57 -47.89 80.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.341 -0.85 . . . . 2.09 109.968 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.868 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.45 88.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.389 -1.484 . . . . 0.32 109.389 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.724 HG22 ' O ' ' B' ' 79' ' ' GLY . 41.8 t -57.34 -47.36 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.366 -1.079 . . . . 0.28 109.121 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.734 ' O ' HD12 ' A' ' 85' ' ' ILE . 16.9 mtp -57.44 -47.21 82.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 1.7 108.966 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.41 83.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.546 -0.721 . . . . 0.37 109.311 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.691 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.1 -47.14 89.86 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.325 -1.51 . . . . 0.28 109.325 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.17 -47.64 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -1.217 . . . . 0.28 109.16 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' O ' ' A' ' 81' ' ' MET . 1.9 mt -57.42 -47.15 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 1.2 109.373 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -57.12 -47.27 88.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.756 -1.338 . . . . 0.33 109.756 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.6 m -57.21 -47.51 81.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -1.21 . . . . 0.34 109.042 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.48 -47.37 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.49 109.329 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -47.0 82.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.456 -0.777 . . . . 0.68 109.363 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 86' ' ' GLY . 4.7 mp -57.07 -47.06 81.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.92 109.204 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 95' ' ' ILE . 78.8 mt -57.16 -47.13 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.87 109.629 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -57.1 -47.59 80.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.164 -1.014 . . . . 1.29 108.823 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -57.86 -48.1 80.79 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.772 -1.205 . . . . 2.64 109.493 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.05 -48.26 83.92 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.064 -1.065 . . . . 1.29 110.668 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -57.63 -46.89 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -1.224 . . . . 2.19 109.373 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 mtm180 -57.18 -47.31 81.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 3.14 109.592 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 3.58 110.212 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.724 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 109.307 -1.517 . . . . 0.3 109.307 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 79' ' ' GLY . 33.2 t -56.93 -47.27 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -1.051 . . . . 0.33 109.571 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 56.6 mmm -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.03 -1.044 . . . . 1.83 108.722 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.17 82.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.435 -0.79 . . . . 0.31 109.076 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.77 -46.76 89.37 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.26 109.454 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 88' ' ' ILE . 54.7 t -56.92 -47.25 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.256 . . . . 0.31 109.336 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.2 -46.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 1.06 109.419 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.531 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.11 -46.85 91.12 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 0.3 109.465 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 14.2 m -56.76 -47.17 80.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -1.155 . . . . 0.32 109.004 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.451 HG13 ' O ' ' B' ' 84' ' ' VAL . 51.0 mt -57.08 -46.98 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.41 109.019 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.726 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.99 -46.45 82.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.403 -0.811 . . . . 1.14 109.156 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 23.3 tp . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 2.02 108.961 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.423 -0.584 . . . . 1.02 109.423 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 80' ' ' VAL . 54.6 mt -57.42 -48.29 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.798 -1.161 . . . . 1.1 109.309 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 78' ' ' PHE . 3.9 tt -58.17 -47.43 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.914 -1.116 . . . . 1.58 108.787 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.559 ' N ' HG23 ' A' ' 77' ' ' ILE . 1.6 m-30 -57.23 -46.79 82.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.524 -0.735 . . . . 2.09 109.557 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.836 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -56.81 -47.04 89.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.629 -1.389 . . . . 0.32 109.629 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' B' ' 79' ' ' GLY . 26.3 t -56.91 -47.59 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.979 -1.306 . . . . 0.28 108.566 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 85' ' ' ILE . 59.0 mtp -57.51 -46.92 83.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.433 -0.951 . . . . 1.7 108.433 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.88 81.69 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.748 -0.595 . . . . 0.37 109.616 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.99 85.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.08 -1.608 . . . . 0.28 109.08 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.98 -47.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.347 . . . . 0.28 108.8 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 81' ' ' MET . 64.3 mt -57.16 -46.83 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 1.2 109.528 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.67 89.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.33 109.536 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.574 HG21 ' CG2' ' B' ' 87' ' ' THR . 22.5 m -56.69 -46.95 80.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.225 . . . . 0.34 109.001 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 91' ' ' ILE . 62.6 mt -57.1 -46.9 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 0.49 109.073 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.98 -46.66 82.07 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.399 -0.813 . . . . 0.68 109.012 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' HG ' ' A' ' 89' ' ' LEU . 5.3 mp -56.69 -47.0 80.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -0.856 . . . . 1.92 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 88' ' ' ILE . 68.3 mt -56.93 -47.12 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.093 -1.004 . . . . 0.87 109.261 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.7 p -57.16 -47.58 80.84 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.441 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -47.45 82.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.17 -0.956 . . . . 2.64 109.341 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.31 89.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.905 -1.278 . . . . 1.29 109.905 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -57.25 -47.06 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.235 . . . . 2.19 108.939 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 9.1 mtm180 -57.06 -47.04 81.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 3.14 109.209 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.248 -0.908 . . . . 3.58 109.964 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 108.754 -1.739 . . . . 0.3 108.754 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.836 HG22 ' CA ' ' A' ' 79' ' ' GLY . 40.1 t -57.35 -47.5 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.191 -1.182 . . . . 0.33 108.698 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.6 -47.0 83.34 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.83 . . . . 1.83 109.193 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.716 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -56.98 -46.68 82.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.31 109.815 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.49 87.1 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.605 -1.798 . . . . 0.26 108.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.421 HG13 ' OG1' ' A' ' 87' ' ' THR . 43.2 t -57.53 -47.3 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -1.1 . . . . 0.31 109.203 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' B' ' 82' ' ' ALA . 38.9 mt -57.25 -47.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 1.06 109.904 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.29 88.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.229 -1.548 . . . . 0.3 109.229 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.574 ' CG2' HG21 ' A' ' 87' ' ' THR . 73.8 m -57.34 -47.09 82.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -1.092 . . . . 0.32 109.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' B' ' 88' ' ' ILE . 57.4 mt -57.13 -47.1 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 0.41 109.694 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.695 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -47.33 81.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 1.14 109.168 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 90' ' ' LEU . . . . . 0.546 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.02 108.871 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 62' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.457 -0.572 . . . . 18.74 109.457 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 30.9 tp60 -104.98 14.14 29.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 16.78 109.55 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.11 -165.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 16.71 109.533 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.0 31.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 14.32 109.415 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 67' ' ' HIS . 32.3 m80 -157.06 -179.61 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 14.47 109.306 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 170.12 -53.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 11.15 109.903 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 69' ' ' SER . 4.6 m-85 -67.47 147.14 53.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 11.57 109.949 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.1 p 51.29 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 7.08 109.99 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -122.12 94.32 48.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 6.49 109.216 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.619 ' HB2' HG23 ' A' ' 74' ' ' THR . 2.5 Cg_endo -60.43 104.91 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.091 1.861 . . . . 2.65 110.479 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -53.07 -39.19 63.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 3.01 109.211 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' N ' ' A' ' 74' ' ' THR . 5.4 tp -64.02 -45.2 97.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.206 -0.934 . . . . 1.48 109.813 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 71' ' ' PRO . 45.4 p -57.0 -46.92 81.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 1.35 109.563 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.003 HD13 HD13 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -67.12 -47.37 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.033 . . . . 1.02 109.546 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.013 HD13 HD13 ' B' ' 75' ' ' LEU . 85.8 mt -57.3 -47.63 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.896 -1.127 . . . . 1.1 108.213 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.71 -47.2 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.64 -0.874 . . . . 1.58 108.64 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.94 -47.14 81.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.601 -0.687 . . . . 2.09 109.468 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.886 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.02 -47.43 87.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.991 -1.644 . . . . 0.32 108.991 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 60.9 t -57.48 -47.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -1.234 . . . . 0.28 108.708 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.447 ' O ' HG12 ' A' ' 85' ' ' ILE . 7.0 mtt -57.54 -46.99 83.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 1.7 109.393 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.6 82.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.414 -0.804 . . . . 0.37 109.722 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.42 87.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.744 -1.742 . . . . 0.28 108.744 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -47.16 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -1.096 . . . . 0.28 109.317 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 81' ' ' MET . 21.6 mm -57.06 -47.15 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 1.2 110.038 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.37 88.08 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.297 -1.521 . . . . 0.33 109.297 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.437 ' OG1' HG13 ' B' ' 84' ' ' VAL . 91.6 m -57.45 -47.19 82.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -1.145 . . . . 0.34 109.065 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' A' ' 91' ' ' ILE . 34.5 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.49 109.43 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -47.05 81.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.68 108.722 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 15.2 tp -57.21 -47.17 81.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 1.92 108.928 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.904 HD11 HD11 ' B' ' 91' ' ' ILE . 81.7 mt -57.28 -46.91 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.87 109.578 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 95' ' ' ILE . 51.0 m -56.93 -47.5 80.46 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.157 -1.017 . . . . 1.29 108.873 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -47.72 81.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 2.64 109.18 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.35 89.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.593 -1.403 . . . . 1.29 109.593 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 92' ' ' SER . 2.1 tp -57.18 -46.81 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -1.069 . . . . 2.19 109.212 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 99' ' ' ILE . 16.7 mtm180 -56.68 -46.6 81.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.897 . . . . 3.14 109.09 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -46.78 82.39 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.776 -1.203 . . . . 3.58 109.201 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -46.96 81.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 2.66 109.564 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 96' ' ' ARG . 2.1 pt -82.55 -112.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 2.2 109.109 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER 47.63 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.777 -1.202 . . . . 3.91 109.575 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.011 -0.995 . . . . 6.53 109.525 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.706 ' O ' HG13 ' B' ' 62' ' ' VAL . 12.0 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.486 -0.561 . . . . 20.22 109.486 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -64.87 146.0 55.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 18.1 109.364 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' B' ' 64' ' ' LEU . 5.6 tp -137.73 6.95 2.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 17.47 109.623 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' B' ' 66' ' ' HIS . . . -80.24 -13.31 59.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 15.58 109.548 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.497 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 1.9 t60 77.93 114.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.354 -0.842 . . . . 14.18 109.645 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' B' ' 66' ' ' HIS . 0.2 OUTLIER 168.2 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 13.39 109.436 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -141.98 -88.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 12.43 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' B' ' 75' ' ' LEU . 64.9 m -88.08 105.96 17.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 8.12 109.467 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 0.8 OUTLIER -68.15 -55.04 13.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 7.29 109.98 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.643 ' HG2' HG21 ' B' ' 74' ' ' THR . 5.0 Cg_exo -60.08 156.61 38.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.96 1.773 . . . . 2.87 110.537 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' B' ' 73' ' ' ILE . 1.6 mt-10 -66.3 -73.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 2.89 109.809 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.5 OUTLIER -39.57 -41.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 2.11 110.184 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.643 HG21 ' HG2' ' B' ' 71' ' ' PRO . 2.0 p -61.38 -46.63 89.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.57 109.433 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.013 HD13 HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -74.11 -47.34 36.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.63 109.97 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 75' ' ' LEU . 64.0 mt -57.56 -48.45 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.702 -1.248 . . . . 1.02 109.492 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.555 HG23 ' N ' ' B' ' 78' ' ' PHE . 0.8 OUTLIER -58.25 -47.21 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.86 108.66 178.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.555 ' N ' HG23 ' B' ' 77' ' ' ILE . 2.0 m-85 -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.655 -0.653 . . . . 2.81 109.51 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.66 -47.02 88.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.328 -1.509 . . . . 0.3 109.328 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.886 HG22 ' C ' ' A' ' 79' ' ' GLY . 87.7 t -57.1 -47.76 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.295 . . . . 0.33 108.681 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' MET . . . . . 0.516 ' HE2' ' HA ' ' B' ' 78' ' ' PHE . 61.3 mtm -57.67 -47.31 82.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 1.83 108.654 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.2 -46.16 83.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.72 -0.613 . . . . 0.31 109.835 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.67 -47.3 86.03 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.302 -1.519 . . . . 0.26 109.302 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.437 HG13 ' OG1' ' A' ' 87' ' ' THR . 58.0 t -57.18 -47.58 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.3 . . . . 0.31 108.993 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 82' ' ' ALA . 48.0 mt -57.4 -47.1 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 1.06 109.866 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.91 -47.08 89.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.3 109.745 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 25.2 m -57.03 -47.15 81.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.161 -1.199 . . . . 0.32 109.115 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.11 -47.02 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.41 109.169 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.08 -46.8 82.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 1.14 108.963 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 27.1 tp -56.9 -47.14 81.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 2.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.904 HD11 HD11 ' A' ' 91' ' ' ILE . 86.6 mt -57.09 -47.35 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.13 -0.981 . . . . 0.77 109.454 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -47.52 80.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.084 -1.047 . . . . 1.53 108.347 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.44 81.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.405 -0.81 . . . . 2.25 109.307 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.46 87.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.251 -1.539 . . . . 1.24 109.251 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.824 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mp -57.21 -47.09 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -1.104 . . . . 1.81 108.86 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -57.17 -46.74 82.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.85 . . . . 2.69 109.639 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.51 -47.19 79.84 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.762 -1.199 . . . . 3.17 107.762 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.813 ' O ' HD12 ' B' ' 99' ' ' ILE . 3.9 mt -57.26 -46.43 83.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.829 -1.174 . . . . 2.09 107.829 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.813 HD12 ' O ' ' B' ' 98' ' ' LEU . 3.6 mt 94.28 102.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.761 0.791 . . . . 2.5 109.362 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 101' ' ' LYS . 2.1 tttt -84.94 124.86 32.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.641 -0.662 . . . . 5.22 109.646 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 18.0 mmtp . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.938 -1.03 . . . . 7.38 109.374 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.544 -0.539 . . . . 18.74 109.544 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 179.89 143.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 16.78 109.541 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -79.69 -53.46 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 16.71 109.443 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 64.15 60.5 0.98 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.308 -0.87 . . . . 14.32 109.301 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -42.99 -61.46 1.29 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 14.47 109.536 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -152.35 74.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 11.15 109.583 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.74 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 11.57 109.301 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' HIS . 85.4 p -104.06 -152.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.183 -0.948 . . . . 7.08 109.753 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.579 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.68 -55.38 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.388 -0.82 . . . . 6.49 109.339 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 3.8 Cg_exo -58.12 83.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.895 1.73 . . . . 2.65 109.839 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' GLU . 4.4 mt-10 -67.51 -72.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.841 . . . . 3.01 109.918 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -52.22 -37.98 23.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.098 -1.002 . . . . 1.48 109.421 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.703 ' N ' HD13 ' A' ' 73' ' ' ILE . 16.5 m -61.16 -46.96 88.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 1.35 108.972 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.089 HD13 ' CD1' ' B' ' 76' ' ' ILE . 0.3 OUTLIER -67.71 -46.62 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.821 . . . . 1.02 109.194 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.053 HD13 HD13 ' B' ' 75' ' ' LEU . 51.1 mt -56.75 -47.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.981 -1.074 . . . . 1.1 108.668 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' ILE . 37.8 mt -57.5 -47.3 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.243 -0.911 . . . . 1.58 108.556 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -57.37 -47.0 82.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.702 -0.624 . . . . 2.09 109.462 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.844 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.22 88.32 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.685 -1.366 . . . . 0.32 109.685 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.881 HG22 ' C ' ' B' ' 79' ' ' GLY . 62.0 t -57.29 -47.81 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.935 -1.332 . . . . 0.28 108.8 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 mtm -57.72 -47.31 82.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 1.7 108.729 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.15 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.662 -0.649 . . . . 0.37 109.738 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.6 -47.31 85.41 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.258 -1.537 . . . . 0.28 109.258 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 93.3 t -57.23 -47.55 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.284 . . . . 0.28 109.033 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.29 -46.95 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.2 109.478 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.7 90.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.329 -1.509 . . . . 0.33 109.329 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.445 ' OG1' HG13 ' B' ' 84' ' ' VAL . 98.0 m -56.77 -47.04 81.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.253 -1.145 . . . . 0.34 109.013 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 91' ' ' ILE . 96.4 mt -57.2 -47.3 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.49 108.826 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.696 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.24 -46.83 82.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.478 -0.934 . . . . 0.68 108.478 179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 39.1 tp -57.01 -46.81 82.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 1.92 109.14 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.643 HD11 HD11 ' B' ' 91' ' ' ILE . 87.7 mt -56.78 -46.99 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.185 -0.947 . . . . 0.87 109.326 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -47.6 80.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.021 -1.072 . . . . 1.29 108.2 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -57.5 -47.43 81.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.318 -0.863 . . . . 2.64 108.953 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.17 89.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.366 -1.494 . . . . 1.29 109.366 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.09 -47.32 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -1.127 . . . . 2.19 108.63 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' HA ' HD11 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -57.31 -47.01 82.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 3.14 108.833 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.27 -47.07 82.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 3.58 109.806 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.9 mt -56.96 -46.84 81.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.029 -1.045 . . . . 2.66 109.161 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 96' ' ' ARG . 18.6 pt -74.99 -45.88 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 2.2 110.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -128.71 166.56 18.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 3.91 109.902 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 6.9 mmtm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.024 -0.989 . . . . 6.53 109.465 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.241 0.543 . . . . 20.22 109.556 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' B' ' 64' ' ' LEU . 0.4 OUTLIER -131.42 38.39 3.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 18.1 109.57 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.464 HD23 ' N ' ' B' ' 65' ' ' ALA . 0.5 OUTLIER 67.71 159.23 0.15 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.402 -0.811 . . . . 17.47 109.572 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.464 ' N ' HD23 ' B' ' 64' ' ' LEU . . . -165.87 68.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 15.58 109.429 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.6 m80 55.86 62.09 2.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 14.18 109.396 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -15.18 62.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.83 . . . . 13.39 109.579 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -71.65 167.75 19.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 12.43 109.666 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' B' ' 70' ' ' GLU . 0.3 OUTLIER -150.57 -152.33 0.43 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 8.12 109.308 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' B' ' 72' ' ' GLU . 0.0 OUTLIER 73.34 98.23 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 7.29 109.53 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.28 58.48 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.369 2.046 . . . . 2.87 110.345 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' B' ' 70' ' ' GLU . 16.3 mt-10 -65.15 -74.95 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 2.89 109.415 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.93 ' O ' HG23 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -44.01 -38.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.228 -0.92 . . . . 2.11 109.538 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.557 ' O ' HG12 ' B' ' 77' ' ' ILE . 89.7 m -59.09 -46.97 86.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 1.57 109.674 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.053 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -75.24 -47.08 29.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.883 -1.135 . . . . 1.63 109.538 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.089 ' CD1' HD13 ' A' ' 75' ' ' LEU . 11.7 mt -57.43 -48.14 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.855 -1.153 . . . . 1.02 109.602 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.93 HG23 ' O ' ' B' ' 73' ' ' ILE . 15.9 pt -58.0 -47.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.043 -1.036 . . . . 1.86 108.522 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.539 ' N ' HG13 ' B' ' 77' ' ' ILE . 0.8 OUTLIER -57.14 -47.28 81.54 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.801 -0.76 . . . . 2.81 109.085 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.881 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.08 -47.3 88.56 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.065 -1.614 . . . . 0.3 109.065 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.844 HG22 ' C ' ' A' ' 79' ' ' GLY . 89.4 t -57.26 -47.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 0.33 108.799 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' B' ' 77' ' ' ILE . 14.5 mtp -57.67 -47.35 82.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.291 -0.881 . . . . 1.83 108.957 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.46 83.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.533 -0.729 . . . . 0.31 109.962 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.37 87.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.319 -1.512 . . . . 0.26 109.319 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.445 HG13 ' OG1' ' A' ' 87' ' ' THR . 55.7 t -57.29 -47.54 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -1.217 . . . . 0.31 109.431 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -57.35 -47.22 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.06 109.79 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.04 -47.0 90.91 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.653 -1.379 . . . . 0.3 109.653 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 93.7 m -56.93 -47.18 81.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -1.172 . . . . 0.32 109.521 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.02 -47.24 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.123 -0.986 . . . . 0.41 109.207 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.731 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -57.28 -46.61 82.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 1.14 109.134 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.8 ' O ' HD13 ' B' ' 90' ' ' LEU . 2.8 tm? -57.2 -46.92 82.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.299 -0.875 . . . . 2.02 109.451 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.92 ' O ' HG23 ' B' ' 95' ' ' ILE . 99.2 mt -57.0 -47.14 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.77 109.623 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.508 ' O ' HG12 ' B' ' 95' ' ' ILE . 28.5 m -57.14 -47.6 80.77 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.891 -1.131 . . . . 1.53 108.634 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -57.69 -47.57 81.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.008 -1.057 . . . . 2.25 109.571 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.53 -47.61 87.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.284 -1.126 . . . . 1.24 110.284 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.92 HG23 ' O ' ' B' ' 91' ' ' ILE . 0.8 OUTLIER -57.33 -47.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.048 -1.266 . . . . 1.81 109.352 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' B' ' 99' ' ' ILE . 22.2 mtm180 -57.07 -47.08 81.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 2.69 109.539 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -46.86 83.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.977 . . . . 3.17 109.812 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -47.07 81.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 2.09 109.374 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' B' ' 96' ' ' ARG . 32.2 pt -70.87 -15.68 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 2.5 108.937 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -115.08 -162.83 0.84 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.432 -0.793 . . . . 5.22 109.374 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' B' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.911 -1.042 . . . . 7.38 109.618 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.379 -0.6 . . . . 18.74 109.379 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 3.0 pp0? -178.77 153.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 16.78 109.409 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -53.98 173.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 16.71 109.342 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.49 104.28 0.61 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.234 -0.916 . . . . 14.32 109.42 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -70.32 -148.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 14.47 109.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -65.94 -175.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 11.15 109.666 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.33 -8.18 11.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 11.57 109.525 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 p -46.62 157.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.885 . . . . 7.08 109.755 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -137.61 154.8 75.28 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 6.49 109.63 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 3.7 Cg_exo -60.67 170.15 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.274 1.983 . . . . 2.65 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.0 mt-10 -63.21 -74.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 3.01 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -41.03 -35.97 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.41 -0.806 . . . . 1.48 110.007 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -64.77 -46.82 80.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 1.35 109.38 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.677 HD13 ' CD1' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -77.45 -47.15 20.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 1.02 109.981 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.933 HG12 HD21 ' B' ' 75' ' ' LEU . 42.2 mt -57.27 -48.48 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.744 -1.223 . . . . 1.1 108.955 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 4.3 tt -58.41 -47.48 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.135 -0.978 . . . . 1.58 108.97 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 2.7 m-85 -57.28 -47.5 81.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.745 . . . . 2.09 110.404 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.881 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.26 -47.6 86.56 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.353 -1.499 . . . . 0.32 109.353 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.71 HG22 ' C ' ' B' ' 79' ' ' GLY . 47.5 t -57.59 -47.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -1.168 . . . . 0.28 109.139 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -46.86 82.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 1.7 109.065 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.67 -46.04 81.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.423 -0.798 . . . . 0.37 109.08 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.488 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.62 -46.97 87.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.249 -1.54 . . . . 0.28 109.249 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.762 HG13 ' OG1' ' B' ' 87' ' ' THR . 8.4 t -57.09 -47.39 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.063 -1.257 . . . . 0.28 109.062 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.7 mt -57.2 -46.86 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 1.2 109.454 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.71 89.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.5 -1.44 . . . . 0.33 109.5 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.661 ' OG1' HG13 ' B' ' 84' ' ' VAL . 60.4 m -56.69 -47.0 80.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.257 . . . . 0.34 108.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 91' ' ' ILE . 49.5 mt -57.01 -46.76 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.115 -0.991 . . . . 0.49 108.705 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.51 82.06 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.682 -0.859 . . . . 0.68 108.682 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.7 mt -56.72 -46.6 81.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 1.92 109.053 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 95' ' ' ILE . 82.0 mt -56.85 -47.04 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 0.87 109.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -56.88 -47.68 79.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.983 -1.087 . . . . 1.29 108.483 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -57.57 -47.5 81.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 2.64 109.004 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.58 -47.17 90.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.345 -1.102 . . . . 1.29 110.345 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.91 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER -57.13 -47.1 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.025 -1.279 . . . . 2.19 109.267 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 99' ' ' ILE . 9.5 mtp180 -57.14 -47.22 81.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 3.14 109.395 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -47.18 83.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.776 -1.203 . . . . 3.58 109.814 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.23 -47.03 82.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.382 -0.824 . . . . 2.66 110.09 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 96' ' ' ARG . 1.0 OUTLIER -81.39 6.25 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 2.2 109.713 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -129.12 80.92 2.0 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 3.91 109.408 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 6.53 109.39 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.305 0.574 . . . . 20.22 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' B' ' 63' ' ' GLN . 20.1 tp60 -128.72 26.07 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 18.1 109.44 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.86 1.81 14.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.843 . . . . 17.47 109.921 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.75 145.86 36.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 15.58 109.397 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 -177.2 3.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 14.18 109.455 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.528 ' O ' ' CB ' ' B' ' 68' ' ' PHE . 11.9 p80 -163.84 -169.49 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 13.39 109.491 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' B' ' 67' ' ' HIS . 0.2 OUTLIER 75.94 -56.15 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 12.43 109.361 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.418 ' O ' ' C ' ' B' ' 70' ' ' GLU . 2.7 m -121.28 128.43 52.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 8.12 109.49 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 69' ' ' SER . 33.5 mt-10 -43.77 110.13 0.92 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 7.29 109.419 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.601 ' HB2' HG23 ' B' ' 74' ' ' THR . 4.0 Cg_exo -59.72 106.43 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.912 1.741 . . . . 2.87 110.287 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.457 ' O ' HG13 ' B' ' 76' ' ' ILE . 4.2 mt-10 -51.98 -48.22 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 2.89 109.237 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.595 HG23 ' N ' ' B' ' 74' ' ' THR . 1.5 tp -55.86 -47.4 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.307 -0.87 . . . . 2.11 110.085 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.601 HG23 ' HB2' ' B' ' 71' ' ' PRO . 53.4 p -55.05 -46.87 75.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.932 -1.105 . . . . 1.57 109.349 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.117 HD23 ' N ' ' B' ' 76' ' ' ILE . 0.0 OUTLIER -65.98 -47.0 76.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 1.63 109.373 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.117 ' N ' HD23 ' B' ' 75' ' ' LEU . 51.8 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.651 -1.281 . . . . 1.02 108.219 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' B' ' 77' ' ' ILE . 21.5 mm -57.7 -47.18 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.503 -0.925 . . . . 1.86 108.503 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' B' ' 74' ' ' THR . 18.5 m-85 -57.12 -47.36 81.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.655 -0.653 . . . . 2.81 110.304 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.71 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.04 -47.65 85.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.813 -1.715 . . . . 0.3 108.813 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 79' ' ' GLY . 52.0 t -57.68 -47.46 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.267 -1.137 . . . . 0.33 108.951 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 8.3 mtp -57.55 -46.93 83.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 1.83 109.164 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.27 81.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.796 . . . . 0.31 109.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.17 87.93 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.838 -1.705 . . . . 0.26 108.838 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.14 -47.35 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -1.233 . . . . 0.31 109.05 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -57.22 -47.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 1.06 109.639 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.06 90.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.574 -1.41 . . . . 0.3 109.574 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.762 ' OG1' HG13 ' A' ' 84' ' ' VAL . 56.3 m -57.07 -47.26 81.42 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.159 -1.201 . . . . 0.32 109.431 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.463 ' HA ' HD12 ' B' ' 91' ' ' ILE . 58.7 mt -57.4 -47.53 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.41 109.098 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.619 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.44 -47.04 82.83 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.747 HD13 ' C ' ' B' ' 90' ' ' LEU . 3.4 tm? -57.02 -46.99 81.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.524 -0.735 . . . . 2.02 109.435 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.681 ' O ' HD12 ' B' ' 95' ' ' ILE . 70.0 mt -56.97 -47.2 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.77 109.418 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' B' ' 96' ' ' ARG . 0.3 OUTLIER -57.37 -47.54 81.38 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.929 -1.108 . . . . 1.53 108.398 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.82 81.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.352 -0.842 . . . . 2.25 109.343 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.65 -47.22 90.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.427 -1.469 . . . . 1.24 109.427 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.681 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.4 mt -57.1 -47.11 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.46 -1.023 . . . . 1.81 109.214 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.496 ' HA ' HD11 ' B' ' 99' ' ' ILE . 4.5 mtm180 -57.08 -47.23 81.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.112 -0.993 . . . . 2.69 109.499 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 100' ' ' LYS . 8.5 ttt180 -57.48 -47.02 83.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 3.17 109.781 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -46.99 81.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.853 . . . . 2.09 109.308 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.517 HG13 ' N ' ' B' ' 100' ' ' LYS . 38.4 pt -75.27 -35.01 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.514 -0.742 . . . . 2.5 109.442 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' B' ' 101' ' ' LYS . 3.1 mmtp -91.78 115.41 28.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -0.819 . . . . 5.22 109.56 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' B' ' 100' ' ' LYS . 4.0 mtmp? . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.049 -0.977 . . . . 7.38 109.416 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.465 -0.568 . . . . 18.74 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -143.08 159.99 41.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 16.78 109.559 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.4 mt -130.31 93.15 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 16.71 109.525 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.24 24.52 1.6 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.026 . . . . 14.32 109.581 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 t60 51.41 77.86 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 14.47 109.277 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -158.88 -55.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 11.15 109.353 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 68.38 -62.92 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 11.57 109.42 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 1.5 m 76.17 48.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 7.08 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 69' ' ' SER . 15.0 mt-10 55.46 101.54 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 6.49 109.49 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.453 ' HG2' ' OG1' ' A' ' 74' ' ' THR . 5.1 Cg_exo -58.21 154.96 37.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.955 1.77 . . . . 2.65 110.209 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -59.29 -70.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 3.01 109.99 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -39.24 -45.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.454 -0.779 . . . . 1.48 110.587 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -59.23 -46.96 87.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.072 -1.018 . . . . 1.35 109.489 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.012 HD13 ' CD1' ' B' ' 76' ' ' ILE . 0.4 OUTLIER -69.14 -47.06 66.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 1.02 109.581 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.074 HD13 HD13 ' B' ' 75' ' ' LEU . 63.8 mt -56.97 -47.44 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.058 -1.026 . . . . 1.1 108.644 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.69 -47.45 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.169 -0.957 . . . . 1.58 108.685 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 74' ' ' THR . 18.8 m-30 -57.42 -47.31 82.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 2.09 109.682 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.897 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.23 -47.13 90.13 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.241 -1.544 . . . . 0.32 109.241 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.843 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.6 t -57.36 -47.81 83.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -1.137 . . . . 0.28 109.962 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -57.8 -47.82 81.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 1.7 108.859 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.37 84.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.626 -0.671 . . . . 0.37 109.887 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' HG13 ' B' ' 80' ' ' VAL . . . -56.85 -47.27 87.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.845 -1.302 . . . . 0.28 109.845 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' OG1' ' B' ' 87' ' ' THR . 97.3 t -57.16 -47.98 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.323 . . . . 0.28 109.199 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mt -57.67 -47.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.012 . . . . 1.2 109.629 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.25 89.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.099 -1.2 . . . . 0.33 110.099 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.447 ' OG1' HG13 ' B' ' 84' ' ' VAL . 47.4 m -57.11 -47.28 81.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -1.141 . . . . 0.34 109.839 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.9 mt -57.43 -47.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.49 109.808 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.86 81.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.68 109.209 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.526 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tt -57.71 -47.5 82.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -0.955 . . . . 1.92 109.298 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.782 HD13 HD13 ' B' ' 91' ' ' ILE . 76.2 mt -57.33 -47.04 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.551 -0.718 . . . . 0.87 109.948 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -47.7 79.82 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.974 -1.079 . . . . 1.29 109.176 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.81 -47.97 81.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.008 -1.058 . . . . 2.64 109.537 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.67 87.47 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.854 -1.298 . . . . 1.29 109.854 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -57.37 -47.21 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -1.085 . . . . 2.19 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' O ' HG13 ' A' ' 99' ' ' ILE . 22.1 mtm180 -56.99 -47.16 81.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.873 . . . . 3.14 109.472 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.94 82.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 3.58 110.075 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.97 -46.9 81.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -0.982 . . . . 2.66 108.821 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.525 HG13 ' N ' ' A' ' 100' ' ' LYS . 37.7 pt -74.87 -36.0 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 2.2 109.432 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -62.99 134.8 56.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.82 . . . . 3.91 109.752 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.07 -0.967 . . . . 6.53 109.467 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.527 HG12 ' N ' ' B' ' 63' ' ' GLN . 73.1 t . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.492 -0.559 . . . . 20.22 109.492 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.54 ' CG ' ' N ' ' B' ' 64' ' ' LEU . 10.9 tt0 61.01 167.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 18.1 109.08 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' B' ' 63' ' ' GLN . 0.2 OUTLIER 175.8 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 17.47 109.692 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' B' ' 66' ' ' HIS . . . -106.24 37.76 2.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 15.58 109.37 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.421 ' CG ' ' O ' ' B' ' 65' ' ' ALA . 78.8 m80 -154.74 63.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 14.18 109.447 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.568 ' O ' ' CD2' ' B' ' 67' ' ' HIS . 54.0 p-80 -101.28 69.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 13.39 109.529 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.52 ' O ' ' CB ' ' B' ' 69' ' ' SER . 44.9 m-85 -67.17 90.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 12.43 109.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' B' ' 68' ' ' PHE . 0.1 OUTLIER 75.9 109.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 8.12 109.546 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.49 145.59 99.04 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 7.29 109.381 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.405 ' HA ' ' OG1' ' B' ' 74' ' ' THR . 2.1 Cg_endo -62.69 -23.53 74.6 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.249 1.966 . . . . 2.87 110.281 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.43 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 18.1 mt-10 -48.54 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 2.89 109.698 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.703 ' O ' HG22 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -45.9 -30.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.206 -0.934 . . . . 2.11 109.926 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.917 HG22 ' CE2' ' B' ' 78' ' ' PHE . 0.5 OUTLIER -64.68 -46.77 80.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 1.57 109.695 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.074 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -74.62 -46.85 35.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.997 -1.065 . . . . 1.63 109.624 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.012 ' CD1' HD13 ' A' ' 75' ' ' LEU . 66.9 mt -56.96 -48.0 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 1.02 109.518 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.703 HG22 ' O ' ' B' ' 73' ' ' ILE . 1.5 tt -57.9 -47.53 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.792 -1.192 . . . . 1.86 108.45 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.917 ' CE2' HG22 ' B' ' 74' ' ' THR . 23.1 m-30 -57.33 -47.26 82.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 2.81 109.721 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.843 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.22 -47.29 88.88 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.897 HG22 ' C ' ' A' ' 79' ' ' GLY . 94.1 t -57.34 -47.71 84.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.282 -1.128 . . . . 0.33 109.714 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 2.9 mtt -57.74 -47.76 81.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 1.83 109.001 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.58 83.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.497 -0.752 . . . . 0.31 109.656 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -56.95 -46.97 90.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.599 -1.4 . . . . 0.26 109.599 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 87' ' ' THR . 98.5 t -56.89 -47.6 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -1.188 . . . . 0.31 109.764 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 85' ' ' ILE . 43.6 mm -57.41 -47.91 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.835 -1.165 . . . . 1.06 109.418 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.14 90.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.364 -1.494 . . . . 0.3 109.364 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.438 ' OG1' HG22 ' A' ' 84' ' ' VAL . 98.5 m -57.1 -47.06 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.999 . . . . 0.32 109.695 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 37.7 mt -57.01 -47.66 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.132 -0.98 . . . . 0.41 109.763 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.025 -1.047 . . . . 1.14 108.752 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 66.1 mt -57.59 -47.22 82.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 2.02 109.429 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.782 HD13 HD13 ' A' ' 91' ' ' ILE . 73.4 mt -57.15 -47.14 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.444 -0.785 . . . . 0.77 110.038 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.51 ' O ' HG22 ' B' ' 95' ' ' ILE . 52.4 m -57.03 -48.01 79.54 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.831 -1.168 . . . . 1.53 108.656 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.9 -47.79 81.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.837 -1.165 . . . . 2.25 109.12 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.27 89.63 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.572 -1.011 . . . . 1.24 110.572 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.51 HG22 ' O ' ' B' ' 92' ' ' SER . 1.6 tt -57.08 -47.22 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -1.212 . . . . 1.81 109.408 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.502 ' O ' HG13 ' B' ' 99' ' ' ILE . 7.2 mtm180 -57.26 -47.28 81.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 2.69 108.898 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.79 83.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 3.17 109.811 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -46.98 80.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 2.09 109.106 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.51 HG13 ' N ' ' B' ' 100' ' ' LYS . 10.4 pt -79.71 -131.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.593 -0.891 . . . . 2.5 108.593 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.51 ' N ' HG13 ' B' ' 99' ' ' ILE . 6.8 tttm 59.47 136.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.137 -0.977 . . . . 5.22 109.958 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' B' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.998 -1.001 . . . . 7.38 109.532 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.342 0.592 . . . . 18.74 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -148.18 164.09 34.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 16.78 109.45 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.3 3.53 15.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 16.71 109.583 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.77 77.77 4.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 14.32 109.531 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.68 145.84 1.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 14.47 109.576 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.54 123.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 11.15 109.503 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.72 153.3 40.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 11.57 109.403 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -126.77 179.61 5.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 7.08 109.614 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.594 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 161.78 -50.03 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.642 -0.661 . . . . 6.49 109.71 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.9 Cg_endo -61.22 75.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.553 1.502 . . . . 2.65 110.024 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -52.85 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 3.01 110.02 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' N ' ' A' ' 74' ' ' THR . 0.8 OUTLIER -42.8 -47.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -0.929 . . . . 1.48 109.836 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.583 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.34 -46.86 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 1.35 108.897 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.99 HD13 HD13 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -67.43 -46.87 71.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 1.02 109.708 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.086 HD13 HD11 ' B' ' 75' ' ' LEU . 35.0 mt -56.92 -48.01 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.85 -1.157 . . . . 1.1 108.72 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 77' ' ' ILE . 34.3 mm -58.02 -47.61 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 1.58 108.693 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.44 -47.25 82.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.753 -0.592 . . . . 2.09 110.278 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.818 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.87 -47.66 84.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.32 109.659 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.824 HG22 ' O ' ' B' ' 79' ' ' GLY . 92.3 t -57.67 -47.49 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.904 -1.351 . . . . 0.28 108.628 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.84 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 1.7 109.037 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.08 81.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.559 -0.713 . . . . 0.37 109.453 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.22 85.67 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.077 -1.609 . . . . 0.28 109.077 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.41 HG22 ' OG1' ' B' ' 87' ' ' THR . 41.7 t -56.93 -47.32 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.973 -1.31 . . . . 0.28 108.907 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 mt -57.21 -46.69 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 1.2 109.813 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.566 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -56.7 -46.9 88.66 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.52 -1.432 . . . . 0.33 109.52 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.793 ' OG1' HG13 ' B' ' 84' ' ' VAL . 17.7 m -57.08 -47.13 81.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.985 -1.303 . . . . 0.34 108.528 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.3 -46.85 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.49 109.226 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -56.81 -46.52 81.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.68 109.371 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.569 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 3.7 mm? -56.66 -47.05 80.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 1.92 108.926 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 95' ' ' ILE . 27.1 mt -56.96 -46.91 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.87 109.302 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -47.28 80.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 1.29 108.466 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -47.57 81.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 2.64 108.976 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.55 -47.24 89.68 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.263 -1.535 . . . . 1.29 109.263 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 91' ' ' ILE . 1.6 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -1.1 . . . . 2.19 109.258 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.543 ' O ' HG13 ' A' ' 99' ' ' ILE . 6.2 ttp180 -57.02 -47.29 81.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 3.14 109.394 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 100' ' ' LYS . 13.9 ttm180 -57.51 -47.0 83.13 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.016 -1.052 . . . . 3.58 109.676 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.06 -46.98 82.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 2.66 110.19 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 96' ' ' ARG . 1.7 pt -76.47 -27.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.101 -0.999 . . . . 2.2 110.376 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' N ' HG13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -142.56 146.92 35.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.997 -1.064 . . . . 3.91 109.748 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 100' ' ' LYS . 1.7 mptp? . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.996 -1.002 . . . . 6.53 109.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.502 -0.555 . . . . 20.22 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.437 ' CG ' ' HB2' ' B' ' 66' ' ' HIS . 0.0 OUTLIER -156.47 157.55 35.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 18.1 109.518 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' B' ' 64' ' ' LEU . 1.4 mm? -94.64 7.41 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 17.47 109.537 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.62 6.64 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.185 -0.947 . . . . 15.58 109.653 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.437 ' HB2' ' CG ' ' B' ' 63' ' ' GLN . 0.1 OUTLIER -115.57 168.04 10.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 14.18 109.472 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -91.59 7.78 39.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 13.39 109.652 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -80.55 -0.61 38.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 12.43 109.552 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.81 36.49 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 8.12 109.559 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.697 ' HG2' HG21 ' B' ' 74' ' ' THR . 0.2 OUTLIER -64.75 166.67 11.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 7.29 109.55 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' B' ' 70' ' ' GLU . 5.6 Cg_exo -59.6 158.9 25.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.289 1.993 . . . . 2.87 110.503 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' B' ' 73' ' ' ILE . 3.3 mp0 -57.89 -72.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 2.89 109.835 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.503 HG23 ' N ' ' B' ' 74' ' ' THR . 0.7 OUTLIER -41.35 -42.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 2.11 110.013 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.697 HG21 ' HG2' ' B' ' 70' ' ' GLU . 6.4 m -57.95 -46.92 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.006 . . . . 1.57 109.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.086 HD11 HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -67.37 -46.76 72.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.955 . . . . 1.63 109.367 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.058 ' N ' HD23 ' B' ' 75' ' ' LEU . 82.8 mt -56.99 -47.5 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.666 -1.271 . . . . 1.02 108.326 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.51 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.346 -0.983 . . . . 1.86 108.346 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.22 -47.1 82.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.658 -0.651 . . . . 2.81 109.885 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.824 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -56.85 -47.41 86.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.129 -1.588 . . . . 0.3 109.129 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 79' ' ' GLY . 94.4 t -57.44 -47.42 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -1.193 . . . . 0.33 108.585 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' MET . . . . . 0.558 ' O ' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -57.45 -46.75 83.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.535 -0.913 . . . . 1.83 108.535 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.82 82.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.208 -0.664 . . . . 0.31 109.208 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.09 86.59 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.662 -1.775 . . . . 0.26 108.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.793 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.0 -47.37 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -1.233 . . . . 0.31 108.592 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.558 HD12 ' O ' ' B' ' 81' ' ' MET . 3.9 mt -57.17 -46.74 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.409 -0.807 . . . . 1.06 109.736 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.39 -46.72 86.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.069 -1.612 . . . . 0.3 109.069 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.41 ' OG1' HG22 ' A' ' 84' ' ' VAL . 25.0 m -56.68 -46.75 80.97 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -1.139 . . . . 0.32 109.051 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.14 -47.3 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.41 109.951 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.31 -46.64 82.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.91 -1.119 . . . . 1.14 108.307 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' B' ' 90' ' ' LEU . 27.6 tp -56.99 -47.11 81.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 2.02 109.013 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.677 ' O ' HD12 ' B' ' 95' ' ' ILE . 73.2 mt -57.13 -47.13 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.883 . . . . 0.77 109.192 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -57.05 -47.58 80.61 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.073 -1.017 . . . . 1.53 108.433 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -47.56 81.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 2.25 109.237 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.49 -47.4 88.45 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.307 -1.517 . . . . 1.24 109.307 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.677 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mt -57.33 -47.16 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -1.09 . . . . 1.81 109.151 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 99' ' ' ILE . 9.9 mtm180 -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 2.69 109.678 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 29.2 ttt180 -57.82 -47.49 82.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.791 -1.193 . . . . 3.17 109.883 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -47.09 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 2.09 110.486 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 96' ' ' ARG . 1.0 OUTLIER -80.24 -13.74 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.918 . . . . 2.5 110.23 -179.091 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' B' ' 97' ' ' ARG . 0.1 OUTLIER -157.82 146.11 19.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.068 -1.02 . . . . 5.22 109.745 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 1.6 tttp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.031 -0.985 . . . . 7.38 109.527 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 1 N--CA 1.568 5.445 0 N-CA-C 107.978 -1.119 . . . . 18.74 107.978 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -157.72 100.91 1.79 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 16.78 109.412 -177.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp 54.47 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 16.71 109.402 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' GLN . . . -159.55 127.86 5.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 14.32 109.299 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -56.16 -77.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.026 -1.046 . . . . 14.47 109.307 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -162.02 -69.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 11.15 109.393 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -86.06 117.2 24.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 11.57 109.278 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 97.7 p -172.98 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.986 -1.071 . . . . 7.08 109.603 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 73' ' ' ILE . 8.9 mt-10 -145.21 136.56 12.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 6.49 109.392 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.02 -34.7 57.86 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.051 1.834 . . . . 2.65 110.115 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -45.49 -58.43 3.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 3.01 109.75 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -56.29 -33.66 38.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.106 -0.996 . . . . 1.48 109.936 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 m -64.15 -47.14 81.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.022 . . . . 1.35 109.748 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.07 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -75.38 -46.96 29.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.987 . . . . 1.02 109.412 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.063 HD13 HD13 ' B' ' 75' ' ' LEU . 48.2 mt -57.04 -47.39 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.167 -1.013 . . . . 1.1 108.519 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.58 -47.54 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.482 -0.933 . . . . 1.58 108.482 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 2.09 109.583 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.812 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.19 -47.31 88.67 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.641 -1.384 . . . . 0.32 109.641 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 57.4 t -57.42 -47.65 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.124 -1.221 . . . . 0.28 108.89 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -47.37 82.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.413 -0.805 . . . . 1.7 109.112 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.64 83.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.718 . . . . 0.37 110.121 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.3 -47.37 88.35 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.251 -1.539 . . . . 0.28 109.251 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.26 -47.32 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.28 109.609 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.3 -47.39 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 1.2 110.004 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.35 -47.31 88.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.232 -1.547 . . . . 0.33 109.232 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG13 ' A' ' 91' ' ' ILE . 25.0 m -57.3 -47.01 82.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -1.039 . . . . 0.34 109.44 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.96 -47.25 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.49 109.596 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.11 -46.73 82.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.005 . . . . 0.68 108.745 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -57.29 -47.02 82.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 1.92 109.277 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.989 HD11 HD11 ' B' ' 91' ' ' ILE . 66.4 mt -57.02 -47.12 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.87 109.805 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -57.01 -47.66 80.33 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.909 -1.119 . . . . 1.29 108.3 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.59 -47.56 81.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.854 . . . . 2.64 109.298 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.35 88.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 1.29 109.5 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mt -57.04 -47.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -1.071 . . . . 2.19 109.096 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' O ' HG13 ' A' ' 99' ' ' ILE . 3.4 ttp180 -57.01 -47.2 81.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 3.14 109.459 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.491 ' CD ' ' O ' ' A' ' 101' ' ' LYS . 6.3 tmm_? -57.83 -47.28 83.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.764 -1.21 . . . . 3.58 109.745 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.19 -47.14 82.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -0.867 . . . . 2.66 110.156 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -80.38 -19.32 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 2.2 109.83 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -142.53 121.09 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 3.91 109.515 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 5.5 tttt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 6.53 109.421 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.439 -0.578 . . . . 20.22 109.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' B' ' 63' ' ' GLN . 8.3 tp60 -116.34 23.37 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 18.1 109.316 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' B' ' 63' ' ' GLN . 8.9 mt -42.23 145.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.341 -0.849 . . . . 17.47 109.436 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.84 122.35 45.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.118 -0.989 . . . . 15.58 109.64 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.35 159.1 4.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 14.18 109.419 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -61.13 -62.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 13.39 109.54 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -81.39 -165.36 0.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 12.43 109.587 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.2 15.12 1.68 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 8.12 109.682 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.71 153.72 52.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 7.29 109.361 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' B' ' 74' ' ' THR . 4.2 Cg_exo -56.83 150.97 51.23 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 2.87 110.468 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 72' ' ' GLU . 67.2 mt-10 -52.63 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 2.89 109.958 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' B' ' 74' ' ' THR . 5.8 tp -44.05 -43.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.152 -0.968 . . . . 2.11 109.837 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 6.3 m -55.12 -47.0 75.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 1.57 108.988 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.063 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -66.54 -46.77 75.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 1.63 109.416 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.07 HD13 HD13 ' A' ' 75' ' ' LEU . 60.5 mt -56.75 -47.58 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.046 -1.034 . . . . 1.02 108.68 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.412 HG23 HD12 ' B' ' 77' ' ' ILE . 28.0 mm -57.6 -47.4 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -0.901 . . . . 1.86 108.645 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -57.42 -47.17 82.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.586 -0.696 . . . . 2.81 109.635 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.01 -47.54 86.58 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.62 -1.276 . . . . 0.3 109.921 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.812 HG22 ' C ' ' A' ' 79' ' ' GLY . 40.4 t -57.5 -47.98 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.338 . . . . 0.33 108.898 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' MET . . . . . 0.436 ' O ' HG12 ' B' ' 85' ' ' ILE . 1.4 mtt -57.77 -47.3 82.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.829 . . . . 1.83 109.139 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.44 82.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.703 -0.623 . . . . 0.31 110.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.5 86.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.072 -1.611 . . . . 0.26 109.072 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.45 -47.38 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -1.19 . . . . 0.31 109.375 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.436 HG12 ' O ' ' B' ' 81' ' ' MET . 45.5 mm -57.3 -47.23 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 1.06 109.989 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.98 -47.06 90.22 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.396 -1.482 . . . . 0.3 109.396 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 87' ' ' THR . 50.9 m -57.03 -47.0 81.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.168 -1.196 . . . . 0.32 109.174 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.92 -47.17 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.41 109.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.767 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -46.98 82.35 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.247 -0.908 . . . . 1.14 108.651 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' B' ' 89' ' ' LEU . 6.9 mp -56.97 -47.14 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 2.02 109.51 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.989 HD11 HD11 ' A' ' 91' ' ' ILE . 99.7 mt -57.13 -47.14 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.988 . . . . 0.77 109.206 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 67.2 m -57.22 -47.67 80.72 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.098 -1.041 . . . . 1.53 108.5 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -47.57 82.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.626 -0.829 . . . . 2.25 109.357 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.48 87.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.949 -1.661 . . . . 1.24 108.949 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' B' ' 95' ' ' ILE . 2.0 mm -57.3 -47.0 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -1.072 . . . . 1.81 108.251 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.587 ' O ' HG13 ' B' ' 99' ' ' ILE . 0.5 OUTLIER -57.04 -46.96 82.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.769 . . . . 2.69 109.242 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 3.8 ttt180 -57.53 -47.12 82.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.764 -1.21 . . . . 3.17 109.549 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 98' ' ' LEU . 5.2 mt -57.07 -47.1 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 2.09 109.989 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.705 HD12 ' HB2' ' B' ' 100' ' ' LYS . 2.3 pp -79.48 -28.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 2.5 109.928 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.705 ' HB2' HD12 ' B' ' 99' ' ' ILE . 0.3 OUTLIER -134.67 129.93 35.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 5.22 109.661 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.993 -1.003 . . . . 7.38 109.505 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.485 -0.561 . . . . 18.74 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.432 ' C ' HD23 ' A' ' 64' ' ' LEU . 48.0 tp60 -109.63 22.21 16.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 16.78 109.362 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.555 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -97.72 -0.79 44.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 16.71 109.627 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' HIS . . . -58.87 -19.85 45.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 14.32 109.63 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CB ' ' O ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER 70.62 -66.05 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 14.47 109.458 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.2 OUTLIER 58.12 -172.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 11.15 109.497 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.92 -176.07 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 11.57 109.43 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.6 m 54.67 74.58 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 7.08 109.676 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -141.12 149.16 54.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.943 . . . . 6.49 109.425 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HB2' HG23 ' A' ' 74' ' ' THR . 2.8 Cg_endo -60.96 121.38 9.59 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.139 1.892 . . . . 2.65 110.002 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -58.31 -58.19 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 3.01 109.625 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.657 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.1 tp -47.56 -46.63 10.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.217 -0.927 . . . . 1.48 110.255 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 73' ' ' ILE . 64.5 p -58.33 -46.55 85.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 1.35 110.032 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.081 HD13 HD13 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -71.78 -47.38 53.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 1.02 110.204 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.103 HD13 HD13 ' B' ' 75' ' ' LEU . 73.0 mt -57.45 -48.1 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 1.1 109.69 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 73' ' ' ILE . 23.1 pt -57.95 -47.14 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.84 -1.162 . . . . 1.58 108.423 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -57.17 -46.92 82.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.652 . . . . 2.09 109.571 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.909 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.86 -47.4 86.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.651 -1.38 . . . . 0.32 109.651 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.871 HG22 ' C ' ' B' ' 79' ' ' GLY . 95.2 t -57.31 -47.63 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.951 -1.323 . . . . 0.28 108.738 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 mmt -57.72 -47.08 83.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 1.7 108.793 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.02 -46.28 82.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.666 -0.646 . . . . 0.37 109.82 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.45 86.42 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.182 -1.567 . . . . 0.28 109.182 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -57.27 -47.75 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.997 -1.296 . . . . 0.28 108.969 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.9 mt -57.5 -46.97 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 1.2 109.859 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.04 89.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.758 -1.337 . . . . 0.33 109.758 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.558 HG21 ' CG2' ' B' ' 87' ' ' THR . 95.7 m -56.86 -47.21 80.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.021 -1.282 . . . . 0.34 108.753 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -57.24 -47.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.49 108.565 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.73 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.487 -0.931 . . . . 0.68 108.487 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.78 -46.84 81.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.478 -0.764 . . . . 1.92 109.124 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.845 HD11 HD11 ' B' ' 91' ' ' ILE . 70.9 mt -56.87 -46.84 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.87 109.031 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.462 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.7 m -56.95 -47.58 80.35 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.007 -1.058 . . . . 1.29 108.371 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.57 -47.72 81.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 2.64 109.05 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.08 90.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.362 -1.495 . . . . 1.29 109.362 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 95' ' ' ILE . 1.5 mm -57.06 -47.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.413 -1.051 . . . . 2.19 109.01 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' HA ' HD11 ' A' ' 99' ' ' ILE . 6.8 mtp180 -57.14 -47.19 81.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 3.14 109.438 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -57.31 -47.11 82.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 3.58 109.825 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mt -56.84 -46.93 81.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 2.66 109.333 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 96' ' ' ARG . 36.4 pt -72.98 -15.35 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 2.2 109.532 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -123.02 -163.78 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.961 . . . . 3.91 109.521 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.03 -0.986 . . . . 6.53 109.454 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.454 HG23 ' N ' ' B' ' 63' ' ' GLN . 13.1 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.305 0.574 . . . . 20.22 109.481 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.454 ' N ' HG23 ' B' ' 62' ' ' VAL . 11.4 tp-100 -120.86 159.53 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 18.1 109.304 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.43 ' N ' ' HG3' ' B' ' 63' ' ' GLN . 0.3 OUTLIER -160.98 34.33 0.15 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 17.47 109.905 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -112.91 -25.42 9.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.973 -1.079 . . . . 15.58 109.703 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 65' ' ' ALA . 93.7 m-70 60.92 131.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 14.18 109.558 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -131.77 113.48 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 13.39 109.46 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -137.01 152.16 49.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 12.43 109.56 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' B' ' 70' ' ' GLU . 0.5 OUTLIER -124.13 123.7 40.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 8.12 109.358 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.593 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 3.6 mm-40 163.18 -52.97 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 7.29 109.95 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 4.6 Cg_exo -61.0 169.55 5.82 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.222 1.948 . . . . 2.87 111.601 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' B' ' 73' ' ' ILE . 10.2 pt-20 -52.39 -44.97 65.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.352 -0.843 . . . . 2.89 109.619 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.616 HG23 ' N ' ' B' ' 74' ' ' THR . 2.5 tp -47.56 -46.34 10.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.053 -1.03 . . . . 2.11 109.798 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.616 ' N ' HG23 ' B' ' 73' ' ' ILE . 0.6 OUTLIER -60.81 -46.98 88.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.107 -0.995 . . . . 1.57 108.93 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.103 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -64.13 -47.25 80.68 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.304 -0.958 . . . . 1.63 109.294 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.081 HD13 HD13 ' A' ' 75' ' ' LEU . 71.1 mt -57.14 -47.68 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.994 -1.066 . . . . 1.02 108.362 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.33 -47.18 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.483 -0.932 . . . . 1.86 108.483 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -57.25 -47.23 81.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.474 -0.766 . . . . 2.81 109.455 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.871 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.9 -47.28 87.89 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.123 -1.591 . . . . 0.3 109.123 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.909 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.7 t -57.37 -47.37 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -1.128 . . . . 0.33 108.79 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -46.95 83.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 1.83 109.41 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.94 -46.4 82.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.444 -0.785 . . . . 0.31 109.65 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.0 90.41 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.783 -1.727 . . . . 0.26 108.783 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.05 -47.21 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.11 . . . . 0.31 109.42 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.99 -47.32 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.051 -1.031 . . . . 1.06 109.779 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.19 89.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.378 -1.489 . . . . 0.3 109.378 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.558 ' CG2' HG21 ' A' ' 87' ' ' THR . 31.5 m -57.1 -46.93 82.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.091 . . . . 0.32 109.361 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.3 mt -56.92 -46.86 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.41 109.148 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.621 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -46.98 81.8 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.029 -1.1 . . . . 1.14 108.029 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.479 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 10.9 tp -57.19 -46.97 82.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.351 -0.843 . . . . 2.02 109.118 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.897 ' O ' HD12 ' B' ' 95' ' ' ILE . 75.0 mt -57.09 -47.2 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.339 -0.851 . . . . 0.77 109.493 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 75.1 m -57.03 -47.36 81.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.117 -1.068 . . . . 1.53 108.117 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -57.42 -47.62 81.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 2.25 109.147 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.61 -47.47 88.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.337 -1.505 . . . . 1.24 109.337 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.897 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mp -57.28 -46.95 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -1.046 . . . . 1.81 109.108 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.516 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 6.8 mtm180 -57.08 -47.27 81.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 2.69 109.369 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.487 ' HA ' ' HG2' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.34 -47.02 82.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 3.17 109.93 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.85 -46.85 81.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 2.09 109.092 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 42.0 pt -72.93 -35.12 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.5 109.601 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.495 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -82.51 9.73 8.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.928 . . . . 5.22 109.862 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.47 ' HG2' ' C ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.944 -1.027 . . . . 7.38 109.823 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 63' ' ' GLN . 3.9 m . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.492 -0.558 . . . . 18.74 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 62' ' ' VAL . 53.2 tp60 57.37 159.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 16.78 109.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -142.5 -177.05 5.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.163 -0.961 . . . . 16.71 109.59 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.98 54.16 0.79 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 14.32 109.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -101.04 -5.15 26.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 14.47 109.421 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.436 ' CG ' ' O ' ' A' ' 67' ' ' HIS . 42.8 t-80 -68.29 68.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 11.15 109.544 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -87.34 175.29 8.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 11.57 109.332 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.4 m -51.05 -57.8 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 7.08 109.666 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 72' ' ' GLU . 2.7 mm-40 -148.06 101.63 3.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 6.49 109.545 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 4.5 Cg_exo -59.06 76.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.108 1.872 . . . . 2.65 110.053 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 70' ' ' GLU . 14.3 pt-20 -57.43 -48.6 78.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 3.01 109.705 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 74' ' ' THR . 1.5 tp -56.11 -46.4 80.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.096 -1.003 . . . . 1.48 109.996 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.605 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -57.1 -47.02 82.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 1.35 109.194 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.021 HD13 HD13 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -66.83 -47.03 73.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.02 109.64 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.968 HD13 HD22 ' B' ' 75' ' ' LEU . 82.3 mt -56.93 -47.85 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 1.1 108.975 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -57.79 -47.46 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 1.58 108.708 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.55 -47.39 82.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 2.09 110.119 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.873 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.25 -47.58 86.66 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.467 -1.453 . . . . 0.32 109.467 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.879 HG22 ' C ' ' B' ' 79' ' ' GLY . 87.7 t -57.65 -47.63 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.249 -1.148 . . . . 0.28 109.095 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -47.29 82.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 1.7 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.47 82.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.37 109.766 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.35 88.08 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.529 -1.428 . . . . 0.28 109.529 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.35 -47.58 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -1.228 . . . . 0.28 109.49 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 85' ' ' ILE . 43.0 mm -57.37 -47.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.934 . . . . 1.2 109.829 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.99 90.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.884 -1.287 . . . . 0.33 109.884 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 91' ' ' ILE . 82.1 m -56.99 -47.16 81.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.34 109.503 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 91' ' ' ILE . 56.2 mt -57.33 -47.28 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.49 109.321 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -46.95 82.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.68 109.208 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 38.5 tp -56.97 -47.01 81.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 1.92 109.466 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.896 ' O ' HG23 ' A' ' 95' ' ' ILE . 60.7 mt -56.92 -47.02 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.87 109.493 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -56.96 -47.56 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.033 -1.067 . . . . 1.29 108.804 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -47.51 81.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.948 -1.095 . . . . 2.64 109.325 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.51 87.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.406 -1.078 . . . . 1.29 110.406 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -57.28 -46.99 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.028 -1.278 . . . . 2.19 109.013 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 99' ' ' ILE . 14.7 mtm180 -57.01 -46.86 82.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 3.14 109.206 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -57.14 -46.64 82.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.998 -1.064 . . . . 3.58 109.716 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mt -56.68 -47.01 80.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 2.66 109.604 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER -74.75 -18.77 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 2.2 109.169 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' N ' HG13 ' A' ' 99' ' ' ILE . 9.6 tptp -96.56 123.0 40.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 3.91 109.761 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.001 -1.0 . . . . 6.53 109.303 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.477 -0.564 . . . . 20.22 109.477 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 161.12 31.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 18.1 109.527 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 71.51 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 17.47 109.464 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.25 78.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 15.58 109.542 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -144.8 -169.6 3.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 14.18 109.31 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -174.65 172.4 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 13.39 109.632 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' B' ' 69' ' ' SER . 26.6 m-85 -116.35 -74.54 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 12.43 109.447 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' B' ' 68' ' ' PHE . 0.5 OUTLIER 64.58 125.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 8.12 109.492 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.446 ' HB3' ' HD2' ' B' ' 71' ' ' PRO . 2.5 mt-10 -169.41 167.7 5.27 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 7.29 109.437 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.447 ' HB2' ' CB ' ' B' ' 74' ' ' THR . 4.7 Cg_exo -59.35 96.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.128 1.886 . . . . 2.87 110.154 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.452 ' O ' HG13 ' B' ' 76' ' ' ILE . 13.5 pt-20 -49.92 -34.62 21.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 2.89 109.526 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.752 HD13 ' C ' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -71.02 -37.97 69.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.192 -0.943 . . . . 2.11 109.324 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.597 ' N ' HD13 ' B' ' 73' ' ' ILE . 23.7 m -63.54 -46.96 83.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.147 -0.97 . . . . 1.57 109.117 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.968 HD22 HD13 ' A' ' 76' ' ' ILE . 3.5 tt -73.28 -47.35 43.65 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.63 109.55 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.021 HD13 HD13 ' A' ' 75' ' ' LEU . 82.2 mt -57.36 -48.14 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.955 -1.09 . . . . 1.02 109.179 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.486 HD13 ' O ' ' B' ' 73' ' ' ILE . 1.1 mp -58.28 -47.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 1.86 108.756 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -47.16 83.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.614 -0.679 . . . . 2.81 109.621 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.879 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.31 -47.65 86.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.669 -1.373 . . . . 0.3 109.669 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.873 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.5 t -57.62 -47.85 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.089 -1.242 . . . . 0.33 109.076 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 29.0 mtt -57.81 -47.43 82.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 1.83 109.103 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.34 83.1 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.719 -0.613 . . . . 0.31 109.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.55 85.78 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.393 -1.483 . . . . 0.26 109.393 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.38 -47.86 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.971 -1.311 . . . . 0.31 109.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.46 -47.2 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 1.06 109.718 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -57.07 -46.95 90.98 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.869 -1.292 . . . . 0.3 109.869 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 87' ' ' THR . 41.6 m -56.97 -47.43 80.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -1.214 . . . . 0.32 109.351 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.31 -47.47 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.41 108.938 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.4 -46.98 82.9 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 1.14 109.12 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.547 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 91.2 mt -56.99 -47.17 81.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 2.02 109.808 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.673 HD11 HD11 ' A' ' 91' ' ' ILE . 62.4 mt -57.19 -47.43 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.09 -1.006 . . . . 0.77 109.622 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.73 81.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.693 -1.203 . . . . 1.53 108.533 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -47.51 82.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.25 109.879 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.49 -47.61 86.96 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 1.24 109.645 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.492 HD13 ' O ' ' B' ' 91' ' ' ILE . 1.1 mp -57.35 -47.4 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -1.183 . . . . 1.81 108.712 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.528 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 21.1 mtm180 -57.24 -47.39 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 2.69 109.571 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -57.4 -47.04 82.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 3.17 109.95 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -47.11 81.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 2.09 109.36 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 39.5 pt -71.45 -32.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.369 -0.832 . . . . 2.5 109.556 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.479 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.1 OUTLIER -104.68 103.95 13.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -0.879 . . . . 5.22 109.528 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.479 ' C ' ' CD ' ' B' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.981 -1.009 . . . . 7.38 109.494 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 62' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.489 -0.56 . . . . 18.74 109.489 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 16.7 tt0 60.44 159.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.943 . . . . 16.78 109.074 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.662 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -88.84 -63.32 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 16.71 109.379 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 73.77 144.06 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.301 -0.874 . . . . 14.32 109.277 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -147.66 -67.65 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 14.47 109.713 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 69' ' ' SER . 18.1 t-80 -166.88 34.68 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 11.15 109.742 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 65.9 -67.71 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 11.57 109.527 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' HIS . 0.4 OUTLIER -60.35 143.57 52.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 7.08 109.525 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER 166.97 93.05 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 6.49 109.62 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HG2' ' CB ' ' A' ' 74' ' ' THR . 5.7 Cg_exo -58.16 158.49 21.8 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.194 1.929 . . . . 2.65 110.372 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 48.9 tt0 -64.65 -86.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 3.01 109.866 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.456 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -39.51 -39.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 1.48 110.071 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.521 ' CB ' ' HG2' ' A' ' 71' ' ' PRO . 99.9 m -59.98 -46.95 87.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.24 -0.913 . . . . 1.35 109.268 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.841 HD13 HD13 ' B' ' 76' ' ' ILE . 3.2 tt -67.91 -47.28 69.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 1.02 109.801 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.94 HD13 HD13 ' B' ' 75' ' ' LEU . 57.7 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.88 -1.138 . . . . 1.1 109.111 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.447 HD11 ' CG1' ' A' ' 73' ' ' ILE . 21.0 mt -58.2 -47.82 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.58 109.122 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -57.62 -47.05 83.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.678 -0.639 . . . . 2.09 109.35 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.806 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.82 -47.17 88.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.884 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.2 t -57.16 -47.84 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.041 -1.27 . . . . 0.28 108.774 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.9 mtm -57.73 -47.21 83.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 1.7 108.93 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.14 -46.42 82.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.37 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.92 -47.26 88.18 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.204 -1.558 . . . . 0.28 109.204 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.3 -47.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.243 . . . . 0.28 109.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.0 mt -57.54 -47.16 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 1.2 109.858 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.07 89.42 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.714 -1.354 . . . . 0.33 109.714 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -56.99 -47.12 81.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.167 -1.196 . . . . 0.34 109.157 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.11 -47.15 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.49 109.133 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.689 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.15 -46.9 82.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.68 109.214 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.6 mt -57.02 -47.11 81.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 1.92 109.455 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.732 HD11 HD11 ' B' ' 91' ' ' ILE . 18.7 mt -57.2 -46.99 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.87 109.305 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 67.5 m -57.05 -47.41 81.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.231 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.24 -46.77 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.539 -0.725 . . . . 2.64 109.12 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.6 -46.25 88.91 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.496 -1.842 . . . . 1.29 108.496 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mt -56.32 -46.5 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -1.081 . . . . 2.19 108.833 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 92' ' ' SER . 10.6 mmt180 -56.66 -47.0 80.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.856 -1.152 . . . . 3.14 108.649 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -57.13 -46.75 82.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 3.58 109.737 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -46.96 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 2.66 109.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 38.7 pt -72.46 -30.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 2.2 109.304 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.3 OUTLIER -82.83 150.84 26.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 3.91 109.547 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.995 -1.002 . . . . 6.53 109.338 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.53 ' O ' HG13 ' B' ' 62' ' ' VAL . 10.0 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.273 0.559 . . . . 20.22 109.509 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.447 ' O ' ' NE2' ' B' ' 63' ' ' GLN . 0.2 OUTLIER -75.84 122.52 24.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 18.1 109.482 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.22 6.0 6.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 17.47 109.573 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -97.25 -10.16 26.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 15.58 109.575 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' B' ' 65' ' ' ALA . 5.4 m80 51.85 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 14.18 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -57.73 -72.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 13.39 109.532 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.49 151.26 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 12.43 109.657 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 73.6 m -105.2 157.72 17.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 8.12 109.382 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -127.66 143.22 46.74 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 7.29 109.643 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' B' ' 74' ' ' THR . 1.7 Cg_endo -63.67 -23.35 69.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.193 1.928 . . . . 2.87 110.124 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 71' ' ' PRO . 0.3 OUTLIER -42.47 -59.99 1.67 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.439 -0.788 . . . . 2.89 109.445 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' B' ' 74' ' ' THR . 3.9 pt -56.47 -45.33 81.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.129 -0.982 . . . . 2.11 108.547 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.548 ' N ' ' CG1' ' B' ' 73' ' ' ILE . 36.4 m -42.81 -47.0 5.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 1.57 108.979 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.94 HD13 HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -72.75 -47.58 45.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 1.63 108.84 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.841 HD13 HD13 ' A' ' 75' ' ' LEU . 84.9 mt -57.79 -48.44 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.145 -1.022 . . . . 1.02 110.222 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.421 HD12 HG13 ' B' ' 73' ' ' ILE . 9.4 mt -58.6 -47.98 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.92 -1.113 . . . . 1.86 109.064 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.896 ' HD2' HD23 ' B' ' 75' ' ' LEU . 0.0 OUTLIER -57.68 -46.99 83.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.575 -0.528 . . . . 2.81 109.575 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.884 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.21 -47.59 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.698 -1.361 . . . . 0.3 109.698 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.806 HG22 ' C ' ' A' ' 79' ' ' GLY . 95.8 t -57.56 -47.79 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.057 -1.261 . . . . 0.33 108.911 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mtm -57.74 -47.25 82.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.413 -0.804 . . . . 1.83 109.337 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.54 82.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.495 -0.753 . . . . 0.31 109.891 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.45 87.3 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.063 -1.615 . . . . 0.26 109.063 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.26 -47.41 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 0.31 109.437 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.4 -47.16 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 1.06 110.021 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.35 88.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.816 -1.314 . . . . 0.3 109.816 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 33.8 m -57.31 -47.36 81.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.13 -1.218 . . . . 0.32 109.226 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.28 -47.2 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.41 109.643 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.577 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -47.12 82.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 1.14 109.178 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 70.3 mt -57.21 -47.17 81.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.965 . . . . 2.02 109.512 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.803 ' O ' HD12 ' B' ' 95' ' ' ILE . 84.4 mt -57.14 -47.26 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.88 . . . . 0.77 109.512 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 5.4 p -57.18 -47.56 80.93 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.056 -1.027 . . . . 1.53 108.672 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -57.77 -47.54 82.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.25 109.449 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.34 89.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.538 -1.425 . . . . 1.24 109.538 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.803 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.1 mp -57.19 -47.25 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -1.099 . . . . 1.81 109.36 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.447 ' O ' HG13 ' B' ' 99' ' ' ILE . 1.8 ttp180 -57.16 -47.25 81.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 2.69 109.482 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.49 -47.34 82.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 3.17 110.17 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -46.94 82.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 2.09 109.598 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.541 HG13 ' N ' ' B' ' 100' ' ' LYS . 36.2 pt -74.01 -34.28 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.505 -0.747 . . . . 2.5 110.203 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.541 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -142.68 136.92 29.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.078 -1.014 . . . . 5.22 110.054 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.918 -1.039 . . . . 7.38 109.329 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 62' ' ' VAL . 70.7 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.413 -0.588 . . . . 18.74 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -115.1 21.47 14.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 16.78 109.411 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.696 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 3.8 mm? 53.03 -87.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 16.71 109.617 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 64' ' ' LEU . . . 164.68 -22.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 14.32 109.911 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.419 ' O ' ' CB ' ' A' ' 67' ' ' HIS . 2.0 m80 -103.02 -155.28 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 14.47 109.661 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER 71.83 157.01 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 11.15 109.549 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -122.08 -43.57 2.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 11.57 109.627 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.78 -170.76 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 7.08 109.567 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.7 147.93 37.33 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 6.49 109.411 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 74' ' ' THR . 2.6 Cg_endo -61.72 -11.86 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.199 1.932 . . . . 2.65 110.156 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' B' ' 72' ' ' GLU . 1.3 mt-10 -45.25 -37.27 4.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 3.01 109.299 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 2.9 tp -69.43 -34.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.171 -0.956 . . . . 1.48 109.339 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -63.79 -47.0 82.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.304 -0.872 . . . . 1.35 109.336 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.087 HD13 HD13 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -78.57 -47.26 17.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 1.02 109.681 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.873 HD13 HD22 ' B' ' 75' ' ' LEU . 81.3 mt -57.43 -48.13 83.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.833 -1.167 . . . . 1.1 109.039 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 74' ' ' THR . 9.3 tt -58.06 -47.29 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.202 -0.936 . . . . 1.58 108.717 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.5 m-85 -57.39 -47.01 82.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.495 -0.753 . . . . 2.09 109.726 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.799 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.9 -47.29 87.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.504 -1.438 . . . . 0.32 109.504 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.2 t -57.41 -47.58 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.296 . . . . 0.28 108.703 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 85' ' ' ILE . 2.3 mmm -57.75 -47.07 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.85 . . . . 1.7 108.991 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.24 82.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.37 109.759 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.76 -47.3 86.66 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.04 -1.624 . . . . 0.28 109.04 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.457 HG13 ' OG1' ' B' ' 87' ' ' THR . 86.4 t -57.3 -47.63 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.1 -1.236 . . . . 0.28 109.356 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 81' ' ' MET . 26.5 mm -57.43 -47.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 1.2 109.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.14 -46.95 91.05 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.789 -1.324 . . . . 0.33 109.789 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.458 ' HA ' HD12 ' A' ' 90' ' ' LEU . 71.2 m -56.95 -47.42 80.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -1.199 . . . . 0.34 109.5 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.39 -47.56 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.49 109.273 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.65 -47.12 83.14 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.662 -0.866 . . . . 0.68 108.662 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 11.8 mt -57.26 -46.81 82.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 1.92 109.601 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.88 ' O ' HD12 ' A' ' 95' ' ' ILE . 42.4 mt -57.02 -47.13 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.87 109.75 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -57.11 -47.74 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.674 -1.21 . . . . 1.29 108.089 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -46.87 82.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.697 . . . . 2.64 109.25 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.54 -46.22 88.58 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.943 -1.663 . . . . 1.29 108.943 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.88 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -56.26 -46.78 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -1.119 . . . . 2.19 108.847 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 92' ' ' SER . 9.4 mmt180 -56.88 -47.16 81.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.888 -1.133 . . . . 3.14 108.726 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -46.96 82.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 3.58 109.935 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -46.95 81.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 2.66 108.752 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 46.7 pt -75.51 -14.32 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.383 -0.823 . . . . 2.2 109.062 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 5.3 tttm -92.15 82.49 5.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 3.91 109.663 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.971 -1.014 . . . . 6.53 109.338 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.584 ' O ' HG13 ' B' ' 62' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.466 -0.568 . . . . 20.22 109.466 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 143.21 5.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 18.1 109.391 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.22 37.01 1.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 17.47 109.663 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' B' ' 66' ' ' HIS . . . -111.61 34.16 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.118 -0.989 . . . . 15.58 109.694 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 0.3 OUTLIER 73.63 -150.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.944 . . . . 14.18 109.541 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 -149.79 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 13.39 109.373 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -120.28 172.61 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.978 . . . . 12.43 109.507 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.476 ' O ' ' CG ' ' B' ' 70' ' ' GLU . 38.8 m -59.58 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 8.12 109.618 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' B' ' 72' ' ' GLU . 86.7 mt-10 -157.92 99.45 1.82 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 7.29 109.391 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.64 59.21 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.168 1.912 . . . . 2.87 110.453 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.536 ' HG2' ' CG ' ' A' ' 72' ' ' GLU . 16.2 mt-10 -69.12 -69.26 0.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 2.89 109.75 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.736 HD13 ' C ' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -52.47 -34.08 18.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.254 -0.904 . . . . 2.11 109.208 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.597 ' N ' HD13 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -63.09 -47.0 84.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 1.57 109.425 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.873 HD22 HD13 ' A' ' 76' ' ' ILE . 3.7 tt -72.05 -47.23 53.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 1.63 109.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.087 HD13 HD13 ' A' ' 75' ' ' LEU . 82.6 mt -57.19 -47.65 83.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.147 -0.971 . . . . 1.02 109.25 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.97 -47.73 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.207 -0.933 . . . . 1.86 108.854 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -46.93 83.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 2.81 109.261 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.907 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.73 -47.14 87.75 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.763 -1.335 . . . . 0.3 109.763 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 79' ' ' GLY . 53.4 t -57.08 -47.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.987 -1.302 . . . . 0.33 108.697 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 36.3 mmm -57.74 -47.06 83.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 1.83 108.749 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.9 -46.25 82.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.64 -0.662 . . . . 0.31 109.777 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.57 -47.21 85.94 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.148 -1.581 . . . . 0.26 109.148 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.13 -47.51 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.021 -1.282 . . . . 0.31 109.171 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.26 -46.95 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 1.06 109.814 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -46.76 90.28 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.6 -1.4 . . . . 0.3 109.6 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 84' ' ' VAL . 63.0 m -56.71 -47.06 80.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.162 -1.199 . . . . 0.32 109.309 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.96 -47.24 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.41 109.022 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.17 -46.84 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 1.14 108.998 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.542 ' O ' HD13 ' B' ' 90' ' ' LEU . 0.2 OUTLIER -56.9 -46.84 81.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.88 . . . . 2.02 109.312 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 1.024 ' O ' HD12 ' B' ' 95' ' ' ILE . 79.8 mt -56.73 -46.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.185 -0.947 . . . . 0.77 108.99 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -56.62 -47.38 79.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.984 -1.073 . . . . 1.53 108.661 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' B' ' 96' ' ' ARG . 0.7 OUTLIER -57.4 -47.4 81.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 2.25 109.19 179.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.7 -47.38 88.93 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.487 -1.445 . . . . 1.24 109.487 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 1.024 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.4 mp -57.47 -47.84 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -1.08 . . . . 1.81 110.562 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' B' ' 93' ' ' TYR . 7.0 ptp180 -57.5 -46.79 83.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.851 -1.156 . . . . 2.69 109.291 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' B' ' 100' ' ' LYS . 22.7 ttp180 -57.1 -46.82 82.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 3.17 109.818 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -47.04 80.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.07 -1.019 . . . . 2.09 109.134 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 42.3 pt -72.26 -26.74 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 2.5 109.133 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' B' ' 101' ' ' LYS . 5.8 tmtm? -109.14 102.21 11.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 5.22 109.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.964 -1.017 . . . . 7.38 109.371 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.51 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 32.7 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.356 -0.609 . . . . 18.74 109.356 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 11.6 pt20 39.31 96.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.498 0.666 . . . . 16.78 110.55 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -9.05 36.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 16.71 109.205 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 66' ' ' HIS . . . -82.77 90.12 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 14.32 109.673 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.7 m-70 71.04 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 14.47 109.488 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -154.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 11.15 109.406 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.77 156.18 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 11.57 109.523 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 t -110.58 94.14 4.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 7.08 109.595 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.601 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.6 OUTLIER -46.21 -53.2 23.88 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 6.49 110.093 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 5.9 Cg_exo -58.91 73.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.751 . . . . 2.65 110.445 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' GLU . 66.0 tt0 -64.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 3.01 109.6 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -42.46 -31.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.341 -0.849 . . . . 1.48 109.767 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -65.11 -46.81 79.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 1.35 109.888 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.027 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -76.09 -47.37 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.02 110.259 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.106 HD13 HD13 ' B' ' 75' ' ' LEU . 72.3 mt -57.58 -48.24 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.676 -1.265 . . . . 1.1 109.457 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 78' ' ' PHE . 19.8 tt -58.28 -47.58 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 1.58 108.975 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 77' ' ' ILE . 8.9 m-30 -57.5 -47.11 82.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 2.09 109.812 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -57.1 -47.28 88.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.7 -1.36 . . . . 0.32 109.7 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.95 HG22 ' C ' ' B' ' 79' ' ' GLY . 56.4 t -57.37 -47.59 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.046 -1.267 . . . . 0.28 109.148 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -57.61 -47.1 83.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.7 109.323 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.42 82.54 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.514 -0.741 . . . . 0.37 109.892 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.34 87.27 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.371 -1.492 . . . . 0.28 109.371 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.8 t -57.1 -47.37 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.121 -1.223 . . . . 0.28 109.74 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.32 -46.91 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 1.2 110.008 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.05 90.46 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.849 -1.3 . . . . 0.33 109.849 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.66 ' CG2' HG21 ' B' ' 87' ' ' THR . 17.0 m -57.24 -47.3 81.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -1.214 . . . . 0.34 109.348 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.22 -47.08 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.49 109.208 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -46.8 82.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.68 109.108 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 32.3 mt -57.01 -47.06 81.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 1.92 109.672 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.926 ' O ' HD12 ' A' ' 95' ' ' ILE . 95.9 mt -57.16 -47.19 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.87 109.141 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.09 -47.43 81.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.212 -1.033 . . . . 1.29 108.212 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -57.47 -47.55 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 2.64 109.253 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.33 -47.25 89.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.266 -1.533 . . . . 1.29 109.266 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.08 -47.03 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.104 . . . . 2.19 108.677 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.572 ' HA ' HD11 ' A' ' 99' ' ' ILE . 10.4 mtm180 -57.05 -47.04 81.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 3.14 109.276 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.17 -46.83 82.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 3.58 109.839 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -46.95 81.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 2.66 109.074 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 96' ' ' ARG . 30.8 pt -73.15 -39.0 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 2.2 109.763 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.506 ' N ' HG13 ' A' ' 99' ' ' ILE . 1.2 mttm -97.9 -166.98 1.45 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 3.91 109.765 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.031 -0.985 . . . . 6.53 109.459 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.427 -0.583 . . . . 20.22 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.658 ' C ' HD23 ' B' ' 64' ' ' LEU . 23.7 tt0 -158.32 143.12 16.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 18.1 109.268 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.658 HD23 ' C ' ' B' ' 63' ' ' GLN . 0.0 OUTLIER -144.78 55.48 1.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 17.47 109.595 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.7 66.74 1.4 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.088 -1.007 . . . . 15.58 109.425 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -92.06 116.93 29.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 14.18 109.525 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -123.37 101.38 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.858 . . . . 13.39 109.094 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.83 84.93 6.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 12.43 109.723 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.67 5.06 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.938 . . . . 8.12 109.446 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.607 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 1.0 OUTLIER -76.95 -45.18 2.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 7.29 110.562 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 1.8 Cg_endo -65.17 55.57 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.658 1.572 . . . . 2.87 110.695 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -72.37 -71.97 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 2.89 109.219 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.8 OUTLIER -50.54 -36.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 2.11 109.456 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.404 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 58.9 p -62.27 -47.13 85.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 1.57 109.587 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.106 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -70.24 -47.08 62.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 1.63 109.612 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.027 HD13 HD13 ' A' ' 75' ' ' LEU . 81.8 mt -57.03 -47.59 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.837 -1.164 . . . . 1.02 108.594 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.75 -47.29 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.302 -0.873 . . . . 1.86 108.736 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.26 -47.3 81.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 2.81 109.535 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.95 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.89 -47.49 86.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.505 . . . . 0.3 109.336 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 79' ' ' GLY . 60.4 t -57.32 -47.64 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -1.234 . . . . 0.33 108.663 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.1 mmm -57.74 -47.04 83.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.424 -0.798 . . . . 1.83 108.968 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.08 -46.56 82.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.534 -0.729 . . . . 0.31 109.86 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.68 85.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.763 -1.735 . . . . 0.26 108.763 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.39 -47.61 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.31 108.931 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' B' ' 88' ' ' ILE . 80.1 mt -57.37 -47.0 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.82 . . . . 1.06 110.031 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.655 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -56.93 -47.21 88.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.626 -1.39 . . . . 0.3 109.626 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 87' ' ' THR . 78.5 m -57.28 -47.26 81.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.276 . . . . 0.32 108.588 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 85' ' ' ILE . 85.9 mt -57.23 -46.96 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.443 -0.786 . . . . 0.41 109.216 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -56.93 -46.47 82.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 1.14 109.25 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.08 -47.25 81.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 2.02 108.893 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.799 HD11 HD11 ' A' ' 91' ' ' ILE . 65.5 mt -57.12 -47.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.185 -0.947 . . . . 0.77 109.115 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.06 -47.36 81.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.122 -0.987 . . . . 1.53 108.427 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -47.47 81.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 2.25 109.494 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.52 87.61 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.119 -1.592 . . . . 1.24 109.119 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.614 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.1 mt -57.21 -47.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -1.06 . . . . 1.81 108.943 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.558 ' O ' HG13 ' B' ' 99' ' ' ILE . 2.8 tpp180 -57.07 -46.89 82.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 2.69 109.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -46.66 82.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.859 -1.15 . . . . 3.17 109.453 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mt -56.78 -46.85 81.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 2.09 109.548 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.558 HG13 ' O ' ' B' ' 96' ' ' ARG . 3.9 pt -82.27 -119.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.112 -0.992 . . . . 2.5 109.199 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 99' ' ' ILE . 0.1 OUTLIER 43.38 81.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.841 -1.162 . . . . 5.22 109.683 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.047 -0.978 . . . . 7.38 109.445 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.615 HG22 ' N ' ' A' ' 63' ' ' GLN . 8.1 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.337 0.589 . . . . 18.74 109.443 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.615 ' N ' HG22 ' A' ' 62' ' ' VAL . 5.5 tp60 -94.32 -160.8 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 16.78 109.086 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.555 ' CB ' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 80.44 7.16 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 16.71 109.398 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 66' ' ' HIS . . . -90.59 30.46 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 14.32 109.515 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.59 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 39.8 m80 66.82 8.42 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 14.47 109.783 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 18.4 p80 40.56 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.498 -0.751 . . . . 11.15 110.105 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' HIS . 0.3 OUTLIER -42.77 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 11.57 109.433 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.49 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 1.9 m -105.85 -94.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.987 . . . . 7.08 109.764 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.578 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.83 -57.56 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 6.49 109.882 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.9 Cg_exo -54.82 -75.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.026 1.817 . . . . 2.65 110.336 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 75' ' ' LEU . 4.4 mt-10 34.25 -131.5 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.804 -0.56 . . . . 3.01 110.89 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.777 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.75 -47.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 1.48 109.881 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.569 ' N ' HG23 ' A' ' 73' ' ' ILE . 3.1 p -55.2 -46.19 75.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 1.35 108.801 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.035 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -71.76 -46.93 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.006 . . . . 1.02 110.04 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.081 HD13 HD13 ' B' ' 75' ' ' LEU . 59.7 mt -57.35 -48.35 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.719 -1.238 . . . . 1.1 110.116 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -58.23 -47.65 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.838 -1.164 . . . . 1.58 108.487 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' N ' HG23 ' A' ' 77' ' ' ILE . 4.4 m-30 -57.26 -47.08 82.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.804 -0.56 . . . . 2.09 109.965 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.781 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.91 -47.41 86.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.595 -1.402 . . . . 0.32 109.595 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.4 t -57.41 -47.66 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.254 . . . . 0.28 108.626 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.3 mmt -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.716 -0.846 . . . . 1.7 108.716 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.05 -46.32 82.52 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.634 -0.666 . . . . 0.37 109.839 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.52 85.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.838 -1.705 . . . . 0.28 108.838 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 61.6 t -57.39 -47.49 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.255 . . . . 0.28 108.908 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 82' ' ' ALA . 20.9 mt -57.2 -47.07 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.414 -0.804 . . . . 1.2 109.798 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.65 -46.92 88.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.546 -1.422 . . . . 0.33 109.546 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 m -56.97 -47.26 81.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.078 -1.248 . . . . 0.34 108.837 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.4 mt -57.23 -47.16 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.85 . . . . 0.49 109.184 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.2 -46.95 82.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.806 . . . . 0.68 109.017 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.48 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 18.2 mt -56.92 -46.89 81.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 1.92 109.074 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 95' ' ' ILE . 33.6 mt -56.85 -46.78 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.87 109.127 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.3 80.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.087 -1.008 . . . . 1.29 108.536 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -47.53 81.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 2.64 108.897 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.54 -47.15 90.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.172 -1.571 . . . . 1.29 109.172 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 91' ' ' ILE . 1.5 mt -57.02 -46.91 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -1.013 . . . . 2.19 109.142 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.544 ' O ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -56.67 -46.62 81.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 3.14 109.079 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.66 81.96 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.94 -1.1 . . . . 3.58 109.205 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.66 -47.03 80.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 2.66 109.325 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 96' ' ' ARG . 6.3 pt -82.03 -118.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 2.2 108.703 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER 61.19 141.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.617 -1.302 . . . . 3.91 109.704 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mttt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.977 -1.011 . . . . 6.53 109.498 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.442 -0.577 . . . . 20.22 109.442 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.512 ' O ' HD12 ' B' ' 64' ' ' LEU . 2.5 pp0? -172.12 163.52 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 18.1 109.4 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.512 HD12 ' O ' ' B' ' 63' ' ' GLN . 1.2 mp -128.68 57.41 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 17.47 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.22 32.63 1.69 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.082 -1.011 . . . . 15.58 109.527 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.58 166.71 11.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 14.18 109.266 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 m170 55.29 72.22 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 13.39 109.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -59.02 -169.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 12.43 109.685 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.2 p -168.56 -163.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 8.12 109.519 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.533 ' CB ' ' HD2' ' B' ' 71' ' ' PRO . 0.7 OUTLIER -125.27 172.92 5.46 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 7.29 109.259 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' B' ' 70' ' ' GLU . 4.4 Cg_exo -57.73 134.1 60.64 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.17 1.913 . . . . 2.87 110.402 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.15 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.436 -0.79 . . . . 2.89 110.586 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.706 HD13 ' C ' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -43.08 -38.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.101 -0.999 . . . . 2.11 110.33 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.695 ' N ' HD13 ' B' ' 73' ' ' ILE . 19.6 m -63.46 -46.78 84.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 1.57 109.713 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.081 HD13 HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -76.32 -47.15 24.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.982 -1.074 . . . . 1.63 109.662 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.035 HD13 HD13 ' A' ' 75' ' ' LEU . 58.3 mt -57.26 -48.24 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.926 -1.109 . . . . 1.02 109.329 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.586 HG23 ' N ' ' B' ' 78' ' ' PHE . 0.6 OUTLIER -57.98 -47.24 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.979 -1.076 . . . . 1.86 108.618 178.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.586 ' N ' HG23 ' B' ' 77' ' ' ILE . 1.5 m-85 -57.24 -47.14 82.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.525 -0.734 . . . . 2.81 109.861 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.13 -47.38 88.03 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.776 -1.33 . . . . 0.3 109.776 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.781 HG22 ' C ' ' A' ' 79' ' ' GLY . 65.8 t -57.37 -47.57 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.002 -1.293 . . . . 0.33 109.065 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' MET . . . . . 0.458 ' O ' HG13 ' B' ' 85' ' ' ILE . 4.7 mtm -57.62 -47.21 82.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.309 -0.869 . . . . 1.83 108.945 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.15 -46.39 82.76 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.546 -0.722 . . . . 0.31 109.913 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.56 86.15 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.476 -1.45 . . . . 0.26 109.476 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.38 -47.56 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.31 . . . . 0.31 109.004 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 82' ' ' ALA . 63.8 mt -57.33 -46.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 1.06 109.759 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.01 90.36 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.836 -1.306 . . . . 0.3 109.836 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 40.5 m -57.04 -47.44 80.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.973 -1.31 . . . . 0.32 108.918 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 35.1 mt -57.4 -46.98 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.41 108.803 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.675 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.59 82.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.029 -0.73 . . . . 1.14 109.029 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.613 ' O ' HD23 ' B' ' 90' ' ' LEU . 0.6 OUTLIER -56.67 -46.97 80.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.238 -0.914 . . . . 2.02 109.145 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.614 ' O ' HD12 ' B' ' 95' ' ' ILE . 82.3 mt -57.03 -47.02 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.124 -0.985 . . . . 0.77 109.074 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 14.8 m -57.01 -47.3 81.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.033 -1.042 . . . . 1.53 108.471 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -47.38 81.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 2.25 108.863 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.2 89.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.175 -1.57 . . . . 1.24 109.175 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.614 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -1.088 . . . . 1.81 108.908 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 99' ' ' ILE . 3.9 mtm180 -57.01 -47.08 81.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 2.69 108.937 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -46.65 82.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.211 -0.931 . . . . 3.17 109.601 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.57 -46.85 80.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 2.09 109.305 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.517 HG13 ' N ' ' B' ' 100' ' ' LYS . 21.6 pt -77.06 -125.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.203 -0.936 . . . . 2.5 108.638 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.517 ' N ' HG13 ' B' ' 99' ' ' ILE . 8.3 tptt 43.53 64.79 1.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.88 -1.138 . . . . 5.22 109.491 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 28.8 mttm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.001 -1.0 . . . . 7.38 109.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.406 -0.59 . . . . 18.74 109.406 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -113.35 121.3 43.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 16.78 109.536 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 3.4 mt -114.31 179.99 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 16.71 109.405 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 66.32 15.26 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 14.32 109.45 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 171.0 7.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 14.47 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.44 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 11.15 109.5 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -79.29 156.46 28.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 11.57 109.36 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 t -107.27 104.27 13.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 7.08 109.297 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.567 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -43.97 -54.22 11.57 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 6.49 109.707 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.0 Cg_endo -63.55 57.73 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.086 1.857 . . . . 2.65 110.285 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' GLU . 7.8 mt-10 -66.15 -49.18 68.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 3.01 109.734 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.679 HD13 ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.68 -39.03 80.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.257 -0.902 . . . . 1.48 109.594 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.679 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -61.69 -46.99 87.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.969 -1.082 . . . . 1.35 109.006 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.81 HD22 HG12 ' B' ' 76' ' ' ILE . 1.4 mt -66.96 -46.65 74.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 1.02 109.16 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.906 ' O ' HG23 ' A' ' 80' ' ' VAL . 26.8 mt -56.66 -47.68 81.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.059 -1.025 . . . . 1.1 108.899 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 73' ' ' ILE . 35.8 mt -57.72 -47.88 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.091 -1.006 . . . . 1.58 109.338 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.92 -48.43 79.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 2.09 109.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.914 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.91 -47.34 89.56 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.104 -1.598 . . . . 0.32 109.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' O ' ' B' ' 79' ' ' GLY . 44.9 t -57.17 -47.26 84.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.708 -0.878 . . . . 0.28 109.934 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 mmm -57.16 -47.32 81.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 1.7 109.153 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.41 82.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.374 -0.829 . . . . 0.37 109.41 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.0 -47.1 90.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.936 -1.266 . . . . 0.28 109.936 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.15 -47.49 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.251 . . . . 0.28 109.619 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -57.29 -47.22 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 1.2 109.565 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.13 -46.9 91.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.97 -1.252 . . . . 0.33 109.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.631 ' OG1' HG13 ' B' ' 84' ' ' VAL . 74.7 m -56.88 -47.17 81.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -1.182 . . . . 0.34 109.209 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.14 -46.94 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.49 108.901 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.14 -46.74 82.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.68 109.066 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -56.85 -46.88 81.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 1.92 109.494 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.76 HD11 HD11 ' B' ' 91' ' ' ILE . 98.1 mt -57.03 -46.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.993 . . . . 0.87 108.905 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -47.39 81.2 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.093 -1.005 . . . . 1.29 108.399 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -57.3 -47.54 81.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 2.64 109.196 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.31 -46.98 91.2 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.036 -1.626 . . . . 1.29 109.036 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 91' ' ' ILE . 2.2 mt -57.05 -46.82 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 2.19 108.86 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HA ' HD11 ' A' ' 99' ' ' ILE . 34.1 ttp180 -56.93 -47.07 81.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 3.14 109.291 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -57.32 -46.88 82.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 3.58 109.891 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.84 -46.95 81.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 2.66 108.777 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 96' ' ' ARG . 34.5 pt -72.59 -19.71 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.91 . . . . 2.2 109.167 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -110.07 84.68 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 3.91 109.565 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.977 -1.011 . . . . 6.53 109.385 -179.898 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.687 -0.486 . . . . 20.22 109.687 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.56 ' OE1' ' HB2' ' B' ' 65' ' ' ALA . 0.1 OUTLIER -136.83 121.04 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 18.1 109.513 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.71 109.35 0.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 17.47 109.39 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.56 ' HB2' ' OE1' ' B' ' 63' ' ' GLN . . . -123.59 22.44 9.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.002 -1.061 . . . . 15.58 109.543 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 46.19 68.05 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 14.18 109.541 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.69 -165.5 2.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 13.39 109.415 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.43 ' CE1' ' OE1' ' B' ' 70' ' ' GLU . 1.1 p90 -61.73 -171.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 12.43 109.349 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 22.5 m -127.98 104.36 7.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 8.12 109.604 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.663 ' O ' HG22 ' B' ' 73' ' ' ILE . 0.1 OUTLIER -64.48 174.12 1.31 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 7.29 109.444 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' B' ' 70' ' ' GLU . 2.4 Cg_endo -62.92 -53.07 1.78 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.982 1.788 . . . . 2.87 110.303 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -48.61 -56.21 9.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 2.89 109.967 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.795 ' O ' HD13 ' B' ' 77' ' ' ILE . 0.3 OUTLIER -56.9 -33.4 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.949 -1.095 . . . . 2.11 109.54 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 21.0 m -62.08 -47.02 86.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.238 -0.914 . . . . 1.57 109.135 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.83 HD23 ' C ' ' B' ' 75' ' ' LEU . 2.8 tt -67.27 -47.23 71.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 1.63 109.343 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.81 HG12 HD22 ' A' ' 75' ' ' LEU . 45.5 mt -57.12 -47.42 83.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.975 -1.078 . . . . 1.02 108.634 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.795 HD13 ' O ' ' B' ' 73' ' ' ILE . 1.5 mp -57.46 -47.56 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 1.86 109.416 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.52 -48.13 80.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.975 -1.078 . . . . 2.81 109.529 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.907 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.73 -47.38 89.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.914 HG22 ' O ' ' A' ' 79' ' ' GLY . 46.2 t -57.43 -47.14 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.644 -0.915 . . . . 0.33 109.733 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.5 mmt -56.95 -46.97 81.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 1.83 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.36 81.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.31 109.361 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.99 -47.16 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.618 -1.393 . . . . 0.26 109.618 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 80' ' ' VAL . 5.3 t -57.02 -47.52 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.283 . . . . 0.31 109.241 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.27 -47.07 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.06 109.669 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.08 89.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.425 -1.47 . . . . 0.3 109.425 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.439 ' O ' HG13 ' B' ' 91' ' ' ILE . 91.6 m -57.14 -47.07 82.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -1.156 . . . . 0.32 108.975 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.41 HG13 ' O ' ' B' ' 84' ' ' VAL . 37.1 mt -57.11 -47.03 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.41 109.14 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.701 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.81 -46.95 81.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.307 -0.871 . . . . 1.14 109.0 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.522 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 6.7 mt -56.8 -47.12 80.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 2.02 109.06 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 91' ' ' ILE . 53.8 mt -57.12 -47.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.77 109.405 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 91.4 p -57.29 -47.77 80.64 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.037 . . . . 1.53 108.651 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -47.66 81.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 2.25 109.231 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.61 -47.27 89.58 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.301 -1.52 . . . . 1.24 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.45 ' O ' HG12 ' B' ' 99' ' ' ILE . 1.9 mm -57.16 -47.31 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.324 -1.104 . . . . 1.81 108.66 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.554 ' HA ' HD11 ' B' ' 99' ' ' ILE . 5.3 mtm180 -57.36 -47.26 82.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 2.69 109.206 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 100' ' ' LYS . 1.2 tmt_? -57.52 -47.12 82.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 3.17 109.883 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 98' ' ' LEU . 50.0 mt -57.02 -47.0 81.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.989 . . . . 2.09 109.295 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' B' ' 96' ' ' ARG . 32.9 pt -71.2 -35.87 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 2.5 109.653 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.466 ' N ' HG13 ' B' ' 99' ' ' ILE . 4.4 tptp -117.79 120.54 38.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 5.22 109.814 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.994 -1.003 . . . . 7.38 109.533 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.475 -0.565 . . . . 18.74 109.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -165.59 119.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 16.78 109.491 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -18.05 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 16.71 109.516 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.83 -15.08 10.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 14.32 109.596 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -110.36 104.8 13.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.904 . . . . 14.47 109.616 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 67' ' ' HIS . 47.4 p-80 -166.87 121.17 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 11.15 109.459 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.1 15.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.913 . . . . 11.57 109.564 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.463 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -128.66 29.23 5.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 7.08 109.425 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -78.47 -53.37 1.29 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 6.49 110.375 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 4.8 Cg_exo -61.38 -11.19 18.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.103 1.869 . . . . 2.65 110.981 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 73' ' ' ILE . 15.9 pt-20 -60.68 -47.39 86.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 3.01 109.322 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 74' ' ' THR . 5.7 tp -63.25 -44.7 99.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.141 -0.974 . . . . 1.48 109.353 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.567 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -53.64 -46.89 70.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 1.35 109.816 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.062 HD13 HD13 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -69.09 -47.16 65.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.02 -1.05 . . . . 1.02 109.908 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.959 HD13 HD13 ' B' ' 75' ' ' LEU . 61.6 mt -57.11 -47.7 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.909 -1.119 . . . . 1.1 108.754 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 73' ' ' ILE . 1.1 mp -57.66 -47.11 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.327 -0.99 . . . . 1.58 108.327 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.24 -47.28 81.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 2.09 109.83 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.859 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.06 -47.38 87.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.178 -1.569 . . . . 0.32 109.178 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 48.4 t -57.59 -47.5 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -1.162 . . . . 0.28 109.238 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 85.0 mtp -57.63 -47.35 82.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 1.7 109.303 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.53 82.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.37 109.876 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.99 -47.42 87.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.529 -1.429 . . . . 0.28 109.529 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.28 -47.48 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 0.28 109.495 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 85' ' ' ILE . 33.4 mm -57.28 -47.41 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 1.2 110.081 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -57.24 -47.19 89.66 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.33 109.642 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 90' ' ' LEU . 98.1 m -57.16 -47.14 81.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -1.194 . . . . 0.34 109.537 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.4 mt -56.97 -47.23 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.49 109.536 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.18 -46.55 82.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.159 -0.963 . . . . 0.68 109.044 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 87' ' ' THR . 8.7 mt -57.13 -47.0 82.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 1.92 109.461 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.105 HD11 HD11 ' B' ' 91' ' ' ILE . 89.2 mt -56.86 -47.16 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.87 109.453 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.4 m -57.16 -47.69 80.55 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.922 -1.111 . . . . 1.29 108.487 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -47.48 82.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.071 -1.018 . . . . 2.64 109.611 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.36 88.77 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.16 -1.176 . . . . 1.29 110.16 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 92' ' ' SER . 1.5 tp -57.07 -46.95 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -1.227 . . . . 2.19 108.983 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HA ' HD11 ' A' ' 99' ' ' ILE . 19.2 mtp180 -56.87 -46.82 81.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 3.14 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -46.96 82.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.867 -1.146 . . . . 3.58 109.365 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -46.97 81.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 2.66 109.139 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.569 HD11 ' HA ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -82.77 -103.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.376 -0.828 . . . . 2.2 109.286 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 1.3 tptt 48.27 31.17 2.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.901 -1.125 . . . . 3.91 109.786 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 tptp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.944 -1.027 . . . . 6.53 109.471 179.854 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.3 0.571 . . . . 20.22 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.83 149.4 23.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 18.1 109.637 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 168.04 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 17.47 109.461 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.69 130.75 38.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.196 -0.94 . . . . 15.58 109.339 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -115.49 137.17 52.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 14.18 109.541 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -127.6 11.52 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 13.39 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.427 ' O ' ' CB ' ' B' ' 69' ' ' SER . 2.6 m-85 -106.56 35.9 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 12.43 109.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' B' ' 68' ' ' PHE . 2.6 p 170.38 86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 8.12 109.511 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -156.86 154.32 26.26 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 7.29 109.345 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.466 ' O ' ' HB ' ' B' ' 74' ' ' THR . 2.1 Cg_endo -62.07 -21.72 72.94 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.166 1.911 . . . . 2.87 109.999 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -48.43 -65.63 0.53 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.88 . . . . 2.89 109.473 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.497 ' O ' HG23 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -46.67 -40.89 4.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.277 -0.89 . . . . 2.11 109.616 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.555 ' O ' HG12 ' B' ' 77' ' ' ILE . 58.8 m -56.28 -46.94 79.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 1.57 109.698 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -69.83 -46.82 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 1.63 109.52 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.062 HD13 HD13 ' A' ' 75' ' ' LEU . 66.3 mt -57.07 -47.8 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.896 -1.127 . . . . 1.02 109.532 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.556 HG13 ' N ' ' B' ' 78' ' ' PHE . 33.7 pt -57.91 -47.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.876 -1.14 . . . . 1.86 108.721 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.556 ' N ' HG13 ' B' ' 77' ' ' ILE . 8.7 m-85 -57.35 -47.05 82.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 2.81 109.505 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.95 -47.14 89.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.525 -1.43 . . . . 0.3 109.525 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' C ' ' A' ' 79' ' ' GLY . 69.7 t -57.1 -47.67 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.24 . . . . 0.33 109.189 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' MET . . . . . 0.461 ' O ' HG13 ' B' ' 85' ' ' ILE . 63.6 mtm -57.57 -47.22 82.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 1.83 108.95 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.26 82.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.616 -0.678 . . . . 0.31 109.672 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.22 86.31 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.26 109.34 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.02 -47.47 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -1.234 . . . . 0.31 109.191 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 81' ' ' MET . 30.7 mt -57.27 -47.12 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 1.06 109.633 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.95 90.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.663 -1.375 . . . . 0.3 109.663 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.504 HG21 ' CG2' ' A' ' 87' ' ' THR . 41.4 m -56.93 -47.03 81.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -1.197 . . . . 0.32 109.37 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' B' ' 91' ' ' ILE . 91.7 mt -57.06 -47.08 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.088 -1.008 . . . . 0.41 108.724 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.04 -46.77 82.15 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.363 -0.977 . . . . 1.14 108.363 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 94.6 mt -56.68 -46.56 81.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 2.02 109.154 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 1.105 HD11 HD11 ' A' ' 91' ' ' ILE . 88.6 mt -56.56 -46.9 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.77 109.191 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.56 ' O ' ' CG2' ' B' ' 95' ' ' ILE . 5.8 m -56.84 -47.43 80.35 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.893 -1.129 . . . . 1.53 108.185 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -47.63 81.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.854 -1.154 . . . . 2.25 109.034 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.84 85.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.785 -0.926 . . . . 1.24 110.785 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.56 ' CG2' ' O ' ' B' ' 92' ' ' SER . 1.2 tt -57.27 -46.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.935 -1.332 . . . . 1.81 109.302 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.505 ' HA ' HD11 ' B' ' 99' ' ' ILE . 3.9 mtm180 -56.9 -47.05 81.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.172 -0.955 . . . . 2.69 109.388 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -46.88 82.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 3.17 109.679 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.71 -46.85 81.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.934 . . . . 2.09 108.971 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.522 HG13 ' N ' ' B' ' 100' ' ' LYS . 35.7 pt -76.61 -130.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.401 -0.812 . . . . 2.5 108.847 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.522 ' N ' HG13 ' B' ' 99' ' ' ILE . 3.5 ttpt 56.3 161.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.939 -1.101 . . . . 5.22 109.748 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' B' ' 100' ' ' LYS . 3.3 mttm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.022 -0.99 . . . . 7.38 109.52 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 42.7 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.366 -0.605 . . . . 18.74 109.366 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 7.8 tp-100 71.13 172.81 0.31 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 16.78 109.361 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 81.34 -4.82 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.756 . . . . 16.71 109.574 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' HIS . . . -93.8 -26.63 16.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 14.32 109.257 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 65' ' ' ALA . 1.7 m-70 54.74 170.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 14.47 109.737 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.2 23.23 0.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -0.859 . . . . 11.15 109.236 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 51.1 -176.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 11.57 109.404 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m 58.39 86.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 7.08 109.262 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -144.77 92.3 5.9 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 6.49 109.581 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 5.0 Cg_exo -59.09 92.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.139 1.893 . . . . 2.65 109.966 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HG3' ' CD1' ' B' ' 75' ' ' LEU . 74.2 tt0 -68.44 -81.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 3.01 109.878 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -45.43 -31.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.124 -0.985 . . . . 1.48 110.109 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -68.04 -47.13 69.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.092 -1.005 . . . . 1.35 109.847 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.868 HD13 HD11 ' B' ' 76' ' ' ILE . 6.9 mt -74.28 -47.25 36.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 1.02 109.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.814 HD11 HD22 ' B' ' 75' ' ' LEU . 26.7 mt -57.14 -47.91 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 118.868 -1.133 . . . . 1.1 108.579 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 73' ' ' ILE . 16.5 mm -58.12 -47.92 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.474 -0.89 . . . . 1.58 109.336 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -57.86 -47.84 81.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.329 -0.857 . . . . 2.09 110.029 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.866 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.41 88.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.32 109.908 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 ' O ' ' B' ' 79' ' ' GLY . 48.7 t -57.25 -47.3 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -1.128 . . . . 0.28 109.037 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.1 mmm -57.41 -47.32 82.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.7 108.72 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.29 -46.68 82.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -0.797 . . . . 0.37 109.749 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.747 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.22 -47.35 88.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.376 -1.49 . . . . 0.28 109.376 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.35 -47.26 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -1.172 . . . . 0.28 109.644 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.2 OUTLIER -57.09 -47.17 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 1.2 109.599 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.03 -47.16 89.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.28 -1.528 . . . . 0.33 109.28 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.0 m -57.17 -46.96 82.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -1.105 . . . . 0.34 109.158 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.05 -47.0 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.49 109.11 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -47.02 81.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.68 108.985 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.548 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tp -57.17 -47.24 81.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.187 -0.946 . . . . 1.92 109.285 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 95' ' ' ILE . 91.6 mt -57.24 -47.29 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.87 109.374 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.8 m -57.26 -47.57 81.07 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.073 -1.017 . . . . 1.29 108.603 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.51 -47.68 81.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 2.64 109.387 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.42 -47.5 87.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.623 . . . . 1.29 109.041 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.4 -47.36 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -1.073 . . . . 2.19 108.841 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.624 ' HA ' HD11 ' A' ' 99' ' ' ILE . 6.1 mtm180 -57.21 -47.06 82.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.865 . . . . 3.14 109.55 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 4.6 ttt180 -57.54 -47.3 82.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.995 -1.065 . . . . 3.58 109.743 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -57.3 -46.72 82.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 2.66 109.494 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -78.22 -81.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 2.2 110.264 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 2.0 mtmt -94.44 125.09 38.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 3.91 110.009 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.043 -0.98 . . . . 6.53 109.459 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.481 -0.562 . . . . 20.22 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.643 ' OE1' ' HB2' ' B' ' 65' ' ' ALA . 1.7 pp0? -124.19 153.57 41.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 18.1 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 94.39 9.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 17.47 109.553 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.643 ' HB2' ' OE1' ' B' ' 63' ' ' GLN . . . -123.37 17.7 9.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.178 -0.952 . . . . 15.58 109.432 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 0.0 OUTLIER 170.21 142.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 14.18 109.397 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 81.29 1.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 13.39 109.515 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 48.6 -171.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 12.43 109.505 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.29 2.4 5.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 8.12 109.548 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.561 ' O ' HG22 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -115.48 115.23 42.25 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 7.29 109.265 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.84 -27.89 85.53 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.911 1.741 . . . . 2.87 110.456 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.77 -53.61 48.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 2.89 109.785 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.561 HG22 ' O ' ' B' ' 70' ' ' GLU . 9.5 tp -66.73 -31.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.04 -1.038 . . . . 2.11 109.177 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 51.4 m -62.08 -47.01 86.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.304 -0.873 . . . . 1.57 109.31 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 76' ' ' ILE . 6.0 mt -68.72 -46.99 67.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -0.944 . . . . 1.63 109.265 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.868 HD11 HD13 ' A' ' 75' ' ' LEU . 72.3 mt -56.98 -47.78 82.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.94 -1.104 . . . . 1.02 108.731 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' B' ' 77' ' ' ILE . 14.1 mm -57.9 -47.79 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 1.86 109.567 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.7 -47.76 81.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 2.81 109.663 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.46 -47.22 89.74 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.301 -1.519 . . . . 0.3 109.301 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 79' ' ' GLY . 26.0 t -57.2 -47.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.498 -1.001 . . . . 0.33 109.704 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 3.4 mtm -57.3 -47.3 81.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 1.83 109.576 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.91 82.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.31 109.72 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.47 -47.31 89.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.646 -1.382 . . . . 0.26 109.646 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.24 -47.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.157 . . . . 0.31 109.668 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 87.4 mt -57.32 -47.22 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.176 -0.952 . . . . 1.06 110.027 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.33 88.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.648 -1.381 . . . . 0.3 109.648 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 73.5 m -57.47 -47.29 82.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -1.215 . . . . 0.32 109.326 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.8 mt -57.41 -47.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.41 109.649 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.84 82.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.412 -0.805 . . . . 1.14 109.216 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -47.21 81.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 2.02 109.212 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.632 HD11 HD11 ' A' ' 91' ' ' ILE . 70.7 mt -57.36 -47.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.77 109.678 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.2 m -57.24 -47.62 80.89 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.947 -1.096 . . . . 1.53 108.919 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.6 -47.5 81.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 2.25 109.244 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.36 -47.17 89.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.184 -1.566 . . . . 1.24 109.184 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.504 HD12 HG22 ' B' ' 91' ' ' ILE . 1.9 mt -57.0 -47.08 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -1.085 . . . . 1.81 108.854 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.506 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 8.5 mtm180 -57.0 -47.4 80.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.078 -1.014 . . . . 2.69 109.516 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -57.38 -47.04 82.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 3.17 109.974 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -46.91 81.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 2.09 109.3 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 44.5 pt -72.54 -18.73 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 2.5 109.435 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.96 59.6 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 5.22 109.581 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.007 -0.997 . . . . 7.38 109.544 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.522 -0.547 . . . . 18.74 109.522 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -126.7 145.76 50.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 16.78 109.506 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -76.6 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.215 -0.928 . . . . 16.71 109.262 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.49 132.06 46.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 14.32 109.333 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.46 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 50.2 t-80 -61.71 -18.07 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 14.47 109.432 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CD2' ' H ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -123.99 -79.25 0.61 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 11.15 109.535 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' H ' ' CD2' ' A' ' 67' ' ' HIS . 0.2 OUTLIER 75.45 -175.62 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 11.57 109.468 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.55 -167.0 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 7.08 109.396 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER 58.17 101.06 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 6.49 109.489 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.403 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.3 Cg_exo -60.29 -37.6 81.3 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.019 1.813 . . . . 2.65 110.348 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' OE2' ' HG3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -47.39 -69.34 0.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -0.935 . . . . 3.01 109.812 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 70' ' ' GLU . 5.0 tp -50.85 -38.33 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.132 -0.98 . . . . 1.48 109.58 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 16.6 m -58.08 -46.94 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 1.35 109.08 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.832 HD22 HG12 ' B' ' 76' ' ' ILE . 0.2 OUTLIER -67.34 -46.83 72.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 1.02 109.392 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.879 HG13 HD21 ' B' ' 75' ' ' LEU . 25.3 mt -56.89 -47.57 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.947 -1.095 . . . . 1.1 108.696 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -57.78 -47.77 85.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.46 -0.896 . . . . 1.58 109.448 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -57.7 -48.08 80.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 2.09 109.495 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.859 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.66 -47.61 87.24 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.07 -1.612 . . . . 0.32 109.07 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.889 HG22 ' O ' ' B' ' 79' ' ' GLY . 43.3 t -57.43 -47.19 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.567 -0.96 . . . . 0.28 109.148 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmm -57.13 -46.9 82.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.37 -0.831 . . . . 1.7 109.074 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.81 -46.23 81.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 0.37 109.314 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.493 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.76 -46.98 89.06 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.314 -1.514 . . . . 0.28 109.314 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.566 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.4 t -56.88 -47.22 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.031 -1.276 . . . . 0.28 109.202 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 82' ' ' ALA . 75.3 mt -57.1 -46.93 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.159 -0.963 . . . . 1.2 109.354 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.84 91.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.33 109.703 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.705 ' OG1' HG13 ' B' ' 84' ' ' VAL . 92.8 m -56.78 -47.46 80.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -1.199 . . . . 0.34 109.068 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.23 -47.11 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.49 108.781 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -46.71 82.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.5 -0.75 . . . . 0.68 108.987 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.483 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 16.8 tp -56.66 -47.02 80.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 1.92 109.463 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 95' ' ' ILE . 57.2 mt -57.03 -47.11 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.043 -1.035 . . . . 0.87 108.408 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.571 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -57.14 -47.23 81.64 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.348 -0.982 . . . . 1.29 108.348 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.92 80.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.956 -1.09 . . . . 2.64 109.344 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.09 -48.2 84.43 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.941 -1.123 . . . . 1.29 110.557 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 92' ' ' SER . 2.8 tp -57.71 -47.02 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.064 -1.256 . . . . 2.19 109.145 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 99' ' ' ILE . 8.1 mtm180 -56.95 -47.05 81.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.858 . . . . 3.14 109.429 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -57.05 -46.85 82.13 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.07 -1.019 . . . . 3.58 109.481 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.651 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.75 -46.9 81.11 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.418 -0.956 . . . . 2.66 108.418 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 96' ' ' ARG . 5.3 pt -85.63 39.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 2.2 109.634 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -155.72 102.17 2.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.995 . . . . 3.91 109.628 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 6.53 109.484 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.393 -0.595 . . . . 20.22 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.442 ' CD ' ' O ' ' B' ' 63' ' ' GLN . 0.0 OUTLIER -150.74 91.08 1.69 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 18.1 109.499 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' B' ' 63' ' ' GLN . 0.1 OUTLIER 44.13 58.28 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 17.47 109.341 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 107.44 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 15.58 109.553 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 1.9 p80 -168.01 122.6 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 14.18 109.368 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 12.3 t-160 66.82 129.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.916 . . . . 13.39 109.206 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -120.62 76.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 12.43 109.689 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' B' ' 70' ' ' GLU . 1.5 m -150.45 99.76 2.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 8.12 109.297 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.567 ' CB ' ' HD3' ' B' ' 71' ' ' PRO . 1.6 mt-10 172.48 -57.17 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 7.29 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' B' ' 70' ' ' GLU . 3.5 Cg_exo -59.81 156.34 38.62 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.926 1.751 . . . . 2.87 110.424 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' B' ' 73' ' ' ILE . 65.5 mm-40 -53.01 -65.99 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 2.89 109.488 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.566 HG23 ' N ' ' B' ' 74' ' ' THR . 0.5 OUTLIER -42.46 -46.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.328 -0.857 . . . . 2.11 110.274 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.566 ' N ' HG23 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -56.69 -47.06 80.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.032 -1.043 . . . . 1.57 109.898 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.879 HD21 HG13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -70.89 -47.12 60.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 1.63 109.861 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.832 HG12 HD22 ' A' ' 75' ' ' LEU . 59.4 mt -57.03 -47.32 83.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.887 -1.133 . . . . 1.02 108.633 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.449 HD13 HG13 ' B' ' 73' ' ' ILE . 1.1 mp -57.61 -47.15 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.78 . . . . 1.86 109.195 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -57.08 -47.62 80.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.089 -1.007 . . . . 2.81 109.767 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.889 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.39 -47.39 88.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.154 -1.578 . . . . 0.3 109.154 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 79' ' ' GLY . 40.9 t -57.37 -47.22 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -1.013 . . . . 0.33 109.578 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.8 mmm -56.97 -47.04 81.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 1.83 108.946 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.554 -0.716 . . . . 0.31 109.298 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.581 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.81 -47.12 88.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.743 -1.343 . . . . 0.26 109.743 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.705 HG13 ' OG1' ' A' ' 87' ' ' THR . 30.1 t -57.1 -47.46 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.387 . . . . 0.31 109.078 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -57.11 -46.95 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 1.06 109.347 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -56.85 -46.87 89.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.811 -1.316 . . . . 0.3 109.811 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.566 ' OG1' HG13 ' A' ' 84' ' ' VAL . 31.7 m -56.65 -47.32 80.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.262 . . . . 0.32 109.193 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' B' ' 88' ' ' ILE . 14.0 mt -57.21 -47.14 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.039 -1.038 . . . . 0.41 108.944 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.669 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.05 -46.83 82.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.511 -0.743 . . . . 1.14 109.306 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.531 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 87.6 mt -57.08 -47.04 81.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.95 . . . . 2.02 109.459 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.859 ' O ' HD12 ' B' ' 95' ' ' ILE . 72.0 mt -57.08 -47.32 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.77 109.602 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 53.4 p -57.22 -47.62 80.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.942 -1.099 . . . . 1.53 108.563 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -47.32 82.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -0.788 . . . . 2.25 109.396 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.33 88.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.685 -1.366 . . . . 1.24 109.685 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.859 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mp -57.14 -47.4 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.109 -1.23 . . . . 1.81 109.048 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 1.5 mtt-85 -57.37 -47.06 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 2.69 109.315 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 100' ' ' LYS . 1.3 ttt-85 -57.23 -46.93 82.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 3.17 109.981 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' B' ' 98' ' ' LEU . 6.9 mt -56.77 -46.95 81.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.144 -0.972 . . . . 2.09 109.216 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 44.5 pt -72.56 -28.8 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 2.5 109.189 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.1 OUTLIER -115.52 109.08 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.424 -0.797 . . . . 5.22 109.665 -179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 7.38 109.622 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.708 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.8 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.403 -0.592 . . . . 18.74 109.403 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -174.6 167.4 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 16.78 109.633 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.04 68.08 9.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 16.71 109.514 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.493 ' O ' ' ND1' ' A' ' 66' ' ' HIS . . . -110.76 -15.57 13.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.079 -1.013 . . . . 14.32 109.543 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 65' ' ' ALA . 14.9 m80 -163.05 54.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 14.47 109.411 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -133.51 158.41 43.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 11.15 109.535 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -162.89 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 11.57 109.521 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.77 138.6 36.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 7.08 109.53 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 46.83 70.46 2.06 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 6.49 109.45 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.492 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 3.9 Cg_exo -60.33 90.83 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.237 1.958 . . . . 2.65 110.169 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -92.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 3.01 109.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -44.16 -32.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.127 -0.983 . . . . 1.48 109.508 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -63.35 -46.98 84.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 1.35 109.398 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.048 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -70.57 -46.99 62.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 1.02 109.593 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.022 HD13 HD13 ' B' ' 75' ' ' LEU . 64.9 mt -56.91 -47.51 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 118.854 -1.139 . . . . 1.1 108.262 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.7 mt -57.57 -47.33 85.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.524 -0.917 . . . . 1.58 108.524 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.3 -46.98 82.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 2.09 109.528 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.891 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.05 -47.42 87.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.885 -1.686 . . . . 0.32 108.885 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.908 HG22 ' C ' ' B' ' 79' ' ' GLY . 88.7 t -57.48 -47.61 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -1.189 . . . . 0.28 108.541 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -47.15 83.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.555 -0.716 . . . . 1.7 109.532 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.16 -46.76 82.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 0.37 109.98 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.4 88.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.491 -1.843 . . . . 0.28 108.491 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' ILE . 58.1 t -57.48 -47.5 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.459 -1.024 . . . . 0.28 110.252 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -57.33 -47.53 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 1.2 110.153 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.38 -47.6 86.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.599 . . . . 0.33 109.101 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.6 m -57.58 -46.91 83.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.46 -1.024 . . . . 0.34 109.175 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 84' ' ' VAL . 19.3 mt -56.86 -47.07 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.497 -0.752 . . . . 0.49 109.621 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.15 -46.78 82.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 0.68 109.015 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 28.3 mt -57.47 -47.31 82.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.007 -1.058 . . . . 1.92 109.27 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.937 HD11 HD11 ' B' ' 91' ' ' ILE . 70.1 mt -57.32 -47.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.803 . . . . 0.87 109.686 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -47.63 80.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.092 -1.005 . . . . 1.29 108.817 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.61 -47.66 81.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.127 -0.983 . . . . 2.64 109.391 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.63 -47.57 87.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.435 . . . . 1.29 109.511 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.32 -47.23 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -1.108 . . . . 2.19 108.956 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 99' ' ' ILE . 4.1 tpp180 -57.13 -47.19 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 3.14 109.565 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -57.27 -47.02 82.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 3.58 109.912 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.796 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -57.1 -46.91 82.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 2.66 108.792 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 96' ' ' ARG . 39.6 pt -72.56 -28.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 2.2 109.499 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -90.02 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 3.91 109.245 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.043 -0.98 . . . . 6.53 109.56 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 62' ' ' VAL . 48.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.461 -0.57 . . . . 20.22 109.461 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.51 124.62 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 18.1 109.503 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.73 39.84 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 17.47 109.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.88 29.7 5.6 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 15.58 109.637 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.562 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 29.2 p-80 -120.83 119.04 31.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.004 . . . . 14.18 109.71 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.08 -57.5 0.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 13.39 109.454 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 42.07 3.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.925 . . . . 12.43 109.527 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.42 ' O ' ' C ' ' B' ' 70' ' ' GLU . 0.3 OUTLIER 47.08 43.71 14.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 8.12 109.621 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.567 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 2.1 mm-40 -44.04 -54.82 10.52 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 7.29 109.58 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 4.0 Cg_exo -61.71 64.71 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.039 1.826 . . . . 2.87 110.175 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' B' ' 70' ' ' GLU . 3.4 tp10 -67.62 -73.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.905 . . . . 2.89 109.922 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.7 OUTLIER -43.55 -46.8 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.176 -0.952 . . . . 2.11 109.577 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.55 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 44.1 p -54.68 -46.85 74.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 1.57 109.177 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.022 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -67.97 -46.77 70.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 1.63 109.457 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.048 HD13 HD13 ' A' ' 75' ' ' LEU . 59.0 mt -56.87 -47.92 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.946 -1.096 . . . . 1.02 109.579 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 74' ' ' THR . 0.4 OUTLIER -57.77 -47.33 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.91 -1.119 . . . . 1.86 108.474 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 74' ' ' THR . 17.8 m-30 -57.37 -46.94 82.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.555 -0.716 . . . . 2.81 109.425 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.908 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.9 -47.16 88.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.579 -1.408 . . . . 0.3 109.579 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.891 HG22 ' C ' ' A' ' 79' ' ' GLY . 44.5 t -57.19 -47.72 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.895 -1.356 . . . . 0.33 108.938 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -47.31 83.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.197 -0.939 . . . . 1.83 108.928 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.7 83.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.31 110.151 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.34 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.359 -1.496 . . . . 0.26 109.359 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.24 -47.3 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.31 109.559 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -57.27 -47.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 1.06 110.364 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.21 -47.42 87.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.333 -1.507 . . . . 0.3 109.333 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 87' ' ' THR . 50.7 m -57.34 -46.97 82.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.246 -1.149 . . . . 0.32 108.904 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 mt -56.92 -46.77 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.573 -0.704 . . . . 0.41 109.792 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.72 -46.79 81.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 1.14 109.006 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER -57.1 -47.14 81.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 2.02 108.763 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.937 HD11 HD11 ' A' ' 91' ' ' ILE . 84.9 mt -57.23 -46.84 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.77 109.583 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' B' ' 96' ' ' ARG . 0.4 OUTLIER -56.73 -47.56 79.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.152 -0.968 . . . . 1.53 109.372 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -47.62 81.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.069 . . . . 2.25 109.009 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.41 -47.0 91.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.736 -1.746 . . . . 1.24 108.736 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' B' ' 95' ' ' ILE . 1.3 mm -56.84 -46.88 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.972 . . . . 1.81 109.138 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 99' ' ' ILE . 0.9 OUTLIER -56.84 -47.33 80.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.025 -1.047 . . . . 2.69 109.45 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 1.4 ttp180 -57.85 -47.21 83.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.767 -1.208 . . . . 3.17 109.587 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -47.07 82.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 2.09 110.215 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -80.87 -13.93 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 2.5 109.808 -179.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' B' ' 101' ' ' LYS . 0.6 OUTLIER -147.49 130.67 16.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 5.22 109.505 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.026 -0.988 . . . . 7.38 109.403 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 62' ' ' VAL . 75.9 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.273 0.558 . . . . 18.74 109.546 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.6 126.75 24.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 16.78 109.415 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.51 -55.4 2.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 16.71 109.443 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.08 86.6 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 14.32 109.488 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 4.3 t-160 -114.44 -71.81 0.73 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 14.47 109.536 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 169.11 131.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 11.15 109.603 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.81 38.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 11.57 109.18 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 4.9 m -145.58 -151.78 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 7.08 109.18 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 173.49 -58.0 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.07 -1.019 . . . . 6.49 110.038 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 5.1 Cg_exo -58.82 152.22 58.77 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.901 1.734 . . . . 2.65 110.227 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 73' ' ' ILE . 34.7 mt-10 -65.65 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 3.01 110.008 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -38.91 -38.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.456 -0.778 . . . . 1.48 110.069 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' HG22 ' A' ' 77' ' ' ILE . 27.3 m -60.9 -46.46 90.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.847 . . . . 1.35 109.476 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.063 HD23 ' N ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -75.32 -47.04 29.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.981 -1.074 . . . . 1.02 110.024 -179.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.077 HD13 HD13 ' B' ' 75' ' ' LEU . 44.2 mt -57.66 -48.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.413 -1.429 . . . . 1.1 109.265 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -58.27 -46.74 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.147 -1.057 . . . . 1.58 108.147 177.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' N ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -56.94 -46.87 81.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.683 -0.636 . . . . 2.09 109.898 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.712 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.38 86.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.257 -1.537 . . . . 0.32 109.257 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.975 HG22 ' C ' ' B' ' 79' ' ' GLY . 39.3 t -57.36 -47.56 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.281 . . . . 0.28 108.557 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.64 -46.88 83.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.7 109.323 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.91 -46.42 81.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.58 -0.7 . . . . 0.37 109.75 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.29 87.79 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.801 -1.72 . . . . 0.28 108.801 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' B' ' 87' ' ' THR . 60.6 t -57.32 -47.34 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.143 -1.21 . . . . 0.28 109.179 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.7 mt -57.32 -47.01 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 1.2 109.883 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.04 90.04 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.738 -1.345 . . . . 0.33 109.738 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.637 ' HA ' HD12 ' A' ' 90' ' ' LEU . 37.2 m -57.09 -47.15 81.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -1.18 . . . . 0.34 109.121 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.849 . . . . 0.49 109.538 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.03 -47.02 81.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.68 109.38 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.637 HD12 ' HA ' ' A' ' 87' ' ' THR . 6.2 mt -56.94 -47.05 81.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 1.92 109.337 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 95' ' ' ILE . 63.6 mt -57.03 -47.09 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.87 109.356 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.39 80.84 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.026 -1.046 . . . . 1.29 108.576 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -57.41 -47.25 82.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.24 -0.913 . . . . 2.64 109.387 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.22 -47.34 88.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.014 -1.634 . . . . 1.29 109.014 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.12 -47.01 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -1.126 . . . . 2.19 108.786 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' O ' HG13 ' A' ' 99' ' ' ILE . 3.3 ttp180 -56.9 -47.07 81.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.828 . . . . 3.14 109.333 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 100' ' ' LYS . 1.4 ttm-85 -57.14 -46.59 82.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 3.58 109.698 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.63 -46.76 80.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 2.66 108.753 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.555 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 25.9 pt -76.84 -26.32 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 2.2 109.268 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -94.27 118.18 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 3.91 109.591 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' OXT' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.902 -1.047 . . . . 6.53 109.356 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.278 0.561 . . . . 20.22 109.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' B' ' 65' ' ' ALA . 0.2 OUTLIER -110.7 157.22 19.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 18.1 109.59 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.72 75.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 17.47 109.573 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' B' ' 63' ' ' GLN . . . -100.98 -19.12 15.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.11 -0.994 . . . . 15.58 109.317 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.7 177.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 14.18 109.297 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -154.14 167.08 31.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 13.39 109.576 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.67 59.49 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -0.958 . . . . 12.43 109.578 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.454 ' O ' ' O ' ' B' ' 70' ' ' GLU . 0.9 OUTLIER -77.02 165.04 25.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 8.12 109.316 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' B' ' 72' ' ' GLU . 13.7 mt-10 49.41 95.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 7.29 109.334 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.432 ' HB2' ' HB ' ' B' ' 74' ' ' THR . 3.0 Cg_exo -60.53 67.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.243 1.962 . . . . 2.87 110.413 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.531 ' OE1' HD11 ' B' ' 76' ' ' ILE . 0.0 OUTLIER -64.67 -72.39 0.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 2.89 109.477 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.45 ' O ' HG13 ' B' ' 77' ' ' ILE . 0.7 OUTLIER -43.12 -32.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.25 -0.906 . . . . 2.11 109.589 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' B' ' 78' ' ' PHE . 39.1 m -67.2 -47.08 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 1.57 109.067 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.077 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -72.95 -46.85 50.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 1.63 109.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.043 HG12 HD21 ' A' ' 75' ' ' LEU . 21.2 mt -56.9 -48.11 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.046 -1.061 . . . . 1.02 108.326 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 73' ' ' ILE . 20.4 mt -58.02 -47.44 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.341 -0.849 . . . . 1.86 108.863 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' B' ' 74' ' ' THR . 3.2 m-85 -57.43 -47.52 81.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.681 -0.637 . . . . 2.81 110.251 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.975 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.35 -47.74 85.69 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.605 -1.398 . . . . 0.3 109.605 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 79' ' ' GLY . 86.0 t -57.74 -47.67 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.286 . . . . 0.33 108.928 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 43.5 mtm -57.72 -47.13 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 1.83 109.664 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.41 82.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.31 110.035 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.51 86.76 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.228 -1.549 . . . . 0.26 109.228 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.415 ' O ' HG13 ' B' ' 88' ' ' ILE . 48.5 t -57.46 -47.53 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -1.185 . . . . 0.31 109.451 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 85' ' ' ILE . 30.6 mt -57.33 -47.16 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 1.06 110.177 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.31 87.38 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.296 . . . . 0.3 109.859 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 84' ' ' VAL . 19.3 m -57.23 -47.27 81.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -1.225 . . . . 0.32 109.256 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 84' ' ' VAL . 49.4 mt -57.44 -47.23 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.809 . . . . 0.41 109.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.589 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.21 -46.99 82.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 1.14 109.534 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 40.4 tp -57.0 -47.35 81.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.182 -0.949 . . . . 2.02 109.509 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 91' ' ' ILE . 46.4 mt -57.21 -47.17 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.77 109.693 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.2 -47.8 80.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.07 . . . . 1.53 108.975 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.64 -47.54 81.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 2.25 109.585 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.32 88.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.724 -1.35 . . . . 1.24 109.724 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.537 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.5 mt -57.06 -47.16 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.269 -1.136 . . . . 1.81 109.201 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.499 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 10.2 ttp180 -57.04 -47.3 81.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 2.69 109.505 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.44 ' HG3' ' OXT' ' B' ' 101' ' ' LYS . 1.1 ttp180 -57.35 -47.28 82.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 3.17 110.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.78 -47.09 80.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 2.09 109.616 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 17.9 pt -71.57 -21.59 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 2.5 109.446 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.462 ' N ' HG13 ' B' ' 99' ' ' ILE . 2.2 mttt -142.13 103.88 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 5.22 109.608 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.44 ' OXT' ' HG3' ' B' ' 97' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.986 -1.007 . . . . 7.38 109.47 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 62' ' ' VAL . 5.7 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 18.74 109.402 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -78.86 159.82 27.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 16.78 109.472 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.709 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -119.47 147.56 44.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.935 . . . . 16.71 109.376 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 64' ' ' LEU . . . 162.33 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 14.32 109.463 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -117.84 136.83 53.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 14.47 109.483 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.61 35.73 4.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 11.15 109.31 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 69' ' ' SER . 41.7 m-85 -100.91 96.02 7.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 11.57 109.59 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 5.5 m 70.09 -165.44 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 7.08 109.628 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 72' ' ' GLU . 2.7 pt-20 -89.68 151.79 46.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 6.49 109.316 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.95 56.72 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.25 1.967 . . . . 2.65 110.692 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 70' ' ' GLU . 11.4 tt0 -73.04 -72.72 0.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.987 . . . . 3.01 108.866 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tp -55.95 -26.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.173 -0.954 . . . . 1.48 108.697 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.6 m -66.26 -47.01 75.1 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.728 -0.841 . . . . 1.35 108.728 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.817 HD13 HD11 ' B' ' 76' ' ' ILE . 5.0 mt -65.71 -47.01 76.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 1.02 108.826 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.718 HD11 HD22 ' B' ' 75' ' ' LEU . 35.6 mt -56.79 -47.69 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 118.899 -1.121 . . . . 1.1 108.155 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 77' ' ' ILE . 2.5 mm -57.85 -47.62 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.58 108.857 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -57.57 -47.89 80.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.341 -0.85 . . . . 2.09 109.968 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.868 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.45 88.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.389 -1.484 . . . . 0.32 109.389 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.724 HG22 ' O ' ' B' ' 79' ' ' GLY . 41.8 t -57.34 -47.36 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.366 -1.079 . . . . 0.28 109.121 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.734 ' O ' HD12 ' A' ' 85' ' ' ILE . 16.9 mtp -57.44 -47.21 82.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 1.7 108.966 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.41 83.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.546 -0.721 . . . . 0.37 109.311 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.691 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.1 -47.14 89.86 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.325 -1.51 . . . . 0.28 109.325 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.17 -47.64 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -1.217 . . . . 0.28 109.16 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' O ' ' A' ' 81' ' ' MET . 1.9 mt -57.42 -47.15 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 1.2 109.373 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -57.12 -47.27 88.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.756 -1.338 . . . . 0.33 109.756 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.6 m -57.21 -47.51 81.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -1.21 . . . . 0.34 109.042 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.48 -47.37 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.49 109.329 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -47.0 82.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.456 -0.777 . . . . 0.68 109.363 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 86' ' ' GLY . 4.7 mp -57.07 -47.06 81.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.92 109.204 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.548 HD11 HD11 ' B' ' 91' ' ' ILE . 78.8 mt -57.16 -47.13 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.87 109.629 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -57.1 -47.59 80.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.164 -1.014 . . . . 1.29 108.823 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -57.86 -48.1 80.79 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.772 -1.205 . . . . 2.64 109.493 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.05 -48.26 83.92 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.064 -1.065 . . . . 1.29 110.668 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -57.63 -46.89 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -1.224 . . . . 2.19 109.373 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.593 ' HA ' HD11 ' A' ' 99' ' ' ILE . 1.7 mtm180 -57.18 -47.31 81.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 3.14 109.592 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -47.17 82.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 3.58 110.212 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -57.17 -47.01 82.26 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.157 -0.964 . . . . 2.66 108.815 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 96' ' ' ARG . 33.8 pt -72.25 -36.46 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 2.2 109.364 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.463 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -97.16 63.49 1.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 3.91 109.408 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.011 -0.995 . . . . 6.53 109.499 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.448 ' O ' HG23 ' B' ' 62' ' ' VAL . 26.0 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.461 -0.57 . . . . 20.22 109.461 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' GLN . . . . . 0.464 ' OE1' ' N ' ' B' ' 64' ' ' LEU . 4.5 tp-100 -171.75 143.26 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 18.1 109.479 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' B' ' 63' ' ' GLN . 0.2 OUTLIER -113.2 -20.31 11.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 17.47 109.505 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.11 21.29 16.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 15.58 109.38 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 m170 56.28 175.09 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 14.18 109.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.552 ' C ' ' CG ' ' B' ' 68' ' ' PHE . 5.8 p-80 -144.15 -49.3 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 13.39 109.47 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.552 ' CG ' ' C ' ' B' ' 67' ' ' HIS . 4.1 p90 39.41 52.22 2.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.745 . . . . 12.43 109.802 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 86.1 p -118.49 -157.14 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 8.12 109.691 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.528 ' CB ' ' HD2' ' B' ' 71' ' ' PRO . 1.8 mt-10 -81.43 174.4 6.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 7.29 109.448 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' B' ' 70' ' ' GLU . 1.9 Cg_endo -63.56 -5.14 8.01 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.421 2.081 . . . . 2.87 110.928 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 24.6 mm-40 -36.86 -56.35 0.86 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.488 -0.758 . . . . 2.89 109.967 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.547 HG23 ' N ' ' B' ' 74' ' ' THR . 6.1 tp -54.71 -45.89 73.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.144 -0.973 . . . . 2.11 109.21 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.547 ' N ' HG23 ' B' ' 73' ' ' ILE . 3.7 m -50.77 -46.8 59.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 1.57 109.318 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.718 HD22 HD11 ' A' ' 76' ' ' ILE . 8.3 mt -68.71 -46.63 68.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 1.63 109.515 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.817 HD11 HD13 ' A' ' 75' ' ' LEU . 79.2 mt -56.81 -48.25 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.002 -1.079 . . . . 1.02 109.264 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ILE . . . . . 0.522 HG12 ' O ' ' B' ' 74' ' ' THR . 28.3 pt -58.21 -47.61 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.069 . . . . 1.86 109.492 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.518 ' N ' HG13 ' B' ' 77' ' ' ILE . 2.2 m-85 -57.76 -47.3 82.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.27 -0.893 . . . . 2.81 109.496 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.724 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.23 -46.88 91.22 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.307 -1.517 . . . . 0.3 109.307 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 79' ' ' GLY . 33.2 t -56.93 -47.27 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -1.051 . . . . 0.33 109.571 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 56.6 mmm -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.03 -1.044 . . . . 1.83 108.722 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.17 82.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.435 -0.79 . . . . 0.31 109.076 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.77 -46.76 89.37 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.26 109.454 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 88' ' ' ILE . 54.7 t -56.92 -47.25 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.256 . . . . 0.31 109.336 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.2 -46.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 1.06 109.419 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.531 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.11 -46.85 91.12 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 0.3 109.465 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 14.2 m -56.76 -47.17 80.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -1.155 . . . . 0.32 109.004 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.451 HG13 ' O ' ' B' ' 84' ' ' VAL . 51.0 mt -57.08 -46.98 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.41 109.019 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.726 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.99 -46.45 82.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.403 -0.811 . . . . 1.14 109.156 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 23.3 tp -56.76 -46.9 81.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 2.02 108.961 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 91' ' ' ILE . 94.3 mt -57.02 -47.01 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.77 108.713 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.52 ' O ' HG22 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -57.01 -47.4 80.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.241 -1.022 . . . . 1.53 108.241 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -47.44 82.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 2.25 109.214 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.43 -47.37 88.61 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.527 -1.429 . . . . 1.24 109.527 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.52 HG22 ' O ' ' B' ' 92' ' ' SER . 0.1 OUTLIER -57.04 -46.83 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -1.159 . . . . 1.81 109.11 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 7.0 mtm180 -56.91 -47.08 81.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 2.69 109.044 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.17 -46.92 82.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 3.17 109.755 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.81 -47.05 81.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 2.09 109.266 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.522 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 40.3 pt -71.45 -20.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 2.5 109.177 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 79.68 1.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 5.22 109.279 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 tttm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.915 -1.041 . . . . 7.38 109.514 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 11.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.491 -0.559 . . . . 18.74 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 71.52 98.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 16.78 109.35 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.527 ' HA ' HD13 ' A' ' 64' ' ' LEU . 1.8 mm? -118.77 -75.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 16.71 109.158 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.13 135.07 54.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.364 -0.835 . . . . 14.32 109.201 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -65.72 118.16 9.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 14.47 109.508 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' CD2' ' N ' ' A' ' 68' ' ' PHE . 40.6 p-80 -166.94 -150.76 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 11.15 109.564 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' N ' ' CD2' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -58.14 161.07 4.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 11.57 109.589 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 t -105.29 84.92 2.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 7.08 109.476 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.564 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -62.41 -56.65 28.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 6.49 109.71 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 4.6 Cg_exo -60.01 76.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.867 1.711 . . . . 2.65 110.016 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 70' ' ' GLU . 13.1 mp0 -61.55 -88.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 3.01 109.815 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -49.4 -32.57 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.019 -1.051 . . . . 1.48 108.822 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.524 ' OG1' ' CA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -53.23 -47.07 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.955 -1.091 . . . . 1.35 108.574 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.043 HD13 HD13 ' B' ' 76' ' ' ILE . 0.2 OUTLIER -78.84 -47.16 17.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 1.02 109.423 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.083 HD13 HD13 ' B' ' 75' ' ' LEU . 54.6 mt -57.42 -48.29 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.798 -1.161 . . . . 1.1 109.309 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 78' ' ' PHE . 3.9 tt -58.17 -47.43 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.914 -1.116 . . . . 1.58 108.787 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.559 ' N ' HG23 ' A' ' 77' ' ' ILE . 1.6 m-30 -57.23 -46.79 82.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.524 -0.735 . . . . 2.09 109.557 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.836 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -56.81 -47.04 89.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.629 -1.389 . . . . 0.32 109.629 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' B' ' 79' ' ' GLY . 26.3 t -56.91 -47.59 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.979 -1.306 . . . . 0.28 108.566 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 85' ' ' ILE . 59.0 mtp -57.51 -46.92 83.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.433 -0.951 . . . . 1.7 108.433 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.88 81.69 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.748 -0.595 . . . . 0.37 109.616 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.99 85.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.08 -1.608 . . . . 0.28 109.08 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.98 -47.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.347 . . . . 0.28 108.8 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 81' ' ' MET . 64.3 mt -57.16 -46.83 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 1.2 109.528 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.67 89.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.33 109.536 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.574 HG21 ' CG2' ' B' ' 87' ' ' THR . 22.5 m -56.69 -46.95 80.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.225 . . . . 0.34 109.001 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 91' ' ' ILE . 62.6 mt -57.1 -46.9 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 0.49 109.073 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.98 -46.66 82.07 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.399 -0.813 . . . . 0.68 109.012 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' HG ' ' A' ' 89' ' ' LEU . 5.3 mp -56.69 -47.0 80.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -0.856 . . . . 1.92 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.684 HD11 HD11 ' B' ' 91' ' ' ILE . 68.3 mt -56.93 -47.12 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.093 -1.004 . . . . 0.87 109.261 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.7 p -57.16 -47.58 80.84 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.441 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -47.45 82.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.17 -0.956 . . . . 2.64 109.341 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.31 89.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.905 -1.278 . . . . 1.29 109.905 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -57.25 -47.06 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.235 . . . . 2.19 108.939 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.525 ' O ' HG13 ' A' ' 99' ' ' ILE . 9.1 mtm180 -57.06 -47.04 81.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 3.14 109.209 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.07 -46.87 82.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.248 -0.908 . . . . 3.58 109.964 -179.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -56.74 -46.74 81.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.912 -1.118 . . . . 2.66 108.722 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.574 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 19.3 pt -77.0 -14.38 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.2 109.522 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 97' ' ' ARG . 2.2 ttpp -105.26 137.08 43.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 3.91 109.847 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 6.53 109.343 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 62' ' ' VAL . 48.0 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.29 0.567 . . . . 20.22 109.473 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.17 166.24 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 18.1 109.367 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mp -113.34 11.85 18.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 17.47 109.7 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -80.33 -6.56 58.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 15.58 109.805 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' ALA . 87.8 m-70 -44.32 167.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 14.18 109.485 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -80.5 -76.23 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 13.39 109.55 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.05 -158.4 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -0.956 . . . . 12.43 109.467 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.7 p -115.52 34.86 4.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 8.12 109.388 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.971 ' O ' HG23 ' B' ' 74' ' ' THR . 14.5 mt-10 -130.53 100.6 17.91 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.853 . . . . 7.29 109.394 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' B' ' 74' ' ' THR . 4.8 Cg_exo -59.14 -27.17 84.27 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.001 1.801 . . . . 2.87 110.106 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.449 ' OE2' ' OE1' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -62.44 -60.92 2.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 2.89 109.518 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.487 HG22 ' O ' ' B' ' 70' ' ' GLU . 2.6 tp -61.04 -26.8 40.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.048 -1.033 . . . . 2.11 109.677 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.971 HG23 ' O ' ' B' ' 70' ' ' GLU . 31.7 p -68.12 -46.93 69.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 1.57 109.501 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 1.083 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -70.23 -47.0 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.63 109.389 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 1.043 HD13 HD13 ' A' ' 75' ' ' LEU . 59.3 mt -56.98 -47.61 83.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 1.02 108.243 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.64 -47.19 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.588 -0.893 . . . . 1.86 108.588 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 74' ' ' THR . 16.3 m-85 -57.21 -47.11 82.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.571 -0.706 . . . . 2.81 109.543 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 80' ' ' VAL . . . -56.96 -47.33 87.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.754 -1.739 . . . . 0.3 108.754 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.836 HG22 ' CA ' ' A' ' 79' ' ' GLY . 40.1 t -57.35 -47.5 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.191 -1.182 . . . . 0.33 108.698 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.6 -47.0 83.34 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.83 . . . . 1.83 109.193 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.716 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -56.98 -46.68 82.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.31 109.815 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.49 87.1 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.605 -1.798 . . . . 0.26 108.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.421 HG13 ' OG1' ' A' ' 87' ' ' THR . 43.2 t -57.53 -47.3 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -1.1 . . . . 0.31 109.203 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' B' ' 82' ' ' ALA . 38.9 mt -57.25 -47.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 1.06 109.904 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.29 88.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.229 -1.548 . . . . 0.3 109.229 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.574 ' CG2' HG21 ' A' ' 87' ' ' THR . 73.8 m -57.34 -47.09 82.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -1.092 . . . . 0.32 109.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' B' ' 88' ' ' ILE . 57.4 mt -57.13 -47.1 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 0.41 109.694 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.695 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -47.33 81.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 1.14 109.168 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 90' ' ' LEU . . . . . 0.546 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 1.1 mm? -57.41 -47.6 81.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.02 108.871 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.684 HD11 HD11 ' A' ' 91' ' ' ILE . 67.9 mt -57.56 -47.17 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.395 -0.815 . . . . 0.77 109.286 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.502 ' O ' HG22 ' B' ' 95' ' ' ILE . 2.2 m -57.08 -47.51 80.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.361 -0.936 . . . . 1.53 108.587 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.51 -47.87 80.79 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.361 -0.935 . . . . 2.25 109.158 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.69 87.3 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.618 -1.393 . . . . 1.24 109.618 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.502 HG22 ' O ' ' B' ' 92' ' ' SER . 0.1 OUTLIER -57.47 -47.15 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -1.091 . . . . 1.81 109.24 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.544 ' O ' HG13 ' B' ' 99' ' ' ILE . 21.9 ttp180 -57.03 -47.21 81.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 2.69 109.26 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.23 -46.69 82.73 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.066 -1.021 . . . . 3.17 109.645 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -46.86 81.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 2.09 109.616 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 96' ' ' ARG . 2.7 pt -78.84 -24.5 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 2.5 110.243 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.529 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -133.82 135.7 43.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.071 -1.018 . . . . 5.22 109.873 -179.438 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 101' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.979 -1.01 . . . . 7.38 109.477 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.598 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.546 -0.539 . . . . 1.02 109.546 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.3 -47.63 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.896 -1.127 . . . . 1.1 108.213 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.71 -47.2 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.64 -0.874 . . . . 1.58 108.64 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.94 -47.14 81.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.601 -0.687 . . . . 2.09 109.468 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.886 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.02 -47.43 87.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.991 -1.644 . . . . 0.32 108.991 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 60.9 t -57.48 -47.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -1.234 . . . . 0.28 108.708 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.447 ' O ' HG12 ' A' ' 85' ' ' ILE . 7.0 mtt -57.54 -46.99 83.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 1.7 109.393 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.6 82.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.414 -0.804 . . . . 0.37 109.722 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.42 87.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.744 -1.742 . . . . 0.28 108.744 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -47.16 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -1.096 . . . . 0.28 109.317 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 81' ' ' MET . 21.6 mm -57.06 -47.15 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 1.2 110.038 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.37 88.08 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.297 -1.521 . . . . 0.33 109.297 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.437 ' OG1' HG13 ' B' ' 84' ' ' VAL . 91.6 m -57.45 -47.19 82.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -1.145 . . . . 0.34 109.065 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' A' ' 91' ' ' ILE . 34.5 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.49 109.43 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -47.05 81.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.68 108.722 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 15.2 tp -57.21 -47.17 81.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 1.92 108.928 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 88' ' ' ILE . 81.7 mt -57.28 -46.91 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.87 109.578 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 95' ' ' ILE . 51.0 m -56.93 -47.5 80.46 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.157 -1.017 . . . . 1.29 108.873 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -47.72 81.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 2.64 109.18 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.35 89.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.593 -1.403 . . . . 1.29 109.593 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 92' ' ' SER . 2.1 tp -57.18 -46.81 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -1.069 . . . . 2.19 109.212 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 16.7 mtm180 -56.68 -46.6 81.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.897 . . . . 3.14 109.09 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 120.776 -1.203 . . . . 3.58 109.201 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.328 -1.509 . . . . 0.3 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.886 HG22 ' C ' ' A' ' 79' ' ' GLY . 87.7 t -57.1 -47.76 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.295 . . . . 0.33 108.681 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 61.3 mtm -57.67 -47.31 82.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 1.83 108.654 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.2 -46.16 83.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.72 -0.613 . . . . 0.31 109.835 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.67 -47.3 86.03 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.302 -1.519 . . . . 0.26 109.302 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.437 HG13 ' OG1' ' A' ' 87' ' ' THR . 58.0 t -57.18 -47.58 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.3 . . . . 0.31 108.993 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 82' ' ' ALA . 48.0 mt -57.4 -47.1 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 1.06 109.866 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.91 -47.08 89.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.3 109.745 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 25.2 m -57.03 -47.15 81.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.161 -1.199 . . . . 0.32 109.115 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.11 -47.02 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.41 109.169 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.08 -46.8 82.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 1.14 108.963 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 27.1 tp . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 2.02 109.538 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.194 -0.669 . . . . 1.02 109.194 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.1 mt -56.75 -47.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.981 -1.074 . . . . 1.1 108.668 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.8 mt -57.5 -47.3 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.243 -0.911 . . . . 1.58 108.556 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -57.37 -47.0 82.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.702 -0.624 . . . . 2.09 109.462 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.844 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.22 88.32 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.685 -1.366 . . . . 0.32 109.685 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.881 HG22 ' C ' ' B' ' 79' ' ' GLY . 62.0 t -57.29 -47.81 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.935 -1.332 . . . . 0.28 108.8 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 mtm -57.72 -47.31 82.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 1.7 108.729 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.15 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.662 -0.649 . . . . 0.37 109.738 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.6 -47.31 85.41 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.258 -1.537 . . . . 0.28 109.258 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 93.3 t -57.23 -47.55 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.284 . . . . 0.28 109.033 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.29 -46.95 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.2 109.478 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.7 90.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.329 -1.509 . . . . 0.33 109.329 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.445 ' OG1' HG13 ' B' ' 84' ' ' VAL . 98.0 m -56.77 -47.04 81.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.253 -1.145 . . . . 0.34 109.013 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 91' ' ' ILE . 96.4 mt -57.2 -47.3 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.49 108.826 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.696 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.24 -46.83 82.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.478 -0.934 . . . . 0.68 108.478 179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 39.1 tp -57.01 -46.81 82.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 1.92 109.14 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 95' ' ' ILE . 87.7 mt -56.78 -46.99 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.185 -0.947 . . . . 0.87 109.326 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -47.6 80.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.021 -1.072 . . . . 1.29 108.2 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -57.5 -47.43 81.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.318 -0.863 . . . . 2.64 108.953 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.17 89.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.366 -1.494 . . . . 1.29 109.366 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.09 -47.32 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -1.127 . . . . 2.19 108.63 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -57.31 -47.01 82.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 3.14 108.833 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 3.58 109.806 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.881 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.065 -1.614 . . . . 0.3 109.065 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.844 HG22 ' C ' ' A' ' 79' ' ' GLY . 89.4 t -57.26 -47.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 0.33 108.799 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 14.5 mtp -57.67 -47.35 82.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.291 -0.881 . . . . 1.83 108.957 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.46 83.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.533 -0.729 . . . . 0.31 109.962 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.37 87.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.319 -1.512 . . . . 0.26 109.319 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.445 HG13 ' OG1' ' A' ' 87' ' ' THR . 55.7 t -57.29 -47.54 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -1.217 . . . . 0.31 109.431 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -57.35 -47.22 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.06 109.79 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.04 -47.0 90.91 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.653 -1.379 . . . . 0.3 109.653 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 93.7 m -56.93 -47.18 81.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -1.172 . . . . 0.32 109.521 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.02 -47.24 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.123 -0.986 . . . . 0.41 109.207 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.731 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -57.28 -46.61 82.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 1.14 109.134 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.8 ' O ' HD13 ' B' ' 90' ' ' LEU . 2.8 tm? . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.299 -0.875 . . . . 2.02 109.451 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.981 -0.378 . . . . 1.02 109.981 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 80' ' ' VAL . 42.2 mt -57.27 -48.48 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.744 -1.223 . . . . 1.1 108.955 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 4.3 tt -58.41 -47.48 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.135 -0.978 . . . . 1.58 108.97 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 2.7 m-85 -57.28 -47.5 81.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.745 . . . . 2.09 110.404 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.881 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.26 -47.6 86.56 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.353 -1.499 . . . . 0.32 109.353 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.71 HG22 ' C ' ' B' ' 79' ' ' GLY . 47.5 t -57.59 -47.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -1.168 . . . . 0.28 109.139 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -46.86 82.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 1.7 109.065 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.67 -46.04 81.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.423 -0.798 . . . . 0.37 109.08 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.488 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.62 -46.97 87.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.249 -1.54 . . . . 0.28 109.249 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.762 HG13 ' OG1' ' B' ' 87' ' ' THR . 8.4 t -57.09 -47.39 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.063 -1.257 . . . . 0.28 109.062 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.7 mt -57.2 -46.86 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 1.2 109.454 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.71 89.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.5 -1.44 . . . . 0.33 109.5 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.661 ' OG1' HG13 ' B' ' 84' ' ' VAL . 60.4 m -56.69 -47.0 80.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.257 . . . . 0.34 108.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 91' ' ' ILE . 49.5 mt -57.01 -46.76 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.115 -0.991 . . . . 0.49 108.705 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.51 82.06 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.682 -0.859 . . . . 0.68 108.682 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.7 mt -56.72 -46.6 81.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 1.92 109.053 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 95' ' ' ILE . 82.0 mt -56.85 -47.04 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 0.87 109.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -56.88 -47.68 79.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.983 -1.087 . . . . 1.29 108.483 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -57.57 -47.5 81.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 2.64 109.004 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.58 -47.17 90.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.345 -1.102 . . . . 1.29 110.345 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.91 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER -57.13 -47.1 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.025 -1.279 . . . . 2.19 109.267 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.485 ' N ' ' CG1' ' A' ' 95' ' ' ILE . 9.5 mtp180 -57.14 -47.22 81.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 3.14 109.395 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.529 0 O-C-N 120.776 -1.203 . . . . 3.58 109.814 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.71 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 108.813 -1.715 . . . . 0.3 108.813 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 79' ' ' GLY . 52.0 t -57.68 -47.46 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.267 -1.137 . . . . 0.33 108.951 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 8.3 mtp -57.55 -46.93 83.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 1.83 109.164 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.27 81.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.796 . . . . 0.31 109.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.17 87.93 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.838 -1.705 . . . . 0.26 108.838 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.14 -47.35 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -1.233 . . . . 0.31 109.05 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -57.22 -47.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 1.06 109.639 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.06 90.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.574 -1.41 . . . . 0.3 109.574 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.762 ' OG1' HG13 ' A' ' 84' ' ' VAL . 56.3 m -57.07 -47.26 81.42 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.159 -1.201 . . . . 0.32 109.431 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 58.7 mt -57.4 -47.53 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.41 109.098 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.619 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.44 -47.04 82.83 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.747 HD13 ' C ' ' B' ' 90' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.524 -0.735 . . . . 2.02 109.435 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.581 -0.526 . . . . 1.02 109.581 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.8 mt -56.97 -47.44 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.058 -1.026 . . . . 1.1 108.644 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.69 -47.45 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.169 -0.957 . . . . 1.58 108.685 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -57.42 -47.31 82.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 2.09 109.682 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.897 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.23 -47.13 90.13 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.241 -1.544 . . . . 0.32 109.241 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.843 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.6 t -57.36 -47.81 83.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -1.137 . . . . 0.28 109.962 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -57.8 -47.82 81.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 1.7 108.859 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.37 84.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.626 -0.671 . . . . 0.37 109.887 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' HG13 ' B' ' 80' ' ' VAL . . . -56.85 -47.27 87.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.845 -1.302 . . . . 0.28 109.845 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' OG1' ' B' ' 87' ' ' THR . 97.3 t -57.16 -47.98 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.323 . . . . 0.28 109.199 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mt -57.67 -47.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.012 . . . . 1.2 109.629 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.25 89.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.099 -1.2 . . . . 0.33 110.099 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.447 ' OG1' HG13 ' B' ' 84' ' ' VAL . 47.4 m -57.11 -47.28 81.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -1.141 . . . . 0.34 109.839 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.9 mt -57.43 -47.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.49 109.808 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.86 81.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.68 109.209 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.526 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tt -57.71 -47.5 82.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -0.955 . . . . 1.92 109.298 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 95' ' ' ILE . 76.2 mt -57.33 -47.04 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.551 -0.718 . . . . 0.87 109.948 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -47.7 79.82 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.974 -1.079 . . . . 1.29 109.176 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.81 -47.97 81.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.008 -1.058 . . . . 2.64 109.537 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.67 87.47 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.854 -1.298 . . . . 1.29 109.854 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -57.37 -47.21 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -1.085 . . . . 2.19 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -56.99 -47.16 81.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.873 . . . . 3.14 109.472 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 3.58 110.075 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.843 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.897 HG22 ' C ' ' A' ' 79' ' ' GLY . 94.1 t -57.34 -47.71 84.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.282 -1.128 . . . . 0.33 109.714 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 2.9 mtt -57.74 -47.76 81.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 1.83 109.001 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.58 83.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.497 -0.752 . . . . 0.31 109.656 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -56.95 -46.97 90.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.599 -1.4 . . . . 0.26 109.599 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 87' ' ' THR . 98.5 t -56.89 -47.6 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -1.188 . . . . 0.31 109.764 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 85' ' ' ILE . 43.6 mm -57.41 -47.91 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.835 -1.165 . . . . 1.06 109.418 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.14 90.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.364 -1.494 . . . . 0.3 109.364 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.438 ' OG1' HG22 ' A' ' 84' ' ' VAL . 98.5 m -57.1 -47.06 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.999 . . . . 0.32 109.695 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 37.7 mt -57.01 -47.66 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.132 -0.98 . . . . 0.41 109.763 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.025 -1.047 . . . . 1.14 108.752 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 66.1 mt . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 2.02 109.429 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.708 -0.479 . . . . 1.02 109.708 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.0 mt -56.92 -48.01 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.85 -1.157 . . . . 1.1 108.72 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 77' ' ' ILE . 34.3 mm -58.02 -47.61 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 1.58 108.693 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.44 -47.25 82.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.753 -0.592 . . . . 2.09 110.278 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.818 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.87 -47.66 84.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.32 109.659 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.824 HG22 ' O ' ' B' ' 79' ' ' GLY . 92.3 t -57.67 -47.49 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.904 -1.351 . . . . 0.28 108.628 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.84 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 1.7 109.037 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.08 81.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.559 -0.713 . . . . 0.37 109.453 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.22 85.67 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.077 -1.609 . . . . 0.28 109.077 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.41 HG22 ' OG1' ' B' ' 87' ' ' THR . 41.7 t -56.93 -47.32 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.973 -1.31 . . . . 0.28 108.907 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 mt -57.21 -46.69 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 1.2 109.813 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.566 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -56.7 -46.9 88.66 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.52 -1.432 . . . . 0.33 109.52 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.793 ' OG1' HG13 ' B' ' 84' ' ' VAL . 17.7 m -57.08 -47.13 81.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.985 -1.303 . . . . 0.34 108.528 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.3 -46.85 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.49 109.226 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -56.81 -46.52 81.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.68 109.371 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.569 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 3.7 mm? -56.66 -47.05 80.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 1.92 108.926 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 95' ' ' ILE . 27.1 mt -56.96 -46.91 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.87 109.302 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -47.28 80.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 1.29 108.466 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -47.57 81.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 2.64 108.976 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.55 -47.24 89.68 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.263 -1.535 . . . . 1.29 109.263 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 91' ' ' ILE . 1.6 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -1.1 . . . . 2.19 109.258 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -57.02 -47.29 81.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 3.14 109.394 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.016 -1.052 . . . . 3.58 109.676 179.817 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.824 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.129 -1.588 . . . . 0.3 109.129 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 79' ' ' GLY . 94.4 t -57.44 -47.42 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -1.193 . . . . 0.33 108.585 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . 0.558 ' O ' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -57.45 -46.75 83.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.535 -0.913 . . . . 1.83 108.535 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.82 82.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.208 -0.664 . . . . 0.31 109.208 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.09 86.59 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.662 -1.775 . . . . 0.26 108.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.793 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.0 -47.37 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -1.233 . . . . 0.31 108.592 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.558 HD12 ' O ' ' B' ' 81' ' ' MET . 3.9 mt -57.17 -46.74 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.409 -0.807 . . . . 1.06 109.736 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.39 -46.72 86.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.069 -1.612 . . . . 0.3 109.069 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.41 ' OG1' HG22 ' A' ' 84' ' ' VAL . 25.0 m -56.68 -46.75 80.97 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -1.139 . . . . 0.32 109.051 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.14 -47.3 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.41 109.951 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.31 -46.64 82.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.91 -1.119 . . . . 1.14 108.307 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' B' ' 90' ' ' LEU . 27.6 tp . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 2.02 109.013 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.412 -0.588 . . . . 1.02 109.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 80' ' ' VAL . 48.2 mt -57.04 -47.39 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.167 -1.013 . . . . 1.1 108.519 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.58 -47.54 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.482 -0.933 . . . . 1.58 108.482 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 2.09 109.583 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.812 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.19 -47.31 88.67 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.641 -1.384 . . . . 0.32 109.641 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 57.4 t -57.42 -47.65 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.124 -1.221 . . . . 0.28 108.89 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -47.37 82.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.413 -0.805 . . . . 1.7 109.112 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.64 83.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.718 . . . . 0.37 110.121 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.3 -47.37 88.35 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.251 -1.539 . . . . 0.28 109.251 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.26 -47.32 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.28 109.609 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.3 -47.39 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 1.2 110.004 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.35 -47.31 88.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.232 -1.547 . . . . 0.33 109.232 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG13 ' A' ' 91' ' ' ILE . 25.0 m -57.3 -47.01 82.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -1.039 . . . . 0.34 109.44 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.96 -47.25 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.49 109.596 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.11 -46.73 82.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.005 . . . . 0.68 108.745 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -57.29 -47.02 82.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 1.92 109.277 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.694 ' O ' HD12 ' A' ' 95' ' ' ILE . 66.4 mt -57.02 -47.12 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.87 109.805 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -57.01 -47.66 80.33 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.909 -1.119 . . . . 1.29 108.3 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.59 -47.56 81.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.854 . . . . 2.64 109.298 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.35 88.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 1.29 109.5 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mt -57.04 -47.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -1.071 . . . . 2.19 109.096 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -57.01 -47.2 81.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 3.14 109.459 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? . . . . . 0 C--N 1.3 -1.572 0 O-C-N 120.764 -1.21 . . . . 3.58 109.745 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.921 -1.272 . . . . 0.3 109.921 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.812 HG22 ' C ' ' A' ' 79' ' ' GLY . 40.4 t -57.5 -47.98 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.338 . . . . 0.33 108.898 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . 0.436 ' O ' HG12 ' B' ' 85' ' ' ILE . 1.4 mtt -57.77 -47.3 82.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.829 . . . . 1.83 109.139 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.44 82.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.703 -0.623 . . . . 0.31 110.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.5 86.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.072 -1.611 . . . . 0.26 109.072 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.45 -47.38 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -1.19 . . . . 0.31 109.375 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.436 HG12 ' O ' ' B' ' 81' ' ' MET . 45.5 mm -57.3 -47.23 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 1.06 109.989 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.98 -47.06 90.22 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.396 -1.482 . . . . 0.3 109.396 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 87' ' ' THR . 50.9 m -57.03 -47.0 81.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.168 -1.196 . . . . 0.32 109.174 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.92 -47.17 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.41 109.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.767 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -46.98 82.35 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.247 -0.908 . . . . 1.14 108.651 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' B' ' 89' ' ' LEU . 6.9 mp . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 2.02 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.204 -0.295 . . . . 1.02 110.204 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.0 mt -57.45 -48.1 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 1.1 109.69 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.547 HG13 ' N ' ' A' ' 78' ' ' PHE . 23.1 pt -57.95 -47.14 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.84 -1.162 . . . . 1.58 108.423 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -57.17 -46.92 82.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.652 . . . . 2.09 109.571 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.909 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.86 -47.4 86.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.651 -1.38 . . . . 0.32 109.651 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.871 HG22 ' C ' ' B' ' 79' ' ' GLY . 95.2 t -57.31 -47.63 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.951 -1.323 . . . . 0.28 108.738 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 mmt -57.72 -47.08 83.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 1.7 108.793 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.02 -46.28 82.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.666 -0.646 . . . . 0.37 109.82 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.45 86.42 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.182 -1.567 . . . . 0.28 109.182 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -57.27 -47.75 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.997 -1.296 . . . . 0.28 108.969 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.9 mt -57.5 -46.97 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 1.2 109.859 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.04 89.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.758 -1.337 . . . . 0.33 109.758 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.558 HG21 ' CG2' ' B' ' 87' ' ' THR . 95.7 m -56.86 -47.21 80.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.021 -1.282 . . . . 0.34 108.753 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -57.24 -47.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.49 108.565 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.73 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.487 -0.931 . . . . 0.68 108.487 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.78 -46.84 81.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.478 -0.764 . . . . 1.92 109.124 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.87 -46.84 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.87 109.031 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.462 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.7 m -56.95 -47.58 80.35 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.007 -1.058 . . . . 1.29 108.371 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.57 -47.72 81.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 2.64 109.05 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.08 90.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.362 -1.495 . . . . 1.29 109.362 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 95' ' ' ILE . 1.5 mm -57.06 -47.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.413 -1.051 . . . . 2.19 109.01 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 92' ' ' SER . 6.8 mtp180 -57.14 -47.19 81.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 3.14 109.438 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 3.58 109.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.871 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.123 -1.591 . . . . 0.3 109.123 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.909 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.7 t -57.37 -47.37 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -1.128 . . . . 0.33 108.79 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -46.95 83.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 1.83 109.41 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.94 -46.4 82.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.444 -0.785 . . . . 0.31 109.65 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.0 90.41 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.783 -1.727 . . . . 0.26 108.783 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.05 -47.21 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.11 . . . . 0.31 109.42 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.99 -47.32 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.051 -1.031 . . . . 1.06 109.779 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.19 89.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.378 -1.489 . . . . 0.3 109.378 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.558 ' CG2' HG21 ' A' ' 87' ' ' THR . 31.5 m -57.1 -46.93 82.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.091 . . . . 0.32 109.361 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.3 mt -56.92 -46.86 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.41 109.148 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.621 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -46.98 81.8 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.029 -1.1 . . . . 1.14 108.029 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.479 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 10.9 tp . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.351 -0.843 . . . . 2.02 109.118 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.681 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.64 -0.504 . . . . 1.02 109.64 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.3 mt -56.93 -47.85 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 1.1 108.975 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -57.79 -47.46 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 1.58 108.708 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.55 -47.39 82.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 2.09 110.119 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.873 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.25 -47.58 86.66 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.467 -1.453 . . . . 0.32 109.467 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.879 HG22 ' C ' ' B' ' 79' ' ' GLY . 87.7 t -57.65 -47.63 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.249 -1.148 . . . . 0.28 109.095 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -47.29 82.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 1.7 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.47 82.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.37 109.766 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.35 88.08 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.529 -1.428 . . . . 0.28 109.529 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.35 -47.58 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -1.228 . . . . 0.28 109.49 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 85' ' ' ILE . 43.0 mm -57.37 -47.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.934 . . . . 1.2 109.829 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.99 90.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.884 -1.287 . . . . 0.33 109.884 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 91' ' ' ILE . 82.1 m -56.99 -47.16 81.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.34 109.503 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 91' ' ' ILE . 56.2 mt -57.33 -47.28 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.49 109.321 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -46.95 82.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.68 109.208 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 38.5 tp -56.97 -47.01 81.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 1.92 109.466 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.896 ' O ' HG23 ' A' ' 95' ' ' ILE . 60.7 mt -56.92 -47.02 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.87 109.493 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -56.96 -47.56 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.033 -1.067 . . . . 1.29 108.804 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -47.51 81.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.948 -1.095 . . . . 2.64 109.325 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.51 87.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.406 -1.078 . . . . 1.29 110.406 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -57.28 -46.99 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.028 -1.278 . . . . 2.19 109.013 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' N ' ' CG1' ' A' ' 95' ' ' ILE . 14.7 mtm180 -57.01 -46.86 82.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 3.14 109.206 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? . . . . . 0 C--N 1.299 -1.622 0 O-C-N 120.998 -1.064 . . . . 3.58 109.716 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.879 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.669 -1.373 . . . . 0.3 109.669 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.873 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.5 t -57.62 -47.85 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.089 -1.242 . . . . 0.33 109.076 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 29.0 mtt -57.81 -47.43 82.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 1.83 109.103 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.34 83.1 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.719 -0.613 . . . . 0.31 109.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.55 85.78 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.393 -1.483 . . . . 0.26 109.393 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.38 -47.86 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.971 -1.311 . . . . 0.31 109.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.46 -47.2 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 1.06 109.718 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -57.07 -46.95 90.98 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.869 -1.292 . . . . 0.3 109.869 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 87' ' ' THR . 41.6 m -56.97 -47.43 80.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -1.214 . . . . 0.32 109.351 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.31 -47.47 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.41 108.938 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.4 -46.98 82.9 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 1.14 109.12 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.547 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 91.2 mt . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 2.02 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 75' ' ' LEU . 3.2 tt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.801 -0.444 . . . . 1.02 109.801 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.88 -1.138 . . . . 1.1 109.111 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -58.2 -47.82 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.58 109.122 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -57.62 -47.05 83.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.678 -0.639 . . . . 2.09 109.35 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.806 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.82 -47.17 88.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.884 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.2 t -57.16 -47.84 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.041 -1.27 . . . . 0.28 108.774 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.9 mtm -57.73 -47.21 83.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 1.7 108.93 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.14 -46.42 82.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.37 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.92 -47.26 88.18 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.204 -1.558 . . . . 0.28 109.204 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.3 -47.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.243 . . . . 0.28 109.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.0 mt -57.54 -47.16 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 1.2 109.858 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.07 89.42 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.714 -1.354 . . . . 0.33 109.714 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -56.99 -47.12 81.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.167 -1.196 . . . . 0.34 109.157 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.11 -47.15 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.49 109.133 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.689 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.15 -46.9 82.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.68 109.214 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.6 mt -57.02 -47.11 81.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 1.92 109.455 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 mt -57.2 -46.99 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.87 109.305 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 67.5 m -57.05 -47.41 81.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.231 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.24 -46.77 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.539 -0.725 . . . . 2.64 109.12 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.6 -46.25 88.91 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.496 -1.842 . . . . 1.29 108.496 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mt -56.32 -46.5 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -1.081 . . . . 2.19 108.833 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 92' ' ' SER . 10.6 mmt180 -56.66 -47.0 80.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.856 -1.152 . . . . 3.14 108.649 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 3.58 109.737 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.884 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.698 -1.361 . . . . 0.3 109.698 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.806 HG22 ' C ' ' A' ' 79' ' ' GLY . 95.8 t -57.56 -47.79 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.057 -1.261 . . . . 0.33 108.911 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mtm -57.74 -47.25 82.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.413 -0.804 . . . . 1.83 109.337 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.54 82.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.495 -0.753 . . . . 0.31 109.891 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.45 87.3 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.063 -1.615 . . . . 0.26 109.063 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.26 -47.41 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 0.31 109.437 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.4 -47.16 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 1.06 110.021 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.35 88.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.816 -1.314 . . . . 0.3 109.816 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 33.8 m -57.31 -47.36 81.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.13 -1.218 . . . . 0.32 109.226 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.28 -47.2 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.41 109.643 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.577 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -47.12 82.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 1.14 109.178 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 70.3 mt . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.965 . . . . 2.02 109.512 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.681 -0.488 . . . . 1.02 109.681 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.3 mt -57.43 -48.13 83.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.833 -1.167 . . . . 1.1 109.039 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 9.3 tt -58.06 -47.29 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.202 -0.936 . . . . 1.58 108.717 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.5 m-85 -57.39 -47.01 82.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.495 -0.753 . . . . 2.09 109.726 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.799 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.9 -47.29 87.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.504 -1.438 . . . . 0.32 109.504 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.2 t -57.41 -47.58 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.296 . . . . 0.28 108.703 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 85' ' ' ILE . 2.3 mmm -57.75 -47.07 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.85 . . . . 1.7 108.991 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.24 82.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.37 109.759 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.76 -47.3 86.66 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.04 -1.624 . . . . 0.28 109.04 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.457 HG13 ' OG1' ' B' ' 87' ' ' THR . 86.4 t -57.3 -47.63 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.1 -1.236 . . . . 0.28 109.356 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 81' ' ' MET . 26.5 mm -57.43 -47.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 1.2 109.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.14 -46.95 91.05 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.789 -1.324 . . . . 0.33 109.789 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.458 ' HA ' HD12 ' A' ' 90' ' ' LEU . 71.2 m -56.95 -47.42 80.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -1.199 . . . . 0.34 109.5 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.39 -47.56 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.49 109.273 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.65 -47.12 83.14 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.662 -0.866 . . . . 0.68 108.662 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 11.8 mt -57.26 -46.81 82.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 1.92 109.601 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.88 ' O ' HD12 ' A' ' 95' ' ' ILE . 42.4 mt -57.02 -47.13 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.87 109.75 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -57.11 -47.74 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.674 -1.21 . . . . 1.29 108.089 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -46.87 82.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.697 . . . . 2.64 109.25 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.54 -46.22 88.58 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.943 -1.663 . . . . 1.29 108.943 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.88 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -56.26 -46.78 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -1.119 . . . . 2.19 108.847 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 92' ' ' SER . 9.4 mmt180 -56.88 -47.16 81.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.888 -1.133 . . . . 3.14 108.726 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 3.58 109.935 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.907 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.763 -1.335 . . . . 0.3 109.763 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 79' ' ' GLY . 53.4 t -57.08 -47.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.987 -1.302 . . . . 0.33 108.697 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 36.3 mmm -57.74 -47.06 83.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 1.83 108.749 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.9 -46.25 82.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.64 -0.662 . . . . 0.31 109.777 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.57 -47.21 85.94 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.148 -1.581 . . . . 0.26 109.148 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.13 -47.51 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.021 -1.282 . . . . 0.31 109.171 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.26 -46.95 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 1.06 109.814 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -46.76 90.28 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.6 -1.4 . . . . 0.3 109.6 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 84' ' ' VAL . 63.0 m -56.71 -47.06 80.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.162 -1.199 . . . . 0.32 109.309 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.96 -47.24 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.41 109.022 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.17 -46.84 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 1.14 108.998 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.542 ' O ' HD13 ' B' ' 90' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.88 . . . . 2.02 109.312 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.7 0.286 . . . . 1.02 110.259 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 80' ' ' VAL . 72.3 mt -57.58 -48.24 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.676 -1.265 . . . . 1.1 109.457 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 78' ' ' PHE . 19.8 tt -58.28 -47.58 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 1.58 108.975 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 77' ' ' ILE . 8.9 m-30 -57.5 -47.11 82.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 2.09 109.812 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -57.1 -47.28 88.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.7 -1.36 . . . . 0.32 109.7 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.95 HG22 ' C ' ' B' ' 79' ' ' GLY . 56.4 t -57.37 -47.59 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.046 -1.267 . . . . 0.28 109.148 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -57.61 -47.1 83.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.7 109.323 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.42 82.54 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.514 -0.741 . . . . 0.37 109.892 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.34 87.27 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.371 -1.492 . . . . 0.28 109.371 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.8 t -57.1 -47.37 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.121 -1.223 . . . . 0.28 109.74 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.32 -46.91 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 1.2 110.008 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.05 90.46 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.849 -1.3 . . . . 0.33 109.849 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.66 ' CG2' HG21 ' B' ' 87' ' ' THR . 17.0 m -57.24 -47.3 81.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -1.214 . . . . 0.34 109.348 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.22 -47.08 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.49 109.208 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -46.8 82.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.68 109.108 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 32.3 mt -57.01 -47.06 81.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 1.92 109.672 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.926 ' O ' HD12 ' A' ' 95' ' ' ILE . 95.9 mt -57.16 -47.19 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.87 109.141 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.09 -47.43 81.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.212 -1.033 . . . . 1.29 108.212 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -57.47 -47.55 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 2.64 109.253 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.33 -47.25 89.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.266 -1.533 . . . . 1.29 109.266 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.08 -47.03 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.104 . . . . 2.19 108.677 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -57.05 -47.04 81.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 3.14 109.276 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 3.58 109.839 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.95 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.505 . . . . 0.3 109.336 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 79' ' ' GLY . 60.4 t -57.32 -47.64 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -1.234 . . . . 0.33 108.663 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.1 mmm -57.74 -47.04 83.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.424 -0.798 . . . . 1.83 108.968 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.08 -46.56 82.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.534 -0.729 . . . . 0.31 109.86 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.68 85.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.763 -1.735 . . . . 0.26 108.763 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.39 -47.61 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.31 108.931 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' B' ' 88' ' ' ILE . 80.1 mt -57.37 -47.0 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.82 . . . . 1.06 110.031 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.655 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -56.93 -47.21 88.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.626 -1.39 . . . . 0.3 109.626 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 87' ' ' THR . 78.5 m -57.28 -47.26 81.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.276 . . . . 0.32 108.588 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 85' ' ' ILE . 85.9 mt -57.23 -46.96 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.443 -0.786 . . . . 0.41 109.216 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -56.93 -46.47 82.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 1.14 109.25 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 2.02 108.893 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.04 -0.355 . . . . 1.02 110.04 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.7 mt -57.35 -48.35 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.719 -1.238 . . . . 1.1 110.116 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -58.23 -47.65 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.838 -1.164 . . . . 1.58 108.487 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' N ' HG23 ' A' ' 77' ' ' ILE . 4.4 m-30 -57.26 -47.08 82.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.804 -0.56 . . . . 2.09 109.965 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.781 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.91 -47.41 86.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.595 -1.402 . . . . 0.32 109.595 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.4 t -57.41 -47.66 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.254 . . . . 0.28 108.626 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.3 mmt -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.716 -0.846 . . . . 1.7 108.716 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.05 -46.32 82.52 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.634 -0.666 . . . . 0.37 109.839 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.52 85.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.838 -1.705 . . . . 0.28 108.838 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 61.6 t -57.39 -47.49 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.255 . . . . 0.28 108.908 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 82' ' ' ALA . 20.9 mt -57.2 -47.07 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.414 -0.804 . . . . 1.2 109.798 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.65 -46.92 88.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.546 -1.422 . . . . 0.33 109.546 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 m -56.97 -47.26 81.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.078 -1.248 . . . . 0.34 108.837 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.4 mt -57.23 -47.16 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.85 . . . . 0.49 109.184 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.2 -46.95 82.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.806 . . . . 0.68 109.017 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.48 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 18.2 mt -56.92 -46.89 81.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 1.92 109.074 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 95' ' ' ILE . 33.6 mt -56.85 -46.78 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.87 109.127 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.3 80.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.087 -1.008 . . . . 1.29 108.536 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -47.53 81.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 2.64 108.897 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.54 -47.15 90.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.172 -1.571 . . . . 1.29 109.172 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 91' ' ' ILE . 1.5 mt -57.02 -46.91 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -1.013 . . . . 2.19 109.142 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' NH2' ' HB2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -56.67 -46.62 81.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 3.14 109.079 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 120.94 -1.1 . . . . 3.58 109.205 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.776 -1.33 . . . . 0.3 109.776 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.781 HG22 ' C ' ' A' ' 79' ' ' GLY . 65.8 t -57.37 -47.57 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.002 -1.293 . . . . 0.33 109.065 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . 0.458 ' O ' HG13 ' B' ' 85' ' ' ILE . 4.7 mtm -57.62 -47.21 82.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.309 -0.869 . . . . 1.83 108.945 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.15 -46.39 82.76 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.546 -0.722 . . . . 0.31 109.913 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.56 86.15 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.476 -1.45 . . . . 0.26 109.476 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.38 -47.56 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.31 . . . . 0.31 109.004 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 82' ' ' ALA . 63.8 mt -57.33 -46.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 1.06 109.759 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.01 90.36 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.836 -1.306 . . . . 0.3 109.836 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 40.5 m -57.04 -47.44 80.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.973 -1.31 . . . . 0.32 108.918 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 35.1 mt -57.4 -46.98 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.41 108.803 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.675 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.59 82.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.029 -0.73 . . . . 1.14 109.029 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.613 ' O ' HD23 ' B' ' 90' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.238 -0.914 . . . . 2.02 109.145 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.546 ' HA ' HD23 ' A' ' 75' ' ' LEU . 1.4 mt . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.16 -0.682 . . . . 1.02 109.16 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.906 ' O ' HG23 ' A' ' 80' ' ' VAL . 26.8 mt -56.66 -47.68 81.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.059 -1.025 . . . . 1.1 108.899 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.8 mt -57.72 -47.88 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.091 -1.006 . . . . 1.58 109.338 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.92 -48.43 79.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 2.09 109.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.914 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.91 -47.34 89.56 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.104 -1.598 . . . . 0.32 109.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' O ' ' B' ' 79' ' ' GLY . 44.9 t -57.17 -47.26 84.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.708 -0.878 . . . . 0.28 109.934 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 mmm -57.16 -47.32 81.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 1.7 109.153 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.41 82.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.374 -0.829 . . . . 0.37 109.41 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.0 -47.1 90.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.936 -1.266 . . . . 0.28 109.936 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.15 -47.49 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.251 . . . . 0.28 109.619 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -57.29 -47.22 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 1.2 109.565 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.13 -46.9 91.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.97 -1.252 . . . . 0.33 109.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.631 ' OG1' HG13 ' B' ' 84' ' ' VAL . 74.7 m -56.88 -47.17 81.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -1.182 . . . . 0.34 109.209 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.14 -46.94 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.49 108.901 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.14 -46.74 82.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.68 109.066 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -56.85 -46.88 81.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 1.92 109.494 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.457 HG22 HD12 ' A' ' 95' ' ' ILE . 98.1 mt -57.03 -46.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.993 . . . . 0.87 108.905 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -47.39 81.2 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.093 -1.005 . . . . 1.29 108.399 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -57.3 -47.54 81.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 2.64 109.196 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.31 -46.98 91.2 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.036 -1.626 . . . . 1.29 109.036 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 91' ' ' ILE . 2.2 mt -57.05 -46.82 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 2.19 108.86 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -56.93 -47.07 81.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 3.14 109.291 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 3.58 109.891 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.907 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.914 HG22 ' O ' ' A' ' 79' ' ' GLY . 46.2 t -57.43 -47.14 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.644 -0.915 . . . . 0.33 109.733 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.5 mmt -56.95 -46.97 81.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 1.83 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.36 81.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.31 109.361 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.99 -47.16 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.618 -1.393 . . . . 0.26 109.618 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 80' ' ' VAL . 5.3 t -57.02 -47.52 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.283 . . . . 0.31 109.241 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.27 -47.07 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.06 109.669 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.08 89.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.425 -1.47 . . . . 0.3 109.425 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -57.14 -47.07 82.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -1.156 . . . . 0.32 108.975 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.41 HG13 ' O ' ' B' ' 84' ' ' VAL . 37.1 mt -57.11 -47.03 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.41 109.14 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.701 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.81 -46.95 81.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.307 -0.871 . . . . 1.14 109.0 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.522 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 6.7 mt . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 2.02 109.06 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.908 -0.405 . . . . 1.02 109.908 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 80' ' ' VAL . 61.6 mt -57.11 -47.7 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.909 -1.119 . . . . 1.1 108.754 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 1.1 mp -57.66 -47.11 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.327 -0.99 . . . . 1.58 108.327 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.24 -47.28 81.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 2.09 109.83 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.859 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.06 -47.38 87.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.178 -1.569 . . . . 0.32 109.178 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 48.4 t -57.59 -47.5 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -1.162 . . . . 0.28 109.238 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 85.0 mtp -57.63 -47.35 82.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 1.7 109.303 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.53 82.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.37 109.876 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.99 -47.42 87.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.529 -1.429 . . . . 0.28 109.529 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.28 -47.48 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 0.28 109.495 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 85' ' ' ILE . 33.4 mm -57.28 -47.41 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 1.2 110.081 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -57.24 -47.19 89.66 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.33 109.642 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 90' ' ' LEU . 98.1 m -57.16 -47.14 81.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -1.194 . . . . 0.34 109.537 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.4 mt -56.97 -47.23 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.49 109.536 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.18 -46.55 82.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.159 -0.963 . . . . 0.68 109.044 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 87' ' ' THR . 8.7 mt -57.13 -47.0 82.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 1.92 109.461 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.86 -47.16 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.87 109.453 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.4 m -57.16 -47.69 80.55 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.922 -1.111 . . . . 1.29 108.487 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -47.48 82.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.071 -1.018 . . . . 2.64 109.611 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.36 88.77 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.16 -1.176 . . . . 1.29 110.16 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 92' ' ' SER . 1.5 tp -57.07 -46.95 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -1.227 . . . . 2.19 108.983 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 19.2 mtp180 -56.87 -46.82 81.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 3.14 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.475 0 O-C-N 120.867 -1.146 . . . . 3.58 109.365 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.525 -1.43 . . . . 0.3 109.525 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' C ' ' A' ' 79' ' ' GLY . 69.7 t -57.1 -47.67 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.24 . . . . 0.33 109.189 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . 0.461 ' O ' HG13 ' B' ' 85' ' ' ILE . 63.6 mtm -57.57 -47.22 82.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 1.83 108.95 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.26 82.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.616 -0.678 . . . . 0.31 109.672 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.22 86.31 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.26 109.34 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.02 -47.47 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -1.234 . . . . 0.31 109.191 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 81' ' ' MET . 30.7 mt -57.27 -47.12 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 1.06 109.633 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.95 90.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.663 -1.375 . . . . 0.3 109.663 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.504 HG21 ' CG2' ' A' ' 87' ' ' THR . 41.4 m -56.93 -47.03 81.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -1.197 . . . . 0.32 109.37 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 91.7 mt -57.06 -47.08 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.088 -1.008 . . . . 0.41 108.724 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.04 -46.77 82.15 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.363 -0.977 . . . . 1.14 108.363 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 94.6 mt . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 2.02 109.154 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HA ' HD23 ' A' ' 75' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.277 -0.638 . . . . 1.02 109.277 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 80' ' ' VAL . 26.7 mt -57.14 -47.91 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 118.868 -1.133 . . . . 1.1 108.579 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -58.12 -47.92 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.474 -0.89 . . . . 1.58 109.336 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -57.86 -47.84 81.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.329 -0.857 . . . . 2.09 110.029 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.866 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.41 88.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.32 109.908 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 ' O ' ' B' ' 79' ' ' GLY . 48.7 t -57.25 -47.3 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -1.128 . . . . 0.28 109.037 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.1 mmm -57.41 -47.32 82.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.7 108.72 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.29 -46.68 82.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -0.797 . . . . 0.37 109.749 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.747 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.22 -47.35 88.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.376 -1.49 . . . . 0.28 109.376 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.35 -47.26 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -1.172 . . . . 0.28 109.644 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.2 OUTLIER -57.09 -47.17 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 1.2 109.599 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.03 -47.16 89.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.28 -1.528 . . . . 0.33 109.28 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.0 m -57.17 -46.96 82.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -1.105 . . . . 0.34 109.158 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.05 -47.0 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.49 109.11 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -47.02 81.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.68 108.985 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.548 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tp -57.17 -47.24 81.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.187 -0.946 . . . . 1.92 109.285 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 95' ' ' ILE . 91.6 mt -57.24 -47.29 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.87 109.374 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.8 m -57.26 -47.57 81.07 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.073 -1.017 . . . . 1.29 108.603 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.51 -47.68 81.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 2.64 109.387 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.42 -47.5 87.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.623 . . . . 1.29 109.041 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.4 -47.36 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -1.073 . . . . 2.19 108.841 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -57.21 -47.06 82.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.865 . . . . 3.14 109.55 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 . . . . . 0 C--N 1.299 -1.589 0 O-C-N 120.995 -1.065 . . . . 3.58 109.743 -179.794 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.487 2.041 0 N-CA-C 109.301 -1.519 . . . . 0.3 109.301 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 79' ' ' GLY . 26.0 t -57.2 -47.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.498 -1.001 . . . . 0.33 109.704 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 3.4 mtm -57.3 -47.3 81.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 1.83 109.576 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.91 82.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.31 109.72 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.47 -47.31 89.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.646 -1.382 . . . . 0.26 109.646 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.24 -47.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.157 . . . . 0.31 109.668 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 87.4 mt -57.32 -47.22 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.176 -0.952 . . . . 1.06 110.027 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.33 88.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.648 -1.381 . . . . 0.3 109.648 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 73.5 m -57.47 -47.29 82.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -1.215 . . . . 0.32 109.326 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.8 mt -57.41 -47.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.41 109.649 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.84 82.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.412 -0.805 . . . . 1.14 109.216 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 2.02 109.212 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.392 -0.596 . . . . 1.02 109.392 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 80' ' ' VAL . 25.3 mt -56.89 -47.57 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.947 -1.095 . . . . 1.1 108.696 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -57.78 -47.77 85.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.46 -0.896 . . . . 1.58 109.448 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -57.7 -48.08 80.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 2.09 109.495 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.859 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.66 -47.61 87.24 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.07 -1.612 . . . . 0.32 109.07 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.889 HG22 ' O ' ' B' ' 79' ' ' GLY . 43.3 t -57.43 -47.19 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.567 -0.96 . . . . 0.28 109.148 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmm -57.13 -46.9 82.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.37 -0.831 . . . . 1.7 109.074 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.81 -46.23 81.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 0.37 109.314 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.493 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.76 -46.98 89.06 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.314 -1.514 . . . . 0.28 109.314 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.566 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.4 t -56.88 -47.22 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.031 -1.276 . . . . 0.28 109.202 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 82' ' ' ALA . 75.3 mt -57.1 -46.93 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.159 -0.963 . . . . 1.2 109.354 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.84 91.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.33 109.703 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.705 ' OG1' HG13 ' B' ' 84' ' ' VAL . 92.8 m -56.78 -47.46 80.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -1.199 . . . . 0.34 109.068 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.23 -47.11 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.49 108.781 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -46.71 82.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.5 -0.75 . . . . 0.68 108.987 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.483 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 16.8 tp -56.66 -47.02 80.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 1.92 109.463 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 95' ' ' ILE . 57.2 mt -57.03 -47.11 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.043 -1.035 . . . . 0.87 108.408 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.571 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -57.14 -47.23 81.64 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.348 -0.982 . . . . 1.29 108.348 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.92 80.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.956 -1.09 . . . . 2.64 109.344 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.09 -48.2 84.43 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.941 -1.123 . . . . 1.29 110.557 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 92' ' ' SER . 2.8 tp -57.71 -47.02 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.064 -1.256 . . . . 2.19 109.145 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 92' ' ' SER . 8.1 mtm180 -56.95 -47.05 81.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.858 . . . . 3.14 109.429 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.07 -1.019 . . . . 3.58 109.481 -179.827 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.889 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.154 -1.578 . . . . 0.3 109.154 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 79' ' ' GLY . 40.9 t -57.37 -47.22 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -1.013 . . . . 0.33 109.578 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.8 mmm -56.97 -47.04 81.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 1.83 108.946 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.554 -0.716 . . . . 0.31 109.298 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.581 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.81 -47.12 88.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.743 -1.343 . . . . 0.26 109.743 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.705 HG13 ' OG1' ' A' ' 87' ' ' THR . 30.1 t -57.1 -47.46 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.387 . . . . 0.31 109.078 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -57.11 -46.95 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 1.06 109.347 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -56.85 -46.87 89.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.811 -1.316 . . . . 0.3 109.811 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.566 ' OG1' HG13 ' A' ' 84' ' ' VAL . 31.7 m -56.65 -47.32 80.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.262 . . . . 0.32 109.193 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' B' ' 88' ' ' ILE . 14.0 mt -57.21 -47.14 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.039 -1.038 . . . . 0.41 108.944 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.669 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.05 -46.83 82.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.511 -0.743 . . . . 1.14 109.306 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.531 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 87.6 mt . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.95 . . . . 2.02 109.459 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.593 -0.521 . . . . 1.02 109.593 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.91 -47.51 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 118.854 -1.139 . . . . 1.1 108.262 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.7 mt -57.57 -47.33 85.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.524 -0.917 . . . . 1.58 108.524 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.3 -46.98 82.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 2.09 109.528 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.891 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.05 -47.42 87.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.885 -1.686 . . . . 0.32 108.885 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.908 HG22 ' C ' ' B' ' 79' ' ' GLY . 88.7 t -57.48 -47.61 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -1.189 . . . . 0.28 108.541 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -47.15 83.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.555 -0.716 . . . . 1.7 109.532 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.16 -46.76 82.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 0.37 109.98 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.4 88.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.491 -1.843 . . . . 0.28 108.491 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' ILE . 58.1 t -57.48 -47.5 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.459 -1.024 . . . . 0.28 110.252 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -57.33 -47.53 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 1.2 110.153 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.38 -47.6 86.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.599 . . . . 0.33 109.101 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.6 m -57.58 -46.91 83.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.46 -1.024 . . . . 0.34 109.175 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 84' ' ' VAL . 19.3 mt -56.86 -47.07 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.497 -0.752 . . . . 0.49 109.621 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.15 -46.78 82.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 0.68 109.015 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 28.3 mt -57.47 -47.31 82.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.007 -1.058 . . . . 1.92 109.27 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.897 ' O ' HD12 ' A' ' 95' ' ' ILE . 70.1 mt -57.32 -47.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.803 . . . . 0.87 109.686 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -47.63 80.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.092 -1.005 . . . . 1.29 108.817 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.61 -47.66 81.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.127 -0.983 . . . . 2.64 109.391 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.63 -47.57 87.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.435 . . . . 1.29 109.511 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.32 -47.23 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -1.108 . . . . 2.19 108.956 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -57.13 -47.19 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 3.14 109.565 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 3.58 109.912 -179.768 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.908 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.579 -1.408 . . . . 0.3 109.579 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.891 HG22 ' C ' ' A' ' 79' ' ' GLY . 44.5 t -57.19 -47.72 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.895 -1.356 . . . . 0.33 108.938 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -47.31 83.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.197 -0.939 . . . . 1.83 108.928 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.7 83.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.31 110.151 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.34 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.359 -1.496 . . . . 0.26 109.359 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.24 -47.3 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.31 109.559 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -57.27 -47.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 1.06 110.364 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.21 -47.42 87.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.333 -1.507 . . . . 0.3 109.333 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 87' ' ' THR . 50.7 m -57.34 -46.97 82.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.246 -1.149 . . . . 0.32 108.904 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 mt -56.92 -46.77 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.573 -0.704 . . . . 0.41 109.792 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.72 -46.79 81.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 1.14 109.006 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 2.02 108.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.063 HD23 ' N ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 110.024 -0.361 . . . . 1.02 110.024 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 1.063 ' N ' HD23 ' A' ' 75' ' ' LEU . 44.2 mt -57.66 -48.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.413 -1.429 . . . . 1.1 109.265 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -58.27 -46.74 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.147 -1.057 . . . . 1.58 108.147 177.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' N ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -56.94 -46.87 81.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.683 -0.636 . . . . 2.09 109.898 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.712 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.38 86.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.257 -1.537 . . . . 0.32 109.257 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.975 HG22 ' C ' ' B' ' 79' ' ' GLY . 39.3 t -57.36 -47.56 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.281 . . . . 0.28 108.557 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.64 -46.88 83.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.7 109.323 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.91 -46.42 81.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.58 -0.7 . . . . 0.37 109.75 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.29 87.79 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.801 -1.72 . . . . 0.28 108.801 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' B' ' 87' ' ' THR . 60.6 t -57.32 -47.34 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.143 -1.21 . . . . 0.28 109.179 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.7 mt -57.32 -47.01 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 1.2 109.883 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.04 90.04 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.738 -1.345 . . . . 0.33 109.738 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.637 ' HA ' HD12 ' A' ' 90' ' ' LEU . 37.2 m -57.09 -47.15 81.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -1.18 . . . . 0.34 109.121 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.849 . . . . 0.49 109.538 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.03 -47.02 81.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.68 109.38 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.637 HD12 ' HA ' ' A' ' 87' ' ' THR . 6.2 mt -56.94 -47.05 81.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 1.92 109.337 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 95' ' ' ILE . 63.6 mt -57.03 -47.09 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.87 109.356 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.39 80.84 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.026 -1.046 . . . . 1.29 108.576 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -57.41 -47.25 82.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.24 -0.913 . . . . 2.64 109.387 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.22 -47.34 88.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.014 -1.634 . . . . 1.29 109.014 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.12 -47.01 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -1.126 . . . . 2.19 108.786 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -56.9 -47.07 81.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.828 . . . . 3.14 109.333 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 3.58 109.698 179.915 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.975 ' C ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.605 -1.398 . . . . 0.3 109.605 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 79' ' ' GLY . 86.0 t -57.74 -47.67 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.286 . . . . 0.33 108.928 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 43.5 mtm -57.72 -47.13 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 1.83 109.664 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.41 82.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.31 110.035 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.51 86.76 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.228 -1.549 . . . . 0.26 109.228 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.415 ' O ' HG13 ' B' ' 88' ' ' ILE . 48.5 t -57.46 -47.53 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -1.185 . . . . 0.31 109.451 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 85' ' ' ILE . 30.6 mt -57.33 -47.16 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 1.06 110.177 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.31 87.38 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.296 . . . . 0.3 109.859 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 84' ' ' VAL . 19.3 m -57.23 -47.27 81.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -1.225 . . . . 0.32 109.256 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 84' ' ' VAL . 49.4 mt -57.44 -47.23 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.809 . . . . 0.41 109.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.589 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.21 -46.99 82.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 1.14 109.534 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 40.4 tp . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.182 -0.949 . . . . 2.02 109.509 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 75' ' ' LEU . 5.0 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.826 -0.805 . . . . 1.02 108.826 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.664 ' O ' HG23 ' A' ' 80' ' ' VAL . 35.6 mt -56.79 -47.69 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 118.899 -1.121 . . . . 1.1 108.155 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 77' ' ' ILE . 2.5 mm -57.85 -47.62 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.58 108.857 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -57.57 -47.89 80.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.341 -0.85 . . . . 2.09 109.968 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.868 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.45 88.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.389 -1.484 . . . . 0.32 109.389 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.724 HG22 ' O ' ' B' ' 79' ' ' GLY . 41.8 t -57.34 -47.36 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.366 -1.079 . . . . 0.28 109.121 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.734 ' O ' HD12 ' A' ' 85' ' ' ILE . 16.9 mtp -57.44 -47.21 82.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 1.7 108.966 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.41 83.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.546 -0.721 . . . . 0.37 109.311 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.691 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.1 -47.14 89.86 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.325 -1.51 . . . . 0.28 109.325 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.17 -47.64 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -1.217 . . . . 0.28 109.16 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' O ' ' A' ' 81' ' ' MET . 1.9 mt -57.42 -47.15 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 1.2 109.373 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -57.12 -47.27 88.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.756 -1.338 . . . . 0.33 109.756 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.6 m -57.21 -47.51 81.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -1.21 . . . . 0.34 109.042 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.48 -47.37 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.49 109.329 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -47.0 82.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.456 -0.777 . . . . 0.68 109.363 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 86' ' ' GLY . 4.7 mp -57.07 -47.06 81.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.92 109.204 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 95' ' ' ILE . 78.8 mt -57.16 -47.13 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.87 109.629 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -57.1 -47.59 80.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.164 -1.014 . . . . 1.29 108.823 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -57.86 -48.1 80.79 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.772 -1.205 . . . . 2.64 109.493 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.05 -48.26 83.92 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.064 -1.065 . . . . 1.29 110.668 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -57.63 -46.89 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -1.224 . . . . 2.19 109.373 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 mtm180 -57.18 -47.31 81.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 3.14 109.592 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 3.58 110.212 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.724 ' O ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 109.307 -1.517 . . . . 0.3 109.307 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 79' ' ' GLY . 33.2 t -56.93 -47.27 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -1.051 . . . . 0.33 109.571 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 56.6 mmm -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.03 -1.044 . . . . 1.83 108.722 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.17 82.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.435 -0.79 . . . . 0.31 109.076 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.77 -46.76 89.37 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.26 109.454 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 88' ' ' ILE . 54.7 t -56.92 -47.25 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.256 . . . . 0.31 109.336 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.2 -46.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 1.06 109.419 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.531 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.11 -46.85 91.12 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 0.3 109.465 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 14.2 m -56.76 -47.17 80.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -1.155 . . . . 0.32 109.004 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.451 HG13 ' O ' ' B' ' 84' ' ' VAL . 51.0 mt -57.08 -46.98 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.41 109.019 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.726 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.99 -46.45 82.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.403 -0.811 . . . . 1.14 109.156 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 23.3 tp . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 2.02 108.961 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.423 -0.584 . . . . 1.02 109.423 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 80' ' ' VAL . 54.6 mt -57.42 -48.29 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.798 -1.161 . . . . 1.1 109.309 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 78' ' ' PHE . 3.9 tt -58.17 -47.43 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.914 -1.116 . . . . 1.58 108.787 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.559 ' N ' HG23 ' A' ' 77' ' ' ILE . 1.6 m-30 -57.23 -46.79 82.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.524 -0.735 . . . . 2.09 109.557 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.836 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -56.81 -47.04 89.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.629 -1.389 . . . . 0.32 109.629 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' B' ' 79' ' ' GLY . 26.3 t -56.91 -47.59 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.979 -1.306 . . . . 0.28 108.566 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 85' ' ' ILE . 59.0 mtp -57.51 -46.92 83.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.433 -0.951 . . . . 1.7 108.433 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.88 81.69 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.748 -0.595 . . . . 0.37 109.616 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.99 85.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.08 -1.608 . . . . 0.28 109.08 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.98 -47.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.347 . . . . 0.28 108.8 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 81' ' ' MET . 64.3 mt -57.16 -46.83 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 1.2 109.528 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.67 89.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.33 109.536 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.574 HG21 ' CG2' ' B' ' 87' ' ' THR . 22.5 m -56.69 -46.95 80.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.225 . . . . 0.34 109.001 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 91' ' ' ILE . 62.6 mt -57.1 -46.9 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 0.49 109.073 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.98 -46.66 82.07 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.399 -0.813 . . . . 0.68 109.012 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' HG ' ' A' ' 89' ' ' LEU . 5.3 mp -56.69 -47.0 80.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -0.856 . . . . 1.92 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 88' ' ' ILE . 68.3 mt -56.93 -47.12 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.093 -1.004 . . . . 0.87 109.261 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.7 p -57.16 -47.58 80.84 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.441 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -47.45 82.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.17 -0.956 . . . . 2.64 109.341 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.31 89.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.905 -1.278 . . . . 1.29 109.905 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -57.25 -47.06 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.235 . . . . 2.19 108.939 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 9.1 mtm180 -57.06 -47.04 81.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 3.14 109.209 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.248 -0.908 . . . . 3.58 109.964 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 80' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 108.754 -1.739 . . . . 0.3 108.754 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.836 HG22 ' CA ' ' A' ' 79' ' ' GLY . 40.1 t -57.35 -47.5 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.191 -1.182 . . . . 0.33 108.698 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.6 -47.0 83.34 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.83 . . . . 1.83 109.193 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.716 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -56.98 -46.68 82.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.31 109.815 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.49 87.1 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.605 -1.798 . . . . 0.26 108.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.421 HG13 ' OG1' ' A' ' 87' ' ' THR . 43.2 t -57.53 -47.3 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -1.1 . . . . 0.31 109.203 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' B' ' 82' ' ' ALA . 38.9 mt -57.25 -47.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 1.06 109.904 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.29 88.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.229 -1.548 . . . . 0.3 109.229 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.574 ' CG2' HG21 ' A' ' 87' ' ' THR . 73.8 m -57.34 -47.09 82.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -1.092 . . . . 0.32 109.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' B' ' 88' ' ' ILE . 57.4 mt -57.13 -47.1 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 0.41 109.694 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.695 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -47.33 81.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 1.14 109.168 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . 0.546 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.02 108.871 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 62' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.457 -0.572 . . . . 18.74 109.457 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 30.9 tp60 -104.98 14.14 29.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 16.78 109.55 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.11 -165.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 16.71 109.533 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.0 31.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 14.32 109.415 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 67' ' ' HIS . 32.3 m80 -157.06 -179.61 8.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 14.47 109.306 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER 170.12 -53.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 11.15 109.903 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 69' ' ' SER . 4.6 m-85 -67.47 147.14 53.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 11.57 109.949 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.1 p 51.29 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 7.08 109.99 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -122.12 94.32 48.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 6.49 109.216 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.619 ' HB2' HG23 ' A' ' 74' ' ' THR . 2.5 Cg_endo -60.43 104.91 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.091 1.861 . . . . 2.65 110.479 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -53.07 -39.19 63.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 3.01 109.211 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' N ' ' A' ' 74' ' ' THR . 5.4 tp -64.02 -45.2 97.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.206 -0.934 . . . . 1.48 109.813 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 71' ' ' PRO . 45.4 p -57.0 -46.92 81.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 1.35 109.563 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.003 HD13 HD13 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -67.12 -47.37 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.033 . . . . 1.02 109.546 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.013 HD13 HD13 ' B' ' 75' ' ' LEU . 85.8 mt -57.3 -47.63 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.896 -1.127 . . . . 1.1 108.213 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.71 -47.2 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.64 -0.874 . . . . 1.58 108.64 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -56.94 -47.14 81.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.601 -0.687 . . . . 2.09 109.468 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.886 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.02 -47.43 87.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.991 -1.644 . . . . 0.32 108.991 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 60.9 t -57.48 -47.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -1.234 . . . . 0.28 108.708 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.447 ' O ' HG12 ' A' ' 85' ' ' ILE . 7.0 mtt -57.54 -46.99 83.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 1.7 109.393 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.96 -46.6 82.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.414 -0.804 . . . . 0.37 109.722 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.42 87.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.744 -1.742 . . . . 0.28 108.744 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -47.16 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -1.096 . . . . 0.28 109.317 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 81' ' ' MET . 21.6 mm -57.06 -47.15 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 1.2 110.038 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.37 88.08 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.297 -1.521 . . . . 0.33 109.297 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.437 ' OG1' HG13 ' B' ' 84' ' ' VAL . 91.6 m -57.45 -47.19 82.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -1.145 . . . . 0.34 109.065 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' A' ' 91' ' ' ILE . 34.5 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.49 109.43 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -56.98 -47.05 81.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.241 -0.912 . . . . 0.68 108.722 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 15.2 tp -57.21 -47.17 81.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 1.92 108.928 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.904 HD11 HD11 ' B' ' 91' ' ' ILE . 81.7 mt -57.28 -46.91 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.87 109.578 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 95' ' ' ILE . 51.0 m -56.93 -47.5 80.46 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.157 -1.017 . . . . 1.29 108.873 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.56 -47.72 81.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 2.64 109.18 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.67 -47.35 89.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.593 -1.403 . . . . 1.29 109.593 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 92' ' ' SER . 2.1 tp -57.18 -46.81 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.384 -1.069 . . . . 2.19 109.212 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 99' ' ' ILE . 16.7 mtm180 -56.68 -46.6 81.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.897 . . . . 3.14 109.09 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -46.78 82.39 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.776 -1.203 . . . . 3.58 109.201 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -46.96 81.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 2.66 109.564 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 96' ' ' ARG . 2.1 pt -82.55 -112.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 2.2 109.109 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER 47.63 -174.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.777 -1.202 . . . . 3.91 109.575 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.011 -0.995 . . . . 6.53 109.525 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.706 ' O ' HG13 ' B' ' 62' ' ' VAL . 12.0 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.486 -0.561 . . . . 20.22 109.486 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -64.87 146.0 55.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 18.1 109.364 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' B' ' 64' ' ' LEU . 5.6 tp -137.73 6.95 2.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 17.47 109.623 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' B' ' 66' ' ' HIS . . . -80.24 -13.31 59.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 15.58 109.548 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.497 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 1.9 t60 77.93 114.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.354 -0.842 . . . . 14.18 109.645 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' B' ' 66' ' ' HIS . 0.2 OUTLIER 168.2 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 13.39 109.436 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -141.98 -88.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 12.43 109.52 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' B' ' 75' ' ' LEU . 64.9 m -88.08 105.96 17.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 8.12 109.467 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 0.8 OUTLIER -68.15 -55.04 13.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 7.29 109.98 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.643 ' HG2' HG21 ' B' ' 74' ' ' THR . 5.0 Cg_exo -60.08 156.61 38.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.96 1.773 . . . . 2.87 110.537 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' B' ' 73' ' ' ILE . 1.6 mt-10 -66.3 -73.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 2.89 109.809 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.5 OUTLIER -39.57 -41.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.459 -0.776 . . . . 2.11 110.184 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.643 HG21 ' HG2' ' B' ' 71' ' ' PRO . 2.0 p -61.38 -46.63 89.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.57 109.433 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.013 HD13 HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -74.11 -47.34 36.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.63 109.97 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 75' ' ' LEU . 64.0 mt -57.56 -48.45 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.702 -1.248 . . . . 1.02 109.492 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.555 HG23 ' N ' ' B' ' 78' ' ' PHE . 0.8 OUTLIER -58.25 -47.21 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 1.86 108.66 178.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.555 ' N ' HG23 ' B' ' 77' ' ' ILE . 2.0 m-85 -57.27 -46.71 82.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.655 -0.653 . . . . 2.81 109.51 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.66 -47.02 88.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.328 -1.509 . . . . 0.3 109.328 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.886 HG22 ' C ' ' A' ' 79' ' ' GLY . 87.7 t -57.1 -47.76 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.295 . . . . 0.33 108.681 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . 0.516 ' HE2' ' HA ' ' B' ' 78' ' ' PHE . 61.3 mtm -57.67 -47.31 82.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 1.83 108.654 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.2 -46.16 83.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.72 -0.613 . . . . 0.31 109.835 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.67 -47.3 86.03 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.302 -1.519 . . . . 0.26 109.302 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.437 HG13 ' OG1' ' A' ' 87' ' ' THR . 58.0 t -57.18 -47.58 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.99 -1.3 . . . . 0.31 108.993 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 82' ' ' ALA . 48.0 mt -57.4 -47.1 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.301 -0.874 . . . . 1.06 109.866 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.91 -47.08 89.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.745 -1.342 . . . . 0.3 109.745 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 25.2 m -57.03 -47.15 81.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.161 -1.199 . . . . 0.32 109.115 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.11 -47.02 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.41 109.169 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.08 -46.8 82.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 1.14 108.963 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.529 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 27.1 tp -56.9 -47.14 81.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.231 -0.918 . . . . 2.02 109.538 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.904 HD11 HD11 ' A' ' 91' ' ' ILE . 86.6 mt -57.09 -47.35 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.13 -0.981 . . . . 0.77 109.454 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.1 -47.52 80.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.084 -1.047 . . . . 1.53 108.347 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -47.44 81.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.405 -0.81 . . . . 2.25 109.307 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.46 87.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.251 -1.539 . . . . 1.24 109.251 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.824 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mp -57.21 -47.09 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -1.104 . . . . 1.81 108.86 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -57.17 -46.74 82.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.85 . . . . 2.69 109.639 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.51 -47.19 79.84 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.762 -1.199 . . . . 3.17 107.762 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.813 ' O ' HD12 ' B' ' 99' ' ' ILE . 3.9 mt -57.26 -46.43 83.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.829 -1.174 . . . . 2.09 107.829 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.813 HD12 ' O ' ' B' ' 98' ' ' LEU . 3.6 mt 94.28 102.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-O 121.761 0.791 . . . . 2.5 109.362 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 101' ' ' LYS . 2.1 tttt -84.94 124.86 32.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.641 -0.662 . . . . 5.22 109.646 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 18.0 mmtp . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.938 -1.03 . . . . 7.38 109.374 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.544 -0.539 . . . . 18.74 109.544 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 179.89 143.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 16.78 109.541 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -79.69 -53.46 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 16.71 109.443 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 64.15 60.5 0.98 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.308 -0.87 . . . . 14.32 109.301 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -42.99 -61.46 1.29 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 14.47 109.536 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -152.35 74.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 11.15 109.583 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.74 84.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 11.57 109.301 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' HIS . 85.4 p -104.06 -152.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.183 -0.948 . . . . 7.08 109.753 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.579 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.68 -55.38 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.388 -0.82 . . . . 6.49 109.339 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 3.8 Cg_exo -58.12 83.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.895 1.73 . . . . 2.65 109.839 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' GLU . 4.4 mt-10 -67.51 -72.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.841 . . . . 3.01 109.918 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -52.22 -37.98 23.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.098 -1.002 . . . . 1.48 109.421 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.703 ' N ' HD13 ' A' ' 73' ' ' ILE . 16.5 m -61.16 -46.96 88.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 1.35 108.972 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.089 HD13 ' CD1' ' B' ' 76' ' ' ILE . 0.3 OUTLIER -67.71 -46.62 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.821 . . . . 1.02 109.194 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.053 HD13 HD13 ' B' ' 75' ' ' LEU . 51.1 mt -56.75 -47.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.981 -1.074 . . . . 1.1 108.668 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' ILE . 37.8 mt -57.5 -47.3 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.243 -0.911 . . . . 1.58 108.556 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -57.37 -47.0 82.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.702 -0.624 . . . . 2.09 109.462 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.844 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.22 88.32 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.685 -1.366 . . . . 0.32 109.685 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.881 HG22 ' C ' ' B' ' 79' ' ' GLY . 62.0 t -57.29 -47.81 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.935 -1.332 . . . . 0.28 108.8 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 mtm -57.72 -47.31 82.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 1.7 108.729 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.15 82.92 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.662 -0.649 . . . . 0.37 109.738 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.6 -47.31 85.41 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.258 -1.537 . . . . 0.28 109.258 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 93.3 t -57.23 -47.55 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.284 . . . . 0.28 109.033 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.29 -46.95 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.2 109.478 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -46.7 90.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.329 -1.509 . . . . 0.33 109.329 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.445 ' OG1' HG13 ' B' ' 84' ' ' VAL . 98.0 m -56.77 -47.04 81.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.253 -1.145 . . . . 0.34 109.013 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 91' ' ' ILE . 96.4 mt -57.2 -47.3 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.49 108.826 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.696 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.24 -46.83 82.62 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.478 -0.934 . . . . 0.68 108.478 179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 39.1 tp -57.01 -46.81 82.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 1.92 109.14 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.643 HD11 HD11 ' B' ' 91' ' ' ILE . 87.7 mt -56.78 -46.99 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.185 -0.947 . . . . 0.87 109.326 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -47.6 80.01 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.021 -1.072 . . . . 1.29 108.2 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -57.5 -47.43 81.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.318 -0.863 . . . . 2.64 108.953 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.17 89.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.366 -1.494 . . . . 1.29 109.366 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.09 -47.32 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -1.127 . . . . 2.19 108.63 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' HA ' HD11 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -57.31 -47.01 82.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 3.14 108.833 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.27 -47.07 82.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 3.58 109.806 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.9 mt -56.96 -46.84 81.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.029 -1.045 . . . . 2.66 109.161 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 96' ' ' ARG . 18.6 pt -74.99 -45.88 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 2.2 110.12 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -128.71 166.56 18.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 3.91 109.902 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 6.9 mmtm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.024 -0.989 . . . . 6.53 109.465 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.241 0.543 . . . . 20.22 109.556 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.461 ' NE2' ' O ' ' B' ' 64' ' ' LEU . 0.4 OUTLIER -131.42 38.39 3.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 18.1 109.57 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.464 HD23 ' N ' ' B' ' 65' ' ' ALA . 0.5 OUTLIER 67.71 159.23 0.15 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.402 -0.811 . . . . 17.47 109.572 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.464 ' N ' HD23 ' B' ' 64' ' ' LEU . . . -165.87 68.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 15.58 109.429 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.6 m80 55.86 62.09 2.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 14.18 109.396 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -15.18 62.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.83 . . . . 13.39 109.579 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -71.65 167.75 19.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 12.43 109.666 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' B' ' 70' ' ' GLU . 0.3 OUTLIER -150.57 -152.33 0.43 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 8.12 109.308 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' B' ' 72' ' ' GLU . 0.0 OUTLIER 73.34 98.23 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 7.29 109.53 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.28 58.48 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.369 2.046 . . . . 2.87 110.345 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' B' ' 70' ' ' GLU . 16.3 mt-10 -65.15 -74.95 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 2.89 109.415 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.93 ' O ' HG23 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -44.01 -38.72 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.228 -0.92 . . . . 2.11 109.538 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.557 ' O ' HG12 ' B' ' 77' ' ' ILE . 89.7 m -59.09 -46.97 86.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 1.57 109.674 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.053 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -75.24 -47.08 29.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.883 -1.135 . . . . 1.63 109.538 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.089 ' CD1' HD13 ' A' ' 75' ' ' LEU . 11.7 mt -57.43 -48.14 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.855 -1.153 . . . . 1.02 109.602 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.93 HG23 ' O ' ' B' ' 73' ' ' ILE . 15.9 pt -58.0 -47.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.043 -1.036 . . . . 1.86 108.522 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.539 ' N ' HG13 ' B' ' 77' ' ' ILE . 0.8 OUTLIER -57.14 -47.28 81.54 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.801 -0.76 . . . . 2.81 109.085 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.881 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.08 -47.3 88.56 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.065 -1.614 . . . . 0.3 109.065 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.844 HG22 ' C ' ' A' ' 79' ' ' GLY . 89.4 t -57.26 -47.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -1.195 . . . . 0.33 108.799 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' B' ' 77' ' ' ILE . 14.5 mtp -57.67 -47.35 82.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.291 -0.881 . . . . 1.83 108.957 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.46 83.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.533 -0.729 . . . . 0.31 109.962 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.37 87.65 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.319 -1.512 . . . . 0.26 109.319 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.445 HG13 ' OG1' ' A' ' 87' ' ' THR . 55.7 t -57.29 -47.54 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -1.217 . . . . 0.31 109.431 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -57.35 -47.22 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 1.06 109.79 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.04 -47.0 90.91 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.653 -1.379 . . . . 0.3 109.653 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 93.7 m -56.93 -47.18 81.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -1.172 . . . . 0.32 109.521 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 86.1 mt -57.02 -47.24 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.123 -0.986 . . . . 0.41 109.207 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.731 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -57.28 -46.61 82.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 1.14 109.134 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.8 ' O ' HD13 ' B' ' 90' ' ' LEU . 2.8 tm? -57.2 -46.92 82.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.299 -0.875 . . . . 2.02 109.451 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.92 ' O ' HG23 ' B' ' 95' ' ' ILE . 99.2 mt -57.0 -47.14 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.9 . . . . 0.77 109.623 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.508 ' O ' HG12 ' B' ' 95' ' ' ILE . 28.5 m -57.14 -47.6 80.77 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.891 -1.131 . . . . 1.53 108.634 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -57.69 -47.57 81.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.008 -1.057 . . . . 2.25 109.571 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.53 -47.61 87.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.284 -1.126 . . . . 1.24 110.284 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.92 HG23 ' O ' ' B' ' 91' ' ' ILE . 0.8 OUTLIER -57.33 -47.1 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.048 -1.266 . . . . 1.81 109.352 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' B' ' 99' ' ' ILE . 22.2 mtm180 -57.07 -47.08 81.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 2.69 109.539 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -46.86 83.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.977 . . . . 3.17 109.812 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -47.07 81.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 2.09 109.374 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' B' ' 96' ' ' ARG . 32.2 pt -70.87 -15.68 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 2.5 108.937 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -115.08 -162.83 0.84 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.432 -0.793 . . . . 5.22 109.374 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' B' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.911 -1.042 . . . . 7.38 109.618 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.379 -0.6 . . . . 18.74 109.379 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 3.0 pp0? -178.77 153.94 0.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 16.78 109.409 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -53.98 173.51 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 16.71 109.342 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.49 104.28 0.61 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.234 -0.916 . . . . 14.32 109.42 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -70.32 -148.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 14.47 109.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -65.94 -175.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 11.15 109.666 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.33 -8.18 11.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 11.57 109.525 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 p -46.62 157.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.885 . . . . 7.08 109.755 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -137.61 154.8 75.28 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 6.49 109.63 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 3.7 Cg_exo -60.67 170.15 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.274 1.983 . . . . 2.65 110.335 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.0 mt-10 -63.21 -74.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 3.01 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' C ' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -41.03 -35.97 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.41 -0.806 . . . . 1.48 110.007 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -64.77 -46.82 80.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 1.35 109.38 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.677 HD13 ' CD1' ' B' ' 76' ' ' ILE . 0.2 OUTLIER -77.45 -47.15 20.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 1.02 109.981 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.933 HG12 HD21 ' B' ' 75' ' ' LEU . 42.2 mt -57.27 -48.48 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.744 -1.223 . . . . 1.1 108.955 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 78' ' ' PHE . 4.3 tt -58.41 -47.48 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.135 -0.978 . . . . 1.58 108.97 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 2.7 m-85 -57.28 -47.5 81.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.745 . . . . 2.09 110.404 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.881 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.26 -47.6 86.56 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.353 -1.499 . . . . 0.32 109.353 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.71 HG22 ' C ' ' B' ' 79' ' ' GLY . 47.5 t -57.59 -47.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -1.168 . . . . 0.28 109.139 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -46.86 82.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 1.7 109.065 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.67 -46.04 81.35 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.423 -0.798 . . . . 0.37 109.08 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.488 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.62 -46.97 87.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.249 -1.54 . . . . 0.28 109.249 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.762 HG13 ' OG1' ' B' ' 87' ' ' THR . 8.4 t -57.09 -47.39 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.063 -1.257 . . . . 0.28 109.062 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.7 mt -57.2 -46.86 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 1.2 109.454 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.71 89.56 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.5 -1.44 . . . . 0.33 109.5 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.661 ' OG1' HG13 ' B' ' 84' ' ' VAL . 60.4 m -56.69 -47.0 80.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.064 -1.257 . . . . 0.34 108.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.443 ' HA ' HD12 ' A' ' 91' ' ' ILE . 49.5 mt -57.01 -46.76 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.115 -0.991 . . . . 0.49 108.705 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.51 82.06 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.682 -0.859 . . . . 0.68 108.682 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 5.7 mt -56.72 -46.6 81.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 1.92 109.053 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 95' ' ' ILE . 82.0 mt -56.85 -47.04 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.235 -0.916 . . . . 0.87 109.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -56.88 -47.68 79.92 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.983 -1.087 . . . . 1.29 108.483 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -57.57 -47.5 81.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 2.64 109.004 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.58 -47.17 90.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.345 -1.102 . . . . 1.29 110.345 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.91 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER -57.13 -47.1 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.025 -1.279 . . . . 2.19 109.267 -179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 99' ' ' ILE . 9.5 mtp180 -57.14 -47.22 81.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 3.14 109.395 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -47.18 83.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.776 -1.203 . . . . 3.58 109.814 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.23 -47.03 82.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.382 -0.824 . . . . 2.66 110.09 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 96' ' ' ARG . 1.0 OUTLIER -81.39 6.25 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 2.2 109.713 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -129.12 80.92 2.0 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 3.91 109.408 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 6.53 109.39 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.305 0.574 . . . . 20.22 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' B' ' 63' ' ' GLN . 20.1 tp60 -128.72 26.07 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 18.1 109.44 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.86 1.81 14.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.843 . . . . 17.47 109.921 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.75 145.86 36.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 15.58 109.397 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 -177.2 3.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.056 -1.028 . . . . 14.18 109.455 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.528 ' O ' ' CB ' ' B' ' 68' ' ' PHE . 11.9 p80 -163.84 -169.49 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 13.39 109.491 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.528 ' CB ' ' O ' ' B' ' 67' ' ' HIS . 0.2 OUTLIER 75.94 -56.15 0.59 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 12.43 109.361 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.418 ' O ' ' C ' ' B' ' 70' ' ' GLU . 2.7 m -121.28 128.43 52.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.888 . . . . 8.12 109.49 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 69' ' ' SER . 33.5 mt-10 -43.77 110.13 0.92 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 7.29 109.419 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.601 ' HB2' HG23 ' B' ' 74' ' ' THR . 4.0 Cg_exo -59.72 106.43 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.912 1.741 . . . . 2.87 110.287 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.457 ' O ' HG13 ' B' ' 76' ' ' ILE . 4.2 mt-10 -51.98 -48.22 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.036 -1.04 . . . . 2.89 109.237 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.595 HG23 ' N ' ' B' ' 74' ' ' THR . 1.5 tp -55.86 -47.4 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 121.307 -0.87 . . . . 2.11 110.085 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.601 HG23 ' HB2' ' B' ' 71' ' ' PRO . 53.4 p -55.05 -46.87 75.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.932 -1.105 . . . . 1.57 109.349 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.117 HD23 ' N ' ' B' ' 76' ' ' ILE . 0.0 OUTLIER -65.98 -47.0 76.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 1.63 109.373 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.117 ' N ' HD23 ' B' ' 75' ' ' LEU . 51.8 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.651 -1.281 . . . . 1.02 108.219 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' B' ' 77' ' ' ILE . 21.5 mm -57.7 -47.18 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.503 -0.925 . . . . 1.86 108.503 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' B' ' 74' ' ' THR . 18.5 m-85 -57.12 -47.36 81.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.655 -0.653 . . . . 2.81 110.304 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.71 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.04 -47.65 85.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.813 -1.715 . . . . 0.3 108.813 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 79' ' ' GLY . 52.0 t -57.68 -47.46 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.267 -1.137 . . . . 0.33 108.951 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 8.3 mtp -57.55 -46.93 83.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.498 -0.751 . . . . 1.83 109.164 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.27 81.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.796 . . . . 0.31 109.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.17 87.93 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.838 -1.705 . . . . 0.26 108.838 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.661 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.14 -47.35 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -1.233 . . . . 0.31 109.05 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -57.22 -47.16 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 1.06 109.639 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.06 90.48 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.574 -1.41 . . . . 0.3 109.574 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.762 ' OG1' HG13 ' A' ' 84' ' ' VAL . 56.3 m -57.07 -47.26 81.42 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.159 -1.201 . . . . 0.32 109.431 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.463 ' HA ' HD12 ' B' ' 91' ' ' ILE . 58.7 mt -57.4 -47.53 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.41 109.098 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.619 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.44 -47.04 82.83 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.747 HD13 ' C ' ' B' ' 90' ' ' LEU . 3.4 tm? -57.02 -46.99 81.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.524 -0.735 . . . . 2.02 109.435 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.681 ' O ' HD12 ' B' ' 95' ' ' ILE . 70.0 mt -56.97 -47.2 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.77 109.418 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' B' ' 96' ' ' ARG . 0.3 OUTLIER -57.37 -47.54 81.38 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.929 -1.108 . . . . 1.53 108.398 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -47.82 81.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.352 -0.842 . . . . 2.25 109.343 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.65 -47.22 90.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.427 -1.469 . . . . 1.24 109.427 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.681 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.4 mt -57.1 -47.11 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.46 -1.023 . . . . 1.81 109.214 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.496 ' HA ' HD11 ' B' ' 99' ' ' ILE . 4.5 mtm180 -57.08 -47.23 81.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.112 -0.993 . . . . 2.69 109.499 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 100' ' ' LYS . 8.5 ttt180 -57.48 -47.02 83.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 3.17 109.781 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -46.99 81.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.853 . . . . 2.09 109.308 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.517 HG13 ' N ' ' B' ' 100' ' ' LYS . 38.4 pt -75.27 -35.01 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.514 -0.742 . . . . 2.5 109.442 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' B' ' 101' ' ' LYS . 3.1 mmtp -91.78 115.41 28.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -0.819 . . . . 5.22 109.56 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' B' ' 100' ' ' LYS . 4.0 mtmp? . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.049 -0.977 . . . . 7.38 109.416 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.465 -0.568 . . . . 18.74 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -143.08 159.99 41.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 16.78 109.559 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.4 mt -130.31 93.15 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 16.71 109.525 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.24 24.52 1.6 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.026 . . . . 14.32 109.581 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 t60 51.41 77.86 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 14.47 109.277 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -158.88 -55.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 11.15 109.353 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 69' ' ' SER . 0.8 OUTLIER 68.38 -62.92 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 11.57 109.42 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 1.5 m 76.17 48.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 7.08 109.493 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 69' ' ' SER . 15.0 mt-10 55.46 101.54 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 6.49 109.49 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.453 ' HG2' ' OG1' ' A' ' 74' ' ' THR . 5.1 Cg_exo -58.21 154.96 37.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.955 1.77 . . . . 2.65 110.209 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -59.29 -70.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 3.01 109.99 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -39.24 -45.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.454 -0.779 . . . . 1.48 110.587 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -59.23 -46.96 87.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.072 -1.018 . . . . 1.35 109.489 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.012 HD13 ' CD1' ' B' ' 76' ' ' ILE . 0.4 OUTLIER -69.14 -47.06 66.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.159 -0.963 . . . . 1.02 109.581 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.074 HD13 HD13 ' B' ' 75' ' ' LEU . 63.8 mt -56.97 -47.44 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.058 -1.026 . . . . 1.1 108.644 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.69 -47.45 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.169 -0.957 . . . . 1.58 108.685 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 74' ' ' THR . 18.8 m-30 -57.42 -47.31 82.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 2.09 109.682 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.897 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.23 -47.13 90.13 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.241 -1.544 . . . . 0.32 109.241 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.843 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.6 t -57.36 -47.81 83.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -1.137 . . . . 0.28 109.962 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -57.8 -47.82 81.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 1.7 108.859 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.37 84.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.626 -0.671 . . . . 0.37 109.887 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' HG13 ' B' ' 80' ' ' VAL . . . -56.85 -47.27 87.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.845 -1.302 . . . . 0.28 109.845 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' OG1' ' B' ' 87' ' ' THR . 97.3 t -57.16 -47.98 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.95 -1.323 . . . . 0.28 109.199 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mt -57.67 -47.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.012 . . . . 1.2 109.629 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.25 89.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.099 -1.2 . . . . 0.33 110.099 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.447 ' OG1' HG13 ' B' ' 84' ' ' VAL . 47.4 m -57.11 -47.28 81.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -1.141 . . . . 0.34 109.839 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.9 mt -57.43 -47.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.49 109.808 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.86 81.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.042 -1.036 . . . . 0.68 109.209 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.526 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tt -57.71 -47.5 82.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.172 -0.955 . . . . 1.92 109.298 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.782 HD13 HD13 ' B' ' 91' ' ' ILE . 76.2 mt -57.33 -47.04 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.551 -0.718 . . . . 0.87 109.948 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -47.7 79.82 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.974 -1.079 . . . . 1.29 109.176 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -57.81 -47.97 81.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.008 -1.058 . . . . 2.64 109.537 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.67 87.47 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.854 -1.298 . . . . 1.29 109.854 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -57.37 -47.21 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -1.085 . . . . 2.19 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' O ' HG13 ' A' ' 99' ' ' ILE . 22.1 mtm180 -56.99 -47.16 81.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.873 . . . . 3.14 109.472 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.94 82.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 3.58 110.075 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.97 -46.9 81.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -0.982 . . . . 2.66 108.821 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.525 HG13 ' N ' ' A' ' 100' ' ' LYS . 37.7 pt -74.87 -36.0 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.393 -0.817 . . . . 2.2 109.432 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -62.99 134.8 56.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.82 . . . . 3.91 109.752 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.07 -0.967 . . . . 6.53 109.467 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.527 HG12 ' N ' ' B' ' 63' ' ' GLN . 73.1 t . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.492 -0.559 . . . . 20.22 109.492 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.54 ' CG ' ' N ' ' B' ' 64' ' ' LEU . 10.9 tt0 61.01 167.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 18.1 109.08 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.54 ' N ' ' CG ' ' B' ' 63' ' ' GLN . 0.2 OUTLIER 175.8 -28.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 17.47 109.692 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' B' ' 66' ' ' HIS . . . -106.24 37.76 2.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.156 -0.965 . . . . 15.58 109.37 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.421 ' CG ' ' O ' ' B' ' 65' ' ' ALA . 78.8 m80 -154.74 63.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 14.18 109.447 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.568 ' O ' ' CD2' ' B' ' 67' ' ' HIS . 54.0 p-80 -101.28 69.29 1.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 13.39 109.529 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.52 ' O ' ' CB ' ' B' ' 69' ' ' SER . 44.9 m-85 -67.17 90.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 12.43 109.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' B' ' 68' ' ' PHE . 0.1 OUTLIER 75.9 109.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 8.12 109.546 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.49 145.59 99.04 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 7.29 109.381 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.405 ' HA ' ' OG1' ' B' ' 74' ' ' THR . 2.1 Cg_endo -62.69 -23.53 74.6 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.249 1.966 . . . . 2.87 110.281 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.43 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 18.1 mt-10 -48.54 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 2.89 109.698 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.703 ' O ' HG22 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -45.9 -30.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.206 -0.934 . . . . 2.11 109.926 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.917 HG22 ' CE2' ' B' ' 78' ' ' PHE . 0.5 OUTLIER -64.68 -46.77 80.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 1.57 109.695 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.074 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -74.62 -46.85 35.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.997 -1.065 . . . . 1.63 109.624 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.012 ' CD1' HD13 ' A' ' 75' ' ' LEU . 66.9 mt -56.96 -48.0 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 1.02 109.518 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.703 HG22 ' O ' ' B' ' 73' ' ' ILE . 1.5 tt -57.9 -47.53 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.792 -1.192 . . . . 1.86 108.45 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.917 ' CE2' HG22 ' B' ' 74' ' ' THR . 23.1 m-30 -57.33 -47.26 82.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.583 -0.698 . . . . 2.81 109.721 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.843 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.22 -47.29 88.88 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.897 HG22 ' C ' ' A' ' 79' ' ' GLY . 94.1 t -57.34 -47.71 84.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.282 -1.128 . . . . 0.33 109.714 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 2.9 mtt -57.74 -47.76 81.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.97 -1.081 . . . . 1.83 109.001 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.58 83.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.497 -0.752 . . . . 0.31 109.656 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -56.95 -46.97 90.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.599 -1.4 . . . . 0.26 109.599 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 87' ' ' THR . 98.5 t -56.89 -47.6 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.181 -1.188 . . . . 0.31 109.764 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 85' ' ' ILE . 43.6 mm -57.41 -47.91 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.835 -1.165 . . . . 1.06 109.418 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.14 90.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.364 -1.494 . . . . 0.3 109.364 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.438 ' OG1' HG22 ' A' ' 84' ' ' VAL . 98.5 m -57.1 -47.06 81.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.501 -0.999 . . . . 0.32 109.695 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 37.7 mt -57.01 -47.66 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.132 -0.98 . . . . 0.41 109.763 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.63 -47.69 81.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.025 -1.047 . . . . 1.14 108.752 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 66.1 mt -57.59 -47.22 82.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 2.02 109.429 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.782 HD13 HD13 ' A' ' 91' ' ' ILE . 73.4 mt -57.15 -47.14 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.444 -0.785 . . . . 0.77 110.038 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.51 ' O ' HG22 ' B' ' 95' ' ' ILE . 52.4 m -57.03 -48.01 79.54 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.831 -1.168 . . . . 1.53 108.656 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.9 -47.79 81.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.837 -1.165 . . . . 2.25 109.12 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.27 89.63 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.572 -1.011 . . . . 1.24 110.572 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.51 HG22 ' O ' ' B' ' 92' ' ' SER . 1.6 tt -57.08 -47.22 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.139 -1.212 . . . . 1.81 109.408 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.502 ' O ' HG13 ' B' ' 99' ' ' ILE . 7.2 mtm180 -57.26 -47.28 81.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 2.69 108.898 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.79 83.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 3.17 109.811 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -46.98 80.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 2.09 109.106 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.51 HG13 ' N ' ' B' ' 100' ' ' LYS . 10.4 pt -79.71 -131.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.593 -0.891 . . . . 2.5 108.593 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.51 ' N ' HG13 ' B' ' 99' ' ' ILE . 6.8 tttm 59.47 136.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.137 -0.977 . . . . 5.22 109.958 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' B' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.998 -1.001 . . . . 7.38 109.532 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.342 0.592 . . . . 18.74 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -148.18 164.09 34.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.13 -0.981 . . . . 16.78 109.45 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.3 3.53 15.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 16.71 109.583 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.77 77.77 4.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 14.32 109.531 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.68 145.84 1.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 14.47 109.576 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 67.54 123.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 11.15 109.503 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.72 153.3 40.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 11.57 109.403 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -126.77 179.61 5.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 7.08 109.614 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.594 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 161.78 -50.03 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.642 -0.661 . . . . 6.49 109.71 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.9 Cg_endo -61.22 75.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.553 1.502 . . . . 2.65 110.024 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -52.85 -69.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 3.01 110.02 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG23 ' N ' ' A' ' 74' ' ' THR . 0.8 OUTLIER -42.8 -47.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -0.929 . . . . 1.48 109.836 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.583 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.34 -46.86 72.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 1.35 108.897 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.99 HD13 HD13 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -67.43 -46.87 71.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 1.02 109.708 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.086 HD13 HD11 ' B' ' 75' ' ' LEU . 35.0 mt -56.92 -48.01 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.85 -1.157 . . . . 1.1 108.72 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 77' ' ' ILE . 34.3 mm -58.02 -47.61 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 1.58 108.693 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -57.44 -47.25 82.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.753 -0.592 . . . . 2.09 110.278 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.818 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.87 -47.66 84.67 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.32 109.659 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.824 HG22 ' O ' ' B' ' 79' ' ' GLY . 92.3 t -57.67 -47.49 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.904 -1.351 . . . . 0.28 108.628 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.84 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 1.7 109.037 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.08 81.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.559 -0.713 . . . . 0.37 109.453 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.22 85.67 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.077 -1.609 . . . . 0.28 109.077 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.41 HG22 ' OG1' ' B' ' 87' ' ' THR . 41.7 t -56.93 -47.32 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.973 -1.31 . . . . 0.28 108.907 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 mt -57.21 -46.69 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 1.2 109.813 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.566 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -56.7 -46.9 88.66 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.52 -1.432 . . . . 0.33 109.52 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.793 ' OG1' HG13 ' B' ' 84' ' ' VAL . 17.7 m -57.08 -47.13 81.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.985 -1.303 . . . . 0.34 108.528 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.3 -46.85 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.49 109.226 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.701 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -56.81 -46.52 81.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.68 109.371 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.569 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 3.7 mm? -56.66 -47.05 80.64 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 1.92 108.926 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 95' ' ' ILE . 27.1 mt -56.96 -46.91 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.87 109.302 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -47.28 80.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.162 -0.962 . . . . 1.29 108.466 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.41 -47.57 81.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 2.64 108.976 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.55 -47.24 89.68 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.263 -1.535 . . . . 1.29 109.263 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.56 HD12 HG22 ' A' ' 91' ' ' ILE . 1.6 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -1.1 . . . . 2.19 109.258 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.543 ' O ' HG13 ' A' ' 99' ' ' ILE . 6.2 ttp180 -57.02 -47.29 81.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 3.14 109.394 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 100' ' ' LYS . 13.9 ttm180 -57.51 -47.0 83.13 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.016 -1.052 . . . . 3.58 109.676 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.06 -46.98 82.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 2.66 110.19 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 96' ' ' ARG . 1.7 pt -76.47 -27.6 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.101 -0.999 . . . . 2.2 110.376 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' N ' HG13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -142.56 146.92 35.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.997 -1.064 . . . . 3.91 109.748 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 100' ' ' LYS . 1.7 mptp? . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.996 -1.002 . . . . 6.53 109.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.502 -0.555 . . . . 20.22 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.437 ' CG ' ' HB2' ' B' ' 66' ' ' HIS . 0.0 OUTLIER -156.47 157.55 35.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 18.1 109.518 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' B' ' 64' ' ' LEU . 1.4 mm? -94.64 7.41 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 17.47 109.537 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.62 6.64 34.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.185 -0.947 . . . . 15.58 109.653 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.437 ' HB2' ' CG ' ' B' ' 63' ' ' GLN . 0.1 OUTLIER -115.57 168.04 10.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 14.18 109.472 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -91.59 7.78 39.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 13.39 109.652 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -80.55 -0.61 38.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 12.43 109.552 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.81 36.49 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 8.12 109.559 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.697 ' HG2' HG21 ' B' ' 74' ' ' THR . 0.2 OUTLIER -64.75 166.67 11.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 7.29 109.55 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' B' ' 70' ' ' GLU . 5.6 Cg_exo -59.6 158.9 25.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.289 1.993 . . . . 2.87 110.503 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' B' ' 73' ' ' ILE . 3.3 mp0 -57.89 -72.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 2.89 109.835 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.503 HG23 ' N ' ' B' ' 74' ' ' THR . 0.7 OUTLIER -41.35 -42.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.287 -0.883 . . . . 2.11 110.013 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.697 HG21 ' HG2' ' B' ' 70' ' ' GLU . 6.4 m -57.95 -46.92 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.006 . . . . 1.57 109.309 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.086 HD11 HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -67.37 -46.76 72.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.955 . . . . 1.63 109.367 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.058 ' N ' HD23 ' B' ' 75' ' ' LEU . 82.8 mt -56.99 -47.5 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.666 -1.271 . . . . 1.02 108.326 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -57.51 -47.23 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.346 -0.983 . . . . 1.86 108.346 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.22 -47.1 82.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.658 -0.651 . . . . 2.81 109.885 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.824 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -56.85 -47.41 86.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.129 -1.588 . . . . 0.3 109.129 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 79' ' ' GLY . 94.4 t -57.44 -47.42 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -1.193 . . . . 0.33 108.585 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . 0.558 ' O ' HD12 ' B' ' 85' ' ' ILE . 0.9 OUTLIER -57.45 -46.75 83.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.535 -0.913 . . . . 1.83 108.535 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.87 -45.82 82.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.208 -0.664 . . . . 0.31 109.208 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.09 86.59 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.662 -1.775 . . . . 0.26 108.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.793 HG13 ' OG1' ' A' ' 87' ' ' THR . 87.0 t -57.0 -47.37 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -1.233 . . . . 0.31 108.592 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.558 HD12 ' O ' ' B' ' 81' ' ' MET . 3.9 mt -57.17 -46.74 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.409 -0.807 . . . . 1.06 109.736 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.39 -46.72 86.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.069 -1.612 . . . . 0.3 109.069 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.41 ' OG1' HG22 ' A' ' 84' ' ' VAL . 25.0 m -56.68 -46.75 80.97 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -1.139 . . . . 0.32 109.051 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.14 -47.3 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.41 109.951 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.792 HD23 ' N ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.31 -46.64 82.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.91 -1.119 . . . . 1.14 108.307 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' B' ' 90' ' ' LEU . 27.6 tp -56.99 -47.11 81.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 2.02 109.013 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.677 ' O ' HD12 ' B' ' 95' ' ' ILE . 73.2 mt -57.13 -47.13 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.883 . . . . 0.77 109.192 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -57.05 -47.58 80.61 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.073 -1.017 . . . . 1.53 108.433 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -47.56 81.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 2.25 109.237 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.49 -47.4 88.45 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.307 -1.517 . . . . 1.24 109.307 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.677 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mt -57.33 -47.16 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.348 -1.09 . . . . 1.81 109.151 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 99' ' ' ILE . 9.9 mtm180 -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 2.69 109.678 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 29.2 ttt180 -57.82 -47.49 82.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.791 -1.193 . . . . 3.17 109.883 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -47.09 82.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 2.09 110.486 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 96' ' ' ARG . 1.0 OUTLIER -80.24 -13.74 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.232 -0.918 . . . . 2.5 110.23 -179.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' B' ' 97' ' ' ARG . 0.1 OUTLIER -157.82 146.11 19.01 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.068 -1.02 . . . . 5.22 109.745 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 1.6 tttp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.031 -0.985 . . . . 7.38 109.527 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 1 N--CA 1.568 5.445 0 N-CA-C 107.978 -1.119 . . . . 18.74 107.978 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -157.72 100.91 1.79 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 16.78 109.412 -177.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp 54.47 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 16.71 109.402 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' GLN . . . -159.55 127.86 5.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 14.32 109.299 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -56.16 -77.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.026 -1.046 . . . . 14.47 109.307 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -162.02 -69.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 11.15 109.393 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -86.06 117.2 24.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 11.57 109.278 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 97.7 p -172.98 36.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.986 -1.071 . . . . 7.08 109.603 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 73' ' ' ILE . 8.9 mt-10 -145.21 136.56 12.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 6.49 109.392 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.02 -34.7 57.86 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.051 1.834 . . . . 2.65 110.115 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -45.49 -58.43 3.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.29 -0.881 . . . . 3.01 109.75 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -56.29 -33.66 38.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.106 -0.996 . . . . 1.48 109.936 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 m -64.15 -47.14 81.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.022 . . . . 1.35 109.748 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.07 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -75.38 -46.96 29.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.987 . . . . 1.02 109.412 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.063 HD13 HD13 ' B' ' 75' ' ' LEU . 48.2 mt -57.04 -47.39 83.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.167 -1.013 . . . . 1.1 108.519 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 mm -57.58 -47.54 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.482 -0.933 . . . . 1.58 108.482 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 2.09 109.583 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.812 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.19 -47.31 88.67 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.641 -1.384 . . . . 0.32 109.641 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 57.4 t -57.42 -47.65 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.124 -1.221 . . . . 0.28 108.89 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -47.37 82.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.413 -0.805 . . . . 1.7 109.112 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.64 83.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.718 . . . . 0.37 110.121 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.3 -47.37 88.35 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.251 -1.539 . . . . 0.28 109.251 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.26 -47.32 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.28 109.609 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.2 mt -57.3 -47.39 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 1.2 110.004 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.35 -47.31 88.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.232 -1.547 . . . . 0.33 109.232 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' HG13 ' A' ' 91' ' ' ILE . 25.0 m -57.3 -47.01 82.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -1.039 . . . . 0.34 109.44 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.96 -47.25 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.49 109.596 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.11 -46.73 82.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.093 -1.005 . . . . 0.68 108.745 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -57.29 -47.02 82.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 1.92 109.277 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.989 HD11 HD11 ' B' ' 91' ' ' ILE . 66.4 mt -57.02 -47.12 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.87 109.805 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -57.01 -47.66 80.33 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.909 -1.119 . . . . 1.29 108.3 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.59 -47.56 81.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.854 . . . . 2.64 109.298 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.35 88.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 1.29 109.5 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mt -57.04 -47.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -1.071 . . . . 2.19 109.096 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' O ' HG13 ' A' ' 99' ' ' ILE . 3.4 ttp180 -57.01 -47.2 81.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 3.14 109.459 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.491 ' CD ' ' O ' ' A' ' 101' ' ' LYS . 6.3 tmm_? -57.83 -47.28 83.12 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.764 -1.21 . . . . 3.58 109.745 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.19 -47.14 82.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.313 -0.867 . . . . 2.66 110.156 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -80.38 -19.32 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 2.2 109.83 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 0.4 OUTLIER -142.53 121.09 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 3.91 109.515 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 5.5 tttt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 6.53 109.421 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.439 -0.578 . . . . 20.22 109.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' B' ' 63' ' ' GLN . 8.3 tp60 -116.34 23.37 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 18.1 109.316 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' B' ' 63' ' ' GLN . 8.9 mt -42.23 145.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.341 -0.849 . . . . 17.47 109.436 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -115.84 122.35 45.13 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.118 -0.989 . . . . 15.58 109.64 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.35 159.1 4.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 14.18 109.419 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -61.13 -62.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 13.39 109.54 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -81.39 -165.36 0.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 12.43 109.587 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.2 15.12 1.68 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 8.12 109.682 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.71 153.72 52.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 7.29 109.361 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' B' ' 74' ' ' THR . 4.2 Cg_exo -56.83 150.97 51.23 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 2.87 110.468 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 72' ' ' GLU . 67.2 mt-10 -52.63 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 2.89 109.958 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' B' ' 74' ' ' THR . 5.8 tp -44.05 -43.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.152 -0.968 . . . . 2.11 109.837 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 6.3 m -55.12 -47.0 75.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.015 -1.053 . . . . 1.57 108.988 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.063 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -66.54 -46.77 75.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 1.63 109.416 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.07 HD13 HD13 ' A' ' 75' ' ' LEU . 60.5 mt -56.75 -47.58 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.046 -1.034 . . . . 1.02 108.68 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.412 HG23 HD12 ' B' ' 77' ' ' ILE . 28.0 mm -57.6 -47.4 85.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -0.901 . . . . 1.86 108.645 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -57.42 -47.17 82.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.586 -0.696 . . . . 2.81 109.635 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.01 -47.54 86.58 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.62 -1.276 . . . . 0.3 109.921 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.812 HG22 ' C ' ' A' ' 79' ' ' GLY . 40.4 t -57.5 -47.98 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.925 -1.338 . . . . 0.33 108.898 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . 0.436 ' O ' HG12 ' B' ' 85' ' ' ILE . 1.4 mtt -57.77 -47.3 82.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.373 -0.829 . . . . 1.83 109.139 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.44 82.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.703 -0.623 . . . . 0.31 110.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.5 86.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.072 -1.611 . . . . 0.26 109.072 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.45 -47.38 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -1.19 . . . . 0.31 109.375 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.436 HG12 ' O ' ' B' ' 81' ' ' MET . 45.5 mm -57.3 -47.23 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 1.06 109.989 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.98 -47.06 90.22 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.396 -1.482 . . . . 0.3 109.396 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 87' ' ' THR . 50.9 m -57.03 -47.0 81.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.168 -1.196 . . . . 0.32 109.174 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -56.92 -47.17 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.41 109.29 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.767 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -46.98 82.35 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.247 -0.908 . . . . 1.14 108.651 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' B' ' 89' ' ' LEU . 6.9 mp -56.97 -47.14 81.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 2.02 109.51 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.989 HD11 HD11 ' A' ' 91' ' ' ILE . 99.7 mt -57.13 -47.14 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.12 -0.988 . . . . 0.77 109.206 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 67.2 m -57.22 -47.67 80.72 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.098 -1.041 . . . . 1.53 108.5 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -47.57 82.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.626 -0.829 . . . . 2.25 109.357 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.48 87.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.949 -1.661 . . . . 1.24 108.949 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' B' ' 95' ' ' ILE . 2.0 mm -57.3 -47.0 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -1.072 . . . . 1.81 108.251 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.587 ' O ' HG13 ' B' ' 99' ' ' ILE . 0.5 OUTLIER -57.04 -46.96 82.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.769 . . . . 2.69 109.242 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 3.8 ttt180 -57.53 -47.12 82.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.764 -1.21 . . . . 3.17 109.549 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 98' ' ' LEU . 5.2 mt -57.07 -47.1 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 2.09 109.989 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.705 HD12 ' HB2' ' B' ' 100' ' ' LYS . 2.3 pp -79.48 -28.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 2.5 109.928 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.705 ' HB2' HD12 ' B' ' 99' ' ' ILE . 0.3 OUTLIER -134.67 129.93 35.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 5.22 109.661 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.993 -1.003 . . . . 7.38 109.505 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.485 -0.561 . . . . 18.74 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.432 ' C ' HD23 ' A' ' 64' ' ' LEU . 48.0 tp60 -109.63 22.21 16.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 16.78 109.362 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.555 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -97.72 -0.79 44.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 16.71 109.627 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' HIS . . . -58.87 -19.85 45.72 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 14.32 109.63 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CB ' ' O ' ' A' ' 65' ' ' ALA . 0.1 OUTLIER 70.62 -66.05 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 14.47 109.458 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.2 OUTLIER 58.12 -172.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 11.15 109.497 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.92 -176.07 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 11.57 109.43 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.6 m 54.67 74.58 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 7.08 109.676 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -141.12 149.16 54.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.943 . . . . 6.49 109.425 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HB2' HG23 ' A' ' 74' ' ' THR . 2.8 Cg_endo -60.96 121.38 9.59 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.139 1.892 . . . . 2.65 110.002 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -58.31 -58.19 9.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 3.01 109.625 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.657 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.1 tp -47.56 -46.63 10.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.217 -0.927 . . . . 1.48 110.255 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 73' ' ' ILE . 64.5 p -58.33 -46.55 85.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 1.35 110.032 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.081 HD13 HD13 ' B' ' 76' ' ' ILE . 0.4 OUTLIER -71.78 -47.38 53.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 1.02 110.204 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.103 HD13 HD13 ' B' ' 75' ' ' LEU . 73.0 mt -57.45 -48.1 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 1.1 109.69 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 73' ' ' ILE . 23.1 pt -57.95 -47.14 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.84 -1.162 . . . . 1.58 108.423 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -57.17 -46.92 82.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.652 . . . . 2.09 109.571 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.909 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.86 -47.4 86.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.651 -1.38 . . . . 0.32 109.651 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.871 HG22 ' C ' ' B' ' 79' ' ' GLY . 95.2 t -57.31 -47.63 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.951 -1.323 . . . . 0.28 108.738 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 mmt -57.72 -47.08 83.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 1.7 108.793 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.02 -46.28 82.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.666 -0.646 . . . . 0.37 109.82 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.45 86.42 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.182 -1.567 . . . . 0.28 109.182 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.2 t -57.27 -47.75 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.997 -1.296 . . . . 0.28 108.969 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.9 mt -57.5 -46.97 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 1.2 109.859 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.04 89.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.758 -1.337 . . . . 0.33 109.758 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.558 HG21 ' CG2' ' B' ' 87' ' ' THR . 95.7 m -56.86 -47.21 80.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.021 -1.282 . . . . 0.34 108.753 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -57.24 -47.11 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.49 108.565 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.73 82.34 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.487 -0.931 . . . . 0.68 108.487 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.78 -46.84 81.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.478 -0.764 . . . . 1.92 109.124 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.845 HD11 HD11 ' B' ' 91' ' ' ILE . 70.9 mt -56.87 -46.84 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.87 109.031 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.462 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.7 m -56.95 -47.58 80.35 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.007 -1.058 . . . . 1.29 108.371 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -57.57 -47.72 81.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 2.64 109.05 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.59 -47.08 90.92 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.362 -1.495 . . . . 1.29 109.362 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 95' ' ' ILE . 1.5 mm -57.06 -47.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.413 -1.051 . . . . 2.19 109.01 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' HA ' HD11 ' A' ' 99' ' ' ILE . 6.8 mtp180 -57.14 -47.19 81.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 3.14 109.438 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -57.31 -47.11 82.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 3.58 109.825 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mt -56.84 -46.93 81.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 2.66 109.333 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.535 HD11 ' HA ' ' A' ' 96' ' ' ARG . 36.4 pt -72.98 -15.35 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 2.2 109.532 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -123.02 -163.78 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.163 -0.961 . . . . 3.91 109.521 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.03 -0.986 . . . . 6.53 109.454 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.454 HG23 ' N ' ' B' ' 63' ' ' GLN . 13.1 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.305 0.574 . . . . 20.22 109.481 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.454 ' N ' HG23 ' B' ' 62' ' ' VAL . 71.0 tp60 -120.86 159.53 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 18.1 109.304 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.43 ' N ' ' HG3' ' B' ' 63' ' ' GLN . 0.3 OUTLIER -160.98 34.33 0.15 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 17.47 109.905 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -112.91 -25.42 9.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.973 -1.079 . . . . 15.58 109.703 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 65' ' ' ALA . 93.7 m-70 60.92 131.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 14.18 109.558 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -131.77 113.48 13.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 13.39 109.46 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -137.01 152.16 49.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 12.43 109.56 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' B' ' 70' ' ' GLU . 0.5 OUTLIER -124.13 123.7 40.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 8.12 109.358 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.593 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 3.6 mm-40 163.18 -52.97 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 7.29 109.95 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 4.6 Cg_exo -61.0 169.55 5.82 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.222 1.948 . . . . 2.87 111.601 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' B' ' 73' ' ' ILE . 10.2 pt-20 -52.39 -44.97 65.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.352 -0.843 . . . . 2.89 109.619 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.616 HG23 ' N ' ' B' ' 74' ' ' THR . 2.5 tp -47.56 -46.34 10.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.053 -1.03 . . . . 2.11 109.798 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.616 ' N ' HG23 ' B' ' 73' ' ' ILE . 0.6 OUTLIER -60.81 -46.98 88.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.107 -0.995 . . . . 1.57 108.93 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.103 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -64.13 -47.25 80.68 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.304 -0.958 . . . . 1.63 109.294 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.081 HD13 HD13 ' A' ' 75' ' ' LEU . 71.1 mt -57.14 -47.68 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.994 -1.066 . . . . 1.02 108.362 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.33 -47.18 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.483 -0.932 . . . . 1.86 108.483 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -57.25 -47.23 81.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.474 -0.766 . . . . 2.81 109.455 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.871 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.9 -47.28 87.89 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.123 -1.591 . . . . 0.3 109.123 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.909 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.7 t -57.37 -47.37 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -1.128 . . . . 0.33 108.79 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -46.95 83.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 1.83 109.41 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.94 -46.4 82.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.444 -0.785 . . . . 0.31 109.65 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.0 90.41 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.783 -1.727 . . . . 0.26 108.783 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.05 -47.21 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.11 . . . . 0.31 109.42 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 85.2 mt -56.99 -47.32 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.051 -1.031 . . . . 1.06 109.779 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.19 89.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.378 -1.489 . . . . 0.3 109.378 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.558 ' CG2' HG21 ' A' ' 87' ' ' THR . 31.5 m -57.1 -46.93 82.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.091 . . . . 0.32 109.361 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.3 mt -56.92 -46.86 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.41 109.148 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.621 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -46.98 81.8 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.029 -1.1 . . . . 1.14 108.029 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.479 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 10.9 tp -57.19 -46.97 82.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.351 -0.843 . . . . 2.02 109.118 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.897 ' O ' HD12 ' B' ' 95' ' ' ILE . 75.0 mt -57.09 -47.2 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.339 -0.851 . . . . 0.77 109.493 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 75.1 m -57.03 -47.36 81.1 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.117 -1.068 . . . . 1.53 108.117 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -57.42 -47.62 81.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 2.25 109.147 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.61 -47.47 88.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.337 -1.505 . . . . 1.24 109.337 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.897 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mp -57.28 -46.95 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.422 -1.046 . . . . 1.81 109.108 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.516 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 6.8 mtm180 -57.08 -47.27 81.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 2.69 109.369 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.487 ' HA ' ' HG2' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.34 -47.02 82.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 3.17 109.93 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.85 -46.85 81.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 2.09 109.092 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 42.0 pt -72.93 -35.12 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.5 109.601 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.495 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -82.51 9.73 8.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.928 . . . . 5.22 109.862 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.47 ' HG2' ' C ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.944 -1.027 . . . . 7.38 109.823 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 63' ' ' GLN . 3.9 m . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.492 -0.558 . . . . 18.74 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 62' ' ' VAL . 53.2 tp60 57.37 159.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 16.78 109.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -142.5 -177.05 5.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.163 -0.961 . . . . 16.71 109.59 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.98 54.16 0.79 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -0.844 . . . . 14.32 109.532 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -101.04 -5.15 26.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 14.47 109.421 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.436 ' CG ' ' O ' ' A' ' 67' ' ' HIS . 42.8 t-80 -68.29 68.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 11.15 109.544 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -87.34 175.29 8.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 11.57 109.332 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.4 m -51.05 -57.8 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 7.08 109.666 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 72' ' ' GLU . 2.7 mm-40 -148.06 101.63 3.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 6.49 109.545 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HB2' ' OG1' ' A' ' 74' ' ' THR . 4.5 Cg_exo -59.06 76.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.108 1.872 . . . . 2.65 110.053 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 70' ' ' GLU . 14.3 pt-20 -57.43 -48.6 78.7 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 3.01 109.705 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 74' ' ' THR . 1.5 tp -56.11 -46.4 80.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.096 -1.003 . . . . 1.48 109.996 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.605 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -57.1 -47.02 82.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 1.35 109.194 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.021 HD13 HD13 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -66.83 -47.03 73.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.02 109.64 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.968 HD13 HD22 ' B' ' 75' ' ' LEU . 82.3 mt -56.93 -47.85 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 1.1 108.975 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.5 mm -57.79 -47.46 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 1.58 108.708 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.55 -47.39 82.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.582 -0.699 . . . . 2.09 110.119 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.873 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.25 -47.58 86.66 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.467 -1.453 . . . . 0.32 109.467 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.879 HG22 ' C ' ' B' ' 79' ' ' GLY . 87.7 t -57.65 -47.63 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.249 -1.148 . . . . 0.28 109.095 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -47.29 82.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 1.7 109.3 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.47 82.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.37 109.766 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.35 88.08 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.529 -1.428 . . . . 0.28 109.529 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.35 -47.58 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -1.228 . . . . 0.28 109.49 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 85' ' ' ILE . 43.0 mm -57.37 -47.23 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.934 . . . . 1.2 109.829 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.99 90.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.884 -1.287 . . . . 0.33 109.884 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 91' ' ' ILE . 82.1 m -56.99 -47.16 81.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.34 109.503 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 91' ' ' ILE . 56.2 mt -57.33 -47.28 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.49 109.321 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -46.95 82.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.68 109.208 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 38.5 tp -56.97 -47.01 81.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 1.92 109.466 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.896 ' O ' HG23 ' A' ' 95' ' ' ILE . 60.7 mt -56.92 -47.02 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.87 109.493 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -56.96 -47.56 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.033 -1.067 . . . . 1.29 108.804 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -47.51 81.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.948 -1.095 . . . . 2.64 109.325 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.51 87.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.406 -1.078 . . . . 1.29 110.406 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -57.28 -46.99 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.028 -1.278 . . . . 2.19 109.013 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 99' ' ' ILE . 14.7 mtm180 -57.01 -46.86 82.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 3.14 109.206 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -57.14 -46.64 82.54 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.998 -1.064 . . . . 3.58 109.716 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mt -56.68 -47.01 80.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 2.66 109.604 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER -74.75 -18.77 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 2.2 109.169 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' N ' HG13 ' A' ' 99' ' ' ILE . 9.6 tptp -96.56 123.0 40.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 3.91 109.761 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 tttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.001 -1.0 . . . . 6.53 109.303 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.477 -0.564 . . . . 20.22 109.477 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 161.12 31.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 18.1 109.527 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 71.51 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 17.47 109.464 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.25 78.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 15.58 109.542 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -144.8 -169.6 3.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 14.18 109.31 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -174.65 172.4 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 13.39 109.632 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' B' ' 69' ' ' SER . 26.6 m-85 -116.35 -74.54 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 12.43 109.447 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' B' ' 68' ' ' PHE . 0.5 OUTLIER 64.58 125.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 8.12 109.492 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.446 ' HB3' ' HD2' ' B' ' 71' ' ' PRO . 2.5 mt-10 -169.41 167.7 5.27 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 7.29 109.437 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.447 ' HB2' ' CB ' ' B' ' 74' ' ' THR . 4.7 Cg_exo -59.35 96.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.128 1.886 . . . . 2.87 110.154 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.452 ' O ' HG13 ' B' ' 76' ' ' ILE . 13.5 pt-20 -49.92 -34.62 21.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 2.89 109.526 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.752 HD13 ' C ' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -71.02 -37.97 69.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.192 -0.943 . . . . 2.11 109.324 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.597 ' N ' HD13 ' B' ' 73' ' ' ILE . 23.7 m -63.54 -46.96 83.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.147 -0.97 . . . . 1.57 109.117 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.968 HD22 HD13 ' A' ' 76' ' ' ILE . 3.5 tt -73.28 -47.35 43.65 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.63 109.55 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.021 HD13 HD13 ' A' ' 75' ' ' LEU . 82.2 mt -57.36 -48.14 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.955 -1.09 . . . . 1.02 109.179 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.486 HD13 ' O ' ' B' ' 73' ' ' ILE . 1.1 mp -58.28 -47.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 1.86 108.756 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -47.16 83.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.614 -0.679 . . . . 2.81 109.621 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.879 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.31 -47.65 86.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.669 -1.373 . . . . 0.3 109.669 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.873 HG22 ' C ' ' A' ' 79' ' ' GLY . 97.5 t -57.62 -47.85 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.089 -1.242 . . . . 0.33 109.076 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 29.0 mtt -57.81 -47.43 82.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 1.83 109.103 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.34 83.1 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.719 -0.613 . . . . 0.31 109.822 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.55 85.78 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.393 -1.483 . . . . 0.26 109.393 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.38 -47.86 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.971 -1.311 . . . . 0.31 109.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.46 -47.2 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 1.06 109.718 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.462 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -57.07 -46.95 90.98 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.869 -1.292 . . . . 0.3 109.869 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.413 ' CG2' HG21 ' A' ' 87' ' ' THR . 41.6 m -56.97 -47.43 80.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -1.214 . . . . 0.32 109.351 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.31 -47.47 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.41 108.938 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' B' ' 90' ' ' LEU . 0.1 OUTLIER -57.4 -46.98 82.9 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 1.14 109.12 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.547 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 91.2 mt -56.99 -47.17 81.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 2.02 109.808 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.673 HD11 HD11 ' A' ' 91' ' ' ILE . 62.4 mt -57.19 -47.43 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.09 -1.006 . . . . 0.77 109.622 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.47 -47.73 81.09 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.693 -1.203 . . . . 1.53 108.533 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -47.51 82.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.25 109.879 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.49 -47.61 86.96 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 1.24 109.645 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.492 HD13 ' O ' ' B' ' 91' ' ' ILE . 1.1 mp -57.35 -47.4 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -1.183 . . . . 1.81 108.712 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.528 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 21.1 mtm180 -57.24 -47.39 81.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.857 . . . . 2.69 109.571 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -57.4 -47.04 82.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.311 -0.868 . . . . 3.17 109.95 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -47.11 81.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 2.09 109.36 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 39.5 pt -71.45 -32.75 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.369 -0.832 . . . . 2.5 109.556 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.479 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.1 OUTLIER -104.68 103.95 13.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -0.879 . . . . 5.22 109.528 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.479 ' C ' ' CD ' ' B' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.981 -1.009 . . . . 7.38 109.494 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 62' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.489 -0.56 . . . . 18.74 109.489 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 16.7 tt0 60.44 159.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.943 . . . . 16.78 109.074 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.662 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -88.84 -63.32 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 16.71 109.379 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 73.77 144.06 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.301 -0.874 . . . . 14.32 109.277 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -147.66 -67.65 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 14.47 109.713 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 69' ' ' SER . 18.1 t-80 -166.88 34.68 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 11.15 109.742 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 65.9 -67.71 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 11.57 109.527 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 67' ' ' HIS . 0.4 OUTLIER -60.35 143.57 52.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 7.08 109.525 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER 166.97 93.05 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 6.49 109.62 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HG2' ' CB ' ' A' ' 74' ' ' THR . 5.7 Cg_exo -58.16 158.49 21.8 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.194 1.929 . . . . 2.65 110.372 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 73' ' ' ILE . 48.9 tt0 -64.65 -86.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 3.01 109.866 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.456 ' N ' ' HG2' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -39.51 -39.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 1.48 110.071 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.521 ' CB ' ' HG2' ' A' ' 71' ' ' PRO . 99.9 m -59.98 -46.95 87.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.24 -0.913 . . . . 1.35 109.268 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.841 HD13 HD13 ' B' ' 76' ' ' ILE . 3.2 tt -67.91 -47.28 69.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 1.02 109.801 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.94 HD13 HD13 ' B' ' 75' ' ' LEU . 57.7 mt -57.31 -47.79 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.88 -1.138 . . . . 1.1 109.111 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.447 HD11 ' CG1' ' A' ' 73' ' ' ILE . 21.0 mt -58.2 -47.82 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 1.58 109.122 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -57.62 -47.05 83.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.678 -0.639 . . . . 2.09 109.35 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.806 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.82 -47.17 88.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.362 -1.495 . . . . 0.32 109.362 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.884 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.2 t -57.16 -47.84 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.041 -1.27 . . . . 0.28 108.774 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.9 mtm -57.73 -47.21 83.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.305 -0.872 . . . . 1.7 108.93 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.14 -46.42 82.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.37 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.92 -47.26 88.18 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.204 -1.558 . . . . 0.28 109.204 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.3 -47.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.243 . . . . 0.28 109.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 82' ' ' ALA . 31.0 mt -57.54 -47.16 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 1.2 109.858 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.07 89.42 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.714 -1.354 . . . . 0.33 109.714 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -56.99 -47.12 81.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.167 -1.196 . . . . 0.34 109.157 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.11 -47.15 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.49 109.133 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.689 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.15 -46.9 82.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.68 109.214 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.6 mt -57.02 -47.11 81.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 1.92 109.455 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.732 HD11 HD11 ' B' ' 91' ' ' ILE . 18.7 mt -57.2 -46.99 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.87 109.305 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 67.5 m -57.05 -47.41 81.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.231 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.24 -46.77 82.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.539 -0.725 . . . . 2.64 109.12 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.6 -46.25 88.91 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.496 -1.842 . . . . 1.29 108.496 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mt -56.32 -46.5 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -1.081 . . . . 2.19 108.833 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 92' ' ' SER . 10.6 mmt180 -56.66 -47.0 80.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.856 -1.152 . . . . 3.14 108.649 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -57.13 -46.75 82.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 3.58 109.737 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -46.96 81.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 2.66 109.333 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 38.7 pt -72.46 -30.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 2.2 109.304 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.3 OUTLIER -82.83 150.84 26.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 3.91 109.547 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.995 -1.002 . . . . 6.53 109.338 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.53 ' O ' HG13 ' B' ' 62' ' ' VAL . 10.0 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.273 0.559 . . . . 20.22 109.509 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.84 122.52 24.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 18.1 109.482 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.22 6.0 6.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 17.47 109.573 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -97.25 -10.16 26.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 15.58 109.575 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' B' ' 65' ' ' ALA . 5.4 m80 51.85 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 14.18 109.365 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -57.73 -72.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 13.39 109.532 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.49 151.26 26.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 12.43 109.657 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 73.6 m -105.2 157.72 17.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 8.12 109.382 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -127.66 143.22 46.74 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 7.29 109.643 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' B' ' 74' ' ' THR . 1.7 Cg_endo -63.67 -23.35 69.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.193 1.928 . . . . 2.87 110.124 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 71' ' ' PRO . 0.3 OUTLIER -42.47 -59.99 1.67 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.439 -0.788 . . . . 2.89 109.445 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' B' ' 74' ' ' THR . 3.9 pt -56.47 -45.33 81.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.129 -0.982 . . . . 2.11 108.547 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.548 ' N ' ' CG1' ' B' ' 73' ' ' ILE . 36.4 m -42.81 -47.0 5.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 1.57 108.979 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.94 HD13 HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -72.75 -47.58 45.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 1.63 108.84 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.841 HD13 HD13 ' A' ' 75' ' ' LEU . 84.9 mt -57.79 -48.44 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.145 -1.022 . . . . 1.02 110.222 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.421 HD12 HG13 ' B' ' 73' ' ' ILE . 9.4 mt -58.6 -47.98 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.92 -1.113 . . . . 1.86 109.064 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.896 ' HD2' HD23 ' B' ' 75' ' ' LEU . 0.0 OUTLIER -57.68 -46.99 83.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.575 -0.528 . . . . 2.81 109.575 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.884 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.21 -47.59 86.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.698 -1.361 . . . . 0.3 109.698 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.806 HG22 ' C ' ' A' ' 79' ' ' GLY . 95.8 t -57.56 -47.79 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.057 -1.261 . . . . 0.33 108.911 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mtm -57.74 -47.25 82.98 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.413 -0.804 . . . . 1.83 109.337 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.54 82.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.495 -0.753 . . . . 0.31 109.891 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.45 87.3 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.063 -1.615 . . . . 0.26 109.063 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.26 -47.41 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -1.148 . . . . 0.31 109.437 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.4 -47.16 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 1.06 110.021 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.35 88.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.816 -1.314 . . . . 0.3 109.816 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 33.8 m -57.31 -47.36 81.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.13 -1.218 . . . . 0.32 109.226 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.28 -47.2 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.41 109.643 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.577 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -47.12 82.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 1.14 109.178 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.521 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 70.3 mt -57.21 -47.17 81.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.965 . . . . 2.02 109.512 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.803 ' O ' HD12 ' B' ' 95' ' ' ILE . 84.4 mt -57.14 -47.26 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.88 . . . . 0.77 109.512 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 5.4 p -57.18 -47.56 80.93 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.056 -1.027 . . . . 1.53 108.672 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -57.77 -47.54 82.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 2.25 109.449 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.56 -47.34 89.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.538 -1.425 . . . . 1.24 109.538 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.803 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.1 mp -57.19 -47.25 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -1.099 . . . . 1.81 109.36 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.447 ' O ' HG13 ' B' ' 99' ' ' ILE . 1.8 ttp180 -57.16 -47.25 81.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 2.69 109.482 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.49 -47.34 82.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 3.17 110.17 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -46.94 82.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 2.09 109.598 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.541 HG13 ' N ' ' B' ' 100' ' ' LYS . 36.2 pt -74.01 -34.28 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.505 -0.747 . . . . 2.5 110.203 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.541 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -142.68 136.92 29.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.078 -1.014 . . . . 5.22 110.054 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.918 -1.039 . . . . 7.38 109.329 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 62' ' ' VAL . 70.7 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.413 -0.588 . . . . 18.74 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -115.1 21.47 14.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 16.78 109.411 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.696 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 3.8 mm? 53.03 -87.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 16.71 109.617 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 64' ' ' LEU . . . 164.68 -22.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 14.32 109.911 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.49 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 2.8 m-70 -103.02 -155.28 0.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 14.47 109.661 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER 71.83 157.01 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 11.15 109.549 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -122.08 -43.57 2.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 11.57 109.627 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.78 -170.76 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 7.08 109.567 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.7 147.93 37.33 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 6.49 109.411 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 74' ' ' THR . 2.6 Cg_endo -61.72 -11.86 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.199 1.932 . . . . 2.65 110.156 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' B' ' 72' ' ' GLU . 1.3 mt-10 -45.25 -37.27 4.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 3.01 109.299 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 2.9 tp -69.43 -34.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.171 -0.956 . . . . 1.48 109.339 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -63.79 -47.0 82.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.304 -0.872 . . . . 1.35 109.336 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.087 HD13 HD13 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -78.57 -47.26 17.57 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 1.02 109.681 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.873 HD13 HD22 ' B' ' 75' ' ' LEU . 81.3 mt -57.43 -48.13 83.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.833 -1.167 . . . . 1.1 109.039 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 74' ' ' THR . 9.3 tt -58.06 -47.29 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.202 -0.936 . . . . 1.58 108.717 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 1.5 m-85 -57.39 -47.01 82.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.495 -0.753 . . . . 2.09 109.726 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.799 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -56.9 -47.29 87.73 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.504 -1.438 . . . . 0.32 109.504 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' C ' ' B' ' 79' ' ' GLY . 92.2 t -57.41 -47.58 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.998 -1.296 . . . . 0.28 108.703 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 85' ' ' ILE . 2.3 mmm -57.75 -47.07 83.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.85 . . . . 1.7 108.991 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.24 82.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.37 109.759 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.76 -47.3 86.66 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.04 -1.624 . . . . 0.28 109.04 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.457 HG13 ' OG1' ' B' ' 87' ' ' THR . 86.4 t -57.3 -47.63 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.1 -1.236 . . . . 0.28 109.356 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 81' ' ' MET . 26.5 mm -57.43 -47.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.966 . . . . 1.2 109.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.14 -46.95 91.05 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.789 -1.324 . . . . 0.33 109.789 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.458 ' HA ' HD12 ' A' ' 90' ' ' LEU . 71.2 m -56.95 -47.42 80.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -1.199 . . . . 0.34 109.5 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.39 -47.56 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.49 109.273 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.579 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.65 -47.12 83.14 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.662 -0.866 . . . . 0.68 108.662 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 11.8 mt -57.26 -46.81 82.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.497 -0.752 . . . . 1.92 109.601 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.88 ' O ' HD12 ' A' ' 95' ' ' ILE . 42.4 mt -57.02 -47.13 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.87 109.75 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -57.11 -47.74 80.35 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.674 -1.21 . . . . 1.29 108.089 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -46.87 82.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.584 -0.697 . . . . 2.64 109.25 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.54 -46.22 88.58 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.943 -1.663 . . . . 1.29 108.943 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.88 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -56.26 -46.78 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -1.119 . . . . 2.19 108.847 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 92' ' ' SER . 9.4 mmt180 -56.88 -47.16 81.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.888 -1.133 . . . . 3.14 108.726 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -46.96 82.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.393 -0.817 . . . . 3.58 109.935 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -46.95 81.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 2.66 108.752 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 96' ' ' ARG . 46.7 pt -75.51 -14.32 15.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.383 -0.823 . . . . 2.2 109.062 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 5.3 tttm -92.15 82.49 5.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 3.91 109.663 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.971 -1.014 . . . . 6.53 109.338 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.584 ' O ' HG13 ' B' ' 62' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.466 -0.568 . . . . 20.22 109.466 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.49 143.21 5.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 18.1 109.391 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.22 37.01 1.49 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 17.47 109.663 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' B' ' 66' ' ' HIS . . . -111.61 34.16 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.118 -0.989 . . . . 15.58 109.694 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 0.3 OUTLIER 73.63 -150.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.944 . . . . 14.18 109.541 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -145.27 -149.79 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 13.39 109.373 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -120.28 172.61 7.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.978 . . . . 12.43 109.507 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.476 ' O ' ' CG ' ' B' ' 70' ' ' GLU . 38.8 m -59.58 -165.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 8.12 109.618 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' B' ' 72' ' ' GLU . 86.7 mt-10 -157.92 99.45 1.82 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 7.29 109.391 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.64 59.21 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.168 1.912 . . . . 2.87 110.453 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.536 ' HG2' ' CG ' ' A' ' 72' ' ' GLU . 16.2 mt-10 -69.12 -69.26 0.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 2.89 109.75 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.736 HD13 ' C ' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -52.47 -34.08 18.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.254 -0.904 . . . . 2.11 109.208 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.597 ' N ' HD13 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -63.09 -47.0 84.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 1.57 109.425 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.873 HD22 HD13 ' A' ' 76' ' ' ILE . 3.7 tt -72.05 -47.23 53.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 1.63 109.4 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.087 HD13 HD13 ' A' ' 75' ' ' LEU . 82.6 mt -57.19 -47.65 83.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.147 -0.971 . . . . 1.02 109.25 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.97 -47.73 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.207 -0.933 . . . . 1.86 108.854 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -46.93 83.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.644 -0.66 . . . . 2.81 109.261 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.907 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.73 -47.14 87.75 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.763 -1.335 . . . . 0.3 109.763 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 79' ' ' GLY . 53.4 t -57.08 -47.63 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.987 -1.302 . . . . 0.33 108.697 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 36.3 mmm -57.74 -47.06 83.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 1.83 108.749 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.9 -46.25 82.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.64 -0.662 . . . . 0.31 109.777 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.57 -47.21 85.94 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.148 -1.581 . . . . 0.26 109.148 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.13 -47.51 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.021 -1.282 . . . . 0.31 109.171 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 73.4 mt -57.26 -46.95 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 1.06 109.814 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -46.76 90.28 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.6 -1.4 . . . . 0.3 109.6 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.457 ' OG1' HG13 ' A' ' 84' ' ' VAL . 63.0 m -56.71 -47.06 80.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.162 -1.199 . . . . 0.32 109.309 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.96 -47.24 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.41 109.022 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.689 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.17 -46.84 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 1.14 108.998 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.542 ' O ' HD13 ' B' ' 90' ' ' LEU . 0.2 OUTLIER -56.9 -46.84 81.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.88 . . . . 2.02 109.312 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 1.024 ' O ' HD12 ' B' ' 95' ' ' ILE . 79.8 mt -56.73 -46.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.185 -0.947 . . . . 0.77 108.99 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -56.62 -47.38 79.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.984 -1.073 . . . . 1.53 108.661 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' B' ' 96' ' ' ARG . 0.7 OUTLIER -57.4 -47.4 81.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 2.25 109.19 179.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.7 -47.38 88.93 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.487 -1.445 . . . . 1.24 109.487 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 1.024 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.4 mp -57.47 -47.84 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -1.08 . . . . 1.81 110.562 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.573 ' CG ' ' O ' ' B' ' 93' ' ' TYR . 7.0 ptp180 -57.5 -46.79 83.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.851 -1.156 . . . . 2.69 109.291 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' B' ' 100' ' ' LYS . 22.7 ttp180 -57.1 -46.82 82.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.166 -0.959 . . . . 3.17 109.818 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -47.04 80.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.07 -1.019 . . . . 2.09 109.134 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 42.3 pt -72.26 -26.74 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 2.5 109.133 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' B' ' 101' ' ' LYS . 5.8 tmtm? -109.14 102.21 11.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 5.22 109.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.964 -1.017 . . . . 7.38 109.371 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.51 ' O ' ' HG3' ' A' ' 63' ' ' GLN . 32.7 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.356 -0.609 . . . . 18.74 109.356 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 11.6 pt20 39.31 96.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.498 0.666 . . . . 16.78 110.55 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -9.05 36.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 16.71 109.205 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 66' ' ' HIS . . . -82.77 90.12 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 14.32 109.673 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.547 ' N ' ' CD2' ' A' ' 66' ' ' HIS . 6.4 m170 71.04 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 14.47 109.488 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.74 -154.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 11.15 109.406 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -90.77 156.18 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 11.57 109.523 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 t -110.58 94.14 4.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 7.08 109.595 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.601 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.6 OUTLIER -46.21 -53.2 23.88 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 6.49 110.093 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 5.9 Cg_exo -58.91 73.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.751 . . . . 2.65 110.445 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 70' ' ' GLU . 66.0 tt0 -64.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 3.01 109.6 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -42.46 -31.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.341 -0.849 . . . . 1.48 109.767 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -65.11 -46.81 79.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 1.35 109.888 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.027 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -76.09 -47.37 24.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 1.02 110.259 -179.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.106 HD13 HD13 ' B' ' 75' ' ' LEU . 72.3 mt -57.58 -48.24 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.676 -1.265 . . . . 1.1 109.457 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 78' ' ' PHE . 19.8 tt -58.28 -47.58 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.068 -1.02 . . . . 1.58 108.975 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' N ' HG23 ' A' ' 77' ' ' ILE . 8.9 m-30 -57.5 -47.11 82.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 2.09 109.812 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -57.1 -47.28 88.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.7 -1.36 . . . . 0.32 109.7 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.95 HG22 ' C ' ' B' ' 79' ' ' GLY . 56.4 t -57.37 -47.59 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.046 -1.267 . . . . 0.28 109.148 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -57.61 -47.1 83.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.7 109.323 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.08 -46.42 82.54 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.514 -0.741 . . . . 0.37 109.892 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.88 -47.34 87.27 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.371 -1.492 . . . . 0.28 109.371 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.8 t -57.1 -47.37 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.121 -1.223 . . . . 0.28 109.74 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.32 -46.91 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 1.2 110.008 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.05 90.46 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.849 -1.3 . . . . 0.33 109.849 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.66 ' CG2' HG21 ' B' ' 87' ' ' THR . 17.0 m -57.24 -47.3 81.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -1.214 . . . . 0.34 109.348 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.22 -47.08 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.49 109.208 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -46.8 82.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.68 109.108 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 32.3 mt -57.01 -47.06 81.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 1.92 109.672 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.926 ' O ' HD12 ' A' ' 95' ' ' ILE . 95.9 mt -57.16 -47.19 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.87 109.141 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.09 -47.43 81.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.212 -1.033 . . . . 1.29 108.212 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -57.47 -47.55 81.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 2.64 109.253 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.33 -47.25 89.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.266 -1.533 . . . . 1.29 109.266 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.926 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.08 -47.03 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.104 . . . . 2.19 108.677 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.572 ' HA ' HD11 ' A' ' 99' ' ' ILE . 10.4 mtm180 -57.05 -47.04 81.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 3.14 109.276 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.17 -46.83 82.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 3.58 109.839 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -46.95 81.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 2.66 109.074 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 96' ' ' ARG . 30.8 pt -73.15 -39.0 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 2.2 109.763 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.506 ' N ' HG13 ' A' ' 99' ' ' ILE . 1.2 mttm -97.9 -166.98 1.45 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 3.91 109.765 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.031 -0.985 . . . . 6.53 109.459 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.427 -0.583 . . . . 20.22 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.658 ' C ' HD23 ' B' ' 64' ' ' LEU . 23.7 tt0 -158.32 143.12 16.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 18.1 109.268 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.658 HD23 ' C ' ' B' ' 63' ' ' GLN . 0.0 OUTLIER -144.78 55.48 1.25 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 17.47 109.595 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.7 66.74 1.4 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.088 -1.007 . . . . 15.58 109.425 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -92.06 116.93 29.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.157 -0.965 . . . . 14.18 109.525 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -123.37 101.38 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.858 . . . . 13.39 109.094 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.83 84.93 6.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 12.43 109.723 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.67 5.06 19.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.938 . . . . 8.12 109.446 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.607 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 1.0 OUTLIER -76.95 -45.18 2.91 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 7.29 110.562 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 1.8 Cg_endo -65.17 55.57 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.658 1.572 . . . . 2.87 110.695 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -72.37 -71.97 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 2.89 109.219 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.8 OUTLIER -50.54 -36.55 14.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 2.11 109.456 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.404 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 58.9 p -62.27 -47.13 85.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 1.57 109.587 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.106 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -70.24 -47.08 62.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 1.63 109.612 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.027 HD13 HD13 ' A' ' 75' ' ' LEU . 81.8 mt -57.03 -47.59 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.837 -1.164 . . . . 1.02 108.594 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.75 -47.29 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.302 -0.873 . . . . 1.86 108.736 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.26 -47.3 81.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 2.81 109.535 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.95 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.89 -47.49 86.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.505 . . . . 0.3 109.336 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 79' ' ' GLY . 60.4 t -57.32 -47.64 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -1.234 . . . . 0.33 108.663 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.1 mmm -57.74 -47.04 83.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.424 -0.798 . . . . 1.83 108.968 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.08 -46.56 82.43 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.534 -0.729 . . . . 0.31 109.86 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.0 -47.68 85.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.763 -1.735 . . . . 0.26 108.763 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.39 -47.61 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.31 108.931 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.422 ' HA ' HD12 ' B' ' 88' ' ' ILE . 80.1 mt -57.37 -47.0 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.82 . . . . 1.06 110.031 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.655 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -56.93 -47.21 88.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.626 -1.39 . . . . 0.3 109.626 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.66 HG21 ' CG2' ' A' ' 87' ' ' THR . 78.5 m -57.28 -47.26 81.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.276 . . . . 0.32 108.588 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 85' ' ' ILE . 85.9 mt -57.23 -46.96 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.443 -0.786 . . . . 0.41 109.216 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.3 OUTLIER -56.93 -46.47 82.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 1.14 109.25 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -57.08 -47.25 81.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.008 . . . . 2.02 108.893 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.799 HD11 HD11 ' A' ' 91' ' ' ILE . 65.5 mt -57.12 -47.1 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.185 -0.947 . . . . 0.77 109.115 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.06 -47.36 81.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.122 -0.987 . . . . 1.53 108.427 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -47.47 81.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 2.25 109.494 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.51 -47.52 87.61 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.119 -1.592 . . . . 1.24 109.119 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.614 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.1 mt -57.21 -47.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -1.06 . . . . 1.81 108.943 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.558 ' O ' HG13 ' B' ' 99' ' ' ILE . 2.8 tpp180 -57.07 -46.89 82.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 2.69 109.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -46.66 82.75 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.859 -1.15 . . . . 3.17 109.453 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mt -56.78 -46.85 81.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 2.09 109.548 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.558 HG13 ' O ' ' B' ' 96' ' ' ARG . 3.9 pt -82.27 -119.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.112 -0.992 . . . . 2.5 109.199 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 99' ' ' ILE . 0.1 OUTLIER 43.38 81.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.841 -1.162 . . . . 5.22 109.683 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.047 -0.978 . . . . 7.38 109.445 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.615 HG22 ' N ' ' A' ' 63' ' ' GLN . 8.1 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.337 0.589 . . . . 18.74 109.443 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.615 ' N ' HG22 ' A' ' 62' ' ' VAL . 5.5 tp60 -94.32 -160.8 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 16.78 109.086 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.555 ' CB ' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 80.44 7.16 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 16.71 109.398 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 66' ' ' HIS . . . -90.59 30.46 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 14.32 109.515 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.59 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 39.8 m80 66.82 8.42 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 14.47 109.783 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 18.4 p80 40.56 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.498 -0.751 . . . . 11.15 110.105 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' HIS . 0.3 OUTLIER -42.77 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 11.57 109.433 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.49 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 1.9 m -105.85 -94.08 0.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.122 -0.987 . . . . 7.08 109.764 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.578 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.83 -57.56 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 6.49 109.882 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.9 Cg_exo -54.82 -75.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.026 1.817 . . . . 2.65 110.336 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 75' ' ' LEU . 4.4 mt-10 34.25 -131.5 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.804 -0.56 . . . . 3.01 110.89 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.777 ' O ' HG22 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.75 -47.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 1.48 109.881 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.569 ' N ' HG23 ' A' ' 73' ' ' ILE . 3.1 p -55.2 -46.19 75.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 1.35 108.801 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.035 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -71.76 -46.93 56.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.006 . . . . 1.02 110.04 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.081 HD13 HD13 ' B' ' 75' ' ' LEU . 59.7 mt -57.35 -48.35 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.719 -1.238 . . . . 1.1 110.116 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -58.23 -47.65 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.838 -1.164 . . . . 1.58 108.487 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' N ' HG23 ' A' ' 77' ' ' ILE . 4.4 m-30 -57.26 -47.08 82.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.804 -0.56 . . . . 2.09 109.965 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.781 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.91 -47.41 86.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.595 -1.402 . . . . 0.32 109.595 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.941 HG22 ' C ' ' B' ' 79' ' ' GLY . 61.4 t -57.41 -47.66 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.254 . . . . 0.28 108.626 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.3 mmt -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.716 -0.846 . . . . 1.7 108.716 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -57.05 -46.32 82.52 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.634 -0.666 . . . . 0.37 109.839 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.52 85.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.838 -1.705 . . . . 0.28 108.838 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' B' ' 87' ' ' THR . 61.6 t -57.39 -47.49 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.255 . . . . 0.28 108.908 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 82' ' ' ALA . 20.9 mt -57.2 -47.07 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.414 -0.804 . . . . 1.2 109.798 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.65 -46.92 88.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.546 -1.422 . . . . 0.33 109.546 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.0 m -56.97 -47.26 81.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.078 -1.248 . . . . 0.34 108.837 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.4 mt -57.23 -47.16 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.85 . . . . 0.49 109.184 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.2 -46.95 82.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.411 -0.806 . . . . 0.68 109.017 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.48 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 18.2 mt -56.92 -46.89 81.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 1.92 109.074 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 95' ' ' ILE . 33.6 mt -56.85 -46.78 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.87 109.127 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.3 80.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.087 -1.008 . . . . 1.29 108.536 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -47.53 81.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 2.64 108.897 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.54 -47.15 90.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.172 -1.571 . . . . 1.29 109.172 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 91' ' ' ILE . 1.5 mt -57.02 -46.91 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -1.013 . . . . 2.19 109.142 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.544 ' O ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -56.67 -46.62 81.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 3.14 109.079 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.95 -46.66 81.96 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.94 -1.1 . . . . 3.58 109.205 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.66 -47.03 80.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 2.66 109.325 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 96' ' ' ARG . 6.3 pt -82.03 -118.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.077 -1.014 . . . . 2.2 108.703 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER 61.19 141.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.617 -1.302 . . . . 3.91 109.704 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mttt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.977 -1.011 . . . . 6.53 109.498 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.442 -0.577 . . . . 20.22 109.442 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.512 ' O ' HD12 ' B' ' 64' ' ' LEU . 2.5 pp0? -172.12 163.52 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 18.1 109.4 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.512 HD12 ' O ' ' B' ' 63' ' ' GLN . 1.2 mp -128.68 57.41 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 17.47 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.22 32.63 1.69 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.082 -1.011 . . . . 15.58 109.527 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.58 166.71 11.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 14.18 109.266 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 m170 55.29 72.22 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 13.39 109.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -59.02 -169.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 12.43 109.685 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.2 p -168.56 -163.2 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 8.12 109.519 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.533 ' CB ' ' HD2' ' B' ' 71' ' ' PRO . 0.7 OUTLIER -125.27 172.92 5.46 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 7.29 109.259 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' B' ' 70' ' ' GLU . 4.4 Cg_exo -57.73 134.1 60.64 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.17 1.913 . . . . 2.87 110.402 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.15 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.436 -0.79 . . . . 2.89 110.586 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.706 HD13 ' C ' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -43.08 -38.65 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.101 -0.999 . . . . 2.11 110.33 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.695 ' N ' HD13 ' B' ' 73' ' ' ILE . 19.6 m -63.46 -46.78 84.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 1.57 109.713 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.081 HD13 HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -76.32 -47.15 24.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.982 -1.074 . . . . 1.63 109.662 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.035 HD13 HD13 ' A' ' 75' ' ' LEU . 58.3 mt -57.26 -48.24 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.926 -1.109 . . . . 1.02 109.329 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.586 HG23 ' N ' ' B' ' 78' ' ' PHE . 0.6 OUTLIER -57.98 -47.24 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.979 -1.076 . . . . 1.86 108.618 178.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.586 ' N ' HG23 ' B' ' 77' ' ' ILE . 1.5 m-85 -57.24 -47.14 82.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.525 -0.734 . . . . 2.81 109.861 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.941 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.13 -47.38 88.03 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.776 -1.33 . . . . 0.3 109.776 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.781 HG22 ' C ' ' A' ' 79' ' ' GLY . 65.8 t -57.37 -47.57 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.002 -1.293 . . . . 0.33 109.065 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . 0.458 ' O ' HG13 ' B' ' 85' ' ' ILE . 4.7 mtm -57.62 -47.21 82.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.309 -0.869 . . . . 1.83 108.945 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -57.15 -46.39 82.76 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.546 -0.722 . . . . 0.31 109.913 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.97 -47.56 86.15 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.476 -1.45 . . . . 0.26 109.476 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.38 -47.56 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.974 -1.31 . . . . 0.31 109.004 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 82' ' ' ALA . 63.8 mt -57.33 -46.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 1.06 109.759 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.01 90.36 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.836 -1.306 . . . . 0.3 109.836 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 84' ' ' VAL . 40.5 m -57.04 -47.44 80.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.973 -1.31 . . . . 0.32 108.918 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 35.1 mt -57.4 -46.98 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.41 108.803 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.675 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.95 -46.59 82.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.029 -0.73 . . . . 1.14 109.029 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.613 ' O ' HD23 ' B' ' 90' ' ' LEU . 0.6 OUTLIER -56.67 -46.97 80.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.238 -0.914 . . . . 2.02 109.145 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.614 ' O ' HD12 ' B' ' 95' ' ' ILE . 82.3 mt -57.03 -47.02 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.124 -0.985 . . . . 0.77 109.074 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 14.8 m -57.01 -47.3 81.2 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.033 -1.042 . . . . 1.53 108.471 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -47.38 81.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 2.25 108.863 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.2 89.87 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.175 -1.57 . . . . 1.24 109.175 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.614 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mt -57.02 -47.17 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -1.088 . . . . 1.81 108.908 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 99' ' ' ILE . 3.9 mtm180 -57.01 -47.08 81.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 2.69 108.937 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -46.65 82.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.211 -0.931 . . . . 3.17 109.601 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.57 -46.85 80.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 2.09 109.305 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.517 HG13 ' N ' ' B' ' 100' ' ' LYS . 21.6 pt -77.06 -125.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.203 -0.936 . . . . 2.5 108.638 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.517 ' N ' HG13 ' B' ' 99' ' ' ILE . 8.3 tptt 43.53 64.79 1.14 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.88 -1.138 . . . . 5.22 109.491 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 28.8 mttm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.001 -1.0 . . . . 7.38 109.402 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.406 -0.59 . . . . 18.74 109.406 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -113.35 121.3 43.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 16.78 109.536 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 3.4 mt -114.31 179.99 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 16.71 109.405 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 66.32 15.26 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 14.32 109.45 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 171.0 7.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 14.47 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.44 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 11.15 109.5 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -79.29 156.46 28.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 11.57 109.36 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 t -107.27 104.27 13.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 7.08 109.297 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.567 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -43.97 -54.22 11.57 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 6.49 109.707 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 2.0 Cg_endo -63.55 57.73 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.086 1.857 . . . . 2.65 110.285 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' GLU . 7.8 mt-10 -66.15 -49.18 68.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 3.01 109.734 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.679 HD13 ' N ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -60.68 -39.03 80.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.257 -0.902 . . . . 1.48 109.594 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.679 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -61.69 -46.99 87.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.969 -1.082 . . . . 1.35 109.006 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.81 HD22 HG12 ' B' ' 76' ' ' ILE . 1.4 mt -66.96 -46.65 74.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 1.02 109.16 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.906 ' O ' HG23 ' A' ' 80' ' ' VAL . 26.8 mt -56.66 -47.68 81.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.059 -1.025 . . . . 1.1 108.899 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 73' ' ' ILE . 35.8 mt -57.72 -47.88 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.091 -1.006 . . . . 1.58 109.338 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.92 -48.43 79.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 2.09 109.588 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.914 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.91 -47.34 89.56 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.104 -1.598 . . . . 0.32 109.104 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.907 HG22 ' O ' ' B' ' 79' ' ' GLY . 44.9 t -57.17 -47.26 84.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.708 -0.878 . . . . 0.28 109.934 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 mmm -57.16 -47.32 81.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 1.7 109.153 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.41 82.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.374 -0.829 . . . . 0.37 109.41 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.0 -47.1 90.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.936 -1.266 . . . . 0.28 109.936 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.15 -47.49 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.251 . . . . 0.28 109.619 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.7 mt -57.29 -47.22 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 1.2 109.565 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.13 -46.9 91.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.97 -1.252 . . . . 0.33 109.97 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.631 ' OG1' HG13 ' B' ' 84' ' ' VAL . 74.7 m -56.88 -47.17 81.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -1.182 . . . . 0.34 109.209 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.3 mt -57.14 -46.94 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.49 108.901 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.14 -46.74 82.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.68 109.066 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 90' ' ' LEU . 9.5 tt -56.85 -46.88 81.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.257 -0.902 . . . . 1.92 109.494 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.76 HD11 HD11 ' B' ' 91' ' ' ILE . 98.1 mt -57.03 -46.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.993 . . . . 0.87 108.905 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -47.39 81.2 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.093 -1.005 . . . . 1.29 108.399 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -57.3 -47.54 81.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 2.64 109.196 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.31 -46.98 91.2 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.036 -1.626 . . . . 1.29 109.036 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 91' ' ' ILE . 2.2 mt -57.05 -46.82 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 2.19 108.86 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' HA ' HD11 ' A' ' 99' ' ' ILE . 34.1 ttp180 -56.93 -47.07 81.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.954 . . . . 3.14 109.291 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -57.32 -46.88 82.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 3.58 109.891 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.84 -46.95 81.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 2.66 108.777 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 96' ' ' ARG . 34.5 pt -72.59 -19.71 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.91 . . . . 2.2 109.167 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -110.07 84.68 1.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 3.91 109.565 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.977 -1.011 . . . . 6.53 109.385 -179.898 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.687 -0.486 . . . . 20.22 109.687 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.71 ' NE2' ' HB2' ' B' ' 65' ' ' ALA . 0.0 OUTLIER -136.83 121.04 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 18.1 109.513 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.71 109.35 0.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 17.47 109.39 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.71 ' HB2' ' NE2' ' B' ' 63' ' ' GLN . . . -123.59 22.44 9.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.002 -1.061 . . . . 15.58 109.543 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 46.19 68.05 0.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 14.18 109.541 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.69 -165.5 2.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 13.39 109.415 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.43 ' CE1' ' OE1' ' B' ' 70' ' ' GLU . 1.1 p90 -61.73 -171.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 12.43 109.349 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 22.5 m -127.98 104.36 7.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 8.12 109.604 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.663 ' O ' HG22 ' B' ' 73' ' ' ILE . 0.1 OUTLIER -64.48 174.12 1.31 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 7.29 109.444 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' B' ' 70' ' ' GLU . 2.4 Cg_endo -62.92 -53.07 1.78 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.982 1.788 . . . . 2.87 110.303 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -48.61 -56.21 9.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 2.89 109.967 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.795 ' O ' HD13 ' B' ' 77' ' ' ILE . 0.3 OUTLIER -56.9 -33.4 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.949 -1.095 . . . . 2.11 109.54 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 21.0 m -62.08 -47.02 86.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.238 -0.914 . . . . 1.57 109.135 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.83 HD23 ' C ' ' B' ' 75' ' ' LEU . 2.8 tt -67.27 -47.23 71.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 1.63 109.343 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.81 HG12 HD22 ' A' ' 75' ' ' LEU . 45.5 mt -57.12 -47.42 83.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.975 -1.078 . . . . 1.02 108.634 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.795 HD13 ' O ' ' B' ' 73' ' ' ILE . 1.5 mp -57.46 -47.56 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.316 -0.865 . . . . 1.86 109.416 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.52 -48.13 80.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.975 -1.078 . . . . 2.81 109.529 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.907 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.73 -47.38 89.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.009 -1.636 . . . . 0.3 109.009 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.914 HG22 ' O ' ' A' ' 79' ' ' GLY . 46.2 t -57.43 -47.14 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.644 -0.915 . . . . 0.33 109.733 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 16.5 mmt -56.95 -46.97 81.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 1.83 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.36 81.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.341 -0.85 . . . . 0.31 109.361 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.412 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.99 -47.16 89.52 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.618 -1.393 . . . . 0.26 109.618 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 80' ' ' VAL . 5.3 t -57.02 -47.52 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.283 . . . . 0.31 109.241 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.27 -47.07 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.06 109.669 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.89 -47.08 89.45 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.425 -1.47 . . . . 0.3 109.425 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.439 ' O ' HG13 ' B' ' 91' ' ' ILE . 91.6 m -57.14 -47.07 82.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -1.156 . . . . 0.32 108.975 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.41 HG13 ' O ' ' B' ' 84' ' ' VAL . 37.1 mt -57.11 -47.03 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.41 109.14 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.701 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -56.81 -46.95 81.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.307 -0.871 . . . . 1.14 109.0 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.522 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 6.7 mt -56.8 -47.12 80.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 2.02 109.06 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 91' ' ' ILE . 53.8 mt -57.12 -47.34 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.949 . . . . 0.77 109.405 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 91.4 p -57.29 -47.77 80.64 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.042 -1.037 . . . . 1.53 108.651 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -47.66 81.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 2.25 109.231 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.61 -47.27 89.58 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.301 -1.52 . . . . 1.24 109.301 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.45 ' O ' HG12 ' B' ' 99' ' ' ILE . 1.9 mm -57.16 -47.31 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.324 -1.104 . . . . 1.81 108.66 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.554 ' HA ' HD11 ' B' ' 99' ' ' ILE . 5.3 mtm180 -57.36 -47.26 82.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 2.69 109.206 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 100' ' ' LYS . 1.2 tmt_? -57.52 -47.12 82.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 3.17 109.883 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 98' ' ' LEU . 50.0 mt -57.02 -47.0 81.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.118 -0.989 . . . . 2.09 109.295 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' B' ' 96' ' ' ARG . 32.9 pt -71.2 -35.87 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 2.5 109.653 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.466 ' N ' HG13 ' B' ' 99' ' ' ILE . 4.4 tptp -117.79 120.54 38.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 5.22 109.814 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.994 -1.003 . . . . 7.38 109.533 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.475 -0.565 . . . . 18.74 109.475 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -165.59 119.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 16.78 109.491 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -18.05 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 16.71 109.516 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.83 -15.08 10.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 14.32 109.596 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -110.36 104.8 13.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.904 . . . . 14.47 109.616 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 67' ' ' HIS . 47.4 p-80 -166.87 121.17 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 11.15 109.459 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -150.1 15.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.913 . . . . 11.57 109.564 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.463 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -128.66 29.23 5.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -0.923 . . . . 7.08 109.425 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.566 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -78.47 -53.37 1.29 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 6.49 110.375 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 4.8 Cg_exo -61.38 -11.19 18.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.103 1.869 . . . . 2.65 110.981 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 73' ' ' ILE . 15.9 pt-20 -60.68 -47.39 86.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 3.01 109.322 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 74' ' ' THR . 5.7 tp -63.25 -44.7 99.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.141 -0.974 . . . . 1.48 109.353 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.567 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -53.64 -46.89 70.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 1.35 109.816 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.062 HD13 HD13 ' B' ' 76' ' ' ILE . 0.5 OUTLIER -69.09 -47.16 65.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.02 -1.05 . . . . 1.02 109.908 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.959 HD13 HD13 ' B' ' 75' ' ' LEU . 61.6 mt -57.11 -47.7 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.909 -1.119 . . . . 1.1 108.754 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 73' ' ' ILE . 1.1 mp -57.66 -47.11 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.327 -0.99 . . . . 1.58 108.327 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.24 -47.28 81.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 2.09 109.83 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.859 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.06 -47.38 87.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.178 -1.569 . . . . 0.32 109.178 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.896 HG22 ' C ' ' B' ' 79' ' ' GLY . 48.4 t -57.59 -47.5 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -1.162 . . . . 0.28 109.238 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 85.0 mtp -57.63 -47.35 82.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 1.7 109.303 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.53 82.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.37 109.876 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.99 -47.42 87.47 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.529 -1.429 . . . . 0.28 109.529 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.28 -47.48 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 0.28 109.495 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 85' ' ' ILE . 33.4 mm -57.28 -47.41 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 1.2 110.081 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . -57.24 -47.19 89.66 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.642 -1.383 . . . . 0.33 109.642 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 90' ' ' LEU . 98.1 m -57.16 -47.14 81.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -1.194 . . . . 0.34 109.537 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.4 mt -56.97 -47.23 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.49 109.536 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -57.18 -46.55 82.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.159 -0.963 . . . . 0.68 109.044 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 87' ' ' THR . 8.7 mt -57.13 -47.0 82.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 1.92 109.461 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.105 HD11 HD11 ' B' ' 91' ' ' ILE . 89.2 mt -56.86 -47.16 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.93 . . . . 0.87 109.453 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.4 m -57.16 -47.69 80.55 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.922 -1.111 . . . . 1.29 108.487 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -47.48 82.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.071 -1.018 . . . . 2.64 109.611 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.5 -47.36 88.77 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.16 -1.176 . . . . 1.29 110.16 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 92' ' ' SER . 1.5 tp -57.07 -46.95 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -1.227 . . . . 2.19 108.983 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HA ' HD11 ' A' ' 99' ' ' ILE . 19.2 mtp180 -56.87 -46.82 81.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 3.14 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -46.96 82.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.867 -1.146 . . . . 3.58 109.365 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -46.97 81.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 2.66 109.139 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.569 HD11 ' HA ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -82.77 -103.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.376 -0.828 . . . . 2.2 109.286 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 1.3 tptt 48.27 31.17 2.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.901 -1.125 . . . . 3.91 109.786 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 tptp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.944 -1.027 . . . . 6.53 109.471 179.854 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.3 0.571 . . . . 20.22 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.83 149.4 23.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 18.1 109.637 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 168.04 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.41 -0.806 . . . . 17.47 109.461 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.69 130.75 38.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.196 -0.94 . . . . 15.58 109.339 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -115.49 137.17 52.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 14.18 109.541 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -127.6 11.52 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 13.39 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.427 ' O ' ' CB ' ' B' ' 69' ' ' SER . 2.6 m-85 -106.56 35.9 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 12.43 109.453 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' B' ' 68' ' ' PHE . 2.6 p 170.38 86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 8.12 109.511 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -156.86 154.32 26.26 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 7.29 109.345 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.466 ' O ' ' HB ' ' B' ' 74' ' ' THR . 2.1 Cg_endo -62.07 -21.72 72.94 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.166 1.911 . . . . 2.87 109.999 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -48.43 -65.63 0.53 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.88 . . . . 2.89 109.473 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.497 ' O ' HG23 ' B' ' 77' ' ' ILE . 0.5 OUTLIER -46.67 -40.89 4.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.277 -0.89 . . . . 2.11 109.616 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.555 ' O ' HG12 ' B' ' 77' ' ' ILE . 58.8 m -56.28 -46.94 79.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 1.57 109.698 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -69.83 -46.82 64.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 1.63 109.52 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.062 HD13 HD13 ' A' ' 75' ' ' LEU . 66.3 mt -57.07 -47.8 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.896 -1.127 . . . . 1.02 109.532 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.556 HG13 ' N ' ' B' ' 78' ' ' PHE . 33.7 pt -57.91 -47.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.876 -1.14 . . . . 1.86 108.721 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.556 ' N ' HG13 ' B' ' 77' ' ' ILE . 8.7 m-85 -57.35 -47.05 82.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 2.81 109.505 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.896 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.95 -47.14 89.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.525 -1.43 . . . . 0.3 109.525 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' C ' ' A' ' 79' ' ' GLY . 69.7 t -57.1 -47.67 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.092 -1.24 . . . . 0.33 109.189 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . 0.461 ' O ' HG13 ' B' ' 85' ' ' ILE . 63.6 mtm -57.57 -47.22 82.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 1.83 108.95 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.26 82.71 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.616 -0.678 . . . . 0.31 109.672 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.22 86.31 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.26 109.34 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.02 -47.47 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.102 -1.234 . . . . 0.31 109.191 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 81' ' ' MET . 30.7 mt -57.27 -47.12 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 1.06 109.633 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.95 90.93 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.663 -1.375 . . . . 0.3 109.663 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.504 HG21 ' CG2' ' A' ' 87' ' ' THR . 41.4 m -56.93 -47.03 81.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -1.197 . . . . 0.32 109.37 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' B' ' 91' ' ' ILE . 91.7 mt -57.06 -47.08 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.088 -1.008 . . . . 0.41 108.724 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.04 -46.77 82.15 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.363 -0.977 . . . . 1.14 108.363 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.508 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 94.6 mt -56.68 -46.56 81.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 2.02 109.154 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 1.105 HD11 HD11 ' A' ' 91' ' ' ILE . 88.6 mt -56.56 -46.9 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.77 109.191 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.56 ' O ' ' CG2' ' B' ' 95' ' ' ILE . 5.8 m -56.84 -47.43 80.35 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.893 -1.129 . . . . 1.53 108.185 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -47.63 81.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.854 -1.154 . . . . 2.25 109.034 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.84 85.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.785 -0.926 . . . . 1.24 110.785 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.56 ' CG2' ' O ' ' B' ' 92' ' ' SER . 1.2 tt -57.27 -46.79 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.935 -1.332 . . . . 1.81 109.302 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.505 ' HA ' HD11 ' B' ' 99' ' ' ILE . 3.9 mtm180 -56.9 -47.05 81.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.172 -0.955 . . . . 2.69 109.388 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -46.88 82.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 3.17 109.679 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.71 -46.85 81.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.934 . . . . 2.09 108.971 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.522 HG13 ' N ' ' B' ' 100' ' ' LYS . 35.7 pt -76.61 -130.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.401 -0.812 . . . . 2.5 108.847 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.522 ' N ' HG13 ' B' ' 99' ' ' ILE . 3.5 ttpt 56.3 161.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.939 -1.101 . . . . 5.22 109.748 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' B' ' 100' ' ' LYS . 3.3 mttm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.022 -0.99 . . . . 7.38 109.52 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 42.7 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.366 -0.605 . . . . 18.74 109.366 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 7.8 tp-100 71.13 172.81 0.31 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 16.78 109.361 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 81.34 -4.82 1.64 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.756 . . . . 16.71 109.574 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' HIS . . . -93.8 -26.63 16.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.205 -0.934 . . . . 14.32 109.257 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 65' ' ' ALA . 1.7 m-70 54.74 170.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 14.47 109.737 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.2 23.23 0.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -0.859 . . . . 11.15 109.236 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 51.1 -176.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.273 -0.892 . . . . 11.57 109.404 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m 58.39 86.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 7.08 109.262 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -144.77 92.3 5.9 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 6.49 109.581 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 5.0 Cg_exo -59.09 92.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.139 1.893 . . . . 2.65 109.966 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HG3' ' CD1' ' B' ' 75' ' ' LEU . 74.2 tt0 -68.44 -81.23 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 3.01 109.878 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -45.43 -31.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.124 -0.985 . . . . 1.48 110.109 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -68.04 -47.13 69.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.092 -1.005 . . . . 1.35 109.847 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.868 HD13 HD11 ' B' ' 76' ' ' ILE . 6.9 mt -74.28 -47.25 36.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 1.02 109.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.814 HD11 HD22 ' B' ' 75' ' ' LEU . 26.7 mt -57.14 -47.91 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 118.868 -1.133 . . . . 1.1 108.579 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 73' ' ' ILE . 16.5 mm -58.12 -47.92 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.474 -0.89 . . . . 1.58 109.336 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -57.86 -47.84 81.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.329 -0.857 . . . . 2.09 110.029 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.866 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.41 88.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.908 -1.277 . . . . 0.32 109.908 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 ' O ' ' B' ' 79' ' ' GLY . 48.7 t -57.25 -47.3 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.283 -1.128 . . . . 0.28 109.037 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.1 mmm -57.41 -47.32 82.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.201 -0.937 . . . . 1.7 108.72 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.29 -46.68 82.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -0.797 . . . . 0.37 109.749 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.747 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.22 -47.35 88.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.376 -1.49 . . . . 0.28 109.376 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.35 -47.26 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -1.172 . . . . 0.28 109.644 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 0.2 OUTLIER -57.09 -47.17 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 1.2 109.599 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.03 -47.16 89.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.28 -1.528 . . . . 0.33 109.28 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.0 m -57.17 -46.96 82.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -1.105 . . . . 0.34 109.158 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.05 -47.0 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.49 109.11 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.97 -47.02 81.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.68 108.985 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.548 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 2.1 tp -57.17 -47.24 81.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.187 -0.946 . . . . 1.92 109.285 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 95' ' ' ILE . 91.6 mt -57.24 -47.29 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.87 109.374 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.8 m -57.26 -47.57 81.07 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.073 -1.017 . . . . 1.29 108.603 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.51 -47.68 81.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 2.64 109.387 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.42 -47.5 87.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.623 . . . . 1.29 109.041 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.4 mt -57.4 -47.36 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -1.073 . . . . 2.19 108.841 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.624 ' HA ' HD11 ' A' ' 99' ' ' ILE . 6.1 mtm180 -57.21 -47.06 82.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.315 -0.865 . . . . 3.14 109.55 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 4.6 ttt180 -57.54 -47.3 82.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.995 -1.065 . . . . 3.58 109.743 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -57.3 -46.72 82.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 2.66 109.494 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 96' ' ' ARG . 0.5 OUTLIER -78.22 -81.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 2.2 110.264 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 2.0 mtmt -94.44 125.09 38.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 3.91 110.009 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.043 -0.98 . . . . 6.53 109.459 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.481 -0.562 . . . . 20.22 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.643 ' OE1' ' HB2' ' B' ' 65' ' ' ALA . 1.7 pp0? -124.19 153.57 41.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 18.1 109.566 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 94.39 9.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 17.47 109.553 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.643 ' HB2' ' OE1' ' B' ' 63' ' ' GLN . . . -123.37 17.7 9.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.178 -0.952 . . . . 15.58 109.432 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' B' ' 65' ' ' ALA . 0.0 OUTLIER 170.21 142.61 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 14.18 109.397 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 81.29 1.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 13.39 109.515 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 48.6 -171.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 12.43 109.505 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.29 2.4 5.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 8.12 109.548 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.561 ' O ' HG22 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -115.48 115.23 42.25 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 7.29 109.265 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.84 -27.89 85.53 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.911 1.741 . . . . 2.87 110.456 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.77 -53.61 48.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 2.89 109.785 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.561 HG22 ' O ' ' B' ' 70' ' ' GLU . 9.5 tp -66.73 -31.97 55.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.04 -1.038 . . . . 2.11 109.177 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 51.4 m -62.08 -47.01 86.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.304 -0.873 . . . . 1.57 109.31 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 76' ' ' ILE . 6.0 mt -68.72 -46.99 67.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.19 -0.944 . . . . 1.63 109.265 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.868 HD11 HD13 ' A' ' 75' ' ' LEU . 72.3 mt -56.98 -47.78 82.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 118.94 -1.104 . . . . 1.02 108.731 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' B' ' 77' ' ' ILE . 14.1 mm -57.9 -47.79 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.226 -0.921 . . . . 1.86 109.567 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.7 -47.76 81.46 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 2.81 109.663 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.46 -47.22 89.74 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.301 -1.519 . . . . 0.3 109.301 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 79' ' ' GLY . 26.0 t -57.2 -47.21 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.498 -1.001 . . . . 0.33 109.704 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 3.4 mtm -57.3 -47.3 81.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 1.83 109.576 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.91 82.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.31 109.72 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.47 -47.31 89.08 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.646 -1.382 . . . . 0.26 109.646 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.24 -47.49 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -1.157 . . . . 0.31 109.668 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 87.4 mt -57.32 -47.22 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.176 -0.952 . . . . 1.06 110.027 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.33 88.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.648 -1.381 . . . . 0.3 109.648 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 73.5 m -57.47 -47.29 82.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.135 -1.215 . . . . 0.32 109.326 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 38.8 mt -57.41 -47.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.41 109.649 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.663 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.1 -46.84 82.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.412 -0.805 . . . . 1.14 109.216 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.18 -47.21 81.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -0.947 . . . . 2.02 109.212 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.632 HD11 HD11 ' A' ' 91' ' ' ILE . 70.7 mt -57.36 -47.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.77 109.678 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.2 m -57.24 -47.62 80.89 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.947 -1.096 . . . . 1.53 108.919 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.6 -47.5 81.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 2.25 109.244 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.36 -47.17 89.98 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.184 -1.566 . . . . 1.24 109.184 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.504 HD12 HG22 ' B' ' 91' ' ' ILE . 1.9 mt -57.0 -47.08 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -1.085 . . . . 1.81 108.854 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.506 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 8.5 mtm180 -57.0 -47.4 80.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.078 -1.014 . . . . 2.69 109.516 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -57.38 -47.04 82.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 3.17 109.974 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -46.91 81.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 2.09 109.3 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 44.5 pt -72.54 -18.73 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 2.5 109.435 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.96 59.6 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 5.22 109.581 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.007 -0.997 . . . . 7.38 109.544 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.522 -0.547 . . . . 18.74 109.522 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -126.7 145.76 50.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.172 -0.955 . . . . 16.78 109.506 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -76.6 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.215 -0.928 . . . . 16.71 109.262 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.49 132.06 46.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 14.32 109.333 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.46 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 50.2 t-80 -61.71 -18.07 58.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 14.47 109.432 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -123.99 -79.25 0.61 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 11.15 109.535 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 67' ' ' HIS . 0.2 OUTLIER 75.45 -175.62 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 11.57 109.468 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.55 -167.0 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 7.08 109.396 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER 58.17 101.06 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 6.49 109.489 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.403 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.3 Cg_exo -60.29 -37.6 81.3 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.019 1.813 . . . . 2.65 110.348 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' OE2' ' HG3' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -47.39 -69.34 0.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -0.935 . . . . 3.01 109.812 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 70' ' ' GLU . 5.0 tp -50.85 -38.33 17.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.132 -0.98 . . . . 1.48 109.58 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 16.6 m -58.08 -46.94 84.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 1.35 109.08 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.832 HD22 HG12 ' B' ' 76' ' ' ILE . 0.2 OUTLIER -67.34 -46.83 72.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 1.02 109.392 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.879 HG13 HD21 ' B' ' 75' ' ' LEU . 25.3 mt -56.89 -47.57 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.947 -1.095 . . . . 1.1 108.696 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -57.78 -47.77 85.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.46 -0.896 . . . . 1.58 109.448 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -57.7 -48.08 80.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -0.992 . . . . 2.09 109.495 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.859 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.66 -47.61 87.24 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.07 -1.612 . . . . 0.32 109.07 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.889 HG22 ' O ' ' B' ' 79' ' ' GLY . 43.3 t -57.43 -47.19 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.567 -0.96 . . . . 0.28 109.148 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 mmm -57.13 -46.9 82.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.37 -0.831 . . . . 1.7 109.074 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.81 -46.23 81.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 0.37 109.314 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.493 ' N ' HG13 ' B' ' 80' ' ' VAL . . . -56.76 -46.98 89.06 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.314 -1.514 . . . . 0.28 109.314 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.566 HG13 ' OG1' ' B' ' 87' ' ' THR . 95.4 t -56.88 -47.22 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.031 -1.276 . . . . 0.28 109.202 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 82' ' ' ALA . 75.3 mt -57.1 -46.93 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.159 -0.963 . . . . 1.2 109.354 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.02 -46.84 91.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.33 109.703 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.705 ' OG1' HG13 ' B' ' 84' ' ' VAL . 92.8 m -56.78 -47.46 80.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.162 -1.199 . . . . 0.34 109.068 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.23 -47.11 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.49 108.781 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.19 -46.71 82.6 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.5 -0.75 . . . . 0.68 108.987 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.483 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 16.8 tp -56.66 -47.02 80.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 1.92 109.463 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 95' ' ' ILE . 57.2 mt -57.03 -47.11 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.043 -1.035 . . . . 0.87 108.408 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.571 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -57.14 -47.23 81.64 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.348 -0.982 . . . . 1.29 108.348 178.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -47.92 80.68 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.956 -1.09 . . . . 2.64 109.344 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.09 -48.2 84.43 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.941 -1.123 . . . . 1.29 110.557 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 92' ' ' SER . 2.8 tp -57.71 -47.02 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.064 -1.256 . . . . 2.19 109.145 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 99' ' ' ILE . 8.1 mtm180 -56.95 -47.05 81.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.858 . . . . 3.14 109.429 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -57.05 -46.85 82.13 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.07 -1.019 . . . . 3.58 109.481 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.651 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.75 -46.9 81.11 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.418 -0.956 . . . . 2.66 108.418 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 96' ' ' ARG . 5.3 pt -85.63 39.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 2.2 109.634 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -155.72 102.17 2.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.995 . . . . 3.91 109.628 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 6.53 109.484 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.393 -0.595 . . . . 20.22 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.458 ' O ' ' NE2' ' B' ' 63' ' ' GLN . 0.7 OUTLIER -150.74 91.08 1.69 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 18.1 109.499 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' B' ' 63' ' ' GLN . 0.1 OUTLIER 44.13 58.28 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 17.47 109.341 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.1 107.44 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 15.58 109.553 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 1.9 p80 -168.01 122.6 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 14.18 109.368 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 12.3 t-160 66.82 129.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -0.916 . . . . 13.39 109.206 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -120.62 76.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 12.43 109.689 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' B' ' 70' ' ' GLU . 1.5 m -150.45 99.76 2.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.91 . . . . 8.12 109.297 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.567 ' CB ' ' HD3' ' B' ' 71' ' ' PRO . 1.6 mt-10 172.48 -57.17 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.924 . . . . 7.29 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' B' ' 70' ' ' GLU . 3.5 Cg_exo -59.81 156.34 38.62 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.926 1.751 . . . . 2.87 110.424 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' B' ' 73' ' ' ILE . 65.5 mm-40 -53.01 -65.99 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 2.89 109.488 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.566 HG23 ' N ' ' B' ' 74' ' ' THR . 0.5 OUTLIER -42.46 -46.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.328 -0.857 . . . . 2.11 110.274 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.566 ' N ' HG23 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -56.69 -47.06 80.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.032 -1.043 . . . . 1.57 109.898 -179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.879 HD21 HG13 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -70.89 -47.12 60.92 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.114 -0.991 . . . . 1.63 109.861 -179.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.832 HG12 HD22 ' A' ' 75' ' ' LEU . 59.4 mt -57.03 -47.32 83.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.887 -1.133 . . . . 1.02 108.633 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.449 HD13 HG13 ' B' ' 73' ' ' ILE . 1.1 mp -57.61 -47.15 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.78 . . . . 1.86 109.195 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -57.08 -47.62 80.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.089 -1.007 . . . . 2.81 109.767 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.889 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.39 -47.39 88.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.154 -1.578 . . . . 0.3 109.154 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 79' ' ' GLY . 40.9 t -57.37 -47.22 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.477 -1.013 . . . . 0.33 109.578 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.8 mmm -56.97 -47.04 81.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 1.83 108.946 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.554 -0.716 . . . . 0.31 109.298 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.581 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.81 -47.12 88.44 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.743 -1.343 . . . . 0.26 109.743 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.705 HG13 ' OG1' ' A' ' 87' ' ' THR . 30.1 t -57.1 -47.46 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.387 . . . . 0.31 109.078 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -57.11 -46.95 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 1.06 109.347 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' B' ' 90' ' ' LEU . . . -56.85 -46.87 89.82 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.811 -1.316 . . . . 0.3 109.811 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.566 ' OG1' HG13 ' A' ' 84' ' ' VAL . 31.7 m -56.65 -47.32 80.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.262 . . . . 0.32 109.193 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' B' ' 88' ' ' ILE . 14.0 mt -57.21 -47.14 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.039 -1.038 . . . . 0.41 108.944 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.669 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.05 -46.83 82.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.511 -0.743 . . . . 1.14 109.306 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.531 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 87.6 mt -57.08 -47.04 81.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.95 . . . . 2.02 109.459 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.859 ' O ' HD12 ' B' ' 95' ' ' ILE . 72.0 mt -57.08 -47.32 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.77 109.602 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 53.4 p -57.22 -47.62 80.87 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.942 -1.099 . . . . 1.53 108.563 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -47.32 82.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -0.788 . . . . 2.25 109.396 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.33 88.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.685 -1.366 . . . . 1.24 109.685 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.859 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.3 mp -57.14 -47.4 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.109 -1.23 . . . . 1.81 109.048 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 1.5 mtt-85 -57.37 -47.06 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 2.69 109.315 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 100' ' ' LYS . 1.3 ttt-85 -57.23 -46.93 82.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 3.17 109.981 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' B' ' 98' ' ' LEU . 6.9 mt -56.77 -46.95 81.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.144 -0.972 . . . . 2.09 109.216 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 44.5 pt -72.56 -28.8 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 2.5 109.189 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 97' ' ' ARG . 0.1 OUTLIER -115.52 109.08 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.424 -0.797 . . . . 5.22 109.665 -179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.998 -1.001 . . . . 7.38 109.622 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.708 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.8 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.403 -0.592 . . . . 18.74 109.403 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -174.6 167.4 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 16.78 109.633 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.04 68.08 9.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 16.71 109.514 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.493 ' O ' ' ND1' ' A' ' 66' ' ' HIS . . . -110.76 -15.57 13.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.079 -1.013 . . . . 14.32 109.543 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 65' ' ' ALA . 14.9 m80 -163.05 54.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 14.47 109.411 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -133.51 158.41 43.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 11.15 109.535 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -162.89 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.846 . . . . 11.57 109.521 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.77 138.6 36.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 7.08 109.53 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 46.83 70.46 2.06 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 6.49 109.45 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.492 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 3.9 Cg_exo -60.33 90.83 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.237 1.958 . . . . 2.65 110.169 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -92.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 3.01 109.537 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -44.16 -32.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.127 -0.983 . . . . 1.48 109.508 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -63.35 -46.98 84.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 1.35 109.398 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.048 HD13 HD13 ' B' ' 76' ' ' ILE . 0.3 OUTLIER -70.57 -46.99 62.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 1.02 109.593 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.022 HD13 HD13 ' B' ' 75' ' ' LEU . 64.9 mt -56.91 -47.51 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 118.854 -1.139 . . . . 1.1 108.262 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.7 mt -57.57 -47.33 85.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.524 -0.917 . . . . 1.58 108.524 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.3 -46.98 82.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 2.09 109.528 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.891 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -57.05 -47.42 87.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.885 -1.686 . . . . 0.32 108.885 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.908 HG22 ' C ' ' B' ' 79' ' ' GLY . 88.7 t -57.48 -47.61 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.179 -1.189 . . . . 0.28 108.541 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -47.15 83.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.555 -0.716 . . . . 1.7 109.532 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -57.16 -46.76 82.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.416 -0.802 . . . . 0.37 109.98 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.23 -47.4 88.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.491 -1.843 . . . . 0.28 108.491 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' ILE . 58.1 t -57.48 -47.5 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.459 -1.024 . . . . 0.28 110.252 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -57.33 -47.53 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 1.2 110.153 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -57.38 -47.6 86.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.599 . . . . 0.33 109.101 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.6 m -57.58 -46.91 83.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.46 -1.024 . . . . 0.34 109.175 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 84' ' ' VAL . 19.3 mt -56.86 -47.07 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.497 -0.752 . . . . 0.49 109.621 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -57.15 -46.78 82.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 0.68 109.015 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.537 ' N ' ' HG ' ' A' ' 89' ' ' LEU . 28.3 mt -57.47 -47.31 82.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.007 -1.058 . . . . 1.92 109.27 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.937 HD11 HD11 ' B' ' 91' ' ' ILE . 70.1 mt -57.32 -47.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.803 . . . . 0.87 109.686 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -47.63 80.38 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.092 -1.005 . . . . 1.29 108.817 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.61 -47.66 81.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.127 -0.983 . . . . 2.64 109.391 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.63 -47.57 87.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.435 . . . . 1.29 109.511 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.32 -47.23 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -1.108 . . . . 2.19 108.956 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 99' ' ' ILE . 4.1 tpp180 -57.13 -47.19 81.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 3.14 109.565 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -57.27 -47.02 82.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 3.58 109.912 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.796 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -57.1 -46.91 82.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 2.66 108.792 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 96' ' ' ARG . 39.6 pt -72.56 -28.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 2.2 109.499 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -90.02 162.76 15.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 3.91 109.245 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.043 -0.98 . . . . 6.53 109.56 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 62' ' ' VAL . 48.2 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.461 -0.57 . . . . 20.22 109.461 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.51 124.62 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 18.1 109.503 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.73 39.84 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 17.47 109.892 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.88 29.7 5.6 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 15.58 109.637 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.562 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 29.2 p-80 -120.83 119.04 31.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.004 . . . . 14.18 109.71 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.08 -57.5 0.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 13.39 109.454 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 42.07 3.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.925 . . . . 12.43 109.527 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.42 ' O ' ' C ' ' B' ' 70' ' ' GLU . 0.3 OUTLIER 47.08 43.71 14.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 8.12 109.621 179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.567 ' N ' ' HD2' ' B' ' 71' ' ' PRO . 2.1 mm-40 -44.04 -54.82 10.52 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 7.29 109.58 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 70' ' ' GLU . 4.0 Cg_exo -61.71 64.71 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.039 1.826 . . . . 2.87 110.175 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' B' ' 70' ' ' GLU . 3.4 tp10 -67.62 -73.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.905 . . . . 2.89 109.922 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' B' ' 74' ' ' THR . 0.7 OUTLIER -43.55 -46.8 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.176 -0.952 . . . . 2.11 109.577 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.55 ' N ' ' CG2' ' B' ' 73' ' ' ILE . 44.1 p -54.68 -46.85 74.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 1.57 109.177 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.022 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -67.97 -46.77 70.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 1.63 109.457 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.048 HD13 HD13 ' A' ' 75' ' ' LEU . 59.0 mt -56.87 -47.92 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.946 -1.096 . . . . 1.02 109.579 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 74' ' ' THR . 0.4 OUTLIER -57.77 -47.33 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.91 -1.119 . . . . 1.86 108.474 178.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 74' ' ' THR . 17.8 m-30 -57.37 -46.94 82.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.555 -0.716 . . . . 2.81 109.425 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.908 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -56.9 -47.16 88.78 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.579 -1.408 . . . . 0.3 109.579 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.891 HG22 ' C ' ' A' ' 79' ' ' GLY . 44.5 t -57.19 -47.72 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 120.895 -1.356 . . . . 0.33 108.938 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -47.31 83.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.197 -0.939 . . . . 1.83 108.928 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.7 83.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.606 -0.684 . . . . 0.31 110.151 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.95 -47.34 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.359 -1.496 . . . . 0.26 109.359 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.24 -47.3 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.31 109.559 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -57.27 -47.21 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 1.06 110.364 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.21 -47.42 87.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.333 -1.507 . . . . 0.3 109.333 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 87' ' ' THR . 50.7 m -57.34 -46.97 82.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.246 -1.149 . . . . 0.32 108.904 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 10.6 mt -56.92 -46.77 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.573 -0.704 . . . . 0.41 109.792 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.72 -46.79 81.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.012 . . . . 1.14 109.006 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 0.6 OUTLIER -57.1 -47.14 81.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 2.02 108.763 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.937 HD11 HD11 ' A' ' 91' ' ' ILE . 84.9 mt -57.23 -46.84 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.77 109.583 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' B' ' 96' ' ' ARG . 0.4 OUTLIER -56.73 -47.56 79.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.152 -0.968 . . . . 1.53 109.372 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -47.62 81.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.99 -1.069 . . . . 2.25 109.009 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.41 -47.0 91.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.736 -1.746 . . . . 1.24 108.736 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' B' ' 95' ' ' ILE . 1.3 mm -56.84 -46.88 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.547 -0.972 . . . . 1.81 109.138 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 99' ' ' ILE . 0.9 OUTLIER -56.84 -47.33 80.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.025 -1.047 . . . . 2.69 109.45 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' B' ' 100' ' ' LYS . 1.4 ttp180 -57.85 -47.21 83.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.767 -1.208 . . . . 3.17 109.587 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -47.07 82.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 2.09 110.215 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 96' ' ' ARG . 0.8 OUTLIER -80.87 -13.93 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 2.5 109.808 -179.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' B' ' 101' ' ' LYS . 0.6 OUTLIER -147.49 130.67 16.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.124 -0.985 . . . . 5.22 109.505 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' B' ' 100' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.026 -0.988 . . . . 7.38 109.403 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 62' ' ' VAL . 75.9 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.273 0.558 . . . . 18.74 109.546 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.6 126.75 24.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 16.78 109.415 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.51 -55.4 2.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 16.71 109.443 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.08 86.6 4.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 14.32 109.488 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 4.3 t-160 -114.44 -71.81 0.73 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 14.47 109.536 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 1.9 m-70 169.11 131.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 11.15 109.603 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.81 38.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 11.57 109.18 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 4.9 m -145.58 -151.78 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 7.08 109.18 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 173.49 -58.0 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.07 -1.019 . . . . 6.49 110.038 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 5.1 Cg_exo -58.82 152.22 58.77 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.901 1.734 . . . . 2.65 110.227 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 73' ' ' ILE . 34.7 mt-10 -65.65 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 3.01 110.008 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 72' ' ' GLU . 0.5 OUTLIER -38.91 -38.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.456 -0.778 . . . . 1.48 110.069 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' HG22 ' A' ' 77' ' ' ILE . 27.3 m -60.9 -46.46 90.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.847 . . . . 1.35 109.476 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.063 HD23 ' N ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -75.32 -47.04 29.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.981 -1.074 . . . . 1.02 110.024 -179.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.077 HD13 HD13 ' B' ' 75' ' ' LEU . 44.2 mt -57.66 -48.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.413 -1.429 . . . . 1.1 109.265 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -58.27 -46.74 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.147 -1.057 . . . . 1.58 108.147 177.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' N ' HG23 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -56.94 -46.87 81.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.683 -0.636 . . . . 2.09 109.898 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.712 ' C ' HG22 ' B' ' 80' ' ' VAL . . . -56.89 -47.38 86.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.257 -1.537 . . . . 0.32 109.257 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.975 HG22 ' C ' ' B' ' 79' ' ' GLY . 39.3 t -57.36 -47.56 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.281 . . . . 0.28 108.557 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.64 -46.88 83.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.7 109.323 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 85' ' ' ILE . . . -56.91 -46.42 81.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.58 -0.7 . . . . 0.37 109.75 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.9 -47.29 87.79 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.801 -1.72 . . . . 0.28 108.801 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.67 HG13 ' OG1' ' B' ' 87' ' ' THR . 60.6 t -57.32 -47.34 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.143 -1.21 . . . . 0.28 109.179 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.7 mt -57.32 -47.01 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 1.2 109.883 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.94 -47.04 90.04 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.738 -1.345 . . . . 0.33 109.738 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.637 ' HA ' HD12 ' A' ' 90' ' ' LEU . 37.2 m -57.09 -47.15 81.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -1.18 . . . . 0.34 109.121 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.15 -46.99 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.341 -0.849 . . . . 0.49 109.538 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.03 -47.02 81.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.68 109.38 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.637 HD12 ' HA ' ' A' ' 87' ' ' THR . 6.2 mt -56.94 -47.05 81.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 1.92 109.337 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 95' ' ' ILE . 63.6 mt -57.03 -47.09 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.87 109.356 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.39 80.84 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.026 -1.046 . . . . 1.29 108.576 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -57.41 -47.25 82.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.24 -0.913 . . . . 2.64 109.387 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.22 -47.34 88.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.014 -1.634 . . . . 1.29 109.014 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp -57.12 -47.01 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -1.126 . . . . 2.19 108.786 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' O ' HG13 ' A' ' 99' ' ' ILE . 3.3 ttp180 -56.9 -47.07 81.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.828 . . . . 3.14 109.333 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 100' ' ' LYS . 1.4 ttm-85 -57.14 -46.59 82.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 3.58 109.698 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -56.63 -46.76 80.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 2.66 108.753 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.555 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 25.9 pt -76.84 -26.32 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 2.2 109.268 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -94.27 118.18 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 3.91 109.591 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' OXT' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.902 -1.047 . . . . 6.53 109.356 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.278 0.561 . . . . 20.22 109.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' B' ' 65' ' ' ALA . 2.8 pm0 -110.7 157.22 19.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 18.1 109.59 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.72 75.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 17.47 109.573 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' B' ' 63' ' ' GLN . . . -100.98 -19.12 15.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.11 -0.994 . . . . 15.58 109.317 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.7 177.04 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 14.18 109.297 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -154.14 167.08 31.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 13.39 109.576 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.67 59.49 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -0.958 . . . . 12.43 109.578 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.454 ' O ' ' O ' ' B' ' 70' ' ' GLU . 0.9 OUTLIER -77.02 165.04 25.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 8.12 109.316 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' B' ' 72' ' ' GLU . 13.7 mt-10 49.41 95.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 7.29 109.334 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.432 ' HB2' ' HB ' ' B' ' 74' ' ' THR . 3.0 Cg_exo -60.53 67.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.243 1.962 . . . . 2.87 110.413 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.531 ' OE1' HD11 ' B' ' 76' ' ' ILE . 0.0 OUTLIER -64.67 -72.39 0.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 2.89 109.477 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.45 ' O ' HG13 ' B' ' 77' ' ' ILE . 0.7 OUTLIER -43.12 -32.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.25 -0.906 . . . . 2.11 109.589 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' B' ' 78' ' ' PHE . 39.1 m -67.2 -47.08 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 1.57 109.067 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.077 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -72.95 -46.85 50.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 1.63 109.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.043 HG12 HD21 ' A' ' 75' ' ' LEU . 21.2 mt -56.9 -48.11 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.046 -1.061 . . . . 1.02 108.326 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 73' ' ' ILE . 20.4 mt -58.02 -47.44 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.341 -0.849 . . . . 1.86 108.863 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' B' ' 74' ' ' THR . 3.2 m-85 -57.43 -47.52 81.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.681 -0.637 . . . . 2.81 110.251 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.975 ' C ' HG22 ' A' ' 80' ' ' VAL . . . -57.35 -47.74 85.69 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.605 -1.398 . . . . 0.3 109.605 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.712 HG22 ' C ' ' A' ' 79' ' ' GLY . 86.0 t -57.74 -47.67 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.014 -1.286 . . . . 0.33 108.928 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 43.5 mtm -57.72 -47.13 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.42 -0.8 . . . . 1.83 109.664 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.41 82.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.31 110.035 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.01 -47.51 86.76 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.228 -1.549 . . . . 0.26 109.228 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.415 ' O ' HG13 ' B' ' 88' ' ' ILE . 48.5 t -57.46 -47.53 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -1.185 . . . . 0.31 109.451 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 85' ' ' ILE . 30.6 mt -57.33 -47.16 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 1.06 110.177 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.86 -47.31 87.38 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.296 . . . . 0.3 109.859 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.67 ' OG1' HG13 ' A' ' 84' ' ' VAL . 19.3 m -57.23 -47.27 81.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -1.225 . . . . 0.32 109.256 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 84' ' ' VAL . 49.4 mt -57.44 -47.23 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.809 . . . . 0.41 109.788 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.589 ' O ' HD12 ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.21 -46.99 82.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.925 . . . . 1.14 109.534 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.516 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 40.4 tp -57.0 -47.35 81.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.182 -0.949 . . . . 2.02 109.509 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 91' ' ' ILE . 46.4 mt -57.21 -47.17 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.77 109.693 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.2 -47.8 80.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.988 -1.07 . . . . 1.53 108.975 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.64 -47.54 81.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 2.25 109.585 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.32 88.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.724 -1.35 . . . . 1.24 109.724 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.537 HD12 ' O ' ' B' ' 91' ' ' ILE . 1.5 mt -57.06 -47.16 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.269 -1.136 . . . . 1.81 109.201 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.499 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 10.2 ttp180 -57.04 -47.3 81.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 2.69 109.505 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.44 ' HG3' ' OXT' ' B' ' 101' ' ' LYS . 1.1 ttp180 -57.35 -47.28 82.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.209 -0.932 . . . . 3.17 110.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.78 -47.09 80.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 2.09 109.616 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 17.9 pt -71.57 -21.59 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 2.5 109.446 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.462 ' N ' HG13 ' B' ' 99' ' ' ILE . 2.2 mttt -142.13 103.88 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 5.22 109.608 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.44 ' OXT' ' HG3' ' B' ' 97' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.986 -1.007 . . . . 7.38 109.47 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 62' ' ' VAL . 5.7 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.402 -0.592 . . . . 18.74 109.402 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -78.86 159.82 27.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 16.78 109.472 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.709 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -119.47 147.56 44.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.935 . . . . 16.71 109.376 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 64' ' ' LEU . . . 162.33 -22.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 14.32 109.463 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -117.84 136.83 53.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 14.47 109.483 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.576 ' N ' ' CD2' ' A' ' 67' ' ' HIS . 1.3 m-70 -126.61 35.73 4.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 11.15 109.31 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 69' ' ' SER . 41.7 m-85 -100.91 96.02 7.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 11.57 109.59 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 5.5 m 70.09 -165.44 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 7.08 109.628 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 72' ' ' GLU . 2.7 pt-20 -89.68 151.79 46.16 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 6.49 109.316 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.95 56.72 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.25 1.967 . . . . 2.65 110.692 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 70' ' ' GLU . 11.4 tt0 -73.04 -72.72 0.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.987 . . . . 3.01 108.866 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 tp -55.95 -26.36 20.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.173 -0.954 . . . . 1.48 108.697 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.6 m -66.26 -47.01 75.1 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.728 -0.841 . . . . 1.35 108.728 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.817 HD13 HD11 ' B' ' 76' ' ' ILE . 5.0 mt -65.71 -47.01 76.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 1.02 108.826 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.718 HD11 HD22 ' B' ' 75' ' ' LEU . 35.6 mt -56.79 -47.69 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 118.899 -1.121 . . . . 1.1 108.155 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 77' ' ' ILE . 2.5 mm -57.85 -47.62 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.58 108.857 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -57.57 -47.89 80.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.341 -0.85 . . . . 2.09 109.968 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.868 ' O ' HG22 ' B' ' 80' ' ' VAL . . . -57.5 -47.45 88.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.389 -1.484 . . . . 0.32 109.389 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.724 HG22 ' O ' ' B' ' 79' ' ' GLY . 41.8 t -57.34 -47.36 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.366 -1.079 . . . . 0.28 109.121 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.734 ' O ' HD12 ' A' ' 85' ' ' ILE . 16.9 mtp -57.44 -47.21 82.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 1.7 108.966 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.41 83.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.546 -0.721 . . . . 0.37 109.311 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.691 ' CA ' HG13 ' B' ' 80' ' ' VAL . . . -57.1 -47.14 89.86 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.325 -1.51 . . . . 0.28 109.325 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.17 -47.64 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -1.217 . . . . 0.28 109.16 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' O ' ' A' ' 81' ' ' MET . 1.9 mt -57.42 -47.15 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 1.2 109.373 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -57.12 -47.27 88.9 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.756 -1.338 . . . . 0.33 109.756 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.6 m -57.21 -47.51 81.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -1.21 . . . . 0.34 109.042 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.7 mt -57.48 -47.37 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.49 109.329 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.67 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -57.29 -47.0 82.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.456 -0.777 . . . . 0.68 109.363 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 86' ' ' GLY . 4.7 mp -57.07 -47.06 81.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.92 109.204 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.548 HD11 HD11 ' B' ' 91' ' ' ILE . 78.8 mt -57.16 -47.13 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.87 109.629 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 1.0 OUTLIER -57.1 -47.59 80.68 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.164 -1.014 . . . . 1.29 108.823 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -57.86 -48.1 80.79 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.772 -1.205 . . . . 2.64 109.493 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.05 -48.26 83.92 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.064 -1.065 . . . . 1.29 110.668 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -57.63 -46.89 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -1.224 . . . . 2.19 109.373 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.593 ' HA ' HD11 ' A' ' 99' ' ' ILE . 1.7 mtm180 -57.18 -47.31 81.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 3.14 109.592 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -47.17 82.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 3.58 110.212 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -57.17 -47.01 82.26 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.157 -0.964 . . . . 2.66 108.815 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.593 HD11 ' HA ' ' A' ' 96' ' ' ARG . 33.8 pt -72.25 -36.46 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.436 -0.79 . . . . 2.2 109.364 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.463 ' N ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -97.16 63.49 1.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 3.91 109.408 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.011 -0.995 . . . . 6.53 109.499 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.448 ' O ' HG23 ' B' ' 62' ' ' VAL . 26.0 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.461 -0.57 . . . . 20.22 109.461 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . 0.464 ' OE1' ' N ' ' B' ' 64' ' ' LEU . 4.5 tp-100 -171.75 143.26 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 18.1 109.479 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.464 ' N ' ' OE1' ' B' ' 63' ' ' GLN . 0.2 OUTLIER -113.2 -20.31 11.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 17.47 109.505 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.11 21.29 16.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 15.58 109.38 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 m170 56.28 175.09 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 14.18 109.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.552 ' C ' ' CG ' ' B' ' 68' ' ' PHE . 1.9 p80 -144.15 -49.3 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 13.39 109.47 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.552 ' CG ' ' C ' ' B' ' 67' ' ' HIS . 4.1 p90 39.41 52.22 2.24 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.745 . . . . 12.43 109.802 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 86.1 p -118.49 -157.14 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 8.12 109.691 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.528 ' CB ' ' HD2' ' B' ' 71' ' ' PRO . 1.8 mt-10 -81.43 174.4 6.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 7.29 109.448 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' B' ' 70' ' ' GLU . 1.9 Cg_endo -63.56 -5.14 8.01 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.421 2.081 . . . . 2.87 110.928 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 24.6 mm-40 -36.86 -56.35 0.86 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.488 -0.758 . . . . 2.89 109.967 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.547 HG23 ' N ' ' B' ' 74' ' ' THR . 6.1 tp -54.71 -45.89 73.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.144 -0.973 . . . . 2.11 109.21 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.547 ' N ' HG23 ' B' ' 73' ' ' ILE . 3.7 m -50.77 -46.8 59.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.365 -0.834 . . . . 1.57 109.318 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.718 HD22 HD11 ' A' ' 76' ' ' ILE . 8.3 mt -68.71 -46.63 68.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 1.63 109.515 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.817 HD11 HD13 ' A' ' 75' ' ' LEU . 79.2 mt -56.81 -48.25 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.002 -1.079 . . . . 1.02 109.264 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . 0.522 HG12 ' O ' ' B' ' 74' ' ' THR . 28.3 pt -58.21 -47.61 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.989 -1.069 . . . . 1.86 109.492 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.518 ' N ' HG13 ' B' ' 77' ' ' ILE . 2.2 m-85 -57.76 -47.3 82.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.27 -0.893 . . . . 2.81 109.496 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.724 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -57.23 -46.88 91.22 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.307 -1.517 . . . . 0.3 109.307 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 79' ' ' GLY . 33.2 t -56.93 -47.27 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.414 -1.051 . . . . 0.33 109.571 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 56.6 mmm -57.2 -47.25 81.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.03 -1.044 . . . . 1.83 108.722 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.12 -46.17 82.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.435 -0.79 . . . . 0.31 109.076 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.515 ' CA ' HG13 ' A' ' 80' ' ' VAL . . . -56.77 -46.76 89.37 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.26 109.454 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 88' ' ' ILE . 54.7 t -56.92 -47.25 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.256 . . . . 0.31 109.336 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.2 -46.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 1.06 109.419 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.531 ' HA2' HD23 ' B' ' 89' ' ' LEU . . . -57.11 -46.85 91.12 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 0.3 109.465 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 14.2 m -56.76 -47.17 80.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -1.155 . . . . 0.32 109.004 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.451 HG13 ' O ' ' B' ' 84' ' ' VAL . 51.0 mt -57.08 -46.98 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.41 109.019 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.726 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.2 OUTLIER -56.99 -46.45 82.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.403 -0.811 . . . . 1.14 109.156 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.55 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 23.3 tp -56.76 -46.9 81.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 2.02 108.961 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.548 HD11 HD11 ' A' ' 91' ' ' ILE . 94.3 mt -57.02 -47.01 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.77 108.713 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.52 ' O ' HG22 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -57.01 -47.4 80.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.241 -1.022 . . . . 1.53 108.241 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -47.44 82.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.114 -0.991 . . . . 2.25 109.214 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.43 -47.37 88.61 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.527 -1.429 . . . . 1.24 109.527 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.52 HG22 ' O ' ' B' ' 92' ' ' SER . 0.1 OUTLIER -57.04 -46.83 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -1.159 . . . . 1.81 109.11 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' B' ' 99' ' ' ILE . 7.0 mtm180 -56.91 -47.08 81.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 2.69 109.044 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.17 -46.92 82.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 3.17 109.755 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.81 -47.05 81.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 2.09 109.266 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.522 ' CG1' ' O ' ' B' ' 96' ' ' ARG . 40.3 pt -71.45 -20.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 2.5 109.177 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.84 79.68 1.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 5.22 109.279 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 tttm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.915 -1.041 . . . . 7.38 109.514 -180.0 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 11.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.491 -0.559 . . . . 18.74 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 71.52 98.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 16.78 109.35 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.527 ' HA ' HD13 ' A' ' 64' ' ' LEU . 1.8 mm? -118.77 -75.06 0.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 16.71 109.158 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.13 135.07 54.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.364 -0.835 . . . . 14.32 109.201 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -65.72 118.16 9.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 14.47 109.508 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' CD2' ' N ' ' A' ' 68' ' ' PHE . 40.6 p-80 -166.94 -150.76 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 11.15 109.564 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' N ' ' CD2' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -58.14 161.07 4.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 11.57 109.589 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 t -105.29 84.92 2.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 7.08 109.476 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.564 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -62.41 -56.65 28.45 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.933 . . . . 6.49 109.71 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 4.6 Cg_exo -60.01 76.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.867 1.711 . . . . 2.65 110.016 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 70' ' ' GLU . 13.1 mp0 -61.55 -88.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -0.946 . . . . 3.01 109.815 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -49.4 -32.57 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.019 -1.051 . . . . 1.48 108.822 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.524 ' OG1' ' CA ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -53.23 -47.07 69.29 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.955 -1.091 . . . . 1.35 108.574 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.043 HD13 HD13 ' B' ' 76' ' ' ILE . 0.2 OUTLIER -78.84 -47.16 17.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 1.02 109.423 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.083 HD13 HD13 ' B' ' 75' ' ' LEU . 54.6 mt -57.42 -48.29 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.798 -1.161 . . . . 1.1 109.309 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 78' ' ' PHE . 3.9 tt -58.17 -47.43 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.914 -1.116 . . . . 1.58 108.787 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.559 ' N ' HG23 ' A' ' 77' ' ' ILE . 1.6 m-30 -57.23 -46.79 82.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.524 -0.735 . . . . 2.09 109.557 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.836 ' CA ' HG22 ' B' ' 80' ' ' VAL . . . -56.81 -47.04 89.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.629 -1.389 . . . . 0.32 109.629 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' B' ' 79' ' ' GLY . 26.3 t -56.91 -47.59 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.979 -1.306 . . . . 0.28 108.566 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 85' ' ' ILE . 59.0 mtp -57.51 -46.92 83.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.433 -0.951 . . . . 1.7 108.433 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.88 81.69 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.748 -0.595 . . . . 0.37 109.616 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.99 85.93 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.08 -1.608 . . . . 0.28 109.08 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.98 -47.34 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.347 . . . . 0.28 108.8 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 81' ' ' MET . 64.3 mt -57.16 -46.83 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 1.2 109.528 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.67 89.42 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.33 109.536 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.574 HG21 ' CG2' ' B' ' 87' ' ' THR . 22.5 m -56.69 -46.95 80.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.225 . . . . 0.34 109.001 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' A' ' 91' ' ' ILE . 62.6 mt -57.1 -46.9 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 0.49 109.073 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.98 -46.66 82.07 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.399 -0.813 . . . . 0.68 109.012 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' HG ' ' A' ' 89' ' ' LEU . 5.3 mp -56.69 -47.0 80.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.33 -0.856 . . . . 1.92 109.302 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.684 HD11 HD11 ' B' ' 91' ' ' ILE . 68.3 mt -56.93 -47.12 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.093 -1.004 . . . . 0.87 109.261 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.7 p -57.16 -47.58 80.84 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.027 -1.069 . . . . 1.29 108.441 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.69 -47.45 82.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.17 -0.956 . . . . 2.64 109.341 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.46 -47.31 89.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.905 -1.278 . . . . 1.29 109.905 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -57.25 -47.06 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.235 . . . . 2.19 108.939 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.525 ' O ' HG13 ' A' ' 99' ' ' ILE . 9.1 mtm180 -57.06 -47.04 81.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 3.14 109.209 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.07 -46.87 82.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.248 -0.908 . . . . 3.58 109.964 -179.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -56.74 -46.74 81.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.912 -1.118 . . . . 2.66 108.722 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.574 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 19.3 pt -77.0 -14.38 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 2.2 109.522 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 97' ' ' ARG . 2.2 ttpp -105.26 137.08 43.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 3.91 109.847 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.513 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 6.53 109.343 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 62' ' ' VAL . 48.0 t . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.29 0.567 . . . . 20.22 109.473 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.17 166.24 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 18.1 109.367 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mp -113.34 11.85 18.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 17.47 109.7 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' B' ' 66' ' ' HIS . . . -80.33 -6.56 58.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 15.58 109.805 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' ALA . 87.8 m-70 -44.32 167.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 14.18 109.485 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -80.5 -76.23 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 13.39 109.55 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.05 -158.4 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -0.956 . . . . 12.43 109.467 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 4.7 p -115.52 34.86 4.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 8.12 109.388 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.971 ' O ' HG23 ' B' ' 74' ' ' THR . 14.5 mt-10 -130.53 100.6 17.91 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.853 . . . . 7.29 109.394 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' B' ' 74' ' ' THR . 4.8 Cg_exo -59.14 -27.17 84.27 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.001 1.801 . . . . 2.87 110.106 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.449 ' OE2' ' OE1' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -62.44 -60.92 2.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 2.89 109.518 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.487 HG22 ' O ' ' B' ' 70' ' ' GLU . 2.6 tp -61.04 -26.8 40.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.048 -1.033 . . . . 2.11 109.677 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.971 HG23 ' O ' ' B' ' 70' ' ' GLU . 31.7 p -68.12 -46.93 69.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 1.57 109.501 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 1.083 HD13 HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -70.23 -47.0 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.63 109.389 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 1.043 HD13 HD13 ' A' ' 75' ' ' LEU . 59.3 mt -56.98 -47.61 83.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 1.02 108.243 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.64 -47.19 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.588 -0.893 . . . . 1.86 108.588 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' B' ' 74' ' ' THR . 16.3 m-85 -57.21 -47.11 82.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.571 -0.706 . . . . 2.81 109.543 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 80' ' ' VAL . . . -56.96 -47.33 87.9 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.754 -1.739 . . . . 0.3 108.754 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.836 HG22 ' CA ' ' A' ' 79' ' ' GLY . 40.1 t -57.35 -47.5 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.191 -1.182 . . . . 0.33 108.698 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.6 -47.0 83.34 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.83 . . . . 1.83 109.193 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.716 ' HA ' HD12 ' B' ' 85' ' ' ILE . . . -56.98 -46.68 82.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.31 109.815 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.49 87.1 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.605 -1.798 . . . . 0.26 108.605 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.421 HG13 ' OG1' ' A' ' 87' ' ' THR . 43.2 t -57.53 -47.3 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -1.1 . . . . 0.31 109.203 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' B' ' 82' ' ' ALA . 38.9 mt -57.25 -47.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 1.06 109.904 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.07 -47.29 88.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.229 -1.548 . . . . 0.3 109.229 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.574 ' CG2' HG21 ' A' ' 87' ' ' THR . 73.8 m -57.34 -47.09 82.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -1.092 . . . . 0.32 109.054 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' B' ' 88' ' ' ILE . 57.4 mt -57.13 -47.1 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.481 -0.762 . . . . 0.41 109.694 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.695 HD12 ' C ' ' B' ' 89' ' ' LEU . 0.1 OUTLIER -57.0 -47.33 81.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.191 -0.943 . . . . 1.14 109.168 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . 0.546 ' N ' ' HG ' ' B' ' 89' ' ' LEU . 1.1 mm? -57.41 -47.6 81.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.02 108.871 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.684 HD11 HD11 ' A' ' 91' ' ' ILE . 67.9 mt -57.56 -47.17 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.395 -0.815 . . . . 0.77 109.286 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.502 ' O ' HG22 ' B' ' 95' ' ' ILE . 2.2 m -57.08 -47.51 80.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.361 -0.936 . . . . 1.53 108.587 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.51 -47.87 80.79 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.361 -0.935 . . . . 2.25 109.158 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.69 87.3 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.618 -1.393 . . . . 1.24 109.618 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.502 HG22 ' O ' ' B' ' 92' ' ' SER . 0.1 OUTLIER -57.47 -47.15 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -1.091 . . . . 1.81 109.24 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.544 ' O ' HG13 ' B' ' 99' ' ' ILE . 21.9 ttp180 -57.03 -47.21 81.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 2.69 109.26 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' B' ' 100' ' ' LYS . 0.0 OUTLIER -57.23 -46.69 82.73 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.066 -1.021 . . . . 3.17 109.645 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -46.86 81.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 2.09 109.616 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 96' ' ' ARG . 2.7 pt -78.84 -24.5 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 2.5 110.243 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.529 ' N ' HG13 ' B' ' 99' ' ' ILE . 0.0 OUTLIER -133.82 135.7 43.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.071 -1.018 . . . . 5.22 109.873 -179.438 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 100' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.979 -1.01 . . . . 7.38 109.477 179.775 . . . . . . . . 2 2 . 1 stop_ save_